<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002848.pub2" GROUP_ID="INFECTN" ID="888099112211075160" MERGED_FROM="" MODIFIED="2010-08-04 16:50:10 +0200" MODIFIED_BY="Anne-Marie Stephani" REVIEW_NO="KSOA" REVMAN_SUB_VERSION="5.0.24" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="8.3">
<COVER_SHEET MODIFIED="2010-08-04 15:37:54 +0100" MODIFIED_BY="[Empty name]">
<TITLE>Rotavirus vaccine for preventing diarrhoea</TITLE>
<CONTACT>
<PERSON ID="12341" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Karla</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Soares-Weiser</LAST_NAME>
<SUFFIX>MD, PhD</SUFFIX>
<POSITION>Director</POSITION>
<EMAIL_1>karla@enhance-reviews.com</EMAIL_1>
<EMAIL_2>ksoares@netvision.net.il</EMAIL_2>
<URL>www.enhance-reviews.com</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Enhance Reviews Ltd</ORGANISATION>
<ADDRESS_1>5 Percy Street, Office 4</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>W1T 1DG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 20 8123 6785</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2010-08-04 14:03:52 +0100" MODIFIED_BY="Anne-Marie Stephani">
<PERSON ID="12341" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Karla</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Soares-Weiser</LAST_NAME>
<SUFFIX>MD, PhD</SUFFIX>
<POSITION>Director</POSITION>
<EMAIL_1>karla@enhance-reviews.com</EMAIL_1>
<EMAIL_2>ksoares@netvision.net.il</EMAIL_2>
<URL>www.enhance-reviews.com</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Enhance Reviews Ltd</ORGANISATION>
<ADDRESS_1>5 Percy Street, Office 4</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>W1T 1DG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 20 8123 6785</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14298" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Elad</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Goldberg</LAST_NAME>
<SUFFIX/>
<POSITION>Resident</POSITION>
<EMAIL_1>eladgo@clalit.org.il</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Medicine E</DEPARTMENT>
<ORGANISATION>Beilinson Campus, Rabin Medical Center</ORGANISATION>
<ADDRESS_1>39 Jabotinsky Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Petah-Tiqva</CITY>
<ZIP>49100</ZIP>
<REGION/>
<COUNTRY CODE="IL">Israel</COUNTRY>
<PHONE_1>+44 972 3 9377358</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14335" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Ghandi</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Tamimi</LAST_NAME>
<SUFFIX/>
<POSITION>Clinician</POSITION>
<EMAIL_1>ghandi_tamimi@yahoo.co.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>MSF Hebron</ORGANISATION>
<ADDRESS_1>PO Box 292</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hebron</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="PS">Palestinian Territory</COUNTRY>
<PHONE_1>+972 02 222 6804</PHONE_1>
<PHONE_2/>
<FAX_1>+972 02 222 6804</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12295" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Leonard</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Leibovici</LAST_NAME>
<SUFFIX/>
<POSITION>Head</POSITION>
<EMAIL_1>leibovic@post.tau.ac.il</EMAIL_1>
<EMAIL_2>leibovici@clalit.org.il</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Medicine E</DEPARTMENT>
<ORGANISATION>Beilinson Campus, Rabin Medical Center</ORGANISATION>
<ADDRESS_1>39 Jabotinsky Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Petah-Tiqva</CITY>
<ZIP>49100</ZIP>
<REGION/>
<COUNTRY CODE="IL">Israel</COUNTRY>
<PHONE_1>+972 3 9376501</PHONE_1>
<PHONE_2>+972 3 9376506</PHONE_2>
<FAX_1>+972 3 9376505</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14326" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Femi</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Pitan</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Paediatrician &amp; Public Health Physician</POSITION>
<EMAIL_1>fpitan@yahoo.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Chevron Corporation</ORGANISATION>
<ADDRESS_1>2 Chevron Drive</ADDRESS_1>
<ADDRESS_2>Lekki</ADDRESS_2>
<CITY>Lagos</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NG">Nigeria</COUNTRY>
<PHONE_1>+234 8034209238</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-10 16:39:58 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="4" MONTH="9" YEAR="2003"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="13" MONTH="10" YEAR="2003"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2004"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2004"/>
</DATES>
<WHATS_NEW MODIFIED="2010-08-04 15:37:54 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-08-04 15:37:54 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="8" YEAR="2010"/>
<DESCRIPTION>
<P>Several of the vaccines investigated in this review are no longer in routine clinical use (for example, live attenuated rhesus-human reassortant tetravalent vaccine) and further new vaccines have been tested and approved for use since this review was written in 2004. For an up-to-date assessment of rotavirus vaccines currently approved for use, please see : Soares-Weiser K, MacLehose H, Ben-Aharon I, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. <I>Cochrane Database of Systematic Reviews</I> 2010, Issue 5. Art. No.: CD008521. DOI: 10.1002/14651858.CD008521.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-08-04 14:07:59 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-08-04 14:07:59 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="8" YEAR="2009"/>
<DESCRIPTION>
<P>Text added to abstract to highlight current actions: The authors are aware that further trials have been conducted for some of the vaccines included in this review. Authors are preparing new reviews that will update the evidence for vaccines approved for use and vaccines in development.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-08-11 11:50:33 +0100" MODIFIED_BY="Anne-Marie Stephani">
<DATE DAY="22" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format with minor editing.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Al-Ahli Hospital, Palestine Authority</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Lagos University Teaching Hospital</NAME>
<COUNTRY CODE="NG">Nigeria</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Rabin Medical Center, Beilinson Campus</NAME>
<COUNTRY CODE="IL">Israel</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Nuffield Trust</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Cochrane Child Health Field Bursary Scheme</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2010-08-04 15:38:35 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-11-09 14:00:14 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-11-09 14:00:14 +0000" MODIFIED_BY="[Empty name]">Rotavirus vaccines can prevent diarrhoea caused by rotavirus, but we are still not clear about safety and whether they prevent deaths</TITLE>
<SUMMARY_BODY>
<P>Rotavirus diarrhoea causes illness and death in young children. The benefits of the vaccine were different depending on the type of vaccine. The reviewers are unable to make conclusive recommendations regarding the use of rotavirus vaccines.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2010-08-04 15:38:35 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>Rotaviruses cause viral gastroenteritis and result in more deaths from diarrhoea in children under 5 years of age than any other single agent, particularly in low- and middle-income countries.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess rotavirus vaccines in relation to preventing rotavirus diarrhoea, death, and adverse events.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched the Cochrane Infectious Diseases Group's trial register (October 2003), the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I> Issue 3, 2003), MEDLINE (1966 to October 2003), EMBASE (January 1980 to October 2003), LILACS (1982 to October 2003), Biological Abstracts (January 1982 to October 2003), reference lists of articles, and contacted researchers and rotavirus vaccine manufacturers.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomized controlled trials comparing rotavirus vaccines to placebo, no intervention, or other rotavirus vaccines in children and adults.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two reviewers independently extracted data and assessed trial methodological quality, and contacted trial authors for additional information.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Sixty-four trials provided information on efficacy and safety of three main types of rotavirus vaccine (bovine, human, and rhesus) for 21,070 children. Different levels of efficacy were demonstrated with different vaccines varying from 22 to 89% to prevent one episode of rotavirus diarrhoea, 11 to 44% to prevent one episode of all-cause diarrhoea, and 43 to 90% to prevent one episode of severe rotavirus diarrhoea. Rhesus vaccine demonstrated a similar efficacy against one episode of rotavirus diarrhoea (37 and 44% respectively), and one episode of all-cause diarrhoea (around 15%) for trials performed in high and middle-income countries. Results on mortality and safety of the vaccines were scarce and incomplete. We noticed important heterogeneity among the pooled studies and were unable to discard a biased estimation of effect.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2010-08-04 15:38:35 +0100" MODIFIED_BY="[Empty name]">
<P>Current evidence shows that rhesus rotavirus vaccines (particularly RRV-TV) and the human rotavirus vaccine 89-12 are efficacious in preventing diarrhoea caused by rotavirus and all-cause diarrhoea. Evidence about safety, and about mortality or prevention of severe outcomes, is scarce and inconclusive. Bovine rotavirus vaccines were also efficacious, but safety data are not available. Trials of new rotavirus vaccines will hopefully improve the evidence base. Randomized controlled trials should be performed simultaneously in high-, middle-, and low-income countries.</P>
<P>
<B>2010 Editor's Note:</B> Several of the vaccines investigated in this review are no longer in routine clinical use (for example, live attenuated rhesus-human reassortant tetravalent vaccine) and further new vaccines have been tested and approved for use since this review was written in 2004. For an up-to-date assessment of rotavirus vaccines currently approved for use, please see : Soares-Weiser K, MacLehose H, Ben-Aharon I, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. <I>Cochrane Database of Systematic Reviews</I> 2010, Issue 5. Art. No.: CD008521. DOI: 10.1002/14651858.CD008521.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-09 14:55:37 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2008-11-09 14:55:37 +0000" MODIFIED_BY="[Empty name]">
<P>Rotaviruses cause viral gastroenteritis, and result in more deaths from diarrhoea than any other single agent (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>). In middle- and low-income countries, rotavirus kills an estimated 1600 to 2400 children every day (600,000 to 870,000 per year), and can cause up to 6% of all mortality in children under 5 years of age. It is estimated that rotavirus is responsible for 20 to 25% of all deaths due to diarrhoeal disease worldwide (<LINK REF="REF-Bresee-1999" TYPE="REFERENCE">Bresee 1999</LINK>; <LINK REF="REF-Glass-1999" TYPE="REFERENCE">Glass 1999</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="2">Biology</HEADING>
<P>People become infected with rotavirus by direct faecal-oral spread, and symptoms develop 1 to 4 days after exposure. Babies in the first 3 months tend to have infections without symptoms because of the protection of antibodies transferred to the baby via the placenta and breastfeeding. In older infants, the disease can be without symptoms, or with mild or severe symptoms, which are characterized by vomiting, fever, watery diarrhoea, and dehydration (<LINK REF="REF-AAP-1998" TYPE="REFERENCE">AAP 1998</LINK>). Infants and children develop immunity to rotavirus infection during the first 2 or 3 years of life, which is thought to protect from subsequent episodes of severe disease (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>).</P>
<P>Rotaviruses have two proteins that induce neutralizing antibodies. These proteins have two different specific antibody-inducing sections, called the P and G types (P is short for the VP4 protease-cleaved protein, and G for the glycoprotein VP7) (<LINK REF="REF-Matson-1990" TYPE="REFERENCE">Matson 1990</LINK>). Children that are infected for the first time usually develop specific antibodies to the infecting rotavirus type, but with subsequent infections develop a broader immunity to other types.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Control</HEADING>
<P>Efforts to prevent disease by improving sanitary conditions have not reduced exposure (<LINK REF="REF-Glass-1999" TYPE="REFERENCE">Glass 1999</LINK>; <LINK REF="REF-Peter-2002" TYPE="REFERENCE">Peter 2002</LINK>). More than 90% of children, in any region of the world, have been exposed and have measurable rotavirus antibody titres by the ages of 3 to 5 years. Hence, the high priority placed on the development of a safe and effective vaccine (<LINK REF="REF-Peter-2002" TYPE="REFERENCE">Peter 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Vaccines</HEADING>
<P>Several rotavirus vaccines have been developed (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>; <LINK REF="REF-Bresee-1999" TYPE="REFERENCE">Bresee 1999</LINK>). Early vaccine candidates were developed from an animal virus strain, but the efficacy of such vaccines was highly variable due to a predominant homotypic response of these so called monovalent vaccines. In an effort to induce a heterotypic response (tetravalent vaccines), combinations of animal or human-animal reassortant strains or attenuated human strains of rotaviruses have been included in the second generation of vaccines (<LINK REF="REF-Henchal-1996" TYPE="REFERENCE">Henchal 1996</LINK>).</P>
<P>The first vaccine tested in the early 1980s was a bovine, monovalent, live-oral rotavirus vaccine for children (NCDV - RIT 4237) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>). The first trials were conducted in Finland (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>), and the vaccine seemed effective both against mild and severe rotavirus infection (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>). After this initial success, the monovalent, live-oral bovine vaccines (RIT 4237 and WC3) were tested in low- and middle-income countries, and much lower efficacy was reported. The hypothesis generated for such lower efficacy was that in these countries the rotavirus diarrhoea was caused by a different strain, not available in the vaccine. Both bovine rotavirus vaccines were therefore withdrawn and have not been used since then (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>).</P>
<P>Monovalent rhesus (RRV) and human attenuated (M37) vaccines were tested next. These vaccines appeared to be promising, but efficacy varied greatly between different countries. This variability was suggested to occur due to serotype-specific protection produced by the monovalent vaccine. This finding was demonstrated in controlled trials conducted in Venezuela in the early 1990s (<LINK REF="REF-Perez_x002d_Schael-1990b" TYPE="REFERENCE">Perez-Schael 1990b</LINK>), and led to the development of a polyvalent reassortant vaccine protecting against the four major serotypes of rotavirus that were in common circulation worldwide.</P>
<P>To broaden the antigenic spectrum of the vaccine, rhesus-human reassortant rotaviruses were developed. These polyvalent vaccines provide serotype-specific immunity against all four predominant human rotavirus serotypes (G1, G2, G3, and G4), and were described as efficacious in reducing the rate of severe rotavirus diarrhoea by 80% - a rate similar to the protection conferred by natural infection (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>).</P>
<P>In August 1998, the rhesus rotavirus tetravalent vaccine (RRV-TV, RotaShield, Wyeth-Lederle Vaccines and Pediatrics, Philadelphia, PA) was licensed by the US Food and Drug Administration for oral administration to infants at 2, 4, and 6 months of age. This vaccine is a live-attenuated, orally administered product derived from four group A rotavirus. Three of the rotaviruses are single gene reassortants of the VP7 gene of human origin (types G1, G2, and G4), and the fourth strain is rhesus rotavirus (type G3), which is antigenically similar to human G3. No data are available to indicate whether this rotavirus vaccine protects against diarrhoea attributable to rotavirus strains not contained in the vaccine (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>).</P>
<P>Several studies in the USA, Finland, and Venezuela have found that RRV-TV is very effective in rotavirus disease (<LINK REF="STD-Perez_x002d_Schael-1997" TYPE="STUDY">Perez-Schael 1997</LINK>; <LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>; <LINK REF="REF-AAP-1998" TYPE="REFERENCE">AAP 1998</LINK>). However, other studies conducted in Peru and Brazil produced conflicting results that showed a much lower efficacy (<LINK REF="STD-Lanata-1996a" TYPE="STUDY">Lanata 1996a</LINK>; <LINK REF="STD-Linhares-1996" TYPE="STUDY">Linhares 1996</LINK>).</P>
<P>Since the introduction of RRV-TV, several cases of bowel obstruction and intussusception following administration of the vaccine have been reported, which have lead to the vaccine being withdrawn. In July 1999, the US Centers for Disease Control and Prevention advised doctors to temporarily stop giving children the vaccine against rotavirus after counting at least 20 infants who developed intussusception in the weeks after vaccination with RRV-TV (<LINK REF="REF-CDC-1999" TYPE="REFERENCE">CDC 1999</LINK>; <LINK REF="REF-CDC-1999a" TYPE="REFERENCE">CDC 1999a</LINK>; <LINK REF="REF-MMWR-1999a" TYPE="REFERENCE">MMWR 1999a</LINK>; <LINK REF="REF-MMWR-1999b" TYPE="REFERENCE">MMWR 1999b</LINK>). In October 1999, the vaccine's manufacturer decided to voluntarily withdraw the vaccine from the market because reports of intussusception possibly linked to the product have reached about 100 (<LINK REF="REF-MMWR-1999b" TYPE="REFERENCE">MMWR 1999b</LINK>).</P>
<P>RRV-TV was also thought to cause febrile reactions 3 to 4 days after vaccination due to the viral antigens. These reactions seem to be more frequent and severe in older children who lack maternally acquired antibodies. Therefore the first dose of the vaccine was recommended to be given between age 2 and 6 months in the USA.</P>
<P>Using the same strategy as RRV-TV, a quadrivalent, human-bovine, reassortant vaccine has been tested. This vaccine incorporates human VP7 with bovine genes (G1 to G3) and VP4 reassortants. Results of efficacy trials with this vaccine are due to be published (Dr Penny Heaton, Vaccine Infectious Diseases - Merck, personal communication).</P>
<P>Other vaccines have been developed (<LINK REF="REF-Bresee-1999" TYPE="REFERENCE">Bresee 1999</LINK>; <LINK REF="REF-Merck-1999" TYPE="REFERENCE">Merck 1999</LINK>; <LINK REF="REF-Jones-2001" TYPE="REFERENCE">Jones 2001</LINK>). In Japan, an inactivated parenteral vaccine (BIRVI) with strains of human origin has been tested. In China, a live oral vaccine that uses a lamb strain appeared to be safe and immunogenic in phase II trials, and efficacy trials are now being planned. Vaccine-like particles for use as an inactivated vaccine are being developed in Korea (<LINK REF="REF-Cunliffe-2002" TYPE="REFERENCE">Cunliffe 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Sources of heterogeneity</HEADING>
<P>The wide variation in protection observed in randomized controlled trials may be related to the response of the immune system to different strains of the rotavirus or of rotavirus vaccine, the study population, or the study design.</P>
<SUBSECTION>
<HEADING LEVEL="3">Rotavirus</HEADING>
<P>Cross-immunization is induced between some, but not all, human and animal strains. The differences in efficacy found in the various studies can be attributed in part to differences in serotypes of circulating strains and the failure of animal strains to elicit heterotypic protection.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Vaccines</HEADING>
<P>Different vaccine formulations may have different efficacy. Premature conclusions about effectiveness were drawn from trials of bovine rotavirus vaccine in low- and middle-income countries, and the same should not be repeated for other vaccines.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Study population</HEADING>
<P>One possible explanation for low efficacy of rotavirus vaccine in low- and middle-income countries may be the interference by other enteric viruses, which are a common cause of diarrhoea in children in such countries (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>). The epidemiology of rotavirus differs in low- and middle-income compared to high-income countries. In low- and middle-income countries, the disease occurs all the year round (compared with seasonal peaks in high-income countries), children are infected at an early age (6 to 9 months), immunization efforts require greater levels of coverage to be effective, and children are often subject to infections with strains that are not included in the current vaccines (<LINK REF="REF-Bresee-1999" TYPE="REFERENCE">Bresee 1999</LINK>).</P>
<P>As a result, it has been speculated that rotavirus vaccine could be more efficacious if given at an earlier age, not associated with other vaccines (particularly 'diphtheria-pertussis-tetanus' (DPT) and oral polio vaccine (OPV)), or breastfeeding. Additionally, it has been suggested that higher titre and multiple doses of the vaccine are more efficacious (<LINK REF="REF-Vesikari-1997" TYPE="REFERENCE">Vesikari 1997</LINK>; <LINK REF="REF-Bresee-1999" TYPE="REFERENCE">Bresee 1999</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Study design</HEADING>
<P>It is also plausible that some methodological issues, such as allocation concealment (adequate or unclear), exclusions after randomization (reported or not reported), sample size (&lt; 1000, &#8805; 1000), and length of follow up (one rotavirus season or more than one rotavirus season) could provide different levels of efficacy.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Significance of rotavirus vaccine</HEADING>
<P>Finding that a rotavirus vaccine is efficacious might encourage immunization in the countries with the highest burden (<LINK REF="REF-Tucker-1998" TYPE="REFERENCE">Tucker 1998</LINK>). This has to be weighed against the available resources (<LINK REF="REF-Griffiths-1995" TYPE="REFERENCE">Griffiths 1995</LINK>). Hence, to become a worthwhile intervention, vaccines against rotavirus will not only have to be proven to be efficacious and not related to major adverse events, but also affordable and cost-effective in comparison with other potential interventions (<LINK REF="REF-Glass-1999" TYPE="REFERENCE">Glass 1999</LINK>).</P>
<P>Efficacy levels of as low as 50 to 60% against severe rotavirus disease could prevent a large number of deaths (<LINK REF="REF-Josefson-1997" TYPE="REFERENCE">Josefson 1997</LINK>). Because rotavirus disease causes up to 6% of all mortality among children less than 5 years of age in low- and middle-income countries, universal immunization with rotavirus vaccine may prevent a significant number of deaths, and the trade off against rare severe adverse effects may well be different from the situation in high-income countries.</P>
</SUBSECTION>
</BACKGROUND>
<OBJECTIVES>
<P>To assess rotavirus vaccines in relation to preventing rotavirus diarrhoea, death, and adverse events.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-09 14:55:37 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-11-09 14:00:45 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>Randomized controlled trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Children and adults.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-10-28 12:38:02 +0000" MODIFIED_BY="[Empty name]">
<P>We included the following interventions and controls regardless of doses and/or schedules used in the different trials.</P>
<SUBSECTION>
<HEADING LEVEL="4">Intervention</HEADING>
<UL>
<LI>Live-attenuated bovine rotavirus vaccine (RIT-4237, WC3, W179-9, QHBRV).</LI>
<LI>Rhesus rotavirus vaccine (RRV, RRV-TV).</LI>
<LI>Human-attenuated rotavirus vaccine (M37, 89-12).</LI>
<LI>Other rotavirus vaccines (BIRVI, Lamb RV).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Control</HEADING>
<UL>
<LI>Placebo or no vaccination.</LI>
<LI>Any of the interventions mentioned above.</LI>
</UL>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-11-09 14:00:45 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Primary</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Rotavirus diarrhoea</HEADING>
<UL>
<LI>Episodes.</LI>
<LI>Severe episodes (defined as an episode that last for more than 24 hour of duration, with more than six stools in 24 hours, presence of vomiting, fever, and dehydration (<LINK REF="REF-WHO-1995" TYPE="REFERENCE">WHO 1995</LINK>)).</LI>
<LI>Episodes requiring hospitalization.</LI>
<LI>Episodes of more than four days duration.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">All-cause diarrhoea</HEADING>
<UL>
<LI>Episodes.</LI>
<LI>Episodes during first week after vaccine.</LI>
<LI>Severe episodes (defined as an episode that last for more than 24 hour of duration, with more than six stools in 24 hours, presence of vomiting, fever, and dehydration (<LINK REF="REF-WHO-1995" TYPE="REFERENCE">WHO 1995</LINK>)).</LI>
<LI>Episodes requiring re-hydration.</LI>
<LI>Episodes requiring hospitalization.</LI>
<LI>Death: all-cause.</LI>
<LI>Death: from rotavirus infection.</LI>
<LI>Malnutrition at follow up.</LI>
<LI>Drop outs before the end of the study.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events</HEADING>
<UL>
<LI>Bowel obstruction and/or intussusception related to the use of the rotavirus vaccine.</LI>
<LI>Serious adverse events that are fatal, life threatening, or require hospitalization.</LI>
<LI>Systemic reaction, such as fever, related to the use of the rotavirus vaccine.</LI>
<LI>Adverse events that require discontinuation of vaccination schedule.</LI>
</UL>
<P>We excluded studies collecting only immunological data.</P>
</SUBSECTION>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-11-09 14:00:50 +0000" MODIFIED_BY="[Empty name]">
<P>We attempted to identify all relevant studies regardless of language or publication status (published, unpublished, in press, and in progress).</P>
<P>We searched the Cochrane Infectious Diseases Group's trials register for relevant trials up to October 2003 using the search terms: rotavirus; diarrhoea; diarrhea; gastroenteritis; and vaccine. Full details of the Cochrane Infectious Diseases Group methods and the journals handsearched are published in <I>The Cochrane Library</I> in the section on Collaborative Review Groups.</P>
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), published in <I>The Cochrane Library</I> (Issue 3, 2003), using the search terms: rotavirus; diarrhoea; diarrhea; gastroenteritis; and vaccine. We also searched the following electronic databases using the search terms in combination with the search strategy developed by The Cochrane Collaboration (<LINK REF="REF-Clarke-2003" TYPE="REFERENCE">Clarke 2003</LINK>); MEDLINE (1966 to October 2003) using the search terms: rotavirus; rotavirus-infections; diarrhoea; diarrhea; gastroenteritis; vaccines-attenuated; and viral-vaccines; EMBASE (January 1980 to October 2003) using the search terms: rotavirus; diarrhoea; diarrhea; gastroenteritis; vaccines-attenuated; and viral-vaccines; and LILACS (www.bireme.br; 1982 to October 2003) using the search terms: rotavirus; diarrhoea; diarrhea; gastroenteritis; and vaccine. Biological Abstracts (January 1982 to October 2003) using the search terms: rotavirus vaccine; diarrhoea; and diarrhea.</P>
<P>We checked the reference lists of all trials identified by the above methods. We also contacted the first or corresponding author of each included study as well as researchers active in the field, and a rotavirus vaccine manufacturer (Merck Sharp &amp; Dohme) for information regarding unpublished trials or complementary information on their own trial.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-09 14:55:37 +0000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2008-10-28 13:18:26 +0000" MODIFIED_BY="[Empty name]">
<P>Two reviewers (Karla Soares-Weiser (KSW), Elad Goldberg (EG)) independently inspected the abstract of each reference identified by the search and determined the potential relevance of each article. For potentially relevant articles, or in cases of disagreement, we obtained the full article and independently inspected it and applied the inclusion criteria. Where we were unable to resolve the disagreement through discussion, we added the article to those 'awaiting assessment' and contacted the authors of the study for clarification. In an event of no reply from the authors within 6 months, a third reviewer (Leonard Leibovici (LL)) checked the article to solve disagreements. We also documented our justification for excluding studies from the review.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-11-09 14:01:16 +0000" MODIFIED_BY="[Empty name]">
<P>Two reviewers (KSW, EG) independently extracted data from the included trials. In case of any disagreement between the two reviewers, a third reviewer (LL) extracted the data. We discussed the data extraction, documented decisions, and where necessary, contacted the study authors for clarification.</P>
<P>We identified trials by the name of the first author and year in which the trial was first published. We extracted, checked, and recorded the following data.</P>
<P>1. Characteristics of trials.<BR/>
</P>
<UL>
<LI>Date location and setting of trial.</LI>
<LI>Publication status.</LI>
<LI>Case definitions used (clinical, serological, virological).</LI>
<LI>Sponsor of trial (specified, known or unknown).</LI>
</UL>
<P>2. Characteristics of participants.<BR/>
</P>
<UL>
<LI>Number of participants in each group.</LI>
<LI>Age, gender, nationality, ethnic group, and risk category.</LI>
<LI>Previous immunization status (if known).</LI>
<LI>Use of breast-bottle feed during the vaccination.</LI>
<LI>Presence of any immunodeficiency.</LI>
</UL>
<P>3. Characteristics of interventions.<BR/>
</P>
<UL>
<LI>Type of vaccine, type of control, dose, and immunization schedule.</LI>
</UL>
<P>4. Characteristics of outcome measures.<BR/>
</P>
<UL>
<LI>Number of people who died in the vaccine and control group.</LI>
<LI>Number of people who developed rotavirus diarrhoea.</LI>
<LI>Number of people who developed any diarrhoea.</LI>
<LI>Number of hospitalizations for diarrhoea, dehydration, or malnutrition.</LI>
<LI>Systemic adverse events, specifically bowel obstruction.</LI>
<LI>Any adverse events.</LI>
<LI>Length of follow up (in months).</LI>
<LI>Loss to follow up (drop outs) before end of study.</LI>
</UL>
<P>We individually extracted adverse event data for each adverse event wherever possible. For trials reporting adverse events for more than one dose, we recorded the average number of people reporting each adverse event for each dose was recorded.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-11-09 14:55:37 +0000" MODIFIED_BY="[Empty name]">
<P>Two reviewers (KWS, EG) assessed the included trials for methodological quality. We extracted information about the method of treatment allocation (random, quasi-random, sequential, not stated), concealment of allocation (adequate (A), unclear (B), inadequate (C) according to <LINK REF="REF-Juni-2001" TYPE="REFERENCE">Juni 2001</LINK>), blinding (double, single, or not blind), sample size (&lt; 1000, &#8805; 1000), and exclusions after randomization (reported, not reported), and the follow-up period (one rotavirus season after immunization, two or more rotavirus seasons).</P>
</QUALITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2008-11-09 14:55:37 +0000" MODIFIED_BY="[Empty name]">
<P>We analysed dichotomous data by calculating the risk ratio (RR) for each trial with the uncertainty in each result being expressed using 95% confidence intervals (CI). Additionally, we tested variability according to differences in type of vaccine (bovine, human, or rhesus).</P>
<P>Using the method of Newcombe-Wilson hybrid score (not continuity corrected (<LINK REF="REF-Newcombe-1998" TYPE="REFERENCE">Newcombe 1998</LINK>)) and the correspondent 95% CI, we estimated the number of children needed to take rotavirus vaccine to avoid one case of rotavirus diarrhoea (NNT) for trials that tested each specific vaccine.</P>
<SUBSECTION>
<HEADING LEVEL="5">Heterogeneity and publication bias</HEADING>
<P>We initially assessed heterogeneity on the results of the trials by inspecting of graphical presentations and by calculating a test of heterogeneity (chi-squared test). However, we were aware of the fact that the chi-squared test has a poor ability to detect statistically significant heterogeneity among studies. Therefore, we have also quantified the impact of heterogeneity in the meta-analysis using a measure of the degree of inconsistency in the studies' results (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). This measure (I<SUP>2</SUP>) describes the percentage of total variation across studies that are due to heterogeneity rather than the play of chance (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). The values of I<SUP>2</SUP> lies between 0 and 100%, and a simplified categorization of heterogeneity could be low, moderate, and high to I<SUP>2</SUP> values of 25, 50, and 75% (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>).</P>
<P>We anticipated between-trial variation in estimation of vaccine efficacy for trials that used different rotavirus strains and were conducted in different geographic locations. We performed subgroup analyses in order to assess the impact of these possible sources of heterogeneity. In addition, we performed sensitivity analyses for the main outcome (rotavirus diarrhoea) in order to assess the robustness of the findings to different aspects of the trials methodology: concealment of allocation (adequate or unclear); exclusions after randomization (reported or not reported); sample size (&lt; 1000, &#8805;1000); and length of follow up (one rotavirus season or more than one rotavirus season). We carried out further exploratory sensitivity analyses to test the impact of different types of vaccines, concomitant use of diphtheria-tetanus-pertussis (DPT) and/or oral polio vaccine (OPV), breastfeeding during vaccination, and number of doses of vaccine (single dose, two to three doses) in the pooled efficacy.</P>
<P>We used a fixed effect model throughout the review, except in the event of statistically significant heterogeneity between the trials (P &lt; 0.10), when we chose the random effects model. And because we demonstrated heterogeneity in most of the outcomes when we performed the analyses using odds ratio or RR either on a fixed effect or random effects model (see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> for an example), we chose to present the results using the RR with the correspondent 95% CI and a random effects model.</P>
<P>We observed moderate to high statistically heterogeneity among most of the outcomes evaluated on this review. Even when we analysed the vaccines separately, we observed heterogeneity in the combined trials for the following vaccines and outcomes: RRV-TV (episodes of rotavirus diarrhoea, episodes of severe rotavirus diarrhoea), RRV (all-cause diarrhoea), RIT-4237 (episodes of rotavirus diarrhoea, episodes of severe rotavirus diarrhoea, all-cause diarrhoea), and WC3 (episodes of rotavirus diarrhoea) vaccines.</P>
<P>We examined a funnel plot estimating the precision of trials (plots of logarithm of the RR for efficacy against the sample size) in order to estimate potential asymmetry.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Personal communication with authors and pharmaceutical industry</HEADING>
<P>We contacted the corresponding authors of the 64 included trials, of which 25 replied and 20 provided additional data. We initially sought data on study design, death, bowel obstruction and/or intussusception, and dehydration. Because of the low response rate in the first round, we attempted to contact the authors for a second time using only e-mail and requesting information only for deaths and adverse events. The results of the personal communication with the authors are summarized in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>. These data were previously published for only three of the trials (<LINK REF="STD-Joensuu-1997" TYPE="STUDY">Joensuu 1997</LINK>; <LINK REF="STD-Santosham-1997" TYPE="STUDY">Santosham 1997</LINK>; <LINK REF="STD-Bresee-2001" TYPE="STUDY">Bresee 2001</LINK>).</P>
<P>We also contacted Merck Sharp &amp; Dohme &#8722; the pharmaceutical industry organizing the field trials of the new bovine quadrivalent vaccine &#8722; for further details on their trials. Dr Penny Heaton (Vaccine Infectious Diseases, Clinical Research) replied and informed us that most of the trials will be published, and they would prefer not to release any further information until after publication (e-mail on 11 March 2002).</P>
</SUBSECTION>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-11-09 14:55:37 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2008-11-09 14:55:37 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Eligibility</HEADING>
<P>We identified 138 potentially relevant references through our search strategy, and 1 trial through contact with authors, who also provided unpublished data (<LINK REF="STD-Perez_x002d_Schael-2002" TYPE="STUDY">Perez-Schael 2002</LINK>). Of these, we included 64 trials (90 references), which are described below and in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>', and excluded 31 studies (33 references) and 16 reviews of the literature.</P>
<P>We have described the 31 excluded studies in the 'Characteristics of excluded studies'. Our main reasons for excluding these studies were because they were not randomized or had an inadequate allocation concealment (7), did not measure any clinical outcome (21), and because all participants received the vaccine and were randomized to different dietary components (3).</P>
<P>Two randomized controlled trials are still awaiting assessment because currently only an abstract without the required information has been published (<LINK REF="STD-Seth-2000" TYPE="STUDY">Seth 2000</LINK>; <LINK REF="STD-Vesikari-2002" TYPE="STUDY">Vesikari 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Participants</HEADING>
<P>All but one study tested vaccines or placebo in children, age ranging from newborns to 12 years old; <LINK REF="STD-Barnes-1997" TYPE="STUDY">Barnes 1997</LINK> is a small safety study included a group of 10 adults (21 to 30 years old). Studies included only healthy children; in a single study, we found a description that children were included if they did not have any debilitating disease (<LINK REF="STD-Perez_x002d_Schael-1990c" TYPE="STUDY">Perez-Schael 1990c</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Interventions</HEADING>
<P>Details of the six different types of vaccines assessed in the included studies can be found in <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>. Only one trial did not use placebo in the control group (<LINK REF="STD-Vesikari-1986a" TYPE="STUDY">Vesikari 1986a</LINK>). In another trial (<LINK REF="STD-Santosham-1991a" TYPE="STUDY">Santosham 1991a</LINK> and <LINK REF="STD-Santosham-1991b" TYPE="STUDY">Santosham 1991b</LINK>), children were allocated to three groups: RIT 4237 (106 children); MMU18006 (108 children); placebo (107 children); the placebo group was arbitrarily divided into two arms, and we report each arm as a separate study.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes</HEADING>
<P>Of the 64 included trials, 49 trials provided information on the safety of rotavirus vaccine in 16,602 children, and 40 trials provided information on the effectiveness of the vaccine to prevent rotavirus diarrhoea in 21,070 children. See the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> for the complete list of outcomes provided by each study; no study reported on malnourishment.</P>
<P>Rotavirus was detected in all studies using serology and stool analysis by the ELISA method. An episode of diarrhoea was defined in the majority of the studies as at least two liquid or semi-liquid stools in 24 hours. The definition of severity of diarrhoea varied according to the criteria used in the trial. Thirty-seven studies used only a clinical definition of severe diarrhoeal diseases. The other studies used either the <LINK REF="STD-Clark-1988" TYPE="STUDY">Clark 1988</LINK> scale (4 studies), <LINK REF="REF-Flores-1987" TYPE="REFERENCE">Flores 1987</LINK> scale (7 studies), <LINK REF="STD-Rennels-1996" TYPE="STUDY">Rennels 1996</LINK> scale (3 studies), <LINK REF="STD-Ruuska-1990" TYPE="STUDY">Ruuska 1990</LINK> scale (6 studies) or the World Health Organization (WHO) criteria (<LINK REF="REF-WHO-1995" TYPE="REFERENCE">WHO 1995</LINK>; 7 studies) for diarrhoea to measure the severity of diarrhoeal diseases.</P>
<P>Twenty-three trials had an unbalanced randomization with more than one experimental group, which may affect the calculation of the NNT: 10 trials tested different strains of the same vaccine in two to four experimental groups; 10 trials tested different dosages of the same vaccine; and 3 trials tested different vaccines in two experimental groups. Of these three trials two provided data only on safety of the vaccine (children were followed up for up to 10 days after vaccination) (<LINK REF="STD-Flores-1990" TYPE="STUDY">Flores 1990</LINK>; <LINK REF="STD-Perez_x002d_Schael-1994" TYPE="STUDY">Perez-Schael 1994</LINK>); we used data on the placebo and rhesus vaccines groups and discarded data on the M37 vaccine. The other trial provided data on the efficacy of two rotavirus vaccines (RIT 4237, MMU18006) against placebo (<LINK REF="STD-Santosham-1991a" TYPE="STUDY">Santosham 1991a</LINK>; <LINK REF="STD-Santosham-1991b" TYPE="STUDY">Santosham 1991b</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Study location</HEADING>
<P>We divided the trials according to the classification of high-, middle-, and low-income countries of the World Bank (<LINK REF="REF-World-Bank-2003" TYPE="REFERENCE">World Bank 2003</LINK>). Trials were conducted in high-income countries: Australia (2), Austria (1), Finland (12), Israel (1), Spain (1), Sweden (1), the United Kingdom (1), the United States of America (29); middle-income countries: Brazil (1), Peru (3), and Venezuela (9); and low-income countries: Bangladesh (1), Central African Republic (1), Gambia (1), Rwanda (1).</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-11-09 14:55:35 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Generation of allocation sequence</HEADING>
<P>Seven trials reported information about generation of allocation sequence in the published version. They used random code assignment or computer-generated randomization. The code was kept by the pharmaceutical industry or academic institutions (including World Health Organization and National Institute of Health, USA) and not broken until the end of the study. In eight trials, randomization was generated by a central computer, and pre-coded vessels were administered sequentially to the children. It was not possible to determine the method used in the remaining 49 trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Concealment of allocation</HEADING>
<P>Fifteen trials had adequate allocation concealment (information was available in the publication in seven trials and sought from authors in eight trials), and scored A. In the remained 49 trials it was not possible to determine the method used to conceal the allocation and these trials scored B (unclear).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding</HEADING>
<P>All trials used placebo in the control arm. Sixty-one trials were reported to be double blind, and three studies provided no information. Only 29 out of the 61 studies reported a procedure to guarantee double blinding. The vaccine and placebo were of identical appearance in 28 trials. In another trial (<LINK REF="STD-Vesikari-1986a" TYPE="STUDY">Vesikari 1986a</LINK>), parents and paediatricians were unaware of the code given to vaccine and placebo.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Exclusions after randomization</HEADING>
<P>Exclusion of participants from the trials after randomization varied from 0 to 23%, except in <LINK REF="STD-Hanlon-1987" TYPE="STUDY">Hanlon 1987</LINK>, where 43% of the randomized children were excluded because they were absent during the epidemic period or too young to be vaccinated.</P>
<P>From the 40 included trials that provided data on efficacy: 6 did not provide any information about drop outs before end of study; in the other trials exclusion of participants from the trials after randomization varied from 0 to 23%, except in <LINK REF="STD-Hanlon-1987" TYPE="STUDY">Hanlon 1987</LINK>, where 43% of the randomized children were excluded because they were absent during the epidemic period or were too young to be vaccinated. Nineteen trials (n = 12,493) provided data for each group (vaccine or placebo) on the number of children dropped out before the end of the study. There was no statistically significant difference in the number of people who dropped out between the vaccine and placebo arms of the rhesus rotavirus vaccine trials (RR 0.95, 95% CI 0.85 to 1.06; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Follow-up period</HEADING>
<P>The follow-up period was less than a month in 21 trials, up to one year (one season) in 20 trials, and of one to four years (two or more seasons) in 23 trials.</P>
<P>We have provided additional information about the methodological quality of the trials in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>'.</P>
</SUBSECTION>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-11-09 14:55:37 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Rotavirus diarrhoea</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Episodes</HEADING>
<P>Forty trials provided information for 21,070 children regarding diarrhoeal disease caused by rotaviruses. Rotavirus vaccine prevents rotavirus diarrhoea in all three groups of vaccines: rhesus (RR 0.59, 95% CI 0.50 to 0.70); bovine (RR 0.59, 95% CI 0.45 to 0.76); and human (RR 0.42, 95% CI 0.21 to 0.85) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<P>Converting these RR values to vaccine efficacy gives the following estimates for preventing on episode of rotavirus diarrhoea: 41% (95% CI 30 to 50%) for rhesus vaccines; 41% (95% CI 24 to 55%) for bovine vaccines; and 58% (95% CI 15 to 79%) for human vaccines.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Severe episodes</HEADING>
<P>Rotavirus vaccines also showed a highly statistically significant benefit in preventing severe episodes of rotavirus infection (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>): rhesus (RR 0.42, 95% CI 0.31 to 0.57); bovine (RR 0.38, 95% CI 0.24 to 0.60); and human (RR 0.21, 95% CI 0.13 to 0.35).</P>
<P>Converting these RR values to vaccine efficacy gives the following estimates to prevent one episode of severe rotavirus diarrhoea: 58% (95% CI 43 to 69%) for rhesus vaccines; 62% (95% CI 40 to 76%) for bovine vaccines; and 79% (95% CI 65 to 87%) for human vaccines.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Episodes requiring hospitalization </HEADING>
<P>Rotavirus vaccines also showed a highly statistically significant benefit in preventing severe rotavirus infection requiring hospitalization (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>): rhesus (RR 0.48, 95% CI 0.27 to 0.86); bovine (RR 0.37, 95% CI 0.18 to 0.74); and human (RR 0.21, 95% CI 0.09 to 0.48).</P>
<P>Converting these RR values to vaccine efficacy gives the following estimates to prevent one episode of rotavirus diarrhoea requiring hospitalization: 52% (95% CI 14 to 73%) for rhesus vaccines; 63% (95% CI 26 to 82%) for bovine vaccines; and 79% (95% CI 52 to 91%) for human vaccines.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Episodes of more than four days duration</HEADING>
<P>Only the rhesus vaccine significantly reduced the number of cases of rotavirus diarrhoea with more than four days of duration (rhesus: RR 0.61, 95% CI 0.42 to 0.87; bovine: RR 1.01, 95% CI 0.51 to 1.99; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">All-cause diarrhoea</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Episodes</HEADING>
<P>Twenty-three trials provided information about all-cause diarrhoea for 11,296 children. A further nine trials provided information on episodes of diarrhoeal disease per person-year in 3944 children. We could not combine the latter in a meta-analysis and have summarized them in <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>. Meta-analysis was also not possible for human vaccines, as only one trial provided data on this outcome.</P>
<P>We found a statistically significant beneficial effect of the rhesus vaccines (RR 0.86, 95% CI 0.80 to 0.92; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>) and bovine vaccines (RR 0.73, 95% CI 0.60 to 0.89; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>), and no statistically significant difference for human vaccines (RR 0.91, 95% CI 0.57 to 1.44; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
<P>Converting these RR values to vaccine efficacy gives the following estimates to prevent one episode of diarrhoea: 14% (95% CI 8 to 20%) for rhesus vaccines; and 27% (95% CI 11 to 40%) for bovine vaccines.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Episodes during first week after vaccine (one or multiple doses)</HEADING>
<P>The data indicated a non statistically significant difference between vaccine and placebo in the number of cases of diarrhoea in the first week after inoculation of the vaccine for both rhesus (RR 1.06, 95% CI 0.98 to 1.14) and bovine vaccines (RR 1.02, 95% CI 0.89 to 1.17), and a slightly statistically significant difference for the human vaccines (RR 1.94, 95% CI 1.03 to 3.65) (<LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>, fixed effect model).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Severe episodes</HEADING>
<P>Rotavirus vaccines showed a non-statistically significant benefit in preventing episodes of severe diarrhoeal diseases: rhesus (RR 0.85, 95% CI 0.72 to 1.00); and bovine (RR 0.51, 95% CI 0.21 to 1.26) (<LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Episodes requiring re-hydration</HEADING>
<P>Rotavirus vaccines also showed a statistically significant benefit in preventing diarrhoeal diseases requiring re-hydration: rhesus (RR 0.51, 95% CI 0.30 to 0.88); and bovine (RR 0.42, 95% CI 0.26 to 0.67) (<LINK REF="CMP-003.05" TYPE="ANALYSIS">Analysis 3.5</LINK>).</P>
<P>Converting these RR values to vaccine efficacy gives the following estimates to prevent one episode of diarrhoea requiring re-hydration: 49% (95% CI 12 to 70%) for rhesus vaccines; and 58% (95% CI 33 to 74%) for bovine vaccines.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Episodes requiring hospitalization</HEADING>
<P>Rotavirus vaccines also showed a non statistically significant benefit in preventing cases of diarrhoea requiring hospitalization: rhesus (RR 0.81, 95% CI 0.66 to 0.99); and bovine (RR 0.55, 95% CI 0.16 to 1.91) (<LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Death</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">All-cause death</HEADING>
<P>Published information about deaths was available in five studies. We received additional information for a further 18 studies after contacting the study authors. Overall, 57 cases of deaths occurred among the different trials. They occurred in trials of rhesus rotavirus vaccine (1 in a RRV-MV trial, 36 in 6 RRV-TV trials), live-attenuated bovine rotavirus vaccines (8 in a RIT-4237 trial, 11 in a WC3 trial), and human-attenuated rotavirus vaccine (1 in a 89-12 trial). Meta-analysis was possible for 4 studies of rhesus rotavirus vaccines, accounting for 10 deaths in 6029 children. An additional 47 deaths occurred during the trials, but we have no information about the specific group to which these participants were allocated, and we could not pool these data together (<I>see</I> <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> for details). The pooled data indicated a non-statistically significant difference between children randomized to receive rhesus rotavirus vaccines or placebo in the number of deaths (RR 0.72, 95% CI 0.16 to 3.12; <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Exploration of heterogeneity</HEADING>
<P>We could not explore heterogeneity with the human rotavirus vaccines because of the small number of trials testing the vaccine. However, we were able to explore heterogeneity with trials from other classes, and the results are described below.</P>
<SUBSECTION>
<HEADING LEVEL="4">Risk of bias (Methodological quality)</HEADING>
<P>Trials with adequate (A) or unclear (B) allocation concealment demonstrated a similar ratio of efficacy on preventing rotavirus diarrhoea for rhesus vaccines (A: RR 0.58, 95% CI 0.45 to 0.76; B: RR 0.57, 95% CI 0.48 to 0.67). As for bovine vaccines the comparison between adequate and unclear allocation concealment could not be undertaken because of small number of trials in at least one subgroup (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK> and <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>).</P>
<P>We also observed a similar RR in trials of rhesus vaccines that did report exclusions after randomization (RR 0.59, 95% CI 0.48 to 0.71) compared to those that did not (RR 0.58, 95% CI 0.44 to 0.76). Levels of efficacy were higher for bovine vaccine trials that reported exclusions (RR 0.50, 95% CI 0.26 to 0.96) than for trials that did not report exclusions after randomization (RR 0.61, 95% CI 0.46, 0.82) (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK> and Analysis 5.4).</P>
<P>Regarding different sample size rhesus vaccine trials presented a slightly higher ratio of efficacy for larger trials when compared to trials with smaller sample size (&lt; 1000 participants: RR 0.66, 95% CI 0.56 to 0.79; &#8805; 1000 participants: RR 0.50, 95% CI 0.39 to 0.65). Once again we could not make the comparison for bovine vaccines because only one trial had a sample size of at least 1000 participants (Analysis 5.5 and Analysis 5.6).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Multiple versus single dose</HEADING>
<P>Trials with multiple dose of rhesus rotavirus vaccine had a higher ratio of efficacy (RR 0.55, 95% CI 0.44 to 0.69) when compared to trials that used single dose of the vaccine (RR 0.64, 95% CI 0.50 to 0.82). Bovine vaccine trials in the other hand had similar ratio of efficacy for both multiple or single doses (multiple doses: RR 0.58, 95% CI 0.39 to 0.86; single dose: RR 0.57, 95% CI 0.40 to 0.83) (Analysis 6.1 and Analysis 6.2). All trials using multiple doses of vaccine were performed in the 1990s.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Administered with other vaccines</HEADING>
<P>Rhesus vaccine trials that allowed the concomitant use of DPT and/or OPV and rotavirus vaccine demonstrated a higher ratio of efficacy on preventing rotavirus diarrhoea (RR 0.57, 95% CI 0.44 to 0.73) than trials that did not allow the concomitant use of DPT and/or OPV (RR 0.71, 95% CI 0.52 to 0.97). We could not make a comparison among bovine vaccine trials because many trials did not provide this information (Analysis 7.1, Analysis 7.2, and Analysis 7.3).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Breastfeeding</HEADING>
<P>Rhesus vaccine trials that allowed breastfeeding had a smaller RR (0.52, 95% CI 0.32 to 0.86) than trials that did not allow breastfeeding at least one hour before or after vaccination (0.61, 95% CI 0.51 to 0.73). Conversely, bovine vaccine trials had a higher RR for trials that allowed breastfeeding at least one hour before or after vaccination (0.64, 95% CI 0.48 to 0.85) than the ones that did not (0.45, 95% CI 0.21 to 0.94) (<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK> and <LINK REF="CMP-008.02" TYPE="ANALYSIS">Analysis 8.2</LINK>). No information was provided about breastfeeding in four trials (<LINK REF="CMP-008.03" TYPE="ANALYSIS">Analysis 8.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Number of seasons of follow up</HEADING>
<P>Rhesus vaccine trials had a similar ratio of efficacy for trials where children where followed up for one or at least two seasons (one season: RR 0.57, 95% CI 0.42 to 0.78; two or more seasons: RR 0.60, 95% CI 0.48 to 0.74). We found a slight difference among bovine vaccine trials that followed up for one season (RR 0.52, 95% CI 0.32 to 0.83) or at least two seasons (RR 0.60, 95% CI 0.43 to 0.84) (<LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK> and <LINK REF="CMP-009.02" TYPE="ANALYSIS">Analysis 9.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Different rotavirus strains</HEADING>
<P>We analysed the following vaccines separately for rotavirus diarrhoea, severe rotavirus diarrhoea, and all-cause diarrhoea: rhesus tetravalent vaccine (RRV-TV), rhesus monovalent vaccines (RRV, RRV-D, RRV-DS1, or RRV-ST3), bovine vaccines (RIT-4237 or WC3), bovine-human vaccine (WC3-QV), and human vaccines (89-12 or M37). We observed a statistically significant beneficial effect for most vaccines, except for the bovine vaccine WC3 and the human vaccine M37 for rotavirus diarrhoea and severe episodes of rotavirus diarrhoea. The complete results are presented in <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK> and <LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>, <LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>, and <LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>.</P>
<P>The NNT for each specific vaccine is available in Appendix 5. Eleven of the 40 trials that dealt with vaccine efficacy had more than one group of vaccine combined for the meta-analysis (<LINK REF="STD-Lanata-1989" TYPE="STUDY">Lanata 1989</LINK>; <LINK REF="STD-Mutz-1989" TYPE="STUDY">Mutz 1989</LINK>; <LINK REF="STD-Vesikari-1992" TYPE="STUDY">Vesikari 1992</LINK>; <LINK REF="STD-Flores-1993" TYPE="STUDY">Flores 1993</LINK>; <LINK REF="STD-Bernstein-1995" TYPE="STUDY">Bernstein 1995</LINK>; <LINK REF="STD-Rennels-1995" TYPE="STUDY">Rennels 1995</LINK>; <LINK REF="STD-Rennels-1996" TYPE="STUDY">Rennels 1996</LINK>; <LINK REF="STD-Lanata-1996a" TYPE="STUDY">Lanata 1996a</LINK>; <LINK REF="STD-Lanata-1996b" TYPE="STUDY">Lanata 1996b</LINK>; <LINK REF="STD-Santosham-1997" TYPE="STUDY">Santosham 1997</LINK>; <LINK REF="STD-Perez_x002d_Schael-2002" TYPE="STUDY">Perez-Schael 2002</LINK>), which generated an imbalance in the number of participants and might imply possible bias on the calculation of the NNT (<LINK REF="REF-Altman-2002" TYPE="REFERENCE">Altman 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Country of origin: income status</HEADING>
<P>We also analysed rotavirus vaccines according to the income status of country of origin. Trials of rhesus and human rotavirus vaccines were performed only in high- and middle-income countries; only three small trials of bovine vaccine were performed in low-income countries. We could only do subgroup analyses for rhesus rotavirus vaccine in high- and middle-income countries. The results did not tend to be significantly different for any of the main outcomes. The complete results are presented in <LINK REF="CMP-011.01" TYPE="ANALYSIS">Analysis 11.1</LINK>, <LINK REF="CMP-011.02" TYPE="ANALYSIS">Analysis 11.2</LINK>, <LINK REF="CMP-011.03" TYPE="ANALYSIS">Analysis 11.3</LINK>, <LINK REF="CMP-011.04" TYPE="ANALYSIS">Analysis 11.4</LINK>, <LINK REF="CMP-011.05" TYPE="ANALYSIS">Analysis 11.5</LINK>, <LINK REF="CMP-011.06" TYPE="ANALYSIS">Analysis 11.6</LINK>, and <LINK REF="CMP-011.07" TYPE="ANALYSIS">Analysis 11.7</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse events</HEADING>
<P>Forty-nine trials provided information on the safety of rotavirus vaccines for 16,602 children. We have summarized the results according to the outcomes collected in the published trials and personal communication with several authors.</P>
<SUBSECTION>
<HEADING LEVEL="4">Bowel obstruction and/or intussusception</HEADING>
<P>Published information about cases of bowel obstruction and/or intussusception was available in two studies. We received additional information for a further 20 studies after contacting the study authors. Overall, four cases of intussusception were reported among trials of the rhesus rotavirus vaccine RRV-TV. Additional cases of intussusception in trials conducted with RRV-TV were described in the literature (<LINK REF="REF-Rennels-1998" TYPE="REFERENCE">Rennels 1998</LINK>; <LINK REF="REF-Murphy-2001" TYPE="REFERENCE">Murphy 2001</LINK>; <LINK REF="REF-Niu-2001" TYPE="REFERENCE">Niu 2001</LINK>; <LINK REF="REF-Zanardi-2001" TYPE="REFERENCE">Zanardi 2001</LINK>; <LINK REF="REF-Murphy-2002" TYPE="REFERENCE">Murphy 2002</LINK>), but we failed to get this information after three attempts of contacting the authors.</P>
<P>The intussusception cases occurred between 6 and 44 days after vaccination: one was reported in the vaccine and three in the placebo group. A meta-analysis was possible for three studies of rhesus rotavirus vaccines with a total of 4123 children. The pooled data indicated a non statistically significant difference in the number of intussusception between children randomized to receive rhesus rotavirus vaccines or placebo (RR 0.42, 95% CI 0.07 to 2.42; <LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Minor adverse events</HEADING>
<P>Fever occurred more frequently among those taking rhesus vaccines (RR 2.00, 95% CI 1.51 to 2.64), and there was a non statistically significant difference between vaccine and placebo for bovine vaccines (RR 0.95, 95% CI 0.73 to 1.23) and human vaccines (RR 1.75, 95% CI 0.85 to 3.64) (<LINK REF="CMP-012.02" TYPE="ANALYSIS">Analysis 12.2</LINK>).</P>
<P>There was no statistically significant difference between vaccine and placebo in the numbers of episodes of vomiting (rhesus: RR 0.96, 95% CI 0.90 to 1.03; bovine: RR 1.05, 95% CI 0.90 to 1.22; human: RR 1.94, 95% CI 1.00 to 3.75; Analysis 12.3, fixed effect model), and irritability (rhesus: RR 1.01, 95% CI 0.85 to 1.20; bovine: RR 1.08, 95% CI 0.86 to 1.36; human: RR 0.70, 95% CI 0.51 to 0.98; Analysis 12.4, fixed effect model).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Funnel plot</HEADING>
<P>Regarding the presence of possible publication bias, the funnel plot of the precision (inverse of the standard error) against the logarithm of the RR does not show an important asymmetry (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-11-09 14:55:04 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Vaccine efficacy</HEADING>
<P>Different rotavirus vaccines afforded different levels of efficacy. The pooled analysis showed an efficacy against one episode of rotavirus diarrhoea of 41% for rhesus and bovine vaccines, and of 58% for human vaccines. Efficacy against one episode of severe rotavirus diarrhoea varied from 79% for human vaccines to 58% for rhesus vaccines. Statistically significant, but lower efficacy was demonstrated against one episode of all-cause diarrhoea, varying from 14% for rhesus vaccines to 27% for bovine vaccines. Heterogeneity among studies, however, compromise the results described here and should be taken into account. The pooled analysis for each specific vaccine showed that rhesus rotavirus vaccines (RRV-TV, RRV-MV), live-attenuated bovine rotavirus vaccine (RIT-4237), and human-attenuated rotavirus vaccine (89-12) were moderate to highly efficacious against one episode of rotavirus diarrhoea (42, 40, 35, and 68% respectively); and rhesus rotavirus vaccine (RRV-TV), live-attenuated bovine rotavirus vaccine (RIT-4237), and human-attenuated rotavirus vaccine (89-12) were highly efficacious against one episode of severe rotavirus diarrhoea (60, 62, and 79% respectively).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Vaccine and mortality</HEADING>
<P>We failed to demonstrate any impact of the tested vaccines on mortality because the included trials did not provide the relevant information. However, as a result of gathering together published and unpublished information, we became aware of 57 deaths that occurred in the rotavirus vaccine trials (rhesus rotavirus vaccines: 1 on RRV-MV, 36 on RRV-TV; bovine rotavirus vaccines: 8 on RIT-4237, 11 on WC3; human rotavirus vaccine: 1 on 89-12); all but six of these deaths occurred in low- or middle-income countries. We could not combine these data because information about the allocation of children in the vaccine or placebo arms of the trial was provided only in three cases. However if one speculates that the non-reported deaths might have happened in the vaccine arm of the trials one could say that one death occurred for every 200 children vaccinated with rhesus tetravalent vaccine (RRV-TV), for every 150 children vaccinated with the bovine vaccine RIT-4237, and for every 35 children vaccinated with the bovine vaccine WC3 (roughly estimations of the number of children needed to be vaccinated to cause one death, not based on accurate information). Yet, according to the investigators the cause of deaths on these trials was not related to the vaccine (<I>see</I> Appendix 3 for more details).</P>
<P>Furthermore, in our communication with investigators of the trials performed in South America (Brazil, Peru, and Venezuela), it became clear that these trials were conducted under ideal circumstances (ie rigorous surveillance and prompt treatment of children participating in the trials) that might not reflect the reality of treating rotavirus diarrhoea in poor communities worldwide. The investigators stated that if a child developed an episode of diarrhoea they would immediately start oral re-hydration and daily visits to the house. This rigorous surveillance might have impacted on the relatively low mortality described in the trials. In addition, most of the trials reportedly tested the vaccine in low risk individuals, however, higher morbidity and mortality occurs in high-risk children, particularly the malnourished ones.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Rare adverse events</HEADING>
<P>We fail to provide any evidence about the possible link of the rhesus rotavirus vaccine RRV-TV and intussusception (<LINK REF="REF-Murphy-2001" TYPE="REFERENCE">Murphy 2001</LINK>; <LINK REF="REF-Cale-2002" TYPE="REFERENCE">Cale 2002</LINK>). In our communication with the principal investigators we also identified two cases of intussusception that occurred in a small trial conducted in China with the bovine vaccine WC3 (Dr Ho, personal communication).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Disease severity</HEADING>
<P>Insufficient or no information was provided for the outcomes measuring the severity of the episodes of all-cause diarrhoea and/or rotavirus diarrhoea (diarrhoea requiring hospitalization, re-hydration, and malnutrition at follow up). In addition, the severity of the episode of diarrhoea was measured using different scales and might not represent the same spectrum of disease severity. Furthermore, once again the rigorous surveillance of children &#8722; particularly in the South American trials &#8722; might have influenced the low frequency of severe diarrhoea measured by hospitalization and dehydration.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">High-, middle-, and low-income countries</HEADING>
<P>Rhesus rotavirus vaccines trials were performed in high- and middle-income countries (South America). Contrary to what has been described in the literature (<LINK REF="REF-Josefson-1997" TYPE="REFERENCE">Josefson 1997</LINK>; <LINK REF="REF-Bresee-1999" TYPE="REFERENCE">Bresee 1999</LINK>; <LINK REF="REF-Cunliffe-2002" TYPE="REFERENCE">Cunliffe 2002</LINK>; <LINK REF="REF-WHO_x002f_UNICEF-2002" TYPE="REFERENCE">WHO/UNICEF 2002</LINK>), when comparing the pooled results of studies performed in these two group of countries, rhesus vaccine demonstrated a similar efficacy against one episode of rotavirus diarrhoea (44% and 36%, respectively), or against one episode of diarrhoea (around 15%), and a slight difference favouring high-income countries for the efficacy of the vaccine against one episode of severe rotavirus diarrhoea (61% and 50%, respectively). As for bovine vaccines, although they were tested in high-, middle-, and low-income countries, we could only pool data for high-income countries showing a 50% of efficacy against one episode of rotavirus diarrhoea, 69% against severe rotavirus diarrhoea, and 31% against all-cause diarrhoea in such countries. We could not stratify or pool data for the three trials performed with the human rotavirus vaccines.<BR/>
<BR/>Another important issue for the future implementation of rotavirus vaccines is whether rotavirus vaccines can become part of the World Health Organization's 'Expanded Program of Immunization'. From the sensitivity analyses performed on this review the concomitant use of DPT and/or OPV did not impact on the efficacy of the rotavirus vaccines. This is particularly relevant for the implementation of rotavirus vaccines in low- and middle-income countries.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Limitations of this systematic review</HEADING>
<P>To avoid publication bias, we have searched different databases and retrieved relevant publications regardless of language, and have contacted authors and checked the references of the included trials. We also performed a funnel plot for the main outcome, which showed no relevant asymmetry. We also made an additional effort in writing every contact author of the included trials in order to obtain further information about methodological issues and results of the published trials. Nevertheless, we were able to identify the procedure used to guarantee the concealment of the allocation in only 15 out of the 64 trials included in this review. Moreover, only 29 out of the 64 trials described the procedure used to guarantee the double blinding in their trials, and only in 19 out of the 40 trials reporting data on efficacy of rotavirus vaccines was it possible to perform the meta-analysis on an intention-to-treat basis.</P>
<P>In addition, we could not fully determine the reasons for heterogeneity among studies, although we have tried to use different statistics to account for the given heterogeneity. Because of this we decided not to perform an overall meta-analysis, which could provide an 'average' statement not easy to interpret quantitatively in relation to the benefits that might accumulate from any rotavirus vaccine. The percentage of total variation across studies due to heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>) was around 70% for all group of vaccines in the main outcome (rotavirus diarrhoea) and for rhesus and bovine vaccines on severe rotavirus infection. This level of heterogeneity was maintained for the rhesus vaccine RRV-TV and the bovine vaccine RIT-4237, even when the meta-analysis pooled together only trials that tested specifically these vaccines. Possible reasons that have been suggested in the literature are the concomitant use of other vaccines, the number of doses of the vaccines, whether mothers were allowed to breastfeed children during the vaccination, and whether trials were performed in low-, middle-, or high-income countries. We performed subgroup analyses to evaluate the impact of these issues and observed that the concomitant use of rotavirus vaccine and DPT or OPV vaccines, and breastfeeding during vaccination did not appear to impact on the pooled data. Conversely, when trials were performed in high-, middle-, or low-income countries, and used a single or multiple doses of vaccine, we observed a statistically significant difference between groups.</P>
</SUBSECTION>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-11-09 14:08:41 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE>
<P>Based on the available information gathered on this review, we cannot recommend rotavirus vaccines in routine clinical practice.</P>
<P>Rhesus, bovine, and human rotavirus vaccines were moderate to highly efficacious against rotavirus diarrhoea, and showed lower, but statistically significant levels of efficacy for all-cause diarrhoea. However, results on mortality and adverse events during the follow up period of the different trials might have served to draw different conclusions about the efficacy of the vaccines. For example, we were unable to obtain detailed information about 47 of the 57 deaths occurred during follow up of different trials, and the lack of data on intussusception precludes the present use of the rhesus vaccine RRV-TV. The high level of heterogeneity observed among different vaccines in the main outcomes could also make the results prone to possible overestimation of effects. </P>
<P>In addition, the current results are mainly based on trials performed in high- and middle-income countries. Only three small trials were performed in low-income countries. It is also important to state that the trials performed in South America countries were done under rigorous surveillance and might not reflect the reality of treating diarrhoea (with or without dehydration and malnutrition) in middle- and low-income countries. Research has been performed on lamb and another human rotavirus vaccine, but efficacy trials are still not available.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-11-09 14:08:41 +0000" MODIFIED_BY="[Empty name]">
<P>Based on the current evidence, we recommend the performance of additional placebo-controlled randomized trials, particularly with the new bovine, human, lamb, and inactivated vaccines. The trials should be conducted in parallel in high-, middle-, and low-income countries, have a simple design, and involve tens of thousands of children. Trials carried out this far had enough power to elucidate efficacy, but safety remains to be clarified. Outcomes of major importance, such as severe diarrhoea, intussusception, and death, should be collected (<LINK REF="REF-Verstraeten-2001" TYPE="REFERENCE">Verstraeten 2001</LINK>). The lively debate that took place after the rhesus tetravalent rotavirus vaccine (RRV-TV) was withdrawn from the market suggests that researchers and sponsors of rotavirus vaccine trials are concerned about the costs of trials if sample size is to aim at rare adverse events (<LINK REF="REF-Jacobson-2001" TYPE="REFERENCE">Jacobson 2001</LINK>). However, uncertainty regarding safety of rotavirus vaccines could end up being harmful and costly, particularly for those in middle- and low-income countries where the vaccine is most needed. Even if use of intussusception as a primary outcome is precluded by the enormous sample size needed, data can be carefully collected for later use in systematic reviews and meta-analyses.</P>
<P>The design and outcomes of trials are often tailored to the type of the disease occurring in high-income countries, and to the outcomes of interest in these countries, but this might not be appropriate for use in low- and middle-income countries (<LINK REF="REF-WHO_x002f_UNICEF-2002" TYPE="REFERENCE">WHO/UNICEF 2002</LINK>). This approach already led to early research being abandoned on bovine vaccines that appeared to be efficacious, and every effort should be make to avoid a repetition of the same mistake.</P>
<P>The proposed trials should account for the different agenda of rotavirus vaccines in different regions of the world (<LINK REF="REF-Josefson-1997" TYPE="REFERENCE">Josefson 1997</LINK>; <LINK REF="REF-Weijer-2000" TYPE="REFERENCE">Weijer 2000</LINK>). The design should take into account that rotavirus infections are caused by different strains, have a different severity and seasonability in high, middle and low-income countries. In particular, trials should take into consideration that, although rotavirus diarrhoea accounts for a high number of hospitalization in high-income countries, death is a rare event. Conversely, in middle- and low-income countries diarrhoea accounts for approximately 13% of all deaths among children under 5 years of age and 20% of such deaths are related to rotavirus (<LINK REF="REF-Weijer-2000" TYPE="REFERENCE">Weijer 2000</LINK>; <LINK REF="REF-Perez_x002d_Schael-2001" TYPE="REFERENCE">Perez-Schael 2001</LINK>, <LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>).</P>
<P>Future trials should have a careful mechanism to promptly identify, treat, and record rare adverse events. Death should be considered a main outcome in such trials and a detailed report on mortality should be made available. Trials should be simple and aim to test the vaccine in real-life situations, especially in middle- and low-income countries.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We thank the Nuffield Trust and The Child Health Field Bursary Scheme for providing funding for this review. We also thank the Infectious Diseases Group for supporting this work and Dr Harriet MacLehose for editing this review.</P>
<P>We express our gratitude to Iain Chalmers, for his support to this review and for helping securing funds for this work while director of the UK Cochrane Centre. </P>
<P>The following authors replied to our contact and kindly supplied additional information on their own trials: Dr David Bernstein, Dr Cynthia Christy, Dr Fred Clark, Dr Penelope Dennehy, Dr Marie Claude Georges-Courbot, Dr Roger Glass, Dr Leif Gothefors, Dr Penny Heaton, Dr Mei-Shang Ho, Dr Jaana Joensuu, Dr Claudio Lanata, Dr Alexandre Linhares, Dr Bonnie Maldonado, Prof Ingomar Mutz, Dr Catherine Peckham, Dr Irene Perez-Schael, Dr Mathuram Santosham, Dr Lois Wagner, and Mr Robert Weatherholtz. Dr Roger Glass and Dr Irene Perez-Schael also made some useful comments on previous version of this systematic review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None declared.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Karla Soares-Weiser: protocol writing, searching, trial selection, data extraction and assimilation, statistical analyses, and review writing. Elad Goldberg: trial selection, data extraction and assimilation, and review writing. Ghandi Tamimi: protocol writing; location of information on rare adverse events. Femi Pitan: protocol writing. Leonard Leibovici: data extraction and assimilation (as third author to resolve disagreements), statistical analyses, and review writing.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-11-09 13:59:19 +0000" MODIFIED_BY="[Empty name]">
<P>1. Objectives: we re-worded the objectives to make them clearer.</P>
<P>2. Change in interventions. We added: W179-9 (live-attenuated bovine rotavirus vaccine); QHBRV (live-attenuated bovine rotavirus vaccine); 89-12 (human attenuated rotavirus vaccine); and other rotavirus vaccines (BIRVI, Lamb RV). We removed NCDV (live-attenuated bovine rotavirus vaccine); WC-QV (live-attenuated bovine rotavirus vaccine); and M37 (human attenuated rotavirus vaccine).</P>
<P>3. Types of outcome measures. We re-worded the following outcomes to make them clearer:</P>
<UL>
<LI>"Number of people who developed diarrhoea from rotavirus infection" becomes "Rotavirus diarrhoea: episodes".</LI>
<LI>"Number of deaths from rotavirus infection" becomes "Death: from rotavirus infection".</LI>
<LI>"Hospitalization with rotavirus infection" becomes "Rotavirus diarrhoea: episodes requiring hospitalization"</LI>
<LI>"Diarrhoea from any cause" becomes "All-cause diarrhoea: episodes".</LI>
<LI>"Diarrhoea requiring hospitalization" becomes "All-cause diarrhoea: episodes requiring hospitalization".</LI>
<LI>"Diarrhoea requiring intravenous infusion" becomes "Rotavirus diarrhoea: episodes requiring re-hydration" and "All-cause diarrhoea: episodes requiring re-hydration"</LI>
</UL>
<P>The outcome "Death from diarrhoea" is no longer used (incorporated in the other 'death' outcomes).</P>
<P>4. The following outcomes are used in the review but were not pre-specified in the protocol, because severity of rotavirus vaccine was measured in different ways and we thought that it would be useful to provide all information: rotavirus diarrhoea: severe episodes; rotavirus diarrhoea: episodes of more than four days duration; all-cause diarrhoea: episodes during first week after vaccine; and all-cause diarrhoea: severe episodes.</P>
<P>5. Elad Goldberg and Leonard Leibovici joined the review team. Prof Shai Ashkenazi left the review team.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2010-08-04 14:08:40 +0100" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-03 11:43:37 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-11-03 11:43:37 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2008-11-03 11:43:37 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-1986" NAME="Anderson 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Anderson E, Belshe R, Bartram J, Crookshanks-Newman F, Chanock R, Kapikian A. Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children. J Infect Dis 1986;153(5):823-31.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson E, Belshe R, Bartram J, Crookshanks-Newman F, Chanock R, Kapikian A</AU>
<TI>Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1986</YR>
<VL>153</VL>
<NO>5</NO>
<PG>823-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barnes-1997" NAME="Barnes 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Barnes G, Lund J, Adams L, Mora A, Mitchell S, Caples A, et al. Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate. J Paediatr Child Health 1997;33(4):300-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barnes G, Lund J, Adams L, Mora A, Mitchell S, Caples A, et al</AU>
<TI>Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate</TI>
<SO>Journal of Paediatrics and Child Health</SO>
<YR>1997</YR>
<VL>33</VL>
<NO>4</NO>
<PG>300-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barnes-2002" NAME="Barnes 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;Barnes GL, Lund JS, Mitchell SV, De Bruyn L, Piggford L, Smith AL, Furmedge J, Masendycz PJ, Bugg HC, Bogdanovic-Sakran N, Carlin JB, Bishop RF. Early phase II trial of human rotavirus vaccine candidate RV3. Vaccine 2002 20;2950-6&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barnes GL, Lund JS, Mitchell SV, De Bruyn L, Piggford L, Smith AL, et al</AU>
<TI>Early phase II trial of human rotavirus vaccine candidate RV3</TI>
<SO>Vaccine</SO>
<YR>2002</YR>
<VL>20</VL>
<NO>23-24</NO>
<PG>2950-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bernstein-1990" NAME="Bernstein 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Bernstein D, Sander D, Smith V, Schiff G, Ward R. Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis 1991;164(2):277-83.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein D, Sander D, Smith V, Schiff G, Ward R</AU>
<TI>Protection from rotavirus reinfection: 2-year prospective study</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1991</YR>
<VL>164</VL>
<NO>2</NO>
<PG>277-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Bernstein D, Smith V, Sander D, Pax K, Schiff G, Ward R. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 1990;162(5):1055-62.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein D, Smith V, Sander D, Pax K, Schiff G, Ward R</AU>
<TI>Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1990</YR>
<VL>162</VL>
<NO>5</NO>
<PG>1055-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ward R, Bernstein D</AU>
<TI>Protection against rotavirus disease after natural rotavirus infection</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1994</YR>
<VL>169</VL>
<NO>4</NO>
<PG>900-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bernstein-1995" NAME="Bernstein 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Bernstein D, Glass R, Rodgers G, Davidson B, Sack D. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA 1995;273(15):1191-6.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein D, Glass R, Rodgers G, Davidson B, Sack D</AU>
<TI>Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>15</NO>
<PG>1191-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ward R, Bernstein D</AU>
<TI>Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group</TI>
<SO>Vaccine</SO>
<YR>1995</YR>
<VL>13</VL>
<NO>13</NO>
<PG>1226-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bernstein-1998" NAME="Bernstein 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein D, Smith V, Sherwood J, Schiff G, Sander D, DeFeudis D, et al</AU>
<TI>Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12</TI>
<SO>Vaccine</SO>
<YR>1998</YR>
<VL>16</VL>
<NO>4</NO>
<PG>381-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bernstein-1999" NAME="Bernstein 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein D, Sack D, Rothstein E, Reisinger K, Smith V, O'Sullivan D, et al</AU>
<TI>Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<NO>9175</NO>
<PG>287-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein DI, Sack DA, Reisinger K, Rothstein E, Ward RL</AU>
<TI>Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>2002</YR>
<VL>186</VL>
<NO>10</NO>
<PG>1487-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bresee-2001" NAME="Bresee 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bresee JS, El Arifeen S, Azim T, Chakraborty J, Mounts AW, Podder G, et al</AU>
<TI>Safety and immunogenicity of tetravalent rhesus-based rotavirus vaccine in Bangladesh</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>2001</YR>
<VL>20</VL>
<NO>12</NO>
<PG>1136-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Christy-1988" NAME="Christy 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Christy C, Madore H, Pichichero M, Gala C, Pincus P, Vosefski D, et al. Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J 1988;7(9):645-50.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christy C, Madore H, Pichichero M, Gala C, Pincus P, Vosefski D, et al</AU>
<TI>Field trial of rhesus rotavirus vaccine in infants</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1988</YR>
<VL>7</VL>
<NO>9</NO>
<PG>645-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Christy-1993" NAME="Christy 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Christy C, Offit P, Clark H, Treanar J. Evaluation of a bovine-human rotavirus reassortant vaccine in infants [letter]. J Infect Dis 1993;168(6):1598-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christy C, Offit P, Clark H, Treanor J</AU>
<TI>Evaluation of a bovine-human rotavirus reassortant vaccine in infants</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1993</YR>
<VL>168</VL>
<NO>6</NO>
<PG>1598-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clark-1988" NAME="Clark 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Clark H, Borian F, Bell L, Modesto K, Gouvea V, Plotkin S. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988;158(3):570-87.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clark H, Borian F, Bell L, Modesto K, Gouvea V, Plotkin S</AU>
<TI>Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1988</YR>
<VL>158</VL>
<NO>3</NO>
<PG>570-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clark-1990" NAME="Clark 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Clark H, Borian F, Plotkin S. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. J Infect Dis 1990;161(6):1099-104.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clark H, Borian F, Plotkin S</AU>
<TI>Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1990</YR>
<VL>161</VL>
<NO>6</NO>
<PG>1099-104</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clark-1995" NAME="Clark 1995" YEAR="1995">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Clark H, Offit P, Ellis R, Eiden J, Krah D, Shaw A, et al</AU>
<TI>The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1996</YR>
<VL>174 Suppl 1</VL>
<PG>73-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Clark H, White C, Offit P, et a. Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine [abstract]. Ped Res 1995;37:172A.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clark H, White C, Offit P, Stinson D, Eiden J, Weaver S, et al</AU>
<TI>Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine [abstract]</TI>
<SO>Pediatric Research</SO>
<YR>1995</YR>
<VL>37</VL>
<PG>172A</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clements_x002d_Mann-1999" NAME="Clements-Mann 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clements-Mann M, Makhene M, Mrukowicz J, Wright P, Hoshino Y, Midthun K, et al</AU>
<TI>Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specifiity for serotypes 1, 2, 3 or 4 in adults, children and infants</TI>
<SO>Vaccine</SO>
<YR>1999</YR>
<VL>17</VL>
<NO>20-21</NO>
<PG>2715-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dagan-1992" NAME="Dagan 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Dagan R, Kassis I, Sarov B, Midthun K, Davidson B, Vesikari T, et al. Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates. Pediatr Infect Dis J 1992;11(12):991-6.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dagan R, Kassis I, Sarov B, Midthun K, Davidson B, Vesikari T, Sarovi I</AU>
<TI>Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates</TI>
<SO>Pediatric Infectious Diseases Journal</SO>
<YR>1992</YR>
<VL>11</VL>
<NO>12</NO>
<PG>991-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Dagan R, Kassis I, Sarov B, Midthun K, Sarov I. Safety and immunogenicity of oral rhesus rotavirus tetravalent vaccine (ORRTV) in neonates. Pediatr Res 1991;29:117.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dagan R, Kassis I, Sarov B, Midthun K, Sarov I</AU>
<TI>Safety and immunogenicity of oral rhesus rotavirus tetravalent vaccine (ORRTV) in neonates</TI>
<SO>Pediatric Research</SO>
<YR>1991</YR>
<VL>29</VL>
<PG>117</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Mol-1986" NAME="De Mol 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;De-Mol P, Zissis G, Butzler J, Mutwewingabo A, Andre F. Failure of live, attenuated oral rotavirus vaccine [letter]. Lancet 1986;2(8498):108.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Mol P, Zissis G, Butzler J, Mutwewingabo A, Andre FE</AU>
<TI>Failure of live, attenuated oral rotavirus vaccine</TI>
<SO>Lancet</SO>
<YR>1986</YR>
<VL>2</VL>
<NO>8498</NO>
<PG>108</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Dennehy-1996" NAME="Dennehy 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dennehy PH, Rodgers GC Jr, Ward RL, Markwick AJ, Zito ET</AU>
<TI>Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1996</YR>
<VL>15</VL>
<NO>11</NO>
<PG>1012-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eichelberger-2002" NAME="Eichelberger 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eichelberger M, Sperber E, Wagner M, Hoshino Y, Dudas R, Hodgins V, et al</AU>
<TI>Clinical evaluation of a single oral dose of human-bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS-1 x UK) (P1A[8],G2)</TI>
<SO>Journal of Medical Virology</SO>
<YR>2002</YR>
<VL>66</VL>
<NO>3</NO>
<PG>407-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Escobar-1988" NAME="Escobar 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Escobar-Castro H, Perdomo-Giraldi M, Tamariz-Martel M, Suarez-Cortina L. [Oral vaccination with live attenuated rotavirus]. An Esp Pediatr 1988;28(6):527-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Escobar Castro H, Perdomo Giraldi M, Tamariz-Martel Moreno A, Suarez Cortina L</AU>
<TI>Oral vaccination with live attenuated rotavirus</TI>
<TO>Vacunacion oral con rotavirus vivo atenuado</TO>
<SO>Anales Espanoles de Pediatria</SO>
<YR>1988</YR>
<VL>28</VL>
<NO>6</NO>
<PG>527-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flores-1988" NAME="Flores 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Flores J, Daoud G, Daoud N, Puig M, Martinez M, Perez-Schael I, et al. Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela. Pediatr Infect Dis J 1988;7(11):776-80.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Flores J, Daoud G, Daoud N, Puig M, Martinez M, Perez-Schael I, et al</AU>
<TI>Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1988</YR>
<VL>7</VL>
<NO>11</NO>
<PG>776-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Kapikian, AZ, Flores J, Midthun K, Hoshino Y, Green K, Gorziglia M, et al. Strategies for the development of a rotavirus vaccine against infantile diarrhea with an update on clinical trials of rotavirus vaccines. Adv Exp Med Biol 1989;257:67-89.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kapikian AZ, Flores J, Midthun K, Hoshino Y, Green KY, Gorziglia M, et al</AU>
<TI>Strategies for the development of a rotavirus vaccine against infantile diarrhea with an update on clinical trials of rotavirus vaccines</TI>
<SO>Advances in Experimental Medicine and Biology</SO>
<YR>1989</YR>
<VL>257</VL>
<PG>67-89</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flores-1989" NAME="Flores 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Flores J, Perez-Schael I, Blanco M, Vilar M, Garcia D, Perez M, et al. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. J Clin Microbiol 1989;27(3):512-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flores J, Perez-Schael I, Blanco M, Vilar M, Garcia D, Perez M, et al</AU>
<TI>Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants</TI>
<SO>Journal of Clinical Microbiology</SO>
<YR>1989</YR>
<VL>27</VL>
<NO>3</NO>
<PG>512-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flores-1990" NAME="Flores 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flores J, Perez-Schael I, Blanco M, White L, Garcia D, Vilar M, et al</AU>
<TI>Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine</TI>
<SO>Lancet</SO>
<YR>1990</YR>
<VL>336</VL>
<NO>8711</NO>
<PG>330-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flores-1993" NAME="Flores 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Flores J, Perez-Schael I, Blanco M, Rojas A, Alfonzo E, Crespo I, et al. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine. J Clin Microbiol 1993;31(9):2439-45.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flores J, Perez-Schael I, Blanco M, Rojas AM, Alfonzo E, Crespo I, et al</AU>
<TI>Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine</TI>
<SO>Journal of Clinical Microbiology</SO>
<YR>1993</YR>
<VL>31</VL>
<NO>9</NO>
<PG>2439-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Georges_x002d_Courbot-1991" NAME="Georges-Courbot 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Georges-Courbot M, Monges J, Siopathis M, Roungou J, Gresenguet G, Bellec L, et al. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 1991;142(5):405-11.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Georges-Courbot MC, Monges J, Siopathis MR, Roungou JB, Gresenguet G, Bellec L, et al</AU>
<TI>Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa</TI>
<SO>Research in Virology</SO>
<YR>1991</YR>
<VL>142</VL>
<NO>5</NO>
<PG>405-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Gothefors-1989" NAME="Gothefors 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Gothefors L, Wadell G, Juto P, Taniguchi K, Kapikian A, Glass R. Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J Infect Dis 1989;159(4):753-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gothefors L, Wadell G, Juto P, Taniguchi K, Kapikian A, Glass RI</AU>
<TI>Prolonged efficacy of rhesus rotavirus vaccine in Swedish children</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1989</YR>
<VL>159</VL>
<NO>4</NO>
<PG>753-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hanlon-1987" NAME="Hanlon 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanlon P, Hanlon L, Marsh V, Byass P, Shenton F, Hassan-King M, et al</AU>
<TI>Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants</TI>
<SO>Lancet</SO>
<YR>1987</YR>
<VL>1</VL>
<NO>8546</NO>
<PG>1342-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ho-1989" NAME="Ho 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Ho M, Floyd R, Glass R, Pallansch M, Jones B, Hamby B, et al. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity. Pediatr Infect Dis J 1989;8(10):692-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ho MS, Floyd RL, Glass RI, Pallansch MA, Jones B, Hamby B, et al</AU>
<TI>Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity</TI>
<SO>Pediatric Infectios Disease Journal</SO>
<YR>1989</YR>
<VL>8</VL>
<NO>10</NO>
<PG>692-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ing-1991" NAME="Ing 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Ing D, Glass R, Woods P, Simonetti M, Pallansch M, Wilcox W, et al. Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine. Am J Dis Child 1991;145(8):892-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ing DJ, Glass RI, Woods PA, Simonetti M, Pallansch MA, Wilcox WD, et al</AU>
<TI>Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1991</YR>
<VL>145</VL>
<NO>8</NO>
<PG>892-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joensuu-1997" NAME="Joensuu 1997" YEAR="1997">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Joensuu J, Koskenniemi E, Pang X, Vesikari T</AU>
<TI>Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis</TI>
<SO>Lancet</SO>
<YR>1997</YR>
<VL>350</VL>
<NO>9086</NO>
<PG>1205-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Joensuu J, Koskenniemi E, Vesikari T. Prolonged efficacy of rhesus-human reassortant rotavirus vaccine. Pediatr Infect Dis J 1998;17(5):427-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joensuu J, Koskenniemi E, Vesikari T</AU>
<TI>Prolonged efficacy of rhesus-human reassortant rotavirus vaccine</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>5</NO>
<PG>427-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Joensuu J, Koskenniemi E, Vesikari T. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. Pediatr Infect Dis J 1998;17(4):334-40.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joensuu J, Koskenniemi E, Vesikari T</AU>
<TI>Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>4</NO>
<PG>334-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Takala A, Koskenniemi E, Joensuu J, Makela M, Vesikari T. Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine. Clin Infect Dis 1998;27(2):272-82.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takala A, Koskenniemi E, Joensuu J, Makela M, Vesikari T</AU>
<TI>Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>2</NO>
<PG>272-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T</AU>
<TI>New vaccine is effective against rotavirus-induced diarrhea</TI>
<SO>American Family Physician</SO>
<YR>1997</YR>
<VL>55</VL>
<NO>4</NO>
<PG>1337</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lanata-1989" NAME="Lanata 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Lanata C, Black R, del-Aguila R, Gil A, Verastegui H, Gerna G, et al. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis 1989;159(3):452-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanata C, Black R, del-Aguila R, Gil A, Verastegui H, Gerna G, et al</AU>
<TI>Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1989</YR>
<VL>159</VL>
<NO>3</NO>
<PG>452-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lanata-1996a" NAME="Lanata 1996a" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Lanata C, Black R, Flores J, Lazo F, Butron B, Linares A, et al. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru. Vaccine 1996;14(3):237-43.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanata C, Black R, Flores J, Lazo F, Butron B, Linhares A, et al</AU>
<TI>Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru</TI>
<SO>Vaccine</SO>
<YR>1996</YR>
<VL>14</VL>
<NO>3</NO>
<PG>237-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lanata-1996b" NAME="Lanata 1996b" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Lanata C, Midthun K, Black R, Butron B, Huapaya A, Penny M, et al. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis 1996;174(2):268-75.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanata CF, Black RE, Flores J, Lazo F, Butron B, Linares A, et al</AU>
<TI>Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1996</YR>
<VL>174</VL>
<NO>2</NO>
<PG>268-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Linhares-1996" NAME="Linhares 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Linhares A, Gabbay Y, Mascarenhas J, de-Freitas R, Oliveira C, Bellesi N, et al. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull World Health Organ 1996;74(5):491-500.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Linhares AC, Gabbay YB, Mascarenhas JD, de Freitas RB, Oliveira CS, Bellesi N, et al</AU>
<TI>Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>1996</YR>
<VL>74</VL>
<NO>5</NO>
<PG>491-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linhares AC, Lanata CF, Hausdorff WP, Gabbay Y, Black RE</AU>
<TI>Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1999</YR>
<VL>18</VL>
<NO>11</NO>
<PG>1001-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Madore-1992" NAME="Madore 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Madore H, Christy C, Pichichero M, Long C, Pincus P, Vosefsky D, et al. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups. J Infect Dis 1992;166(2):235-43.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Madore H, Christy C, Pichichero M, Long C, Pincus P, Vosefsky D, et al</AU>
<TI>Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1992</YR>
<VL>166</VL>
<NO>2</NO>
<PG>235-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Maldonado-1986" NAME="Maldonado 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Maldonado Y, Hestvik L, Wilson M, Townsend T, O'Hare J, Wee S, et al. Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants. J Pediatr 1986;109(6):931-5.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maldonado Y, Hestvik L, Wilson M, Townsend T, O'Hare J, Wee S, et al</AU>
<TI>Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants</TI>
<SO>Journal of Pediatrics</SO>
<YR>1986</YR>
<VL>109</VL>
<NO>6</NO>
<PG>931-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Mutz-1989" NAME="Mutz 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Mutz I, Krainer F, Deutsch J, Kunz C, Teuwen D. A trial of RIT-4237 rotavirus vaccine in 1-month-old infants. Eur J Pediatr 1989;148(7):634-5.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mutz I, Krainer F, Deutsch J, Kunz C, Teuwen D</AU>
<TI>A trial of RIT-4237 rotavirus vaccine in 1-month-old infants</TI>
<SO>European Journal of Pediatrics</SO>
<YR>1989</YR>
<VL>148</VL>
<NO>7</NO>
<PG>634-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Perez_x002d_Schael-1990a" MODIFIED="2008-11-03 11:43:37 +0000" MODIFIED_BY="[Empty name]" NAME="Perez-Schael 1990a" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Flores J, Perez-Schael I, Gonzalez M, Garcia D, Perez M, Daoud N, et al</AU>
<TI>Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants</TI>
<SO>Lancet</SO>
<YR>1987</YR>
<VL>1</VL>
<NO>8538</NO>
<PG>882-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Perez-Schael I, Garcia D, Gonzalez M, Gonzalez R, Daoud N, Perez M, et al. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol 1990;30(3):219-29.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Schael I, Garcia D, Gonzalez M, Gonzalez R, Daoud N, Perez M, et al</AU>
<TI>Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine</TI>
<SO>Journal of Medical Virology</SO>
<YR>1990</YR>
<VL>30</VL>
<NO>3</NO>
<PG>219-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-03 11:43:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Schael I, Garcia D, White L, Blanco M, Gonzalez R, Urbina G, et al</AU>
<TI>Field tests for anti-rotavirus vaccine carried out in Venezuela</TI>
<TO>Pruebas de campo de una vacuna anti-rotavirus realizadas en Venezuela (1985-1989)</TO>
<SO>Archivos Venezolanos de Puericultura y Pediatria</SO>
<YR>1990</YR>
<VL>53 Suppl</VL>
<NO>2</NO>
<PG>29-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Perez-Schael I, Gonzalez M, Daoud N, Perez M, Soto I, Garcia D, et al. Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children. J Infect Dis 1987;155(2):334-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Schael I, Gonzalez M, Daoud N, Perez M, Soto I, Garcia D, et al</AU>
<TI>Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1987</YR>
<VL>155</VL>
<NO>2</NO>
<PG>334-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perez_x002d_Schael-1990c" NAME="Perez-Schael 1990c" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Perez-Schael I, Blanco M, Vilar M, Garcia D, White L, Gonzalez R, et al. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol 1990;28(3):553-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Schael I, Blanco M, Vilar M, Garcia D, White L, Gonzalez R, et al</AU>
<TI>Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants</TI>
<SO>Journal of Clinical Microbiology</SO>
<YR>1990</YR>
<VL>28</VL>
<NO>3</NO>
<PG>553-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Perez_x002d_Schael-1994" NAME="Perez-Schael 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Perez-Schael I, Blanco M, Garcia D, White L, Alfonzo E, Crespo I, et al. Evaluation of the antigenicity and reactogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates. J Med Virol 1994;42:330-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Schael I, Blanco M, Garcia D, White L, Alfonzo E, Crespo I, et al</AU>
<TI>Evaluation of the antigenicity and reactogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates</TI>
<SO>Journal of Medical Virology</SO>
<YR>1994</YR>
<VL>42</VL>
<NO>4</NO>
<PG>330-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Perez_x002d_Schael-1997" NAME="Perez-Schael 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Perez-Schael I, Guntinas MJ, Perez M, Pagone V, Rojas AM, Gonzalez R, Cunto W, Hoshino Y, Kapikian AZ. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. New England Journal of Medicine 1997; 337(17): 1181-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Schael I, Guntinas MJ, Perez M, Pagone V, Rojas AM, Gonzalez R, et al</AU>
<TI>Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela</TI>
<SO>New England Journal of Medicine</SO>
<YR>1997</YR>
<VL>337</VL>
<NO>17</NO>
<PG>1181-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Perez_x002d_Schael-2002" NAME="Perez-Schael 2002" YEAR="2002">
<REFERENCE PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Perez-Schael I, Salinas B, Linhares A, Guerrero M, Ruiz-Palacios G, Clemens S, Jacquet J, De Vos B</AU>
<TI>Protective Efficacy Of An Oral Human Rotavirus (HRV) Vaccine In Latin American Infants</TI>
<SO>42nd Annual ICAAC</SO>
<YR>2002</YR>
<PG>18, LB-23</PG>
<CY>San Diego, California</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pichichero-1990" NAME="Pichichero 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Pichichero M, Losonsky G, Rennels M, Disney F, Green J, Francis A, et al. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group. Pediatr Infect Dis J 1990;9(5):339-44.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pichichero ME, Losonsky GA, Rennels MB, Disney FA, Green JL, Francis AB, et al</AU>
<TI>Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1990</YR>
<VL>9</VL>
<NO>5</NO>
<PG>339-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pichichero-1993" NAME="Pichichero 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Pichichero M, Losonsky G. Asymptomatic infections due to wild-type rotavirus may prime for a heterotypic response to vaccination with rhesus rotavirus. Clin Infect Dis 1993;16(1):86-92.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pichichero ME, Losonsky GA</AU>
<TI>Asymptomatic infections due to wild-type rotavirus may prime for a heterotypic response to vaccination with rhesus rotavirus</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>1993</YR>
<VL>16</VL>
<NO>1</NO>
<PG>86-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Pichichero M, Marsocci S, Francis A, Green J, Disney F, Rennels M, et al. A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants. Vaccine 1993;11(7):747-53.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pichichero ME, Marsocci SM, Francis AB, Green JL, Disney FA, Rennels MB, et al</AU>
<TI>A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants</TI>
<SO>Vaccine</SO>
<YR>1993</YR>
<VL>11</VL>
<NO>7</NO>
<PG>747-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rennels-1987" NAME="Rennels 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Losonsky G, Rennels M, Kapikian A, Midthun K, Ferra P, Fortier D, et al. Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants. Pediatr Infect Dis 1986;5(1):25-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Losonsky GA, Rennels MB, Kapikian AZ, Midthun K, Ferra PJ, Fortier DN, et al</AU>
<TI>Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants</TI>
<SO>Pediatric Infectious Disease</SO>
<YR>1986</YR>
<VL>5</VL>
<NO>1</NO>
<PG>25-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Rennels M, Losonsky G, Levine M, Kapikian A. Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children. Pediatr Infect Dis 1986;5(5):587-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rennels MB, Losonsky GA, Levine MM, Kapikian AZ</AU>
<TI>Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children</TI>
<SO>Pediatric Infectious Disease</SO>
<YR>1986</YR>
<VL>5</VL>
<NO>5</NO>
<PG>587-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Rennels M, Losonsky G, Shindledecker C, Hughes T, Kapikian A, Levine M. Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children. Pediatr Infect Dis J 1987;6(3):260-4.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rennels MB, Losonsky GA, Shindledecker CL, Hughes TP, Kapikian AZ, Levine MM</AU>
<TI>Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>3</NO>
<PG>260-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rennels-1990" NAME="Rennels 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Rennels M, Losonsky G, Young A, Shindledecker C, Kapikian A, Levine M. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group. Am J Dis Child 1990;144(5):601-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rennels MB, Losonsky GA, Young AE, Shindledecker CL, Kapikian AZ, Levine MM</AU>
<TI>An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1990</YR>
<VL>144</VL>
<NO>5</NO>
<PG>601-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rennels-1995" NAME="Rennels 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Rennels M, Wasserman S, Glass R, Keane V. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group. Pediatrics 1995;96(6):1132-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rennels MB, Wasserman SS, Glass RI, Keane VA</AU>
<TI>Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group</TI>
<SO>Pediatrics</SO>
<YR>1995</YR>
<VL>96</VL>
<NO>6</NO>
<PG>1132-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rennels-1996" NAME="Rennels 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Dennehy P, Rodgers G, Jr, Ward R, Markwick A, Mack M, Zito E. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group. Pediatr Infect Dis J 1996;15(11):1012-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dennehy PH, Rodgers GC Jr, Ward RL, Markwick AJ, Mack M, Zito ET</AU>
<TI>Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1996</YR>
<VL>15</VL>
<NO>11</NO>
<PG>1012-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Griffiths R, Anderson G, Powe N, Oliveras E, Herbert R, Grant C, et al. Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial. Arch Pediatr Adolesc Med 1995;149(4):407-14.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Griffiths RI, Anderson GF, Powe NR, Oliveras E, Herbert RJ, Grant CC, et al</AU>
<TI>Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial</TI>
<SO>Archives of Pediatrics &amp; Adolescent Medicine</SO>
<YR>1995</YR>
<VL>149</VL>
<NO>4</NO>
<PG>407-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Rennels M, Glass R, Dennehy P, Bernstein D, Pichichero M, Zito E, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics 1996;97(1):7-13.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, et al</AU>
<TI>Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group</TI>
<SO>Pediatrics</SO>
<YR>1996</YR>
<VL>97</VL>
<NO>1</NO>
<PG>7-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Rennels M, Ward R, Mack M, Zito E. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group [published erratum appears in J Infect Dis 1996 Jun;173(6):1529]. J Infect Dis 1996;173(2):306-13.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rennels MB, Ward RL, Mack ME, Zito ET</AU>
<TI>Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1996</YR>
<VL>173</VL>
<NO>2</NO>
<PG>306-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ruuska-1990" NAME="Ruuska 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Ruuska T, Vesikari T, Delem A, Andre F, Beards G, Flewett T. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period. Scand J Infect Dis 1990;22(3):269-78.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ruuska T, Vesikari T, Delem A, Andre F, Beards G, Flewett T</AU>
<TI>Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period</TI>
<SO>Scandinavian Journal of Infectious Diseases</SO>
<YR>1990</YR>
<VL>22</VL>
<NO>3</NO>
<PG>269-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Ruuska T, Delem A, Andre F. Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report. Pediatr Infect Dis J 1987;6(2):164-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Ruuska T, Delem A, Andre F</AU>
<TI>Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>2</NO>
<PG>164-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Santosham-1991a" NAME="Santosham 1991a" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Santosham M, Letson G, Wolff M, Reid R, Gahagan S, Adams R, et al. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 1991;163(3):483-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santosham M, Letson GW, Wolff M, Reid R, Gahagan S, Adams R, et al</AU>
<TI>A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1991</YR>
<VL>163</VL>
<NO>3</NO>
<PG>483-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Santosham-1991b" NAME="Santosham 1991b" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Santosham M, Letson G, Wolff M, Reid R, Gahagan S, Adams R, et al. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 1991;163(3):483-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santosham M, Letson GW, Wolff M, Reid R, Gahagan S, Adams R, et al</AU>
<TI>A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1991</YR>
<VL>163</VL>
<NO>3</NO>
<PG>483-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Santosham-1997" NAME="Santosham 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Santosham M, Moulton L, Reid R, Croll J, Weatherholt R, Ward R, et al. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations [see comments]. J Pediatr 1997;131(4):632-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santosham M, Moulton LH, Reid R, Croll J, Weatherholt R, Ward R, et al</AU>
<TI>Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations</TI>
<SO>Journal of Pediatrics</SO>
<YR>1997</YR>
<VL>131</VL>
<NO>4</NO>
<PG>632-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Senturia-1987" NAME="Senturia 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Senturia Y, Peckham C, Cordery M, Chrystie I, Banatvala J, Andre F. Live attenuated oral rotavirus vaccine [letter]. Lancet 1987;2(8567):1091-2.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Senturia YD, Peckham CS, Cordery M, Chrystie IA, Banatvala JE, Andre FE</AU>
<TI>Live attenuated oral rotavirus vaccine</TI>
<SO>Lancet</SO>
<YR>1987</YR>
<VL>2</VL>
<NO>8567</NO>
<PG>1091-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Treanor-1995" NAME="Treanor 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clark HF, Offit PA, Ellis RW, Eiden JJ, Krah D, Shaw AR, et al</AU>
<TI>The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1996</YR>
<VL>174 Suppl 1</VL>
<PG>73-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Treanor J, C, HF, Pichichero M, Christy C, Gouvea V, Shrager D, et al. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatr Infect Dis J 1995;14(4):301-7.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Treanor JJ, Clark HF, Pichichero M, Christy C, Gouvea V, Shrager D, et al</AU>
<TI>Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1995</YR>
<VL>14</VL>
<NO>4</NO>
<PG>301-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1984" NAME="Vesikari 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Isolauri E, D'Hondt E, Delem A, Andre F, Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1984;1(8384):977-81.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Isolauri E, D'Hondt E, Delem A, Andre FE, Zissis G</AU>
<TI>Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine</TI>
<SO>Lancet</SO>
<YR>1984</YR>
<VL>1</VL>
<NO>8384</NO>
<PG>977-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Isolauri E, D'Hondt E, Delem A, Andre F. Increased &amp;quot;take&amp;quot; rate of oral rotavirus vaccine in infants after milk feeding [letter]. Lancet 1984;2(8404):700.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Isolauri E, D'Hondt E, Delem A, Andre FE</AU>
<TI>Increased "take" rate of oral rotavirus vaccine in infants after milk feeding</TI>
<SO>Lancet</SO>
<YR>1984</YR>
<VL>2</VL>
<NO>8404</NO>
<PG>700</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1985a" NAME="Vesikari 1985a" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Isolauri E, Delem A, d'Hondt E, Andre F, Beards G, et al. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 1985;107(2):189-94.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Isolauri E, Delem A, d'Hondt E, Andre FE, Beards GM, et al</AU>
<TI>Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic</TI>
<SO>Journal of Pediatrics</SO>
<YR>1985</YR>
<VL>107</VL>
<NO>2</NO>
<PG>189-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Isoulari E, Andre F. Protection of children for two years against rotavirus diarrhea by RIT 4237 (NCDV) rotavirus vaccine. In: Holmgren J LA, Mollby R, editor. Development of vaccines and drugs against diarrhea. 11th Nobel Conference, Stockolm 1985. Lund, Sweden: Studentlitteratur; 1986. p. 189-94.&lt;/p&gt;" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Vesikari T, Isoulari E, Andre F</AU>
<TI>Protection of children for two years against rotavirus diarrhea by RIT 4237 (NCDV) rotavirus vaccine</TI>
<SO>Development of vaccines and drugs against diarrhea. 11th Nobel Conference, Stockolm 1985</SO>
<YR>1986</YR>
<PG>189-94</PG>
<ED>Holmgren J, Linderg A, Mollby R</ED>
<PB>Studentlitteratur</PB>
<CY>Lund, Sweden</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Vesikari T. Rotavirus infections and their prevention by vaccination. Antiviral Res 1985(Suppl 1):293-300.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T</AU>
<TI>Rotavirus infections and their prevention by vaccination</TI>
<SO>Antiviral Research</SO>
<YR>1985</YR>
<VL>Suppl 1</VL>
<PG>293-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1986a" NAME="Vesikari 1986a" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Kapikian A, Delem A, Zissis G. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis 1986;153(5):832-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Kapikian AZ, Delem A, Zissis G</AU>
<TI>A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1986</YR>
<VL>153</VL>
<NO>5</NO>
<PG>832-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1987b" NAME="Vesikari 1987b" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Ruuska T, Delem A, Andre FE</AU>
<TI>Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>2</NO>
<PG>164-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1990" NAME="Vesikari 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Rautanen T, Varis T, Beards G, Kapikian A. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age. Am J Dis Child 1990;144(3):285-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ</AU>
<TI>Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1990</YR>
<VL>144</VL>
<NO>3</NO>
<PG>285-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1991a" NAME="Vesikari 1991a" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Ruuska T, Delem A, Andre F, Beards G, Flewett T. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Acta Paediatr Scand 1991;80(2):173-80.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Ruuska T, Delem A, Andre FE, Beards GM, Flewett TH</AU>
<TI>Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1991</YR>
<VL>80</VL>
<NO>2</NO>
<PG>173-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1991b" NAME="Vesikari 1991b" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Ruuska T, Koivu H, Green K, Flores J, Kapikian A. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. Pediatr Infect Dis J 1991;10(12):912-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Ruuska T, Koivu HP, Green KY, Flores J, Kapikian AZ</AU>
<TI>Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1991</YR>
<VL>10</VL>
<NO>12</NO>
<PG>912-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1991c" NAME="Vesikari 1991c" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Varis T, Green K, Flores J, Kapikian A. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity. Vaccine 1991;9(5):334-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Varis T, Green K, Flores J, Kapikian AZ</AU>
<TI>Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity</TI>
<SO>Vaccine</SO>
<YR>1991</YR>
<VL>9</VL>
<NO>5</NO>
<PG>334-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1992" NAME="Vesikari 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Ruuska T, Green K, Flores J, Kapikian A. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Pediatr Infect Dis J 1992;11(7):535-42.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Ruuska T, Green KY, Flores J, Kapikian AZ</AU>
<TI>Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1992</YR>
<VL>11</VL>
<NO>7</NO>
<PG>535-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1999" NAME="Vesikari 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Joensuu J, Baer M, Kayhty H, Olander R, Sormunen H, Miettinen A, Ward R, Guillot T. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Acta Paediatrica 1999;88:513-20.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Joensuu J, Baer M, Kayhty H, Olander RM, Sormunen H, et al</AU>
<TI>Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines</TI>
<SO>Acta Paediatrica</SO>
<YR>1999</YR>
<VL>88</VL>
<NO>5</NO>
<PG>513-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wright-1987" NAME="Wright 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Wright P, Tajima T, Thompson J, Kokubun K, Kapikian A, Karzon D. Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation. Pediatrics 1987;80(4):473-80.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wright PF, Tajima T, Thompson J, Kokubun K, Kapikian A, Karzon DT</AU>
<TI>Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation</TI>
<SO>Pediatrics</SO>
<YR>1987</YR>
<VL>80</VL>
<NO>4</NO>
<PG>473-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Ceyhan-1993" NAME="Ceyhan 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Ceyhan M, Kanra G, Secmeer G, Midthun K, Davidson B, Zito E, et al. Take of rhesus-human reassortant tetravalent rotavirus vaccine in breast-fed infants. Acta Paediatr 1993;82(3):223-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ceyhan M, Kanra G, Secmeer G, Midthun K, Davidson BL, Zito ET, et al</AU>
<TI>Take of rhesus-human reassortant tetravalent rotavirus vaccine in breast-fed infants</TI>
<SO>Acta Paediatrica</SO>
<YR>1993</YR>
<VL>82</VL>
<NO>3</NO>
<PG>223-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Christy-1986" NAME="Christy 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Christy C, Madore H, Treaner J, Pray K, Kapikian A, Chanock R, et al. Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine. J Infect Dis 1986;154(6):1045-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christy C, Madore HP, Treaner JJ, Pray K, Kapikian AZ, Chanock RM, et al</AU>
<TI>Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1986</YR>
<VL>154</VL>
<NO>6</NO>
<PG>1045-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clements_x002d_Mann-2001" NAME="Clements-Mann 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clements-Mann ML, Dudas R, Hoshino Y, Nehring P, Sperber E, Wagner M, et al</AU>
<TI>Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants</TI>
<SO>Vaccine</SO>
<YR>2001</YR>
<VL>19</VL>
<NO>32</NO>
<PG>4676-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Friedman-1993" NAME="Friedman 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Friedman M, Segal B, Zedaka R, Sarov B, Margalith M, Bishop R, et al. Serum and salivary responses to oral tetravalent reassortant rotavirus vaccine in newborns. Clin Exp Immunol 1993;92(2):194-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Friedman MG, Segal B, Zedaka R, Sarov B, Margalith M, Bishop R, et al</AU>
<TI>Serum and salivary responses to oral tetravalent reassortant rotavirus vaccine in newborns</TI>
<SO>Clinical and Experimental Immunology</SO>
<YR>1993</YR>
<VL>92</VL>
<NO>2</NO>
<PG>194-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giammanco-1988" NAME="Giammanco 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Giammanco G, De G, V, Lupo L, Mistretta A, Pignato S, Teuween D, et al. Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine. Eur J Epidemiol 1988;4(1):121-3.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giammanco G, De Grandi V, Lupo L, Mistretta A, Pignato S, Teuween D, et al</AU>
<TI>Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine</TI>
<SO>European Journal of Epidemiology</SO>
<YR>1988</YR>
<VL>4</VL>
<NO>1</NO>
<PG>121-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Halsey-1988" NAME="Halsey 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Halsey N, Anderson E, Sears S, Steinhoff M, Wilson M, Belshe R, et al. Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children. J Infect Dis 1988;158(6):1261-7.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Halsey NA, Anderson EL, Sears SD, Steinhoff M, Wilson M, Belshe RB, et al</AU>
<TI>Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1988</YR>
<VL>158</VL>
<NO>6</NO>
<PG>1261-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Midthun K, Halsey N, Jett-Goheen M, Clements M, Steinhoff M, King J, et al. Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants. J Infect Dis 1991;164(4):792-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Midthun K, Halsey NA, Jett-Goheen M, Clements ML, Steinhoff M, King JC, et al</AU>
<TI>Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1991</YR>
<VL>164</VL>
<NO>4</NO>
<PG>792-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Isolauri-1995" NAME="Isolauri 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Isolauri, E, Joensuu, J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995;13:310-2.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Isolauri, E, Joensuu, J, Suomalainen H, Luomala M, Vesikari T</AU>
<TI>Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG</TI>
<SO>Vaccine</SO>
<YR>1995</YR>
<VL>13</VL>
<NO>3</NO>
<PG>310-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jalil-1991" NAME="Jalil 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Jalil F, Zaman S, Carlsson B, , et, al. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphteria-tetanus-pertussis vaccine. Trans R Soc Trop Med Hyg 1991;85:292-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jalil F, Zaman S, Carlsson B, Glass RI, Kapikian AZ, Mellander L, et al</AU>
<TI>Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphteria-tetanus-pertussis vaccine</TI>
<SO>Transactions of the Royal Society of Tropical Medicine and Hygiene</SO>
<YR>1991</YR>
<VL>85</VL>
<NO>2</NO>
<PG>292-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jin-1996" NAME="Jin 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jin Q, Ward RL, Knowlton DR, Gabbay YB, Linhares AC, Rappaport R, et al</AU>
<TI>Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses</TI>
<SO>Archives of Virology</SO>
<YR>1996</YR>
<VL>141</VL>
<NO>11</NO>
<PG>2057-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kobayashi-1993" NAME="Kobayashi 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Kobayashi M, Araki K, Thompson J, Tollefson S, Wright P. Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children. J Infect Dis 1993;167(3):748-52.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kobayashi M, Araki K, Thompson J, Tollefson SJ, Wright PF</AU>
<TI>Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1993</YR>
<VL>167</VL>
<NO>3</NO>
<PG>748-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kobayashi-1994" NAME="Kobayashi 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Kobayashi M, Thompson J, Tollefson S, Reed G, Wright P. Tetravalent rhesus rotavirus vaccine in young infants. J Infect Dis 1994;170(5):1260-3.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kobayashi M, Thompson J, Tollefson SJ, Reed GW, Wright PF</AU>
<TI>Tetravalent rhesus rotavirus vaccine in young infants</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1994</YR>
<VL>170</VL>
<NO>5</NO>
<PG>1260-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Losonsky-1988" NAME="Losonsky 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Losonsky GA, Rennels MB, Lim Y, Krall G, Kapikian AZ, Levine MM</AU>
<TI>Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006</TI>
<SO>Pediatric Infectious Disease</SO>
<YR>1988</YR>
<VL>7</VL>
<NO>6</NO>
<PG>388-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Markwick-1998" NAME="Markwick 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Markwick A, Rennels M, Zito E, Wade M, Mack M. Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. US Rhesus Rotavirus Vaccine Study Group. Pediatr Infect Dis J 1998;17(10):913-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Markwick AJ, Rennels MB, Zito ET, Wade MS, Mack ME</AU>
<TI>Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. US Rhesus Rotavirus Vaccine Study Group</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>10</NO>
<PG>913-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Midthun-1989" NAME="Midthun 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Midthun K, Pang LZ, Flores J, Kapikian AZ</AU>
<TI>Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates</TI>
<SO>Journal of Clinical Microbiology</SO>
<YR>1989</YR>
<VL>27</VL>
<NO>12</NO>
<PG>2799-804</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Padilla-1992" NAME="Padilla 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Padilla-Noriega L, Fiore L, Rennels M, Losonsky G, Mackow E, Greenberg H. Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with Rhesus rotavirus. J Clin Microbiol 1992;30(6):1392-1397.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Padilla-Noriega L, Fiore L, Rennels M, Losonsky G, Mackow E, Greenberg H</AU>
<TI>Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus</TI>
<SO>Journal of Clinical Microbiology</SO>
<YR>1992</YR>
<VL>30</VL>
<NO>6</NO>
<PG>1392-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pang-1999a" NAME="Pang 1999a" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Pang X, Joensuu J, Hoshino Y, Kapikian A, Vesikari T. Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis. J Clin Virol 1999;13(1-2):9-16.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pang XL, Joensuu J, Hoshino Y, Kapikian AZ, Vesikari T</AU>
<TI>Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis</TI>
<SO>Journal of Clinical Virology</SO>
<YR>1999</YR>
<VL>13</VL>
<NO>1-2</NO>
<PG>9-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pang-1999b" NAME="Pang 1999b" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Pang X, Vesikari T. Human astrovirus-associated gastroenteritis in children under 2 years of age followed prospectively during a rotavirus vaccine trial. Acta Paediatrica 1999;88(5):532-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pang XL, Vesikari T</AU>
<TI>Human astrovirus-associated gastroenteritis in children under 2 years of age followed prospectively during a rotavirus vaccine trial</TI>
<SO>Acta Paediatrica</SO>
<YR>1999</YR>
<VL>88</VL>
<NO>5</NO>
<PG>532-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pang-1999c" NAME="Pang 1999c" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Pang X, Koskenniemi E, Joensuu J, Vesikari T. Effect of rhesus rotavirus vaccine on enteric adenovirus--associated diarrhea in children. J Pediatr Gastroenterol Nutr 1999;29(3):366-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pang XL, Koskenniemi E, Joensuu J, Vesikari T</AU>
<TI>Effect of rhesus rotavirus vaccine on enteric adenovirus--associated diarrhea in children</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>1999</YR>
<VL>29</VL>
<NO>3</NO>
<PG>366-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pang-1999d" NAME="Pang 1999d" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Pang, XL, Joensuu J, Vesikari T. Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial. Pediatr Infect Dis J 1999;18(5):420-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pang XL, Joensuu J, Vesikari T</AU>
<TI>Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1999</YR>
<VL>18</VL>
<NO>5</NO>
<PG>420-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pickering-1995" NAME="Pickering 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Pickering L, Morrow A, Herrera I, O'Ryan M, Estes M, Guilliams S, et al. Effect of maternal rotavirus immunization on milk and serum antibody titers. J Infect Dis 1995;172(3):723-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pickering LK, Morrow AL, Herrera I, O'Ryan M, Estes MK, Guilliams SE, et al</AU>
<TI>Effect of maternal rotavirus immunization on milk and serum antibody titers</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1995</YR>
<VL>172</VL>
<NO>3</NO>
<PG>723-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simasathien-1994" NAME="Simasathien 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Migasena S, Simasathien S, Samakoses R, Pitisuttitham P, Sangaroon P, van S, G, et al. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 1995;13:168-74.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Migasena S, Simasathien S, Samakoses R, Pitisuttitham P, Sangaroon P, van Steenis G, et al</AU>
<TI>Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants</TI>
<SO>Vaccine</SO>
<YR>1995</YR>
<VL>13</VL>
<NO>2</NO>
<PG>168-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Simasathien S, Migasena S, Samakoses R, Pitisuttitham P, Sangaroon P, Aree C, et al. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine. Pediatr Infect Dis J 1994;13(7):590-6.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Simasathien S, Migasena S, Samakoses R, Pitisuttitham P, Sangaroon P, Aree C, et al</AU>
<TI>Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1994</YR>
<VL>13</VL>
<NO>7</NO>
<PG>590-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tajima-1990" NAME="Tajima 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Tajima T, Thompson J, Wright P, Kondo Y, Tollefson S, King J, et al. Evaluation of a reassortant rhesus rotavirus vaccine in young children. Vaccine 1990;8(1):70-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tajima T, Thompson J, Wright PF, Kondo Y, Tollefson SJ, King J, et al</AU>
<TI>Evaluation of a reassortant rhesus rotavirus vaccine in young children</TI>
<SO>Vaccine</SO>
<YR>1990</YR>
<VL>8</VL>
<NO>1</NO>
<PG>70-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ukae-1994" NAME="Ukae 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ukae S, Nakata S, Adachi N, Kogawa K, Chiba S</AU>
<TI>Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus</TI>
<SO>Vaccine</SO>
<YR>1994</YR>
<VL>12</VL>
<NO>10</NO>
<PG>933-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1983" NAME="Vesikari 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Isolauri E, Delem A, D'Hondt E, Andre F, Zissis G. Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet 1983;2(8354):807-11.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Isolauri E, Delem A, D'Hondt E, Andre FE, Zissis G</AU>
<TI>Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children</TI>
<SO>Lancet</SO>
<YR>1983</YR>
<VL>2</VL>
<NO>8354</NO>
<PG>807-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1985b" NAME="Vesikari 1985b" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Ruuska T, Bogaerts H, et a. Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants. Pediatr Infect Dis 1985;4(6):622-625.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Ruuska T, Bogaerts H, Delem A, Andre F</AU>
<TI>Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants</TI>
<SO>Pediatric Infectious Disease</SO>
<YR>1985</YR>
<VL>4</VL>
<NO>6</NO>
<PG>622-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1986b" NAME="Vesikari 1986b" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, , Ruuska, T, , Delem, A, , Andr&amp;#233;, FE. Oral rotavirus vaccination in breast- and bottle-fed infants aged 6 to 12 months. Acta Paediatr Scand 1986;75:573-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Ruuska T, Delem A, Andre FE</AU>
<TI>Oral rotavirus vaccination in breast- and bottle-fed infants aged 6 to 12 months</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1986</YR>
<VL>75</VL>
<NO>4</NO>
<PG>573-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-1987a" NAME="Vesikari 1987a" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Vesikari T, Rautanen T, Isolauri E, Delem A, Andre F. Immunogenicity and safety of a low passage level bovine rotavirus candidate vaccine RIT 4256 in human adults and young infants. Vaccine 1987;5(2):105-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Rautanen T, Isolauri E, Delem A, Andre FE</AU>
<TI>Immunogenicity and safety of a low passage level bovine rotavirus candidate vaccine RIT 4256 in human adults and young infants</TI>
<SO>Vaccine</SO>
<YR>1987</YR>
<VL>5</VL>
<NO>2</NO>
<PG>105-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vodopija-1986" NAME="Vodopija 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Vodopija I, Baklaic Z, Vlatkovic R, Bogaerts H, Delem A, Andre F. Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain. Vaccine 1986;4(4):233-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vodopija I, Baklaic Z, Vlatkovic R, Bogaerts H, Delem A, Andre FE</AU>
<TI>Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain</TI>
<SO>Vaccine</SO>
<YR>1986</YR>
<VL>4</VL>
<NO>4</NO>
<PG>233-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Wright-1991" NAME="Wright 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Wright P, King J, K, , Kondo Y, Thompson J, Tollefson S, et al. Simultaneous administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children. J Infect Dis 1991;164(2):271-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wright PF, King J, Araki K, Kondo Y, Thompson J, Tollefson SJ, et al</AU>
<TI>Simultaneous administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1991</YR>
<VL>164</VL>
<NO>2</NO>
<PG>271-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zoppi-1986" NAME="Zoppi 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Zoppi G, Ferrarini G, Rigolin F, Bogaerts H, Andr&amp;#233; F. Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants. Helv Paediatr Acta 1986;41:203-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zoppi G, Ferrarini G, Rigolin F, Bogaerts H, Andre FE</AU>
<TI>Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants</TI>
<SO>Helvetica Paediatrica Acta</SO>
<YR>1986</YR>
<VL>41</VL>
<NO>3</NO>
<PG>203-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zoppi-1989" NAME="Zoppi 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Zoppi G, Mantovanelli F, Pittschieler K, Delem A, Teuwen D. Response to RIT 4237 oral rotavirus vaccine in human milk, adapted-and soy-formula fed infants. Acta Paediatr Scand 1989;78(5):759-62.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zoppi G, Mantovanelli F, Pittschieler K, Delem A, Teuwen DE</AU>
<TI>Response to RIT 4237 oral rotavirus vaccine in human milk, adapted-and soy-formula fed infants</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1989</YR>
<VL>78</VL>
<NO>5</NO>
<PG>759-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Seth-2000" NAME="Seth 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;50. Seth R, Mohan A. Efficacy of monovalent human rotavirus vaccine 89-12 in infants. National Medical Journal of India 2000;13:253-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seth R, Mohan A</AU>
<TI>Efficacy of monovalent human rotavirus vaccine 89-12 in infants</TI>
<SO>National Medical Journal of India</SO>
<YR>2000</YR>
<VL>13</VL>
<NO>5</NO>
<PG>253-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vesikari-2002" NAME="Vesikari 2002" YEAR="2002">
<REFERENCE PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Vesikari T, Karvonen A, Espo M, Korhonen T, Delem A, de Vos B</AU>
<TI>Efficacy evaluation of an oral human rotavirus (HRV) vaccine in previously uninfected Finnish infants</TI>
<SO>42nd Interscience Conference on Antimicrobial Agents and Chemotherapy</SO>
<YR>2002</YR>
<CY>San Diego, CA</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-03 11:32:00 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-03 11:32:00 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AAP-1998" MODIFIED="2008-11-03 11:28:43 +0000" MODIFIED_BY="[Empty name]" NAME="AAP 1998" TYPE="JOURNAL_ARTICLE">
<AU>American Academy of Pediatrics</AU>
<TI>Prevention of rotavirus disease: guidelines for use of rotavirus vaccine</TI>
<SO>Pediatrics</SO>
<YR>1998</YR>
<VL>102</VL>
<NO>6</NO>
<PG>1483-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Altman-2002" NAME="Altman 2002" TYPE="JOURNAL_ARTICLE">
<AU>Altman DG, Deeks JJ</AU>
<TI>Meta-analysis, Simpson's paradox, and the number needed to treat</TI>
<SO>BMC Medical Research Methodology</SO>
<YR>2002</YR>
<VL>2</VL>
<NO>1</NO>
<PG>3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bresee-1999" MODIFIED="2008-10-29 13:57:24 +0000" MODIFIED_BY="[Empty name]" NAME="Bresee 1999" TYPE="JOURNAL_ARTICLE">
<AU>Bresee JS, Glass RI, Ivanoff B, Gentsch JR</AU>
<TI>Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries</TI>
<SO>Vaccine</SO>
<YR>1999</YR>
<VL>17</VL>
<NO>18</NO>
<PG>2207-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cale-2002" MODIFIED="2008-10-29 13:57:26 +0000" MODIFIED_BY="[Empty name]" NAME="Cale 2002" TYPE="JOURNAL_ARTICLE">
<AU>Cale CM, Klein NJ</AU>
<TI>The link between rotavirus vaccination and intussusception: implications for vaccine strategies</TI>
<SO>Gut</SO>
<YR>2002</YR>
<VL>50</VL>
<NO>1</NO>
<PG>11-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CDC-1999" MODIFIED="2008-11-03 11:32:00 +0000" MODIFIED_BY="[Empty name]" NAME="CDC 1999" TYPE="JOURNAL_ARTICLE">
<AU>Center for Disease Control and Prevention</AU>
<TI>Intussusception among recipients of rotavirus vaccine--United States, 1998-1999</TI>
<SO>Journal of American Medical Association</SO>
<YR>1999</YR>
<VL>282</VL>
<NO>6</NO>
<PG>520-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CDC-1999a" MODIFIED="2008-11-03 11:31:48 +0000" MODIFIED_BY="[Empty name]" NAME="CDC 1999a" TYPE="JOURNAL_ARTICLE">
<AU>Center for Disease Control and Prevention</AU>
<TI>Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)</TI>
<SO>MMWR. Recommendations and reports</SO>
<YR>1999</YR>
<VL>48</VL>
<NO>RR-2</NO>
<PG>1-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clarke-2003" NAME="Clarke 2003" TYPE="OTHER">
<AU>Clarke M, Oxman A, editors</AU>
<TI>Optimal search strategy for RCTs. Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]; Appendix C</TI>
<SO>In: The Cochrane Library [database on CDROM]. The Cochrane Collaboration. Chichester: Wiley; 2003, issue 3</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cunliffe-2002" NAME="Cunliffe 2002" TYPE="JOURNAL_ARTICLE">
<AU>Cunliffe NA, Bresee JS, Hart CA</AU>
<TI>Rotavirus vaccines: development, current issues and future prospects</TI>
<SO>Journal of Infection</SO>
<YR>2002</YR>
<VL>45</VL>
<NO>1</NO>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Flores-1987" NAME="Flores 1987" TYPE="JOURNAL_ARTICLE">
<AU>Flores J, Perez-Schael I, Gonzalez M, Garcia D, Perez M, Daoud N, et al</AU>
<TI>Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants</TI>
<SO>Lancet</SO>
<YR>1987</YR>
<VL>1</VL>
<NO>8538</NO>
<PG>882-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Glass-1999" MODIFIED="2008-10-29 13:57:35 +0000" MODIFIED_BY="[Empty name]" NAME="Glass 1999" TYPE="JOURNAL_ARTICLE">
<AU>Glass RI, Bresee JS, Parashar UD, Holman RC, Gentsch JR</AU>
<TI>First rotavirus vaccine licensed: is there really a need?</TI>
<SO>Acta Paediatrica. Supplement</SO>
<YR>1999</YR>
<VL>88</VL>
<NO>426</NO>
<PG>2-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Griffiths-1995" MODIFIED="2008-10-29 13:57:40 +0000" MODIFIED_BY="[Empty name]" NAME="Griffiths 1995" TYPE="JOURNAL_ARTICLE">
<AU>Griffiths RI, Anderson GF, Powe NR, Oliveras E, Herbert RJ, Grant CC, et al</AU>
<TI>Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial</TI>
<SO>Archives of Pediatrics &amp; Adolescent Medicine</SO>
<YR>1995</YR>
<VL>149</VL>
<NO>4</NO>
<PG>407-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Henchal-1996" NAME="Henchal 1996" TYPE="JOURNAL_ARTICLE">
<AU>Henchal LS, Midthun K, Goldenthal KL</AU>
<TI>Selected regulatory and scientific topics for candidate rotavirus vaccine development</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1996</YR>
<VL>174 Suppl 1</VL>
<PG>112-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency is preferable to testing for heterogeneity in meta-analysis</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jacobson-2001" MODIFIED="2008-10-29 13:57:43 +0000" MODIFIED_BY="[Empty name]" NAME="Jacobson 2001" TYPE="JOURNAL_ARTICLE">
<AU>Jacobson RM, Adegbenro A, Pankratz VS, Poland GA</AU>
<TI>Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study</TI>
<SO>Vaccine</SO>
<YR>2001</YR>
<VL>19</VL>
<NO>17-19</NO>
<PG>2428-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-2001" MODIFIED="2008-10-29 13:57:47 +0000" MODIFIED_BY="[Empty name]" NAME="Jones 2001" TYPE="JOURNAL_ARTICLE">
<AU>Jones T</AU>
<TI>Rotavirus vaccine AVANT/GlaxoSmithKline</TI>
<SO>Current Opinion in Investigational Drugs</SO>
<YR>2001</YR>
<VL>2</VL>
<NO>7</NO>
<PG>893-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Josefson-1997" MODIFIED="2008-10-29 13:57:49 +0000" MODIFIED_BY="[Empty name]" NAME="Josefson 1997" TYPE="JOURNAL_ARTICLE">
<AU>Josefson D</AU>
<TI>Rotavirus vaccine is effective in developing countries</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>1111-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Juni-2001" NAME="Juni 2001" TYPE="JOURNAL_ARTICLE">
<AU>Juni P, Altman DG, Egger M</AU>
<TI>Systematic reviews in healthcare: Assessing the quality of controlled trials</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>323</VL>
<NO>7303</NO>
<PG>42-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Matson-1990" MODIFIED="2008-10-29 13:57:51 +0000" MODIFIED_BY="[Empty name]" NAME="Matson 1990" TYPE="JOURNAL_ARTICLE">
<AU>Matson DO, Estes MK</AU>
<TI>Impact of rotavirus infection at a large at a large pediatric hospital</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1990</YR>
<VL>162</VL>
<NO>3</NO>
<PG>598-604</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Merck-1999" MODIFIED="2008-11-03 11:30:00 +0000" MODIFIED_BY="[Empty name]" NAME="Merck 1999" TYPE="JOURNAL_ARTICLE">
<AU>Merck and Co</AU>
<TI>Rotavirus W179-9 vaccine</TI>
<SO>Drugs in R&amp;D</SO>
<YR>1999</YR>
<VL>2</VL>
<NO>3</NO>
<PG>220-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-MMWR-1999a" MODIFIED="2008-11-03 11:30:29 +0000" MODIFIED_BY="[Empty name]" NAME="MMWR 1999a" TYPE="JOURNAL_ARTICLE">
<AU>MMWR</AU>
<TI>Intussusception among recipients of rotavirus vaccine--United States, 1998-1999</TI>
<SO>Morbidity and mortality weekly report</SO>
<YR>1999</YR>
<VL>48</VL>
<NO>27</NO>
<PG>577-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-MMWR-1999b" MODIFIED="2008-11-03 11:29:33 +0000" MODIFIED_BY="[Empty name]" NAME="MMWR 1999b" TYPE="JOURNAL_ARTICLE">
<AU>MMWR</AU>
<TI>Withdrawal of rotavirus vaccine recommendation</TI>
<SO>Morbidity and mortality weekly report</SO>
<YR>1999</YR>
<VL>48</VL>
<NO>43</NO>
<PG>1007</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murphy-2001" MODIFIED="2008-10-29 13:57:59 +0000" MODIFIED_BY="[Empty name]" NAME="Murphy 2001" TYPE="JOURNAL_ARTICLE">
<AU>Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al</AU>
<TI>Intussusception among infants given an oral rotavirus vaccine</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>344</VL>
<NO>8</NO>
<PG>564-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murphy-2002" MODIFIED="2008-10-29 13:58:02 +0000" MODIFIED_BY="[Empty name]" NAME="Murphy 2002" TYPE="JOURNAL_ARTICLE">
<AU>Murphy TV, Gargiullo PM, Wharton M</AU>
<TI>More on rotavirus vaccination and intussusception</TI>
<SO>New England Journal of Medicine</SO>
<YR>2002</YR>
<VL>346</VL>
<NO>3</NO>
<PG>211-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Newcombe-1998" NAME="Newcombe 1998" TYPE="JOURNAL_ARTICLE">
<AU>Newcombe RG</AU>
<TI>Interval estimation for the difference between independent proportions: comparison of eleven methods</TI>
<SO>Statistics in Medicine</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>8</NO>
<PG>873-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Niu-2001" MODIFIED="2008-10-29 13:58:04 +0000" MODIFIED_BY="[Empty name]" NAME="Niu 2001" TYPE="JOURNAL_ARTICLE">
<AU>Niu MT, Erwin DE, Braun MM</AU>
<TI>Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination</TI>
<SO>Vaccine</SO>
<YR>2001</YR>
<VL>19</VL>
<NO>32</NO>
<PG>4627-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perez_x002d_Schael-1990b" MODIFIED="2008-10-29 13:58:09 +0000" MODIFIED_BY="[Empty name]" NAME="Perez-Schael 1990b" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Schael I, Blanco M, Vilar M, Garcia D, White L, Gonzalez R, et al</AU>
<TI>Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants</TI>
<SO>Journal of Clinical Microbiology</SO>
<YR>1990</YR>
<VL>28</VL>
<NO>3</NO>
<PG>553-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perez_x002d_Schael-2001" MODIFIED="2008-10-29 13:58:11 +0000" MODIFIED_BY="[Empty name]" NAME="Perez-Schael 2001" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Schael I</AU>
<TI>Future of research into rotavirus vaccine. Developing countries must apply mathematics to take their own decisions</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>322</VL>
<NO>7278</NO>
<PG>106-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peter-2002" NAME="Peter 2002" TYPE="JOURNAL_ARTICLE">
<AU>Peter G, Myers MG; National Vaccine Advisory Committee; National Vaccine Program Office</AU>
<TI>Intussusception, rotavirus, and oral vaccines: summary of a workshop</TI>
<SO>Pediatrics</SO>
<YR>2002</YR>
<VL>110</VL>
<NO>6</NO>
<PG>1-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rennels-1998" MODIFIED="2008-10-29 13:58:12 +0000" MODIFIED_BY="[Empty name]" NAME="Rennels 1998" TYPE="JOURNAL_ARTICLE">
<AU>Rennels MB, Parashar UD, Holman RC, Le CT, Chang HG, Glass RI</AU>
<TI>Lack of an apparent association between intussusception and wild or vaccine rotavirus infection</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>10</NO>
<PG>924-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tucker-1998" MODIFIED="2008-10-29 13:58:16 +0000" MODIFIED_BY="[Empty name]" NAME="Tucker 1998" TYPE="JOURNAL_ARTICLE">
<AU>Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI</AU>
<TI>Cost-effectiveness analysis of a rotavirus immunization program for the United States</TI>
<SO>Journal of American Medical Association</SO>
<YR>1998</YR>
<VL>279</VL>
<NO>17</NO>
<PG>1371-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Verstraeten-2001" MODIFIED="2008-10-29 13:58:19 +0000" MODIFIED_BY="[Empty name]" NAME="Verstraeten 2001" TYPE="JOURNAL_ARTICLE">
<AU>Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT; Vaccine Adverse Event Reporting System Team</AU>
<TI>Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination</TI>
<SO>American Journal of Epidemiology</SO>
<YR>2001</YR>
<VL>154</VL>
<NO>11</NO>
<PG>1006-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vesikari-1997" MODIFIED="2008-10-29 13:58:21 +0000" MODIFIED_BY="[Empty name]" NAME="Vesikari 1997" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T</AU>
<TI>Rotavirus vaccines against diarrhoeal disease</TI>
<SO>Lancet</SO>
<YR>1997</YR>
<VL>350</VL>
<NO>9090</NO>
<PG>1538-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weijer-2000" MODIFIED="2008-10-29 13:58:24 +0000" MODIFIED_BY="[Empty name]" NAME="Weijer 2000" TYPE="JOURNAL_ARTICLE">
<AU>Weijer C</AU>
<TI>The future of research into rotavirus vaccine</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>321</VL>
<NO>7260</NO>
<PG>525-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1995" NAME="WHO 1995" TYPE="BOOK">
<AU>World Health Organization. Diarrhoeal Disease Control Programme</AU>
<SO>The treatment of diarrhoea: a manual for physicians and other senior health workers</SO>
<YR>1995</YR>
<EN>3rd</EN>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2003" NAME="WHO 2003" TYPE="OTHER">
<AU>World Health Organization. Child and Adolescent Health and Development</AU>
<TI>Proportional mortality among children under fives, regions [2001]</TI>
<SO>http://www.who.int/child-adolescent-health/OVERVIEW/CHILD_HEALTH/map_01_regions.jpg</SO>
<YR>(accessed 23 October 2003)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO_x002f_UNICEF-2002" NAME="WHO/UNICEF 2002" TYPE="BOOK">
<AU>World Health Organization. Dept. of Vaccines and Biologicals</AU>
<SO>State of the world's vaccines and immunization</SO>
<YR>2002</YR>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-World-Bank-2003" NAME="World Bank 2003" TYPE="OTHER">
<AU>The World Bank Group</AU>
<TI>Data &amp; statistics: country group</TI>
<SO>http://www.worldbank.org/data/countryclass/classgroups.htm</SO>
<YR>(accessed 23 October 2003)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zanardi-2001" MODIFIED="2008-10-29 13:58:29 +0000" MODIFIED_BY="[Empty name]" NAME="Zanardi 2001" TYPE="JOURNAL_ARTICLE">
<AU>Zanardi LR, Haber P, Mootrey GT, Niu MT, Wharton M</AU>
<TI>Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>6</NO>
<PG>E97</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-11-09 14:57:44 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-11-09 14:57:44 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-11-09 14:40:02 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Anderson-1986">
<CHAR_METHODS MODIFIED="2008-11-09 14:40:02 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details </P>
<P>Allocation concealment: no details</P>
<P>Blinding: single (placebo and vaccine looked similar)</P>
<P>Data collection: no details</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: none</P>
<P>Follow-up period: 8 days after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 13:39:53 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 8 to 60 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: 50 to 75%</P>
<P>Immunization status: no information</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:15:37 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus vaccine (MMU 18006), 10^6.5 PFU single dose (n = 13)</P>
<P>2. Placebo (similac formula), 30 ml single dose (n = 10)</P>
<P>30 ml similac formula given with vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:15:44 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 8 days</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-28 13:36:06 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Two separate trials</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:16:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barnes-1997">
<CHAR_METHODS MODIFIED="2008-10-28 13:40:11 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (vaccine and placebo ampoules identified by participant number only)</P>
<P>Data collection: no details</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: none</P>
<P>Follow-up period: 4 weeks after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 13:40:28 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 3 to 360 months</P>
<P>Health status: healthy</P>
<P>Immunization status: no information</P>
<P>Breastfeeding: no information</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:16:09 +0000" MODIFIED_BY="[Empty name]">
<P>1. Human vaccine (RV3), 6.5 x 10^5 PFU, single dose (n = 15).</P>
<P>2. Placebo (uninfected monkey kidney culture fluids), single dose (n = 15)</P>
<P>1 h fasting and then 30 ml soy formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:16:16 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 4 weeks of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-28 13:40:37 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Australia</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barnes-2002">
<CHAR_METHODS MODIFIED="2008-10-28 13:45:40 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: block randomization in groups of 6 independently done by the University of Melbourne Statistical</P>
<P>Consulting Centre</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (vaccine and placebo ampoules identical)</P>
<P>Data collection: no details</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 1/60 withdrawn from follow up by parents; 5/59 excluded from analysis due to wild-type infection before or during trial</P>
<P>Follow-up period: 7 days after vaccination; 2 rotavirus seasons after completion of all vaccinations</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 13:47:31 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 3 months</P>
<P>Health status: healthy</P>
<P>Immunization status: vaccine administered not closer than 14 days to routine immunizations</P>
<P>Breastfeeding: &gt; 75%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:16:33 +0000" MODIFIED_BY="[Empty name]">
<P>1. Human vaccine (RV3), 6.5 x 10^5 PFU with soy-based formula (n = 20) or without soy-based formula (n = 20), 3 doses</P>
<P>2. Placebo (uninfected monkey kidney culture fluids) with soy-based formula, 3 doses (n = 20)</P>
<P>1 h fasting and then 10 ml soy formula given before vaccine (only in 1 of 2 vaccine groups) or placebo</P>
<P>400 mg of sodium bicarbonate given to all groups before vaccination</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:16:42 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination.</P>
<P>2. Efficacy: diarrhoea within 2 rotavirus seasons of beginning of trial</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Australia</P>
<P>Clinical symptoms: clinical evaluation, severity score measured by <LINK REF="REF-Flores-1987" TYPE="REFERENCE">Flores 1987</LINK> scale</P>
<P>Laboratory studies: serology by ELISA, stool analysis by ELISA and PCR</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bernstein-1990">
<CHAR_METHODS MODIFIED="2008-10-28 13:48:58 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: randomization code provided by Institut Merieux</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (no further details)</P>
<P>Data collection: 7 September 1987 to 30 June 1989</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 1\206 not evaluated; 42\205 not followed over the second year because of no consent</P>
<P>Follow-up period: 7 days after vaccination; 2 rotavirus seasons after beginning of trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 13:49:05 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 12 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: DTP and OPV vaccination not allowed within 2 weeks of WC3 vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:17:01 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine vaccine (WC3), 10^7 PFU, single dose (n = 103)</P>
<P>2. Placebo (diluent), 2 ml single dose (n = 103)</P>
<P>30 ml formula or 1 ml/kg antacid given before vaccine or placebo<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:16:58 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
<P>2. Efficacy: diarrhoea within 2 rotavirus seasons of beginning of trial</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Feeding was withheld from infants for at least 1 h before vaccine. Breastfeeding also withheld for 1 h after vaccine</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 2 watery stools in 24 h); severity score measured by <LINK REF="STD-Clark-1988" TYPE="STUDY">Clark 1988</LINK> scale</P>
<P>Laboratory studies: serology by ELISA and fluorescent focus reduction assay; stool analysis by plaque assay and ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bernstein-1995">
<CHAR_METHODS MODIFIED="2008-10-28 13:50:15 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: random code prepared by the pharmaceutical industry</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (identical appearing vials)</P>
<P>Data collection: 10 October 1989 to 1 July 1991</P>
<P>Intention to treat: no</P>
<P>Interim analysis: performed after first season; no changes made on the study protocol as a result of the interim analysis</P>
<P>Exclusion from analysis: 17\1006 not vaccinated 91\989 not included in first year follow up; 34\898 not included in second year follow up</P>
<P>Follow-up period: 5 days after vaccination; 2 rotavirus seasons after beginning of trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 13:50:30 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1 to 6.5 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: OPV vaccination given within 2 weeks of RRV vaccination in 120 participants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:17:22 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human tetravalent vaccine (RRV-TV), 4 x 10^4 PFU, single dose (n = 332).</P>
<P>2. Monovalent vaccine (D x RRV), 4 x 10^4 PFU, single dose (n = 327)</P>
<P>3. Placebo (uninfected tissue culture fluids), single dose (n = 330)</P>
<P>400 mg sodium bicarbonate in 30 ml cow milk or soy formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:17:20 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 5 days of vaccination</P>
<P>2. Efficacy: gastrointestinal illness within 2 rotavirus seasons of beginning of trial</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]">
<P>Country: USA</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 watery or loose stools in 24 h); severity score measured by <LINK REF="REF-Flores-1987" TYPE="REFERENCE">Flores 1987</LINK> scale</P>
<P>Laboratory studies: serology by ELISA and focus reduction assay; stool analysis by ELISA</P>
<P>All other vaccines given as scheduled</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:56:34 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bernstein-1998">
<CHAR_METHODS MODIFIED="2008-10-28 13:51:43 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: code was not available until end of study </P>
<P>Blinding: double (no details)</P>
<P>Data collection: enrolment between August 1995 and November 1995, end of vaccination December 1995</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 1\116 not followed because of persistent otitis</P>
<P>Follow-up period: 1 week after each vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-11-09 14:56:34 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1.5 to 60 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no vaccination allowed within 2 weeks of rotavirus vaccination</P>
<P>Clinical symptoms: clinical evaluation, diarrhoea was defined as 3 or more unformed stools within 48 h. Fever was<BR/>defined as a rectal temperature &gt; 38.1 ºC in paediatric participants, confirmed within 20 minutes</P>
<P>Laboratory studies: stool analysis by ELISA and PCR</P>
<P>Serology by plaque reduction neutralization and ELISA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:17:39 +0000" MODIFIED_BY="[Empty name]">
<P>1. Human (89-12), 10^5 PFU single dose for adults and children (n = 40), 2 doses for infants (n = 21)</P>
<P>2. Placebo (n = 55), no further details</P>
<P>50 ml sodium bicarbonate for adults and 0.5 ml/kg Mylanta-DS for infants and children given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:17:37 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of each vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:40:31 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 watery or loose stools in 24 h, fever defined as &gt; 100.4 ºF)</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
<P>Immunization with other vaccines separated by at least 2 weeks from the RV</P>
<P>3 separate trials: adults and children (2 to 12 years) for initial trials; infants (6 to 26 weeks) for last trial</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bernstein-1999">
<CHAR_METHODS MODIFIED="2008-10-28 13:54:04 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: computer generated, blocks of 10, provided by sponsor</P>
<P>Allocation concealment: code was not available until end of study</P>
<P>Blinding: double (no further details)</P>
<P>Data collection: August 1997 to May 1999</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 1\215 not vaccinated because of persistent fever; 1\214 not re-vaccinated because of congenital malformation; 1\213 died of pneumococcal sepsis; 28\212 were not available for second season follow up, no further details</P>
<P>Follow-up period: 1 week after each vaccination; 2 rotavirus season after beginning of trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 13:54:15 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 10 to 16 weeks</P>
<P>Health status: healthy</P>
<P>Breastfeeding: 50 to 75%</P>
<P>Immunization status: no other vaccine allowed within 2 weeks of vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:18:11 +0000" MODIFIED_BY="[Empty name]">
<P>1. Human (89-12), 10^5 PFU, two doses (n = 108)</P>
<P>2. Placebo (tissue culture medium), 1 ml, 2 doses (n = 107)</P>
<P>2 ml antacid given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:18:06 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of each vaccination.</P>
<P>2. Efficacy: gastroenteritis (rotavirus or other) within the study period (18 months)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Feeding withheld for at least 1 h before and after vaccine</P>
<P>Clinical symptoms: clinical evaluation (gastroenteritis defined as vomiting, &#8805; 3 loose stools), severity score measured by <LINK REF="REF-Flores-1987" TYPE="REFERENCE">Flores 1987</LINK> scale</P>
<P>Laboratory studies: serology by ELISA and antigen reduction assay; stool analysis by ELISA</P>
<P>All other immunizations separated from RV by at least 2 weeks</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:18:23 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bresee-2001">
<CHAR_METHODS MODIFIED="2008-10-28 16:18:34 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: block randomization in groups of 6</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (vaccine and placebo that tasted and appeared identical)</P>
<P>Data collection: October 1998 to February 1998 enrolment, no further details</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 9\120 not vaccinated because of parental refusal (8) or death (1 case due to severe pneumonia); 2\111 did not complete trial because of death (1 case due to suspected sudden infant death syndrome) or relocation (1)</P>
<P>Follow-up period: 1 week after each vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:19:03 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 6 weeks</P>
<P>Health status: healthy, full term</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:18:23 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human tetravalent vaccine (RRV-TV), 4 x 10^5 PFU, 3 doses (n = 60)</P>
<P>2. Placebo (lyophilized growth medium with 10% SPG), 3 ml, 3 doses (n = 60)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-28 16:19:20 +0000" MODIFIED_BY="[Empty name]">
<P>Safety: clinical symptoms within 7 days of each vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-28 16:19:23 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Bangladesh</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology by ELISA and by neutralizing antibody titers; stool analysis by ELISA, polyacrylamide gel electrophoresis (PAGE) and by reverse transcriptase (RT)-PCR</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:40:52 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Christy-1988">
<CHAR_METHODS MODIFIED="2008-10-28 16:19:55 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: sequential enrolment and vaccination according to table of random numbers</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (similar appearance to vaccine and placebo vials)</P>
<P>Data collection: October 1986 to July 1986</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 1\176 for "reasons unrelated to trial"</P>
<P>Follow-up period: 10 days after each vaccination; 10 months after beginning of trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:20:39 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 4 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: DPT and polio vaccinations not allowed within 4 weeks before and 3 weeks after vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:18:40 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU 18006), 10^4 PFU, single dose (n = 88)</P>
<P>2. Placebo (soy formula), 1 ml single dose (n = 88)</P>
<P>400 mg sodium bicarbonate in 30 ml soy formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:18:38 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 10 days of each vaccination.</P>
<P>2. Efficacy: gastroenteritis (rotavirus or other) within 10 months of beginning of trial</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:40:52 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>All feedings withheld for 1 h before and after vaccine</P>
<P>Clinical symptoms: clinical evaluation, severity measured by WHO criteria (fever (&#8805; 38) vomiting, dehydration, &gt; 6 stools in 24 h, and illness duration &#8805; 24 h)</P>
<P>Laboratory studies: serology by micro neutralization assay and ELISA; stool analysis by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:40:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Christy-1993">
<CHAR_METHODS MODIFIED="2008-10-28 16:21:19 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: block randomization scheme</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (no further details)</P>
<P>Data collection: 21 November 1991 to 1 June 1992</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 4/31 excluded for having diarrhoea from wild-type rotavirus; 1/27 did not receive second dose "for reasons unrelated to vaccination"</P>
<P>Follow-up period: 10 days after each vaccination; 6 months after beginning of trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:21:31 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 6 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:18:51 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine + human reassortant (WI79-9),10^7.5 PFU, 2 doses (n = 16)</P>
<P>2. Placebo (cell culture medium with cherry syrup), 2.5 ml, 2 doses (n = 15)</P>
<P>400 mg sodium bicarbonate in 30 ml soy formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:19:04 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 10 days of each vaccination</P>
<P>2. Efficacy: gastroenteritis within 6 months of beginning of trial</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:40:58 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Breastfeeding withheld for 1 h before vaccine</P>
<P>Clinical symptoms: clinical evaluation (significant diarrhoea defined as &#8805; 2 watery stools in 24 h)</P>
<P>Laboratory studies: stool analysis by ELISA; serology by micro-neutralization</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clark-1988">
<CHAR_METHODS MODIFIED="2008-10-28 16:23:20 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: serial coding according to table of random numbers</P>
<P>Allocation concealment: code unbroken until end of trial, no further details</P>
<P>Blinding: double (numbered identical vials)</P>
<P>Data collection: September 1985 to June 1986</P>
<P>Intention to treat: unknown (only number of infants completing the trial mentioned)</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: unknown</P>
<P>Follow-up period: 1 week after each vaccination; 10 months after beginning of trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:23:33 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 3 to 12 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: DPT vaccination not allowed within 1 week before vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:19:20 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (WC3), 10^7.5 PFU, single dose (n = 49)</P>
<P>2. Placebo (cell culture medium with 0.5 ml cherry syrup), 2.5 ml single dose (n = 55)</P>
<P>30 ml formula or 85 mg antacid given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:19:25 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of each vaccination</P>
<P>2. Efficacy: gastroenteritis (rotavirus or other) within 10 months of beginning of trial</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>No feeding 1 h before vaccine, and no breastfeeding 1 h after vaccine</P>
<P>Clinical symptoms: clinical evaluation (significant diarrhoea defined as &#8805; 2 watery stools in 24 h); severity score measured by <LINK REF="STD-Clark-1988" TYPE="STUDY">Clark 1988</LINK> (modified Duffy 1986) scale</P>
<P>Laboratory studies: serology by plaque reduction neutralization; stool analysis by PAGE-SS analysis and ELISA</P>
<P>At least 1 week between DTP and RV</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:41:10 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clark-1990">
<CHAR_METHODS MODIFIED="2008-10-28 16:24:38 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: table of random numbers</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (numbered vials)</P>
<P>Data collection: September 1987 to July 1988</P>
<P>Intention to treat: no details, only number of infants completing the trial mentioned</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: no details</P>
<P>Follow-up period: 1 week after each vaccination; 17 weeks after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:24:58 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 11 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: DPT and polio vaccinations not allowed within 7 days of vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:41:10 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine + human reassortant (WI79-9), 2 x 10^7 PFU, 2 doses (n = 38)</P>
<P>2. Placebo (cell culture medium with 20% cherry syrup), 2 doses (n = 39)</P>
<P>30 ml formula or 85 mg antacid given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:19:41 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of each vaccination</P>
<P>2. Efficacy: gastroenteritis within 17 weeks of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-28 16:25:40 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation; severity score measured by modified Duffy 1986 scale</P>
<P>Laboratory studies: serology by plaque reduction neutralization test; stool analysis by latex agglutination test</P>
<P>At least 7 days between DTP and RV</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:20:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clark-1995">
<CHAR_METHODS MODIFIED="2008-10-28 16:26:14 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (no further details)</P>
<P>Data collection: no information</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 12/417 were not evaluated, no further details</P>
<P>Follow-up period: 1 week after each vaccination; 1 rotavirus season after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:26:29 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 6 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:19:57 +0000" MODIFIED_BY="[Empty name]">
<P>1. Human-bovine QHBRV, 4 x 10^7 PFU, 3 doses (n = 199)</P>
<P>2. Placebo (no details), 3 doses (n = 206)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:20:01 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of each vaccination</P>
<P>2. Efficacy: gastroenteritis within 1 rotavirus season of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-28 16:27:15 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation; severity score measured by modified Duffy 1986 scale</P>
<P>Laboratory studies: stool analysis by solid phase immunoassay and electropherotype analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:56:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clements_x002d_Mann-1999">
<CHAR_METHODS MODIFIED="2008-10-28 16:27:45 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (no further details)</P>
<P>Data collection: no information</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 5/182 were excluded for exceeding the age limit</P>
<P>Follow-up period: 1 week after each vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:27:58 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1.5 to 60 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no vaccination allowed within 2 weeks of rotavirus vaccination<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:20:56 +0000" MODIFIED_BY="[Empty name]">
<P>1. Human-bovine D x UK, 10^4.8 PFU, single dose (n = 17)</P>
<P>2. Human-bovine D x UK, 10^5.8 PFU, single dose (n = 20)</P>
<P>3. Human-bovine DS-1 x UK, 10^4.3 PFU, single dose (n = 18)</P>
<P>4. Human-bovine DS-1 x UK, 10^5.3 PFU, single dose (n = 11)</P>
<P>5. Human-bovine P x UK, 10^4.3 PFU, single dose (n = 10)</P>
<P>6. Human-bovine P x UK, 10^5.3 PFU, single dose (n = 21)</P>
<P>7. Human-bovine ST3 x UK, 10^4.8 PFU, single dose (n = 8)</P>
<P>8. Human-bovine ST3 x UK, 10^5.8 PFU, single dose (n = 14).</P>
<P>9. Placebo (buffered solution), single dose (n = 63)</P>
<P>30 ml of formula mixed with 0.4 g of sodium bicarbonate given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:20:59 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of each vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:56:37 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>1 h fasting before vaccination</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea was defined as 3 or more unformed stools within 48 h; fever was defined as a rectal temperature &gt; 38.1 ºC in paediatric participants, confirmed within 20 minutes</P>
<P>Laboratory studies: stool analysis by ELISA and PCR; serology by plaque reduction neutralization and ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:56:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dagan-1992">
<CHAR_METHODS MODIFIED="2008-11-09 14:56:37 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (vaccine and placebo vials looked alike and were coded)</P>
<P>Data collection: study started July 1988, no further details.</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 19\240 did not receive second vaccine</P>
<P>Follow-up period: 10 days after each vaccine, 1 year after beginning of trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:29:58 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 days old infants</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &gt; 75%</P>
<P>Immunization status: no OPV vaccines allowed within 2 weeks of vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:21:11 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human tetravalent vaccine (D x RRV + DS1 x RRV + RRV + ST3 x RRV), 4 x 10^4 PFU, 2 doses (n = 183)</P>
<P>2. Placebo (uninfected cell culture fluid), 2 doses (n = 57)</P>
<P>200 mg citrate-bicarbonate in 20 ml similac formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:21:14 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 10 days of each vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-28 16:30:52 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Israel</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology by ELISA</P>
<P>At least 14 days were allowed between OPV and RV</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:56:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-De-Mol-1986">
<CHAR_METHODS MODIFIED="2008-11-09 14:56:37 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (no further details)</P>
<P>Data collection: April 1985 to August 1985</P>
<P>Intention to treat: no information</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: no information</P>
<P>Follow-up period: 4 months after beginning of trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:31:31 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 3 to 8 months</P>
<P>Health status: without fever</P>
<P>Breastfeeding: &gt; 75%</P>
<P>Immunization status: no OPV vaccines allowed within 2 weeks of vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:21:23 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine RIT 4237, single dose (n = 122), no further details</P>
<P>2. Placebo (no further details), single dose (n = 123)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:21:26 +0000" MODIFIED_BY="[Empty name]">
<P>1. Efficacy: gastroenteritis within 4 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-28 16:32:18 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Rwanda</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:41:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dennehy-1996">
<CHAR_METHODS MODIFIED="2008-10-28 16:32:39 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (vaccine and placebo vials looked identical)</P>
<P>Data collection: 1 July 1991 to 1 December 1991</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 2\195 were not followed</P>
<P>Follow-up period: 5 days after each vaccine</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:32:44 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 6 to 24 weeks</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no DTP, OPV, or Hib vaccines allowed within 2 weeks of vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:21:39 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human tetravalent vaccine (RRV-TV), 4 x 10^6 PFU, single dose (n = 69)</P>
<P>2. Rhesus + human tetravalent vaccine (RRV-TV), 4 x 10^5 PFU, single dose (n = 60)</P>
<P>3. Placebo (tissue culture medium), single dose (n = 64)</P>
<P>3 ml sodium citrate-bicarbonate given with vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:21:42 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 5 days of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:41:29 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>At least 2 weeks were allowed between DTP, OPV, Hib, and RV</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea defined as &#8805; 3 looser than normal stools in 24 h and 1 or more vomiting; fever defined as &gt; 38 ºC)</P>
<P>Laboratory studies: serology by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:56:40 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eichelberger-2002">
<CHAR_METHODS MODIFIED="2008-10-28 16:33:32 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (no further details)</P>
<P>Data collection: no information</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: none</P>
<P>Follow-up period: 1 week after each vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:33:42 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1.5 to 60 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no vaccination allowed within 2 weeks of rotavirus vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:41:34 +0000" MODIFIED_BY="[Empty name]">
<P>1. Human-bovine Wa x UK, 10^6.3 PFU, single dose (n = 21)</P>
<P>2. Human-bovine Wa x UK, 10^7.3 PFU, single dose (n = 21)</P>
<P>3. Human-bovine Wa x (DS-1xUK), 10^6.4 PFU, single dose (n = 14)</P>
<P>4. Human-bovine Wa x (DS-1xUK), 10^7.4 PFU, single dose (n = 22)</P>
<P>5. Placebo (buffered soy-based formula), single dose (n = 37)</P>
<P>30 ml of formula mixed with 0.4 g of sodium bicarbonate given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:22:11 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of each vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:56:40 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>1 h fasting before vaccination</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea was defined as 3 or more unformed stools within 48 h; fever was defined as a rectal temperature &gt; 38.1 ºC in paediatric participants, confirmed within 20 minutes</P>
<P>Laboratory studies: stool analysis by ELISA and PCR; serology by plaque reduction neutralization and ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:22:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Escobar-1988">
<CHAR_METHODS MODIFIED="2008-10-28 16:34:47 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (vaccine and placebo were identical)</P>
<P>Data collection: no details</P>
<P>Intention to treat: no information</P>
<P>Interim analysis: no information</P>
<P>Exclusion from analysis: no information</P>
<P>Follow-up period: 3 weeks after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:34:58 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 6 to 18 months</P>
<P>Health status: without diarrhoea, no further details</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:22:20 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine RIT 4237, 0.5 ml, 10^8 DICT 50, single dose (n = 52)</P>
<P>2. Placebo (same preparation without the virus), single dose (n = 51)</P>
<P>110 ml of formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:22:22 +0000" MODIFIED_BY="[Empty name]">
<P>1. Efficacy: rotavirus diarrhoea within 3 weeks of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-28 16:35:20 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Spain</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:41:45 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flores-1988">
<CHAR_METHODS MODIFIED="2008-10-28 16:35:46 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (no details)</P>
<P>Data collection: no details</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: none</P>
<P>Follow up-period: 10 days after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:35:51 +0000" MODIFIED_BY="[Empty name]">
<P>Age: newborns</P>
<P>Health status: healthy newborns and mothers, normal pregnancy</P>
<P>Breastfeeding: &gt; 75%</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:22:33 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU18006) vaccine, 10^4 PFU, single dose (n = 20)</P>
<P>2. Placebo (buffered formula), single dose (n = 20)</P>
<P>200 mg citrate-bicarbonate in 15 ml formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:22:36 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 10 days of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:41:45 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Venezuela</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea defined as &#8805; 3 liquid or semi-liquid stools in 24 h</P>
<P>Laboratory studies: serology by ELISA, complement-fixation assay, plaque reduction neutralization assay, tube neutralization assay, and VP-7 competition assay; stool analysis by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:56:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flores-1989">
<CHAR_METHODS MODIFIED="2008-11-09 14:56:42 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: random code assignment to 5 groups</P>
<P>Allocation concealment: code prepared in advance, not disclosed to field team, broken at NIH laboratory after follow up ended</P>
<P>Blinding: double (same size of ampoules given to each group).</P>
<P>Data collection: no details</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 20\116 excluded from study for having diarrhoea, nausea, or vomiting in the week prior to vaccination.</P>
<P>Follow-up period: 1 week after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:36:57 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1 to 5 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: polio vaccine not given within 2 weeks of vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:41:49 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human (D x RRV), 10^4 PFU, single dose (n = 24)</P>
<P>2. Rhesus + human (DS1 x RRV), 10^4 PFU, single dose (n = 25)</P>
<P>3. Rhesus (RRV 3), 10^4 PFU, single dose (n = 21)</P>
<P>4. Rhesus + human (D x RRV + RRV), 5 x 10^3 PFU, single dose (n = 23)</P>
<P>5. Placebo (formula alone or with red soda), 1 ml single dose (n = 23)</P>
<P>400 mg citrate-bicarbonate in 30 ml similac formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:22:57 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 1 week of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Venezuela</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea defined as &#8805; 3 watery or loose stools in 24 h; severity score measured by <LINK REF="REF-Flores-1987" TYPE="REFERENCE">Flores 1987</LINK> scale</P>
<P>Laboratory studies: serology by ELISA and plaque reduction neutralization assay; stool analysis by ELISA and cultures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:42:04 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flores-1990">
<CHAR_METHODS MODIFIED="2008-10-28 16:38:40 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: random order assignment to 4 groups</P>
<P>Allocation concealment: code not disclosed to field team until end of analysis, broken at NIH</P>
<P>Blinding: double (no further details)</P>
<P>Data collection: no details</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: none</P>
<P>Follow-up period: 1 week after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:40:25 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 10 to 20 weeks</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:23:16 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human quadrivalent vaccine (3 RRV + D x RRV + DS1 x RRV + ST3 x RRV), 10^4 PFU, single dose (n = 23)</P>
<P>2. Rhesus + human quadrivalent vaccine (3 RRV + D x RRV + DS1 x RRV + ST3 x RRV), 5 x 10^4 PFU, single dose (n = 22)</P>
<P>3. Human vaccine (M37), 10^4 PFU, single dose (n = 23)</P>
<P>4. Placebo (formula), 1 ml, single dose (n= 22)</P>
<P>400 mg citrate-bicarbonate in 30 ml similac formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:23:05 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 1 week of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:42:04 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Venezuela</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea defined as &#8805; 3 watery or loose stools in 24 h</P>
<P>Laboratory studies: serology by ELISA and plaque reduction neutralization assay; stool analysis by ELISA and cultures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:42:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flores-1993">
<CHAR_METHODS MODIFIED="2008-10-28 16:43:20 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: code not revealed at any time to field team, no further details</P>
<P>Data collection: no details</P>
<P>Blinding: double (no further details)</P>
<P>Intention to treat: no</P>
<P>Interim analysis: yes</P>
<P>Exclusion from analysis: 22\302 dropped from study, no further details</P>
<P>Follow-up period: 1 week after each vaccination, passive follow up for 8 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:43:32 +0000" MODIFIED_BY="[Empty name]">
<P>Age: newborns</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: OPV and DPT vaccinations were given 2 weeks after each RRV dose</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:23:33 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human quadrivalent vaccine (3 RRV + D x RRV + DS1 x RRV + ST3 x RRV), 10^5 PFU, 3 doses (n = 101)</P>
<P>2. Rhesus + human quadrivalent vaccine (3 RRV + D x RRV + DS1 x RRV + ST3 x RRV), 10^6 PFU, 3 doses (n = 99)</P>
<P>3. Placebo (uninfected tissue culture fluids), 3 doses (n = 102)</P>
<P>400 mg citrate-bicarbonate in 30 ml similac formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:23:36 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 1 week of vaccination</P>
<P>2. Efficacy: diarrhoea (rotavirus or other) within 8 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:42:09 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Venezuela</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea defined as &#8805; 3 watery or loose stools in 24 h</P>
<P>Laboratory studies: serology by ELISA and plaque reduction neutralization assays; stool analysis by ELISA</P>
<P>Vaccine given between OPV and DPT vaccines.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Georges_x002d_Courbot-1991">
<CHAR_METHODS MODIFIED="2008-10-28 16:44:40 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: table of random numbers, administered in numeric order in the first dose</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (identical precoded vials)</P>
<P>Data collection: no information</P>
<P>Intention to treat: no</P>
<P>Interim analysis: yes</P>
<P>Exclusion from analysis: 69\539 did not receive vaccine (7 deaths), 56/470 did not finish follow up (4 deaths)</P>
<P>Follow-up period: 9 months after first vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:44:51 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 3 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &gt; 75%</P>
<P>Immunization status: DTCP vaccine given with rotavirus vaccine</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:23:51 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (WC3), 10^7 PFU, 2 doses (n = 237)</P>
<P>2. Placebo (sacharose and lactose substrates), 2 doses (n = 235)</P>
<P>Milk given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:23:54 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 1 week of vaccination</P>
<P>2. Efficacy: diarrhoea within 9 months of first vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]">
<P>Country: Central African Republic</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea defined as &#8805; 3 watery or loose stools in 24 h; severity score measured by <LINK REF="STD-Clark-1988" TYPE="STUDY">Clark 1988</LINK> (modified Duffy 1986) scale</P>
<P>Laboratory studies: stool analysis by latex agglutination and ELISA; serology by plaque reduction neutralization assay</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:42:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gothefors-1989">
<CHAR_METHODS MODIFIED="2008-10-28 16:45:43 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: no details</P>
<P>Data collection: started December 1984, lasted 2 winter seasons</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 2\106 excluded for infection with serotype distinct from vaccine strain</P>
<P>Follow-up period: 2 winter seasons.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:45:56 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 4 to 12 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:24:07 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU18006), 1 ml vaccine diluted 1\10 orally, single dose (n = 54)</P>
<P>2. Placebo (distilled water with added color), single dose (n = 52)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:24:09 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 1 week of vaccination</P>
<P>2. Efficacy: diarrhoea within 2 winter seasons (rotavirus or other)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:42:19 +0000" MODIFIED_BY="[Empty name]">
<P>Country: Sweden</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea defined as &#8805; 3 watery or loose stools in 24 h, clinically significant diarrhoea defined as &gt; 3 loose stools\24 h and symptoms &gt; 48 h, WHO criteria</P>
<P>Laboratory studies: stool analysis and serology by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:57:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hanlon-1987">
<CHAR_METHODS MODIFIED="2008-11-09 14:56:54 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: none (one group not blinded because of IM vaccination)</P>
<P>Data collection: January 1985 to March 1986</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 180\433 excluded (absent during epidemic period or too young to be vaccinated)</P>
<P>Follow-up period: 7 days after vaccination; 1 rotavirus season</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-28 16:48:05 +0000" MODIFIED_BY="[Empty name]">
<P>Age: &gt; 2.5 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: OPV and IPV given with rotavirus vaccine, no further details</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:24:25 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237) 10^7.8 per monodose vial and OPV, 3 doses (n = 78)</P>
<P>2. Bovine (RIT 4237) 10^7.8 per monodose vial and IPV, 3 doses (n = 92)</P>
<P>3. Placebo (uninfected primary monkey kidney cells) 0.5 ml and OPV, 3 doses (n = 83)</P>
<P>Vaccine given with OPV or IM polio vaccine</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:24:22 +0000" MODIFIED_BY="[Empty name]">
<P>1. Efficacy: diarrhoea (rotavirus) within 1 rotavirus season</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:57:05 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Gambia</P>
<P>Mothers encouraged to breastfeed before and after vaccination</P>
<P>Clinical symptoms: clinical evaluation; diarrhoea defined as &#8805; 3 loose to watery stools in 24 h); severity measured by WHO criteria (fever (&#8805; 38 ºC) vomiting, dehydration, &gt; 6 stools in 24 h, and illness duration &#8805; 24 h)</P>
<P>Laboratory studies: stool analysis by ELISA and silver staining polyacrylamide gel technique; serology by standard viral neutralization methods</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:57:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ho-1989">
<CHAR_METHODS MODIFIED="2008-10-29 10:20:39 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double for 2 groups (no further details)</P>
<P>Data collection: September 1987 to January 1988</P>
<P>Intention to treat: no information</P>
<P>Interim analysis: no information</P>
<P>Exclusion from analysis: no information</P>
<P>Follow-up period: 5 days after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 10:21:35 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 3 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: DPT/OPV given with RRV in one group, and 2 weeks apart in a second group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:25:27 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU18006) 10^4 PFU alone, single dose (n = 30).</P>
<P>2. Rhesus (MMU18006) 10^4 PFU with OPV/DTP, single dose (n = 36)</P>
<P>3. Placebo (soybean formula) with OPV/DTP single dose (n = 36)</P>
<P>400 mg sodium bicarbonate in 30 ml soybean formula given before vaccine or placebo</P>
<P>1 group received the vaccine together with OPV\DTP (this group received acetaminophen prophylactically for 24 h)</P>
<P>The second group received the vaccine after 2 weeks of OPV\DTP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:25:31 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 5 days of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:57:07 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Breast or bottle feeding delayed for 1 h before and after RV</P>
<P>Clinical symptoms: clinical evaluation (irritability defined as &gt; 20 minutes unexplained crying, gastroenteritis defined as diarrhoea and vomiting)</P>
<P>Laboratory studies: serology by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:57:08 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ing-1991">
<CHAR_METHODS MODIFIED="2008-10-29 10:23:57 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: prepared randomization schedule</P>
<P>Allocation concealment: no details</P>
<P>Blinding: none</P>
<P>Data collection: January 1989 to November 1989</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: none</P>
<P>Follow-up period: 5 days after vaccination; 2 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 10:24:03 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1.5 to 4 months</P>
<P>Health status: healthy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:25:40 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human tetravalent vaccine (RRV-TV), 4 x 10^5 PFU, with OPV/DTP vaccination, single dose (n = 135).</P>
<P>2. OPV/DTP alone (n = 39)</P>
<P>400 mg sodium bicarbonate in 25 ml soybean formula given before vaccine</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:25:47 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 5 days of vaccination</P>
<P>2. Illness or diarrhoea within 2 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:57:08 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 loose to watery stools in 24 h)</P>
<P>Laboratory studies: serology by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Joensuu-1997">
<CHAR_METHODS MODIFIED="2008-10-29 10:25:23 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: computer-generated randomization schedule, blocks of four, provided by the pharmaceutical industry</P>
<P>Allocation concealment: code sent to investigator in sealed envelopes and returned to pharmaceutical industry unbroken at the end of the study</P>
<P>Blinding: double (except 4th year of follow up), identically appearing vaccine and placebo</P>
<P>Data collection: September 1993 to June 1997</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 38\2398 excluded, no further details</P>
<P>Follow-up period: 5 days after vaccination; 4 rotavirus seasons after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 10:25:42 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1.5 to 4.5 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: all other vaccinations given according to schedule without delays</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:25:55 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human tetravalent vaccine (RRV-TV), 4 x 10^5 PFU, 3 doses (n = 1191)</P>
<P>2. Placebo (tissue culture fluid), 3 ml, 3 doses (n = 1207)</P>
<P>3 ml sodium bicarbonate and citric acid buffer given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:26:01 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 5 days of vaccination.</P>
<P>2. Efficacy: gastroenteritis (rotavirus or other) within 4 rotavirus seasons</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:46:46 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Clinical symptoms: clinical evaluation (gastroenteritis defined as &#8805; 3 looser than normal stools or &#8805; 3 loose stools and one vomiting episode in 24 h); severity score measured by <LINK REF="STD-Ruuska-1990" TYPE="STUDY">Ruuska 1990</LINK> scale</P>
<P>Laboratory studies: stool analysis by ELISA and PCR; serology by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:57:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lanata-1989">
<CHAR_METHODS MODIFIED="2008-10-29 10:26:43 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (identical pre-coded vials)</P>
<P>Data collection: November 1984 to July 1986</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 32\43 excluded for not receiving all 3 doses; 50/391 did not finish surveillance (8 deaths, no details)</P>
<P>Follow-up period: 7 days after vaccination; 18 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-11-09 14:57:09 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 18 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: 50 to 75% (vaccinees only)</P>
<P>Immunization status: no information</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 liquid or semi-liquid stools in 24 h), WHO dehydration criteria used</P>
<P>Laboratory studies: stool analysis by ELISA; serology by CF.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:26:19 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^8.3 TCID50, 3 doses (n = 358 child years).</P>
<P>2. Placebo (uninfected primary monkey kidney cells), 0.5 ml, 3 doses (n = 127 child years)</P>
<P>100 ml evaporated milk given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:26:15 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
<P>2. Efficacy: diarrhoea within 18 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 10:27:20 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Peru</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:43:02 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lanata-1996a">
<CHAR_METHODS MODIFIED="2008-10-29 10:27:45 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: 12 letter codes allocated by block randomization</P>
<P>Allocation concealment: code kept at NIH and WHO, and not revealed until study ended</P>
<P>Blinding: double (identical appearing vaccine and placebo vials)</P>
<P>Data collection: August 1987 to October 1990</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 115\800 not followed 24 months (13 deaths unrelated to vaccine)</P>
<P>Follow-up period: 6 days after vaccination; 24 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 10:28:36 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: DPT and OPV vaccination began 1 month after rotavirus vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:26:42 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU18006) 10^4 PFU, single dose (n = 200)</P>
<P>2. Rhesus + human (D x RRV) 10^4 PFU, single dose (n = 200)</P>
<P>3. Rhesus + human (DS1 x RRV), 10^4 PFU, single dose (n = 200)</P>
<P>4. Placebo (milk or minimum essential media), single dose (n = 200)</P>
<P>400 mg sodium bicarbonate in 30 ml milk given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:26:37 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 6 days of vaccination.</P>
<P>2. Efficacy: diarrhoea (rotavirus or other) within 24 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:43:02 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Peru</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 liquid or semi-liquid stools in 24 h), WHO dehydration criteria used</P>
<P>Laboratory studies: stool analysis by ELISA; serology by ELISA and plaque reduction neutralization assay</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:57:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lanata-1996b">
<CHAR_METHODS MODIFIED="2008-10-29 10:30:06 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: computerized randomization, blocks of 12</P>
<P>Allocation concealment: pre-coded vessels administered sequentially to children; code kept at pharmaceutical industry and not broken until end of study</P>
<P>Blinding: double (identical appearing vaccine and placebo vials)</P>
<P>Data collection: October 1988 to October 1990</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 60\700 excluded for not completing 3 doses of vaccine; 60\640 not followed for 24 months (6 deaths unrelated to vaccine)</P>
<P>Follow-up period: 6 days after vaccination; 24 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 10:30:23 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: DPT and polio vaccinations given with RRV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-29 10:30:37 +0000" MODIFIED_BY="[Empty name]">
<P>Rhesus + human tetravalent vaccine (RRV + D x RRV + DS1 x RRV + ST3 x RRV), 10^4 PFU, 3 doses (n = 467)</P>
<P>Placebo (uninfected cell cultures), 1 ml, 3 doses (n = 232)</P>
<P>400 mg sodium bicarbonate in 30 ml milk given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:27:04 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 6 days of vaccination</P>
<P>2. Efficacy: diarrhoea (rotavirus or other) within 24 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:57:09 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Peru</P>
<P>Breastfeeding withheld for 1 h before and after RV</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 liquid or semi-liquid stools in 24 h), WHO dehydration criteria used; severity score measured by Kapikian's scale (modified <LINK REF="REF-Flores-1987" TYPE="REFERENCE">Flores 1987</LINK>)</P>
<P>Laboratory studies: stool analysis by ELISA; serology by ELISA and plaque reduction neutralization assay</P>
<P>Children were concurrently immunized with IPV, DTP, BCG (at birth), and MMR</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:57:11 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Linhares-1996">
<CHAR_METHODS MODIFIED="2008-10-29 10:31:30 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: block randomization, numbered serially</P>
<P>Allocation concealment: code kept by pharmaceutical industry and WHO and not broken until end of study</P>
<P>Blinding: double (identical appearing vaccine and placebo vials)</P>
<P>Data collection: February 1990 to January 1991</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 74\540 not followed 24 months (8 deaths, no further details)</P>
<P>Follow-up period: 7 days after each vaccination; 24 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-11-09 14:57:11 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1 to 2 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: OPV vaccine given at least 15 days before or after RRV<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:27:16 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human tetravalent vaccine (RRV-TV), 10^4 PFU, 3 doses (n = 270)</P>
<P>2. Placebo (uninfected cell cultures), 1.2 ml, 3 doses (n = 270)</P>
<P>400 mg sodium bicarbonate in 30 ml milk given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:27:21 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination.</P>
<P>2. Efficacy: diarrhoea (rotavirus or other) within 24 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:43:13 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Brazil</P>
<P>Breastfeeding or bottle feeding withheld for 1 h before or after vaccine</P>
<P>OPV given at an interval of at least 2 weeks before or after RV</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 liquid or semi-liquid stools in 24 h), WHO dehydration criteria used; severity score measured by Flores scale</P>
<P>Laboratory studies: stool analysis by ELISA; serology by ELISA and plaque reduction neutralization assay</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:43:25 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Madore-1992">
<CHAR_METHODS MODIFIED="2008-10-29 10:36:09 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: table of random numbers</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (identical placebo and vaccine vials)</P>
<P>Data collection: 15 September 1987 to 8 August 1990</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Excluded subjects: none</P>
<P>Follow-up period: 10 days after vaccination; 3 years after enrolment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 10:36:19 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 4 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: DPT and OPV vaccinations not given 4 weeks before and 3 weeks after RRV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:28:00 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU 18006), 10^4 PFU, single dose (n = 76)</P>
<P>2. Rhesus + human (RRV x D), 10^4 PFU, single dose (n = 74)</P>
<P>3. Placebo (soy formula), 1 ml single dose (n = 73)</P>
<P>400 mg sodium bicarbonate in 30 ml soy formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:27:57 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 10 days of vaccination</P>
<P>2. Efficacy: gastroenteritis (rotavirus or other) within 3 years of enrolment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:43:25 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 loose stools in 24 h), severity measured by WHO criteria (fever (&#8805; 38) vomiting, dehydration, &gt; 6 stools in 24 h and illness duration &#8805; 24 h)</P>
<P>Laboratory studies: serology by micro-neutralization assay and ELISA; stool analysis by ELISA</P>
<P>All other vaccines withheld for 4 weeks before and 3 weeks after RV</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:28:27 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maldonado-1986">
<CHAR_METHODS MODIFIED="2008-10-29 10:57:55 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: block randomization 2:2:1</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (coded preparations)</P>
<P>Data collection: enrolment between June 1984 and January 1985, no further details</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 11\54 excluded for non-compliance</P>
<P>Follow-up period: 7 days before and 7 days after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 10:58:02 +0000" MODIFIED_BY="[Empty name]">
<P>Age: &lt; 1 month</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:28:23 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^8 TCID50, 2 doses (n = 19)</P>
<P>2. Bovine (RIT 4237), 10^7 TCID50, 2 doses (n = 20)</P>
<P>3. Placebo (uninfected tissue culture fluid), 0.5 ml, 2 doses (n = 10)</P>
<P>Formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:28:27 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 11:04:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as any noticeable change in frequency of stools or development of of watery/loose stools)</P>
<P>Laboratory studies: serology by plaque reduction neutralization; stool analysis by ELISA<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:28:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mutz-1989">
<CHAR_METHODS MODIFIED="2008-10-29 11:04:56 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: confirmed by investigator, no further details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (confirmed by investigator), no further details</P>
<P>Data collection: no details</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: no details</P>
<P>Follow-up period: 3 to 4 weeks after vaccination; 6 months after end of safety period</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 11:05:07 +0000" MODIFIED_BY="[Empty name]">
<P>Age: &gt; 1 month</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:28:34 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^6.5 TCID50, 1 dose (n = 243)</P>
<P>2. Placebo (n = 103), no further details</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:28:37 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 3 to 4 weeks of vaccination</P>
<P>2. Efficacy: diarrhoea within 6 months of safety period ending</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 11:12:26 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Austria</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology by ELISA; stool analysis (no details)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:43:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez_x002d_Schael-1990a">
<CHAR_METHODS MODIFIED="2008-10-29 11:28:10 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: code assigned to vials</P>
<P>Allocation concealment: vials administered serially to participants; codes partially disclosed at NIH before end of trial to analyse reactions to vaccine, and kept at NIH until end of study</P>
<P>Blinding: double (vaccine and placebo looked alike)</P>
<P>Data collection: vaccination between February 1985 and February 1986, end of study February 1987</P>
<P>Intention to treat: no</P>
<P>Interim analysis: yes, after phase 1</P>
<P>Exclusion from analysis: 63\320 dropped from follow up</P>
<P>Follow-up period: 1 week after vaccination, 1 year after safety period</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 11:28:19 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1 to 10 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:28:45 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU-18006), 10^4 PFU, single dose (n = 151)</P>
<P>2. Placebo (buffered formula), single dose (n = 151)</P>
<P>400 mg citrate-bicarbonate in 30 ml similac formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:28:49 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 1 week of vaccination</P>
<P>2. Efficacy: diarrhoea within 1 year of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:43:33 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Venezuela</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 watery or loose stools in 24 h)</P>
<P>Laboratory studies: serology by ELISA and plaque reduction neutralization assay; stool analysis by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:29:00 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez_x002d_Schael-1990c">
<CHAR_METHODS MODIFIED="2008-10-29 11:30:48 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: code, no further details</P>
<P>Allocation concealment: code broken at NIH after completion of safety analysis but not disclosed to field team</P>
<P>Blinding: double, no further details</P>
<P>Data collection: no information</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: yes, doses were evaluated sequentially</P>
<P>Exclusion from analysis: none</P>
<P>Follow-up period: 1 week after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 11:31:57 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2.5 to 5 months</P>
<P>Health status: no debilitating disease</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:28:57 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human quadrivalent vaccine (3 RRV + D x RRV + DS1 x RRV + ST3 x RRV), 0.25 x 10^4 PFU or 0.5 x 10^4 PFU or 10^4 PFU, single dose (n = 67)</P>
<P>2. Placebo (buffered formula), single dose (n = 63)</P>
<P>400 mg citrate-bicarbonate in 30 ml similac formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:29:00 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 1 week of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 11:29:14 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Venezuela</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology by ELISA and plaque reduction neutralization assay; stool analysis by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:29:14 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez_x002d_Schael-1994">
<CHAR_METHODS MODIFIED="2008-10-29 11:33:00 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: confirmed by letter to author, no further details.</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (confirmed by letter to author), no further details</P>
<P>Data collection: no details</P>
<P>Intention to treat: no details</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: no details</P>
<P>Follow-up period: 1 week after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 11:33:12 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2.5 to 5 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:29:09 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human quadrivalent vaccine (3 RRV + D x RRV + DS1 x RRV + ST3 x RRV), 10^4 PFU or 5 x 10^4 PFU, 2 doses (n = 87)</P>
<P>2. Placebo, 2 doses (n = 82), no further details</P>
<P>400 mg bicarbonate in 30 ml similac formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:29:13 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 1 week of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 11:33:36 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Venezuela</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology by ELISA and plaque reduction neutralization assay; stool analysis by ELISA and cultures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez_x002d_Schael-1997">
<CHAR_METHODS MODIFIED="2008-10-29 11:34:04 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: computerized randomization algorithm that balanced the number of children in groups of 500 numbers</P>
<P>Allocation concealment: sequential code numbers</P>
<P>Blinding: double (identical looking vaccine and placebo)</P>
<P>Data collection: March 1992 to October 1995</P>
<P>Intention to treat: yes for safety, no for efficacy</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 443\2480 dropped from study, similar distribution in vaccine and placebo groups according to author, no further details</P>
<P>Follow-up period: 6 days after each vaccination; 19 to 20 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 11:34:23 +0000" MODIFIED_BY="[Empty name]">
<P>Age: newborns (&lt; 1 month)</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &gt; 75%</P>
<P>Immunization status: DPT vaccination given with RRV, OPV not given within 2 to 4 weeks of RRV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:32:31 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human quadrivalent vaccine (RRV-TV), 4 x 10^5 PFU, 3 doses (n = 1247)</P>
<P>2. Placebo (uninfected tissue culture fluids), 2.5 ml, 3 doses (n = 1233)</P>
<P>400 mg citrate-bicarbonate in 30 ml similac formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:32:38 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 6 days of vaccination</P>
<P>2. Efficacy: gastroenteritis within 19 to 20 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Venezuela</P>
<P>Clinical symptoms: clinical evaluation (gastroenteritis defined as &#8805; 3 watery or loose stools or 1 bloody stool with or without vomiting in 24 h); WHO dehydration criteria used; severity score measured by <LINK REF="STD-Ruuska-1990" TYPE="STUDY">Ruuska 1990</LINK> scale</P>
<P>Laboratory studies: stool analysis by ELISA and PCR; serology by ELISA</P>
<P>Children were concurrently immunized with DTP; IPV was separated from RV by at least 2 weeks</P>
<P>85 to 95% of children were breastfeeding while receiving at least 1 of the doses of RV</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez_x002d_Schael-2002">
<CHAR_METHODS MODIFIED="2008-10-29 12:19:11 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double, no further details</P>
<P>Data collection: no details</P>
<P>Intention to treat: no details</P>
<P>Interim analysis: yes</P>
<P>Exclusion from analysis: no details</P>
<P>Follow-up period: 6 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:18:44 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1.5 to 3 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: DPT, HBV, and HiB vaccination given with RRV; OPV not given within 2 weeks of RRV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:32:59 +0000" MODIFIED_BY="[Empty name]">
<P>1. Human 89-12 (RIX4414) 105.0 PFU/dose, 2 doses (n = 493)</P>
<P>2. Human 89-12 (RIX4414) 105.5 PFU/dose, 2 doses (n = 496)</P>
<P>3. Human 89-12 (RIX4414) 106.0 PFU/dose, 2 doses (n = 493)</P>
<P>4. Placebo, 2 doses (n = 504), no further details</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:32:43 +0000" MODIFIED_BY="[Empty name]">
<P>1. Efficacy: rotavirus gastroenteritis within 6 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Venezuela, Brazil, Mexico</P>
<P>Clinical symptoms: clinical evaluation; severity score measured by <LINK REF="STD-Ruuska-1990" TYPE="STUDY">Ruuska 1990</LINK> scale</P>
<P>Laboratory studies: stool analysis by ELISA</P>
<P>Data taken from poster presented at ICAAC 2002</P>
<P>This is an interim analysis of an ongoing trial</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:43:50 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pichichero-1990">
<CHAR_METHODS MODIFIED="2008-10-29 12:20:16 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: code supplied by pharmaceutical industry</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (coded vials)</P>
<P>Data collection: before September 1987, no further details</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 1\96 gave only safety information because of no consent</P>
<P>Follow-up period: 1 week after each vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:20:32 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 5 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: no medication given within 2 weeks before vaccination<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:33:18 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU 18006), 10^3 PFU, single dose (n = 22)</P>
<P>2. Rhesus (MMU 18006), 10^4 PFU, single dose (n = 25)</P>
<P>3. Rhesus (MMU 18006), 10^5 PFU, single dose (n = 23)</P>
<P>4. Placebo (buffered formula), 1ml, single dose (n = 25)</P>
<P>Half the infants received 30 ml formula before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:33:07 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:43:50 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>All feedings withheld for 1 h before and after RV</P>
<P>Clinical symptoms: clinical evaluation (diarrhea defined as &#8805; 3 looser than usual stools in 24 h)</P>
<P>Laboratory studies: serology by ELISA and plaque reduction neutralization assay; stool analysis by ELISA and cultures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:57:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pichichero-1993">
<CHAR_METHODS MODIFIED="2008-10-29 12:26:48 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (identical appearing vials)</P>
<P>Data collection: 31 May 1988 to 2 March 1988</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 1\213 did not supply safety information</P>
<P>Follow-up period: 1 week after each vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:28:52 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1.5 to 4 months</P>
<P>Health status: healthy</P>
<P>Breast feeding: &gt; 75%</P>
<P>Immunization status: no medication given within 2 weeks before vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:43:57 +0000" MODIFIED_BY="[Empty name]">
<P>1. RRV S1, 10^4 or 10^5 PFU, single dose (n = 40)</P>
<P>2. RRV S2, 10^4 or 10^5 PFU, single dose (n = 37)</P>
<P>3. RRV S3, 10^4 or 10^5 PFU, single dose (n = 39)</P>
<P>4. RRV S4, 10^4 or 10^5 PFU, single dose (n = 39)</P>
<P>5. RRV-TV, 10^4 or 10^5 PFU, single dose (n = 38)</P>
<P>6. Placebo, single dose (n = 19), no details</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:33:23 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:57:13 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>No buffer or formula given with vaccine; feeding allowed after vaccination</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 looser than usual stools in 24 h)</P>
<P>Laboratory studies: serology by ELISA and plaque reduction neutralization</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:44:06 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rennels-1987">
<CHAR_METHODS MODIFIED="2008-10-29 12:30:59 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: code, no further details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (coded preparations)</P>
<P>Data collection: May 1985 to October 1985</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Excluded subjects: none</P>
<P>Follow-up period: 7 days after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:31:04 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 3 to 12 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: no other vaccines allowed within 2 weeks of vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:33:50 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU 18006), 10^4 PFU, single dose (n = 12)</P>
<P>2. Rhesus (MMU 18006), 10^3 PFU, single dose (n = 8)</P>
<P>3. Placebo (buffered formula), 1 ml, single dose (n = 11)</P>
<P>400 mg sodium bicarbonate in 30 ml formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:33:43 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:44:06 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Breastfeeding or bottle feeding withheld for 1 h before or after vaccine</P>
<P>Clinical symptoms: clinical evaluation (diarrhea defined as &#8805; 3 loose stools in 24 h)</P>
<P>Laboratory studies: serology by plaque reduction neutralization assay; stool analysis by ELISA and cultures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rennels-1990">
<CHAR_METHODS MODIFIED="2008-10-29 12:31:50 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (coded preparations)</P>
<P>Data collection: no information</P>
<P>Interim analysis: none</P>
<P>Excluded subjects: 2\114 did not complete surveillance</P>
<P>Follow-up period: 7 days after vaccination, 2 years after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:32:00 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 5 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: all other vaccinations not given within 2 weeks of RRV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:34:03 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU 18006), 10^4 PFU, single dose (n = 64)</P>
<P>2. Placebo (formula), single dose (n = 50)</P>
<P>30 ml formula containing 400 mg sodium bicarbonate given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:33:59 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination.</P>
<P>2. Efficacy: diarrhoea (rotavirus or other) within 2 years of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 looser than normal stools in 24 h); severity score measured by <LINK REF="REF-Flores-1987" TYPE="REFERENCE">Flores 1987</LINK> scale</P>
<P>Laboratory studies: serology by plaque reduction neutralization assay; stool analysis by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:44:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rennels-1995">
<CHAR_METHODS MODIFIED="2008-10-29 12:33:54 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double, no further details</P>
<P>Data collection: vaccination between 10 August 1989 and 16 July 1990</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Excluded participants: 173\989 did not complete surveillance</P>
<P>Follow-up period: 2 years after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:34:14 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1 to 6.5 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:34:16 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human monovalent vaccine (RRV-S1), 4 x 10^4 PFU, 3 doses (n = 280)</P>
<P>2. Rhesus + human quadrivalent vaccine (RRV-TV), 4 x 10^4 PFU, 3 doses (n = 264)</P>
<P>3. Placebo (tissue culture medium), 3 doses (n = 272)</P>
<P>30 ml formula containing 400 mg sodium bicarbonate given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:34:09 +0000" MODIFIED_BY="[Empty name]">
<P>1. Efficacy: gastroenteritis (rotavirus related) within 2 years of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:44:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation (gastroenteritis defined as &#8805; 3 loose stools in 24 h or emesis)</P>
<P>Laboratory studies: serology by ELISA and fluorescent focus reduction assay</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rennels-1996">
<CHAR_METHODS MODIFIED="2008-10-29 12:35:28 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: code provided by pharmaceutical industry, no further details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (identical appearing vials)</P>
<P>Data collection: vaccination between 5 July 1991 and 24 January 1992</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Excluded participants: 91\1278 did not complete efficacy surveillance</P>
<P>Follow-up period: 5 days after vaccination, 1 rotavirus season after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:35:43 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1.25 to 6.25 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: all other vaccines allowed with RRV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:34:33 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human monovalent vaccine (RRV-S1), 4 x 10^5 PFU, 3 doses (n = 425)</P>
<P>2. Rhesus + human quadrivalent vaccine (RRV-TV), 4 x 10^5 PFU, 3 doses (n = 428)</P>
<P>3. Placebo (tissue culture medium), 3 doses (n = 425)</P>
<P>3 ml sodium bicarbonate given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:34:26 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 5 days of vaccination</P>
<P>2. Efficacy: gastroenteritis (rotavirus or other) within 1 rotavirus season</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 loose stools in 24 h; gastroenteritis defined as diarrhea, vomiting, or both); severity score measured by <LINK REF="STD-Rennels-1996" TYPE="STUDY">Rennels 1996</LINK> (modified <LINK REF="REF-Flores-1987" TYPE="REFERENCE">Flores 1987</LINK>) scale</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
<P>Other vaccines allowed with RV but not required</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:34:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ruuska-1990">
<CHAR_METHODS MODIFIED="2008-10-29 12:38:25 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (identical vaccine and placebo appearance)</P>
<P>Data collection: October 1984 to June 1987</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 22% of first group and 13% of second group did not finish follow up, no further details</P>
<P>Follow-up period: 7 days after vaccination, 24 to 32 months after safety period</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:38:40 +0000" MODIFIED_BY="[Empty name]">
<P>Age: newborns</P>
<P>Health status: healthy</P>
<P>Immunization status: no vaccine except BCG given before rotavirus vaccine</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:34:47 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^8.3 TCID, single dose (n = 519 person years)</P>
<P>2. Placebo (uninfected tissue culture), single dose (n = 481 person years)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:34:42 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
<P>2. Efficacy: diarrhoea within 2 seasons of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 12:39:00 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Clinical symptoms: definitions and laboratory methods mentioned in different paper</P>
<P>No buffer or formula given with vaccine</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:44:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Santosham-1991a">
<CHAR_METHODS MODIFIED="2008-10-29 12:39:14 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: table of random numbers</P>
<P>Blinding: no details</P>
<P>Data collection: 1 January 1992 to 31 January 1994</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 11/332 were not followed because the left the area</P>
<P>Follow-up period: 5 days after vaccination, 17 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:39:25 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 5 months</P>
<P>Health status: no illness or immunodeficiency</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: OPV vaccination not given within 3 weeks of rotavirus vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:34:56 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU18006), 10^4 PFU, single dose (n = 108)</P>
<P>2. Placebo (soy formula), 1 ml, single dose (n = 107)</P>
<P>400 mg sodium bicarbonate in 30 ml soy formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:35:01 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 5 days of vaccination.</P>
<P>2. Efficacy: diarrhoeal illness (rotavirus or other) within 17 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:44:29 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: diarrhoea &#8805; 3 watery stools in 24 h</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
<P>OPV given at an interval of at least 3 weeks before or after RV</P>
<P>Breastfeeding allowed during vaccination</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Santosham-1991b">
<CHAR_METHODS MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Santosham-1991a" TYPE="STUDY">Santosham 1991a</LINK> and 1991b are two arms of a single trial</P>
<P>See <LINK REF="STD-Santosham-1991a" TYPE="STUDY">Santosham 1991a</LINK> for details</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>See <LINK REF="STD-Santosham-1991a" TYPE="STUDY">Santosham 1991a</LINK> for details</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:35:08 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^8 PFU, single dose (n = 106)</P>
<P>2. Placebo (soy formula), 1 ml, single dose (n = 107)</P>
<P>400 mg sodium bicarbonate in 30 ml soy formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>See <LINK REF="STD-Santosham-1991a" TYPE="STUDY">Santosham 1991a</LINK> for details</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>See <LINK REF="STD-Santosham-1991a" TYPE="STUDY">Santosham 1991a</LINK> for details</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Santosham-1997">
<CHAR_METHODS MODIFIED="2008-10-29 12:41:20 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: blocks of 6 to receive either RRV-TV, RRV-S1, or placebo. Packages containing 3 doses of study drug, code-labelled, were provided to the study sites</P>
<P>Allocation concealment: schedule generated by the biostatistics division at Wyeth Ayerst</P>
<P>Blinding: no details</P>
<P>Data collection: enrolment between September 1985 and February 1987, no further details</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 101/1185 did not complete 2 years follow up, 171\1084 did not complete 2 years follow up, no further details</P>
<P>Follow-up period: 5 days after vaccination, 2 years after beginning of trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:41:33 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 1.5 to 6 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: all other vaccines allowed with RRV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:35:27 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human tetravalent vaccine (RRV-TV), 10^5 PFU, 3 doses (n = 396)</P>
<P>2. Rhesus + human monovalent vaccine (RRV-S1), 4 x 10^5 PFU, 3 doses (n = 398)</P>
<P>3. Placebo (tissue culture medium), 3 doses (n = 391)</P>
<P>3 ml sodium citrate bicarbonate given with vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:35:22 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 5 days of vaccination</P>
<P>2. Efficacy: gastroenteritis within 2 years of beginning of trial</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation (gastroenteritis defined as &#8805; 3 watery or loose stools in 24 h); severity score measured by <LINK REF="STD-Rennels-1996" TYPE="STUDY">Rennels 1996</LINK> (modified from <LINK REF="REF-Flores-1987" TYPE="REFERENCE">Flores 1987</LINK>) scale</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
<P>Simultaneous administration of routine childhood vaccines was permitted but not required</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:35:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Senturia-1987">
<CHAR_METHODS MODIFIED="2008-10-29 12:42:25 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double, no further details</P>
<P>Data collection: winter 1985 to 1986</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: none</P>
<P>Follow-up period: 1 winter season after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:42:42 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 8 to 48 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:35:39 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), single dose (n = 105), no further details</P>
<P>2. Placebo (no details), single dose (n = 106)</P>
<P>Milk drink given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:35:33 +0000" MODIFIED_BY="[Empty name]">
<P>1. Efficacy: diarrhoea (rotavirus or other) within 1 winter season of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 12:43:04 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: UK</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: stool analysis by ELISA; serology by serum neutralization</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Treanor-1995">
<CHAR_METHODS MODIFIED="2008-10-29 12:43:52 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: block 2:1 (Rochester), 1:1 (Philadelphia), no further details</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double, no further details</P>
<P>Data collection: 18 June 1992 to 15 June 1993</P>
<P>Intention to treat: no information</P>
<P>Interim analysis: no information</P>
<P>Exclusion from analysis: 13/325 did not complete the study because of relocation out of the area or negative compliance</P>
<P>Follow-up period: 7 days after vaccination, 1 winter season after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:44:03 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 8 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &lt; 50%</P>
<P>Immunization status: no other vaccine given within 7 days of rotavirus vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:35:50 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine + human (WI79-9), 10^7.3 PFU, 3 doses (n = 207).</P>
<P>2. Placebo (cell culture media and cherry syrup), 2.5 ml, 3 doses (n = 118)</P>
<P>30 ml soy or milk formula or 400 mg sodium bicarbonate in 30 ml soy formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:35:46 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
<P>2. Efficacy: gastroenteritis (rotavirus or other) within 1 winter season</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Breastfeeding and bottle feeding withheld for 1 h before and after RV</P>
<P>Clinical symptoms: clinical evaluation (gastroenteritis defined as &#8805; 1 watery stool or &#8805; 3 liquid stools and\or &#8805; 1 vomiting episode in 24 h); severity score measured by <LINK REF="STD-Clark-1988" TYPE="STUDY">Clark 1988</LINK> (modified Duffy 1986) scale</P>
<P>Laboratory studies: stool analysis by ELISA, gel electrophoresis, and PCR</P>
<P>Other vaccines given at least 7 days after RV</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:36:08 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1984">
<CHAR_METHODS MODIFIED="2008-10-29 12:44:58 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: code not available until end of study</P>
<P>Blinding: double (code-labelled vials)</P>
<P>Data collection: January 1983 to June 1983</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 12/190 did not complete vaccination or follow up</P>
<P>Follow-up period: 10 days after vaccination, 5 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 12:45:56 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 8 to 11 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:36:00 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^8.1 TCID50, single dose (n = 86)</P>
<P>2. Placebo (uninfected primary monkey kidney cells), 0.5 ml, single dose (n = 92)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:36:08 +0000" MODIFIED_BY="[Empty name]">
<P>1. Clinical symptoms within 10 days of vaccination</P>
<P>2. Diarrhoea and other gastrointestinal upsets within 5 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 12:46:05 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>No restriction on breastfeeding or bottle feeding were imposed</P>
<P>Clinical symptoms: clinical evaluation (clinically significant diarrhoea defined as watery stools &gt; 24 h)</P>
<P>Laboratory studies: serology and stool analysis ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:36:59 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1985a">
<CHAR_METHODS MODIFIED="2008-10-29 13:07:47 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: predetermined scheme</P>
<P>Allocation concealment: code unavailable until end of study</P>
<P>Blinding: double (indistinguishable vaccine and placebo)</P>
<P>Data collection: September 1983 to April 1985</P>
<P>Intention to treat: no</P>
<P>Interim analysis: yes</P>
<P>Exclusion from analysis: 19/347 were not followed until end of study</P>
<P>Follow-up period: 10 days after vaccination, 2 rotavirus season after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:08:04 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 6 to 12 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: 50 to 75%</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:36:55 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^8.1 TCID50, single dose (n = 168)</P>
<P>2. Placebo (uninfected primary monkey kidney cells), 0.5 ml, single dose (n = 163)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:36:59 +0000" MODIFIED_BY="[Empty name]">
<P>1. Clinical symptoms within 10 days of vaccination</P>
<P>2. Diarrhoea and other gastrointestinal upsets within 2 rotavirus seasons of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 13:08:43 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Clinical symptoms: clinical evaluation (clinically significant diarrhoea defined as diarrhoea requiring rehydration)</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
<P>No specific orders concerning feeding</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:57:14 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1986a">
<CHAR_METHODS MODIFIED="2008-11-09 14:57:14 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: coded list of the 2 vaccines</P>
<P>Allocation concealment: code not broken until end of trial</P>
<P>Blinding: double (parents and paediatricians unaware of the code)</P>
<P>Data collection: vaccination between 10 December 1984 and 17</P>
<P>December 1984, no further details</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 2/51 excluded for lost incomplete data</P>
<P>Follow-up period: 7 days after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:09:19 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 8 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:37:06 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^8.3 TCID50, single dose (n = 24)</P>
<P>2. Rhesus (MMU18006), 10^5 PFU, single dose (n = 25)</P>
<P>Ordinary meal or breast milk given before vaccines</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:37:08 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 13:09:34 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Clinical symptoms: clinical evaluation, no definitions given</P>
<P>Laboratory studies: serology by ELISA CF and plaque reduction neutralization assay; stool analysis by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:57:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1987b">
<CHAR_METHODS MODIFIED="2008-10-29 13:09:57 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: done at pharmaceutical industry</P>
<P>Allocation concealment: code kept at pharmaceutical industry until end of study</P>
<P>Blinding: double (identical vaccine and placebo appearance).</P>
<P>Data collection: enrolment at October 1984</P>
<P>Intention to treat: no information</P>
<P>Interim analysis: yes</P>
<P>Exclusion from analysis: no information</P>
<P>Follow-up period: 10 days after vaccination, 16 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:10:06 +0000" MODIFIED_BY="[Empty name]">
<P>Age: newborns</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &gt; 75%</P>
<P>Immunization status: no other vaccine given before rotavirus vaccination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:37:14 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^8.3 TCID50, single dose (n = 119)</P>
<P>2. Placebo (uninfected tissue culture fluid), 0.6 ml, single dose (n = 120)</P>
<P>Ordinary meal or breast milk given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:37:20 +0000" MODIFIED_BY="[Empty name]">
<P>1. Clinical symptoms within 10 days of vaccination</P>
<P>2. Diarrhoea (rotavirus or other) within 16 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:57:16 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Clinical symptoms: clinical evaluation, no definitions given</P>
<P>Laboratory studies: stool analysis and serology by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:45:02 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1990">
<CHAR_METHODS MODIFIED="2008-10-29 13:10:56 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: code kept at WHO until end of trial</P>
<P>Blinding: double (identical vaccine and placebo appearance)</P>
<P>Data collection: July 1985 to June 1987</P>
<P>Intention to treat: yes to efficacy, no to safety</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 5/200 did not finish safety follow up</P>
<P>Follow-up period: 7 days after vaccination, 2 rotavirus seasons after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:11:01 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 5 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &gt; 75%</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:37:28 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU18006), 10^4 PFU, single dose (n = 100).</P>
<P>2. Placebo (minimal essential medium), 1 ml, single dose (n = 100)</P>
<P>30 ml soy milk formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:37:33 +0000" MODIFIED_BY="[Empty name]">
<P>1. Clinical symptoms within 7 days of vaccination</P>
<P>2. Diarrhoea (rotavirus or other) within 2 rotavirus seasons</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:45:02 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Most of the infants were breastfed. Feeding withheld for 90 minutes before vaccination and 2 h after vaccination</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 unformed stools); severity score by Vesikary 1990 scale</P>
<P>Laboratory studies: stool analysis by ELISA; serology by plaque reduction neutralization assay and tube neutralization assay</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1991a">
<CHAR_METHODS MODIFIED="2008-10-29 13:12:07 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: sequentially numbered code from 1 to 252</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (identical vaccine and placebo appearance)</P>
<P>Data collection: February 1985 to June 1987</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 41/252 did not finish follow up</P>
<P>Follow-up period: 2 rotavirus seasons</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:12:14 +0000" MODIFIED_BY="[Empty name]">
<P>Age: newborns</P>
<P>Health status: healthy</P>
<P>Breastfeeding: &gt; 75%</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:37:42 +0000" MODIFIED_BY="[Empty name]">
<P>1. Bovine (RIT 4237), 10^8.3 TCID50, 2 doses (n = 244 person years)</P>
<P>2. Placebo (uninfected tissue culture fluid), 2 doses (n = 217 person years)</P>
<P>0.5% sodium bicarbonate in 50 ml 5% glucose solution given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:37:37 +0000" MODIFIED_BY="[Empty name]">
<P>1. Diarrhoea (rotavirus or other) within 2 rotavirus seasons</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>All infants breastfed at first vaccination, 64% breastfed at second vaccination</P>
<P>Clinical symptoms: clinical evaluation, severity score by <LINK REF="STD-Ruuska-1990" TYPE="STUDY">Ruuska 1990</LINK> scale</P>
<P>Laboratory studies: stool analysis by latex test and ELISA; serology by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1991b">
<CHAR_METHODS MODIFIED="2008-10-29 13:13:01 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: computer-generated randomization list</P>
<P>Allocation concealment: code kept at WHO, not available until end of trial</P>
<P>Blinding: double, no further details</P>
<P>Data collection: October 1989 to June 1990</P>
<P>Intention to treat: yes for efficacy, no for safety</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 2/282 excluded from safety analysis.</P>
<P>Follow-up period: 7 days after vaccination, 6 to 8 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:13:12 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 7 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: all other vaccinations not given within 2 weeks of rotavirus vaccination<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:37:56 +0000" MODIFIED_BY="[Empty name]">
<P>1. Human (M37), 10^4 PFU, (n = 102) single dose</P>
<P>2. Human (M37), 10^5 PFU, (n = 39) single dose</P>
<P>3. Placebo (dilution medium), single dose (n = 141)</P>
<P>400 mg sodium bicarbonate in 30 ml soy milk formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:37:50 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination.</P>
<P>2. Efficacy: diarrhoea (rotavirus or other) within 6 to 8 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 watery or loose stools in 24 h); severity score by <LINK REF="STD-Ruuska-1990" TYPE="STUDY">Ruuska 1990</LINK> scale</P>
<P>Laboratory studies: stool analysis by ELISA; serology by ELISA and plaque reduction neutralization assay</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:38:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1991c">
<CHAR_METHODS MODIFIED="2008-10-29 13:13:57 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: randomization list</P>
<P>Allocation concealment: no details</P>
<P>Blinding: no details</P>
<P>Data collection: no information</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 6/89 excluded from analysis</P>
<P>Follow-up period: 7 days after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:14:02 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 4 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:38:07 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human monovalent vaccine (D x RRV or DS1 x RRV), 10^4 PFU, single dose (n = 61)</P>
<P>2. Placebo (dilution medium), single dose (n = 24)</P>
<P>400 mg sodium bicarbonate in 40 ml soy milk formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:38:01 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 13:14:31 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: stool analysis by ELISA; serology by ELISA and plaque reduction neutralization assay</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1992">
<CHAR_METHODS MODIFIED="2008-10-29 13:14:55 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: computer-generated randomization list</P>
<P>Allocation concealment: code kept at WHO, not available until end of trial</P>
<P>Blinding: double, no details</P>
<P>Data collection: August 1987 to June 1989</P>
<P>Intention to treat: yes for efficacy, no for safety</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: None</P>
<P>Follow-up period: 7 days after vaccination, 7 to 10 months after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:15:01 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2 to 5 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:38:21 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human monovalent vaccine (D x RRV or DS1 x RRV), 10^4 or 10^5 PFU, single dose (n = 239)</P>
<P>2. Placebo (essential medium), single dose (n = 120)</P>
<P>400 mg sodium bicarbonate in 30 ml soy milk formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:38:15 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 7 days of each dose</P>
<P>2. Efficacy: diarrhoea (rotavirus or other) within 7 to 10 months of vaccination</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Clinical symptoms: clinical evaluation (diarrhoea defined as &#8805; 3 watery or loose stools in 24 h); severity score by <LINK REF="STD-Ruuska-1990" TYPE="STUDY">Ruuska 1990</LINK> scale</P>
<P>Laboratory studies: serology and stool analysis by ELISA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:38:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-1999">
<CHAR_METHODS MODIFIED="2008-10-29 13:15:47 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: schedule generated by pharmaceutical industry</P>
<P>Allocation concealment: no details</P>
<P>Blinding: double (code-labelled package)</P>
<P>Data collection: no data</P>
<P>Intention to treat: no</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: 6\249 did not receive 3 doses because of medical problems</P>
<P>Follow-up period: 5 days after each dose</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:15:51 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 2.5 to 3.5 months</P>
<P>Health status: healthy</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: pentavalent DTP + Hib + polio vaccine and HBV vaccine given with RRV-TV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:38:29 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus + human tetravalent vaccine (RRV-TV), 4 x 10^5 PFU, 3 doses (n = 126).</P>
<P>2. Placebo (identical preparation without vaccine), 3 doses (n = 123)</P>
<P>2.5 ml citric acid and bicarbonate given with vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:38:32 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 5 days of each dose</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-29 13:16:19 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: Finland</P>
<P>Clinical symptoms: clinical evaluation, no further details</P>
<P>Laboratory studies: serology by ELISA</P>
<P>Vaccine given with pentavalent (DTP + HiB + IPV) vaccine and hepatitis B vaccine</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 14:45:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wright-1987">
<CHAR_METHODS MODIFIED="2008-10-29 13:16:37 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization: no details</P>
<P>Allocation concealment: code broken at the end of the trial, no further details</P>
<P>Blinding: yes, no details</P>
<P>Data collection: winter 1984 to spring 1986</P>
<P>Intention to treat: yes</P>
<P>Interim analysis: none</P>
<P>Exclusion from analysis: none</P>
<P>Follow-up period: 3 days before vaccination and 9 days after vaccination</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-29 13:16:43 +0000" MODIFIED_BY="[Empty name]">
<P>Age: 4 to 70 months</P>
<P>Health status: no information</P>
<P>Breastfeeding: no information</P>
<P>Immunization status: no information.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:38:40 +0000" MODIFIED_BY="[Empty name]">
<P>1. Rhesus (MMU18006), 3.6 x 10^4 to 7.5 x 10^6 TCID, single dose (n = 41)</P>
<P>2. Placebo (no details), single dose (n = 39)</P>
<P>Sodium bicarbonate tablet or in formula given before vaccine or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:38:44 +0000" MODIFIED_BY="[Empty name]">
<P>1. Safety: clinical symptoms within 9 days of vaccination</P>
<P>2. Efficacy: fever, gastrointestinal illness, and upper respiratory illness during 2 winter seasons</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:45:17 +0000" MODIFIED_BY="[Empty name]">
<P>Study location: USA</P>
<P>Clinical symptoms: clinical evaluation (fever defined as &#8805; 38.3 ºC; gastrointestinal illness defined as &gt; 3 stools in 24 h or 1 vomiting in 24 h; upper respiratory tract illness defined as any respiratory sign leading to clinical impression of illness)</P>
<P>Laboratory studies: stool analysis by cell culture and ELISA; serology by ELISA, complement fixation, immune adherence haemaglutination, and tube neutralization assays</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>Vaccines: </B>BCG: Bacillus Calmette-Guerrin vaccine; DTP: diphtheria-tetanus-pertussis vaccine; HiB: haemophilus influenza B vaccine; IPV: intramuscular polio vaccine; MMR: measles-mumps-rubella vaccine; OPV: oral polio vaccine; RRV: rhesus rotavirus vaccine; RV: rotavirus vaccine; DTCP: diphtheria-tetanus-coqueluche-polio; RRV-TV: rhesus-human reassortant rotavirus vaccine.</P>
<P>
<B>Institutions: </B>NIH: National Institute of Health; WHO: World Health Organization.</P>
<P>
<B>Serology: </B>PFU: plaque-forming units; ELISA: enzyme-linked immunosorbent assay; PCR: polymerase chain reaction; SPG: Shirasu porous glass; CF: complement fixation; TCID: tissue culture infectious doses; PAGE-SS: polyacrylamide gel electrophoresis and silver stain.</P>
<P>IM vaccination: intra-muscular vaccination; ICAAC: Interscience Conference on Antimicrobial Agents and Chemotherapy HBV: hepatitis B virus.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-11-09 14:57:44 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Ceyhan-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomization of children to breastfeed or bottle feed, not to vaccine. Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Turkey.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Christy-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.<BR/>Study design: clinical trial.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Clements_x002d_Mann-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Friedman-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized, only collected immunological data.<BR/>Study design: clinical trial.<BR/>Study location: Israel.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Giammanco-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Italy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Halsey-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.<BR/>Study design: clinical trial.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-09 14:57:44 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Isolauri-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-09 14:57:44 +0000" MODIFIED_BY="[Empty name]">
<P>Randomization of children to receive Lactobacillus casei GG or not with the rotavirus vaccine. All children received the rotavirus vaccine.<BR/>Study design: RCT.<BR/>Study location: Finland.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-09 14:57:44 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jalil-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-09 14:57:44 +0000" MODIFIED_BY="[Empty name]">
<P>Not randomized. All children received the rotavirus vaccine.<BR/>Study design: CCT.<BR/>Study location: Pakistan.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jin-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kobayashi-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kobayashi-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Losonsky-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Markwick-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Midthun-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Venezuela.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Padilla-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: clinical trial.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pang-1999a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Finland.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pang-1999b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Finland.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pang-1999c">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Finland.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pang-1999d">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Finland.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pickering-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Simasathien-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Thailand.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tajima-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ukae-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.<BR/>Study design: CCT.<BR/>Study location: Japan.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vesikari-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.<BR/>Study design: clinical trial.<BR/>Study location: Finland.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vesikari-1985b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Finland.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vesikari-1986b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Finland.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vesikari-1987a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Yugoslavia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vodopija-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Yugoslavia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wright-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: USA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zoppi-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomization of children to receive milk or soy formula, not to vaccine. Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Italy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zoppi-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomization of children to receive milk or soy formula, not to vaccine. Only collected immunological data.<BR/>Study design: RCT.<BR/>Study location: Italy.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomized controlled trial<BR/>CCT: controlled clinical trial (not randomized)</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2008-11-09 14:47:53 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2008-11-09 14:47:45 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Seth-2000">
<CHAR_METHODS MODIFIED="2008-11-09 14:47:39 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-11-09 14:47:42 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:47:43 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:47:44 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:45 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2008-11-09 14:47:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vesikari-2002">
<CHAR_METHODS MODIFIED="2008-11-09 14:47:51 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-11-09 14:47:52 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 14:47:52 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 14:47:53 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 14:47:53 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-11-09 14:15:25 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-11-09 14:15:25 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-11-09 14:56:08 +0000" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-11-03 11:24:41 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Drop outs before end of study</NAME>
<DICH_OUTCOME CHI2="14.230660946178356" CI_END="1.0443130244743837" CI_START="0.848673628258745" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9414249431147121" ESTIMABLE="YES" EVENTS_1="714" EVENTS_2="592" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.018830694476306694" LOG_CI_START="-0.0712592929095381" LOG_EFFECT_SIZE="-0.026214299216615652" METHOD="MH" NO="1" P_CHI2="0.7139357270277897" P_Q="0.0" P_Z="0.2540293886229853" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="7108" TOTAL_2="5385" WEIGHT="199.99999999999997" Z="1.1406169283712455">
<NAME>Drop outs before end of study</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="8.998715389738097" CI_END="1.0588554277010986" CI_START="0.8539318148900366" DF="13" EFFECT_SIZE="0.9508892349180135" ESTIMABLE="YES" EVENTS_1="658" EVENTS_2="527" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.02483666715393849" LOG_CI_START="-0.06857680565669289" LOG_EFFECT_SIZE="-0.021870069251377206" NO="1" P_CHI2="0.77304058381882" P_Z="0.3587560451996179" STUDIES="14" TAU2="0.0" TOTAL_1="6377" TOTAL_2="4751" WEIGHT="99.99999999999999" Z="0.9177380260552261">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.0640066711745026" CI_START="0.4357811267127327" EFFECT_SIZE="0.9483960948396095" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="9" LOG_CI_END="0.3147110966613715" LOG_CI_START="-0.36073158258449906" LOG_EFFECT_SIZE="-0.023010242961563787" ORDER="1" O_E="0.0" SE="0.3967583732842099" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.15741720677113244" WEIGHT="1.9126787733780743"/>
<DICH_DATA CI_END="1.2569380004853448" CI_START="0.5607058297483836" EFFECT_SIZE="0.8395072748370972" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="34" LOG_CI_END="0.09931385627692084" LOG_CI_START="-0.2512649284486931" LOG_EFFECT_SIZE="-0.07597553608588611" ORDER="165" O_E="0.0" SE="0.2059317135407981" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.042407870641849324" WEIGHT="7.099827116961853"/>
<DICH_DATA CI_END="133.55254019972568" CI_START="0.36689680276182907" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.125652152815888" LOG_CI_START="-0.4354560727873746" LOG_EFFECT_SIZE="0.8450980400142568" ORDER="166" O_E="0.0" SE="1.5044076494095364" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="2.2632423756019264" WEIGHT="0.1330341607250684"/>
<DICH_DATA CI_END="1.3683258188924403" CI_START="0.2737242803056702" EFFECT_SIZE="0.612" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.1361895217254375" LOG_CI_START="-0.5626866774343151" LOG_EFFECT_SIZE="-0.2132485778544388" ORDER="167" O_E="0.0" SE="0.4105233388794185" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.1685294117647059" WEIGHT="1.7865638217261461"/>
<DICH_DATA CI_END="14.996011533391602" CI_START="0.061836286666864464" EFFECT_SIZE="0.9629629629629629" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.175975765764344" LOG_CI_START="-1.2087565981406827" LOG_EFFECT_SIZE="-0.01639041618816937" ORDER="168" O_E="0.0" SE="1.4008035951733964" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="1.9622507122507122" WEIGHT="0.15344040803545542"/>
<DICH_DATA CI_END="1.4031280728142295" CI_START="0.7089179672894705" EFFECT_SIZE="0.9973478336198739" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="63" LOG_CI_END="0.14709731377815394" LOG_CI_START="-0.14940401645966617" LOG_EFFECT_SIZE="-0.0011533513407561322" ORDER="169" O_E="0.0" SE="0.17416634908695108" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.030333917154277704" WEIGHT="9.925805111957084"/>
<DICH_DATA CI_END="1.5053532165053396" CI_START="0.7449148606576085" EFFECT_SIZE="1.0589428603628988" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="38" LOG_CI_END="0.17763841486731802" LOG_CI_START="-0.1278933616940637" LOG_EFFECT_SIZE="0.02487252658662713" ORDER="170" O_E="0.0" SE="0.1794708779588414" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.03220979603531734" WEIGHT="9.3477322745377"/>
<DICH_DATA CI_END="1.527007263294038" CI_START="0.6548757324459705" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="37" LOG_CI_END="0.18384110280692478" LOG_CI_START="-0.18384110280692478" LOG_EFFECT_SIZE="0.0" ORDER="171" O_E="0.0" SE="0.21597834763384652" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.04664664664664665" WEIGHT="6.454666553769456"/>
<DICH_DATA CI_END="1.8975905440629668" CI_START="0.7770326430702533" EFFECT_SIZE="1.2142857142857142" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="28" LOG_CI_END="0.27820250754446224" LOG_CI_START="-0.10956073614439052" LOG_EFFECT_SIZE="0.08432088570003587" ORDER="172" O_E="0.0" SE="0.227774048801845" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.05188101730758528" WEIGHT="5.803443447736549"/>
<DICH_DATA CI_END="1.154836924085823" CI_START="0.8239639681644337" EFFECT_SIZE="0.9754711756646445" ESTIMABLE="YES" EVENTS_1="220" EVENTS_2="223" LOG_CI_END="0.06252066131048215" LOG_CI_START="-0.08409177952801299" LOG_EFFECT_SIZE="-0.010785559108765408" ORDER="173" O_E="0.0" SE="0.08612087349181885" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.0074168048509938665" WEIGHT="40.595452624760085"/>
<DICH_DATA CI_END="12.184324360785784" CI_START="0.05009318074823785" EFFECT_SIZE="0.78125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0858014519025396" LOG_CI_START="-1.3002213911982765" LOG_EFFECT_SIZE="-0.10720996964786836" ORDER="174" O_E="0.0" SE="1.401561629040978" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="1.964375" WEIGHT="0.15327447659210297"/>
<DICH_DATA CI_END="0.9566804698496826" CI_START="0.46622791465172425" EFFECT_SIZE="0.667855628445287" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="47" LOG_CI_END="-0.019233091850161078" LOG_CI_START="-0.33140172734853335" LOG_EFFECT_SIZE="-0.17531740959934722" ORDER="175" O_E="0.0" SE="0.18336940175141123" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.033624337498670456" WEIGHT="8.954482745348296"/>
<DICH_DATA CI_END="1.5104603607484361" CI_START="0.6816997317369757" EFFECT_SIZE="1.014731699870239" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="33" LOG_CI_END="0.1791093324996611" LOG_CI_START="-0.16640687690542239" LOG_EFFECT_SIZE="0.006351227797119391" ORDER="176" O_E="0.0" SE="0.2029579317373665" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.04119192205510952" WEIGHT="7.309407644362755"/>
<DICH_DATA CI_END="3.9044944569299305" CI_START="0.11382893466671921" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5915648106131298" LOG_CI_START="-0.9437473287244924" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="177" O_E="0.0" SE="0.9018499505645788" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.8133333333333332" WEIGHT="0.3701908401093594"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.532194853623809" CI_END="1.2199994013446516" CI_START="0.5566537860176263" DF="4" EFFECT_SIZE="0.8240857271532726" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="65" I2="11.742541325165694" ID="CMP-001.01.02" LOG_CI_END="0.08635961756591365" LOG_CI_START="-0.2544148327808013" LOG_EFFECT_SIZE="-0.08402760760744377" NO="2" P_CHI2="0.3387471861986501" P_Z="0.3337593306583492" STUDIES="5" TAU2="0.026327706216781287" TOTAL_1="731" TOTAL_2="634" WEIGHT="99.99999999999999" Z="0.966569438818501">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.7154694063943199" CI_START="0.5829308271383644" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.2343829772726327" LOG_CI_START="-0.23438297727263271" LOG_EFFECT_SIZE="0.0" ORDER="1" O_E="0.0" SE="0.27535544212878726" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.0758206195099399" WEIGHT="39.22635941715594"/>
<DICH_DATA CI_END="2.6629816416892305" CI_START="0.007216889144997359" EFFECT_SIZE="0.1386306001690617" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4253681724695284" LOG_CI_START="-2.1416499656299934" LOG_EFFECT_SIZE="-0.8581408965802325" ORDER="1" O_E="0.0" SE="1.5078791612643776" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="2.2736995649753626" WEIGHT="1.742112795358393"/>
<DICH_DATA CI_END="3.237149233206586" CI_START="0.12066944458197347" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5101627209237998" LOG_CI_START="-0.9184026862356492" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="180" O_E="0.0" SE="0.8391463916782737" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="0.7041666666666666" WEIGHT="5.485198911253481"/>
<DICH_DATA CI_END="1.0680753910488192" CI_START="0.39751791607417586" EFFECT_SIZE="0.6515973477998794" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="35" LOG_CI_END="0.028601908835703606" LOG_CI_START="-0.4006432929778043" LOG_EFFECT_SIZE="-0.18602069207105035" ORDER="181" O_E="0.0" SE="0.2521407563432718" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.06357496100935718" WEIGHT="44.56938890075674"/>
<DICH_DATA CI_END="6.767843969732727" CI_START="0.5334951512390631" EFFECT_SIZE="1.9001610305958132" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="3" LOG_CI_END="0.8304503376395358" LOG_CI_START="-0.2728695233804454" LOG_EFFECT_SIZE="0.27879040712954517" ORDER="182" O_E="0.0" SE="0.6480955478845313" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.4200278391877508" WEIGHT="8.976939975475432"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Rotavirus diarrhoea</NAME>
<DICH_OUTCOME CHI2="125.72961523475456" CI_END="0.665869355236876" CI_START="0.5059264097333427" CI_STUDY="95" CI_TOTAL="95" DF="39" EFFECT_MEASURE="RR" EFFECT_SIZE="0.580414414230426" ESTIMABLE="YES" EVENTS_1="1474" EVENTS_2="1515" I2="68.98105515778315" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.17661097182884078" LOG_CI_START="-0.29591264950605367" LOG_EFFECT_SIZE="-0.2362618106674472" METHOD="MH" NO="1" P_CHI2="4.713884838025706E-11" P_Q="0.0" P_Z="8.299651743775515E-15" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="40" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10565457354441231" TOTALS="SUB" TOTAL_1="12569" TOTAL_2="8501" WEIGHT="300.0" Z="7.76291916167856">
<NAME>Episodes</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="61.389483948141915" CI_END="0.6962582148594345" CI_START="0.4978550046445706" DF="19" EFFECT_SIZE="0.5887577063552241" ESTIMABLE="YES" EVENTS_1="1014" EVENTS_2="1011" I2="69.05007376173737" ID="CMP-002.01.01" LOG_CI_END="-0.15722966772905816" LOG_CI_START="-0.3028971228058836" LOG_EFFECT_SIZE="-0.23006339526747088" NO="1" P_CHI2="2.3282043652983475E-6" P_Z="5.977141051492646E-10" STUDIES="20" TAU2="0.08018378183785074" TOTAL_1="7872" TOTAL_2="5433" WEIGHT="100.00000000000001" Z="6.191032425841877">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="2.1325900111078266"/>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="1" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="1.352464903142693"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="3.0841239417622592"/>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="1" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="6.92494467422182"/>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="4.095316856394639"/>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="1" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="6.476554680416904"/>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="4.334517383477554"/>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="1" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="7.903708818252188"/>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="4.49191036405089"/>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="3.346189700275959"/>
<DICH_DATA CI_END="0.6498878927155749" CI_START="0.3898971264110547" EFFECT_SIZE="0.5033780109014878" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.18716155377888236" LOG_CI_START="-0.4090499656030404" LOG_EFFECT_SIZE="-0.2981057596909614" ORDER="2" O_E="0.0" SE="0.13033835147086315" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.01698808586414225" WEIGHT="7.534591641678998"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="2" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="7.264552790376745"/>
<DICH_DATA CI_END="0.8120480917527467" CI_START="0.12970876126162564" EFFECT_SIZE="0.3245454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="-0.09041824986674628" LOG_CI_START="-0.8870306882253174" LOG_EFFECT_SIZE="-0.48872446904603184" ORDER="2" O_E="0.0" SE="0.46793408958699123" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.2189623121976063" WEIGHT="2.4474674976267408"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="2" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="3.4475364959854105"/>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="2" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="2.4217622249579005"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="2" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="8.122637908718223"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="2" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="7.302229267834055"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="3.2878476202945746"/>
<DICH_DATA CI_END="0.9617690037595611" CI_START="0.4454601368846169" EFFECT_SIZE="0.6545454545454545" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="55" LOG_CI_END="-0.016929223636822716" LOG_CI_START="-0.35119115381709043" LOG_EFFECT_SIZE="-0.1840601887269566" ORDER="2" O_E="0.0" SE="0.19634711241112907" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.03855218855218855" WEIGHT="6.166205066490899"/>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="2" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="7.862848152933735"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="44.56261823599323" CI_END="0.7562484684134028" CI_START="0.4543106334655442" DF="16" EFFECT_SIZE="0.5861499131981857" ESTIMABLE="YES" EVENTS_1="393" EVENTS_2="413" I2="64.09546693314174" ID="CMP-002.01.02" LOG_CI_END="-0.12133549189025988" LOG_CI_START="-0.34264709809322236" LOG_EFFECT_SIZE="-0.2319912949917411" NO="2" P_CHI2="1.6192007717164003E-4" P_Z="3.972223651125138E-5" STUDIES="17" TAU2="0.13816075102139852" TOTAL_1="2967" TOTAL_2="2316" WEIGHT="100.00000000000003" Z="4.109089357867879">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="2.0501182100324087"/>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="1" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="5.770779216549121"/>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="3.7491304308477433"/>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="1" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="5.216171814667468"/>
<DICH_DATA CI_END="0.6267170703918006" CI_START="0.19635640354517492" EFFECT_SIZE="0.35079895949461165" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.2029284759143624" LOG_CI_START="-0.7069549310170087" LOG_EFFECT_SIZE="-0.4549417034656856" ORDER="1" O_E="0.0" SE="0.29606763469848557" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.08765604431595589" WEIGHT="7.483889120533753"/>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="1" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="3.3509386638163936"/>
<DICH_DATA CI_END="1.0100113315938297" CI_START="0.0036038497772461773" EFFECT_SIZE="0.06033182503770739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.00432624627874643" LOG_CI_START="-2.4432333204323675" LOG_EFFECT_SIZE="-1.2194535370768107" ORDER="1" O_E="0.0" SE="1.437708605101362" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="2.067006033182504" WEIGHT="0.7663764346374073"/>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="1" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="9.887678675206203"/>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="1" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="7.597598841069343"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="0.6707948744708078"/>
<DICH_DATA CI_END="1.4440853901075372" CI_START="0.5418961953766118" EFFECT_SIZE="0.8846153846153846" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="26" LOG_CI_END="0.15959287422812996" LOG_CI_START="-0.2660838981345802" LOG_EFFECT_SIZE="-0.0532455119532251" ORDER="1" O_E="0.0" SE="0.25004464321986253" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.06252232360294835" WEIGHT="8.421177824898614"/>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="1" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="1.2589982411070362"/>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="9.176987666580304"/>
<DICH_DATA CI_END="1.0318595193566296" CI_START="0.29941894419434845" EFFECT_SIZE="0.5558401639344263" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" LOG_CI_END="0.013620575080836642" LOG_CI_START="-0.523720725373086" LOG_EFFECT_SIZE="-0.25505007514612466" ORDER="2" O_E="0.0" SE="0.31563693976896945" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.09962667774672006" WEIGHT="7.107137103984739"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="5.985861169995372"/>
<DICH_DATA CI_END="0.9714613192689926" CI_START="0.623318925603991" EFFECT_SIZE="0.7781582267075149" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="62" LOG_CI_END="-0.012574487048211035" LOG_CI_START="-0.20528968658369665" LOG_EFFECT_SIZE="-0.10893208681595384" ORDER="2" O_E="0.0" SE="0.11320186216276716" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.012814661597118134" WEIGHT="11.1937952581012"/>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="10.312566453502086"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.414379605367589" CI_END="0.8462089593290466" CI_START="0.20922278829861987" DF="2" EFFECT_SIZE="0.4207685800462014" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="91" I2="73.0253897635331" ID="CMP-002.01.03" LOG_CI_END="-0.07252238084049784" LOG_CI_START="-0.6793910143872329" LOG_EFFECT_SIZE="-0.37595669761386535" NO="3" P_CHI2="0.024546489766415602" P_Z="0.015165373484083193" STUDIES="3" TAU2="0.2749661661301803" TOTAL_1="1730" TOTAL_2="752" WEIGHT="100.0" Z="2.4284055768818904">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="1" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="30.868927890826615"/>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="2" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="28.71461091915693"/>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="3" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="40.416461190016456"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="71.33928006144151" CI_END="0.4435217481895472" CI_START="0.28265965772883084" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3540701986026925" ESTIMABLE="YES" EVENTS_1="404" EVENTS_2="714" I2="69.16144937115664" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-0.3530850795816659" LOG_CI_START="-0.5487361712628255" LOG_EFFECT_SIZE="-0.4509106254222457" METHOD="MH" NO="2" P_CHI2="4.0647192101062046E-7" P_Q="0.0" P_Z="1.6531386686737838E-19" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.20958431974180042" TOTALS="SUB" TOTAL_1="9582" TOTAL_2="6868" WEIGHT="300.0" Z="9.034128851315133">
<NAME>Severe episodes</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="32.76754193067218" CI_END="0.569063331019912" CI_START="0.3079404590808873" DF="10" EFFECT_SIZE="0.4186139312067512" ESTIMABLE="YES" EVENTS_1="261" EVENTS_2="443" I2="69.48199525873054" ID="CMP-002.02.01" LOG_CI_END="-0.24483939831152327" LOG_CI_START="-0.5115332471110295" LOG_EFFECT_SIZE="-0.3781863227112764" NO="1" P_CHI2="2.979973428832716E-4" P_Z="2.7183783023207168E-8" STUDIES="11" TAU2="0.16336736561563983" TOTAL_1="6059" TOTAL_2="4547" WEIGHT="100.00000000000001" Z="5.558670177781141">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.1795633625396562" CI_START="0.04632957397102283" EFFECT_SIZE="0.09120906801007557" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="100" LOG_CI_END="-0.7457822705083856" LOG_CI_START="-1.334141693383821" LOG_EFFECT_SIZE="-1.0399619819461035" ORDER="1" O_E="0.0" SE="0.345605237423145" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.11944298013430842" WEIGHT="8.677725521863008"/>
<DICH_DATA CI_END="0.7033226163459516" CI_START="0.2817068598791358" EFFECT_SIZE="0.4451188669701568" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" LOG_CI_END="-0.15284541700103546" LOG_CI_START="-0.5502025773259718" LOG_EFFECT_SIZE="-0.3515239971635037" ORDER="1" O_E="0.0" SE="0.23340956292453388" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.05448002406462194" WEIGHT="11.265457707632969"/>
<DICH_DATA CI_END="0.7715368475652773" CI_START="0.012961143763330034" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.11264332778342294" LOG_CI_START="-1.8873566722165767" LOG_EFFECT_SIZE="-1.0" ORDER="1" O_E="0.0" SE="1.0424754034927717" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="1.0867549668874172" WEIGHT="1.9631283206079564"/>
<DICH_DATA CI_END="1.012292162157116" CI_START="0.2092587824801562" EFFECT_SIZE="0.4602510460251046" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.005305874263223388" LOG_CI_START="-0.6793163058430487" LOG_EFFECT_SIZE="-0.33700521578991266" ORDER="1" O_E="0.0" SE="0.40215045752887174" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.16172499049068087" WEIGHT="7.549087233409461"/>
<DICH_DATA CI_END="0.5987519438893242" CI_START="0.27685001228189854" EFFECT_SIZE="0.40714184631350536" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="85" LOG_CI_END="-0.22275306360821712" LOG_CI_START="-0.557755452885439" LOG_EFFECT_SIZE="-0.3902542582468281" ORDER="1" O_E="0.0" SE="0.19678206175001164" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.0387231798265854" WEIGHT="12.143816771788732"/>
<DICH_DATA CI_END="1.7852310923406094" CI_START="0.40105526642056916" EFFECT_SIZE="0.8461538461538461" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.2516944420909467" LOG_CI_START="-0.3967957763881701" LOG_EFFECT_SIZE="-0.07255066714861173" ORDER="1" O_E="0.0" SE="0.38092636441298616" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.14510489510489513" WEIGHT="7.955822508736375"/>
<DICH_DATA CI_END="1.9440155409681266" CI_START="0.12859979497668989" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28869973246768516" LOG_CI_START="-0.8907597237956476" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="1" O_E="0.0" SE="0.6928203230275509" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.48" WEIGHT="3.8145400067236004"/>
<DICH_DATA CI_END="0.9161896071520315" CI_START="0.3333389286080207" EFFECT_SIZE="0.5526315789473685" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="38" LOG_CI_END="-0.03801463897570007" LOG_CI_START="-0.4771139647900816" LOG_EFFECT_SIZE="-0.2575643018828908" ORDER="1" O_E="0.0" SE="0.2579291175600855" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.06652742968532441" WEIGHT="10.675102722305667"/>
<DICH_DATA CI_END="0.9667371658326467" CI_START="0.44198406197334955" EFFECT_SIZE="0.6536684323227769" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="38" LOG_CI_END="-0.014691584804480032" LOG_CI_START="-0.3545933911075277" LOG_EFFECT_SIZE="-0.18464248795600385" ORDER="2" O_E="0.0" SE="0.19966000356348707" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.039864117022971664" WEIGHT="12.075641644189673"/>
<DICH_DATA CI_END="0.7438943926384873" CI_START="0.2876714303749857" EFFECT_SIZE="0.4625982749408442" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="33" LOG_CI_END="-0.1284887149242854" LOG_CI_START="-0.5411032672254031" LOG_EFFECT_SIZE="-0.33479599107484426" ORDER="2" O_E="0.0" SE="0.2423718304966511" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.05874410421829737" WEIGHT="11.049184254176906"/>
<DICH_DATA CI_END="0.5472427167348773" CI_START="0.2843050186045062" EFFECT_SIZE="0.3944411879640485" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="72" LOG_CI_END="-0.2618200097561964" LOG_CI_START="-0.5462154739957807" LOG_EFFECT_SIZE="-0.40401774187598855" ORDER="2" O_E="0.0" SE="0.1670553034745842" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.02790747441898542" WEIGHT="12.830493308565666"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="28.110369554151546" CI_END="0.5975941481486045" CI_START="0.24138872113969054" DF="9" EFFECT_SIZE="0.37980585459173005" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="218" I2="67.9833451400826" ID="CMP-002.02.02" LOG_CI_END="-0.22359366393565167" LOG_CI_START="-0.6172830261244613" LOG_EFFECT_SIZE="-0.4204383450300565" NO="2" P_CHI2="9.14192435182426E-4" P_Z="2.835821493599692E-5" STUDIES="10" TAU2="0.3036688567387469" TOTAL_1="1933" TOTAL_2="1710" WEIGHT="100.0" Z="4.186265076592707">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.49718286349299734" CI_START="0.028416957778963605" EFFECT_SIZE="0.11886304909560723" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="18" LOG_CI_END="-0.30348384869227213" LOG_CI_START="-1.5464224179824027" LOG_EFFECT_SIZE="-0.9249531333373373" ORDER="1" O_E="0.0" SE="0.7301082682461691" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.53305808336142" WEIGHT="6.39144140449989"/>
<DICH_DATA CI_END="0.3654769919562603" CI_START="0.043907453932020925" EFFECT_SIZE="0.1266774020397209" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="18" LOG_CI_END="-0.43713995818889184" LOG_CI_START="-1.3574617456633802" LOG_EFFECT_SIZE="-0.8973008519261361" ORDER="1" O_E="0.0" SE="0.5406015736288353" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.292250061409973" WEIGHT="8.97419270700526"/>
<DICH_DATA CI_END="1.1529787394529891" CI_START="0.017999116591201656" EFFECT_SIZE="0.14405762304921968" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.061821299121777605" LOG_CI_START="-1.7447488098401032" LOG_EFFECT_SIZE="-0.8414637553591628" ORDER="1" O_E="0.0" SE="1.0611882246704736" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="1.1261204481792717" WEIGHT="3.7403351604475352"/>
<DICH_DATA CI_END="1.4707139942162637" CI_START="0.5880462845566141" EFFECT_SIZE="0.9299719887955182" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="21" LOG_CI_END="0.16752822486189484" LOG_CI_START="-0.23058848967820864" LOG_EFFECT_SIZE="-0.03153013240815689" ORDER="1" O_E="0.0" SE="0.23385572883037695" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.0546885019067868" WEIGHT="14.923346989245255"/>
<DICH_DATA CI_END="0.8052997862943447" CI_START="0.0029445761454306423" EFFECT_SIZE="0.04869565217391304" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.09404241615803753" LOG_CI_START="-2.530977210536785" LOG_EFFECT_SIZE="-1.3125098133474113" ORDER="1" O_E="0.0" SE="1.4314675612398584" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="2.0490993788819876" WEIGHT="2.2730208306326287"/>
<DICH_DATA CI_END="1.3088284690680698" CI_START="0.27505514168432793" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" LOG_CI_END="0.11688273301482338" LOG_CI_START="-0.5605802322475362" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="1" O_E="0.0" SE="0.3979450992908726" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.15836030204962243" WEIGHT="11.57479156346123"/>
<DICH_DATA CI_END="0.6192770239174124" CI_START="0.15889690599860884" EFFECT_SIZE="0.31368966042332874" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="33" LOG_CI_END="-0.20811503265147768" LOG_CI_START="-0.7988845591854038" LOG_EFFECT_SIZE="-0.5034997959184407" ORDER="1" O_E="0.0" SE="0.347020944242348" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.12042353574285078" WEIGHT="12.610203116173002"/>
<DICH_DATA CI_END="0.8662469474617329" CI_START="0.15480904625884115" EFFECT_SIZE="0.3662005785920926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.06235828277304996" LOG_CI_START="-0.8102036649353841" LOG_EFFECT_SIZE="-0.436280973854217" ORDER="2" O_E="0.0" SE="0.4392880793765001" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.19297401668229427" WEIGHT="10.768082047324377"/>
<DICH_DATA CI_END="1.0633674611113753" CI_START="0.4500505159968466" EFFECT_SIZE="0.691786870768325" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="43" LOG_CI_END="0.026683366833919513" LOG_CI_START="-0.3467387360305029" LOG_EFFECT_SIZE="-0.16002768459829167" ORDER="2" O_E="0.0" SE="0.21934999169178265" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.048114418855185116" WEIGHT="15.202232682004606"/>
<DICH_DATA CI_END="0.7179656953268364" CI_START="0.2197344608609051" EFFECT_SIZE="0.39719240297274977" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="35" LOG_CI_END="-0.14389630601699868" LOG_CI_START="-0.6581018275214423" LOG_EFFECT_SIZE="-0.4009990667692205" ORDER="240" O_E="0.0" SE="0.3020468686900926" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.09123231088549007" WEIGHT="13.542353499206218"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6084286712326639" CI_END="0.3490813787178486" CI_START="0.1320707884863827" DF="1" EFFECT_SIZE="0.2147171463418323" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="53" I2="0.0" ID="CMP-002.02.03" LOG_CI_END="-0.4570733174298166" LOG_CI_START="-0.879193229335224" LOG_EFFECT_SIZE="-0.6681332733825204" NO="3" P_CHI2="0.43538023691638006" P_Z="5.487825462841406E-10" STUDIES="2" TAU2="0.0" TOTAL_1="1590" TOTAL_2="611" WEIGHT="100.0" Z="6.20447941814241">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.46051655088281557" CI_START="0.04349894471460124" EFFECT_SIZE="0.14153439153439154" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="21" LOG_CI_END="-0.3367547567203159" LOG_CI_START="-1.361521278911678" LOG_EFFECT_SIZE="-0.8491380178159968" ORDER="1" O_E="0.0" SE="0.6019529278113018" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.3623473273005983" WEIGHT="16.967654775030056"/>
<DICH_DATA CI_END="0.3985458640164984" CI_START="0.13716135414275926" EFFECT_SIZE="0.23380566801619435" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="32" LOG_CI_END="-0.3995216934820587" LOG_CI_START="-0.8627682359089087" LOG_EFFECT_SIZE="-0.6311449646954838" ORDER="246" O_E="0.0" SE="0.2721133121288995" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.07404565463775989" WEIGHT="83.03234522496994"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.463415037971878" CI_END="0.5464390485752504" CI_START="0.2495994360637445" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.36931135694369266" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="163" I2="44.09091014281619" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-0.2624582735014648" LOG_CI_START="-0.6027564002183019" LOG_EFFECT_SIZE="-0.43260733685988334" METHOD="MH" NO="3" P_CHI2="0.043992626791910405" P_Q="0.0" P_Z="6.25260703769957E-7" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.19725573006277536" TOTALS="SUB" TOTAL_1="6785" TOTAL_2="4912" WEIGHT="300.0" Z="4.983246942165472">
<NAME>Episodes requiring hospitalization</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="13.383351560840794" CI_END="0.8626941248294577" CI_START="0.2718760441642373" DF="6" EFFECT_SIZE="0.48429935575257754" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="125" I2="55.1681806106343" ID="CMP-002.03.01" LOG_CI_END="-0.06414315961001002" LOG_CI_START="-0.5656290577513264" LOG_EFFECT_SIZE="-0.31488610868066824" NO="1" P_CHI2="0.037336538649730855" P_Z="0.013841637962428294" STUDIES="7" TAU2="0.2366734654438093" TOTAL_1="4233" TOTAL_2="3570" WEIGHT="100.0" Z="2.461347106802037">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.6052539177138491" CI_START="0.14832957666232618" EFFECT_SIZE="0.29962819858569656" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="33" LOG_CI_END="-0.21806239075694459" LOG_CI_START="-0.8287722427644523" LOG_EFFECT_SIZE="-0.5234173167606985" ORDER="1" O_E="0.0" SE="0.35873399013173285" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.1286900756758342" WEIGHT="23.750209583989346"/>
<DICH_DATA CI_END="2.2108377197122735" CI_START="0.028269827062718106" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3445568655909182" LOG_CI_START="-1.548676848246843" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="1" O_E="0.0" SE="1.1120948551663286" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="1.2367549668874172" WEIGHT="5.88929905622274"/>
<DICH_DATA CI_END="0.40821006870015514" CI_START="0.0014966833651320242" EFFECT_SIZE="0.024717629726632835" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.38911628740292603" LOG_CI_START="-2.8248700682747545" LOG_EFFECT_SIZE="-1.6069931778388402" ORDER="1" O_E="0.0" SE="1.4307738280597828" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="2.047113747060845" WEIGHT="3.799592461341167"/>
<DICH_DATA CI_END="1.3379594148962786" CI_START="0.4614093162335333" EFFECT_SIZE="0.7857142857142857" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="28" LOG_CI_END="0.12644293992364353" LOG_CI_START="-0.3359136409636695" LOG_EFFECT_SIZE="-0.104735350520013" ORDER="1" O_E="0.0" SE="0.27159054431519475" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.07376142376142375" WEIGHT="27.952594819982515"/>
<DICH_DATA CI_END="7.7109576353923535" CI_START="0.013380598324132867" EFFECT_SIZE="0.3212121212121212" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8871083170834013" LOG_CI_START="-1.8735244663096358" LOG_EFFECT_SIZE="-0.4932080746131172" ORDER="1" O_E="0.0" SE="1.6216093623177397" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="2.6296169239565463" WEIGHT="3.0274185435047345"/>
<DICH_DATA CI_END="7.946196188253989" CI_START="0.031240682588898096" EFFECT_SIZE="0.49824150058616645" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.9001592834004785" LOG_CI_START="-1.5052794856349017" LOG_EFFECT_SIZE="-0.3025601011172115" ORDER="1" O_E="0.0" SE="1.4129666400453245" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="1.9964747258809736" WEIGHT="3.8857522799650233"/>
<DICH_DATA CI_END="1.106064978857614" CI_START="0.519816859366691" EFFECT_SIZE="0.7582553814944213" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="38" LOG_CI_END="0.04378064155308812" LOG_CI_START="-0.28414963901125884" LOG_EFFECT_SIZE="-0.12018449872908535" ORDER="249" O_E="0.0" SE="0.19262787008456614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.03710549633331649" WEIGHT="31.695133254994484"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2298147091500051" CI_END="0.7353353125024504" CI_START="0.18492750693024365" DF="3" EFFECT_SIZE="0.36875971322644474" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="-0.13351457770197808" LOG_CI_START="-0.732998485165778" LOG_EFFECT_SIZE="-0.43325653143387804" NO="2" P_CHI2="0.7458628287926117" P_Z="0.00461142317144437" STUDIES="4" TAU2="0.0" TOTAL_1="962" TOTAL_2="731" WEIGHT="100.00000000000001" Z="2.832994137472904">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="4.284918285674742" CI_START="0.009999957325499529" EFFECT_SIZE="0.207" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6319425442477975" LOG_CI_START="-2.000001853333962" LOG_EFFECT_SIZE="-0.6840296545430823" ORDER="1" O_E="0.0" SE="1.5460171674744119" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="2.390169082125604" WEIGHT="5.18801996271493"/>
<DICH_DATA CI_END="1.3284788461358168" CI_START="0.019683372038407615" EFFECT_SIZE="0.16170634920634921" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.12335464336832916" LOG_CI_START="-1.7059004987794266" LOG_EFFECT_SIZE="-0.7912729277055487" ORDER="1" O_E="0.0" SE="1.0745135254565819" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="1.1545793163891325" WEIGHT="10.74005461236961"/>
<DICH_DATA CI_END="0.9254276064702758" CI_START="0.13598748373215408" EFFECT_SIZE="0.3547486033519553" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="-0.03365754918572558" LOG_CI_START="-0.8665010621901095" LOG_EFFECT_SIZE="-0.45007930568791754" ORDER="2" O_E="0.0" SE="0.4892164021806536" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.23933268816258302" WEIGHT="51.81174793769893"/>
<DICH_DATA CI_END="1.9099163764334488" CI_START="0.1680925952886181" EFFECT_SIZE="0.5666063893911996" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.28101435256262075" LOG_CI_START="-0.7744514174119447" LOG_EFFECT_SIZE="-0.24671853242466196" ORDER="255" O_E="0.0" SE="0.619985817922883" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.38438241442550625" WEIGHT="32.26017748721654"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0011735399403463016" CI_END="0.48295183054435065" CI_START="0.0899278337234849" DF="1" EFFECT_SIZE="0.20840060439846383" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" I2="0.0" ID="CMP-002.03.03" LOG_CI_END="-0.3160961834762591" LOG_CI_START="-1.0461058682041118" LOG_EFFECT_SIZE="-0.6811010258401855" NO="3" P_CHI2="0.9726722408066966" P_Z="2.5488253878466337E-4" STUDIES="2" TAU2="0.0" TOTAL_1="1590" TOTAL_2="611" WEIGHT="100.0" Z="3.6573034807824802">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="4.07970823927158" CI_START="0.009625546598610708" EFFECT_SIZE="0.1981651376146789" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106291055886245" LOG_CI_START="-2.0165745991680097" LOG_EFFECT_SIZE="-0.7029727467896927" ORDER="1" O_E="0.0" SE="1.5432324610421255" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="2.381566428814135" WEIGHT="7.72093236008188"/>
<DICH_DATA CI_END="0.5019922024345329" CI_START="0.08724910160680603" EFFECT_SIZE="0.20928059794456555" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" LOG_CI_END="-0.29930302880309956" LOG_CI_START="-1.0592390362222548" LOG_EFFECT_SIZE="-0.6792710325126773" ORDER="3" O_E="0.0" SE="0.4463901725019172" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.19926418610629137" WEIGHT="92.27906763991813"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.106058277964285" CI_END="0.9381799344782954" CI_START="0.4941686796698932" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6808958360233421" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="134" I2="1.4925050402861106" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="-0.027713859854584282" LOG_CI_START="-0.3061247835749385" LOG_EFFECT_SIZE="-0.16691932171476145" METHOD="MH" NO="4" P_CHI2="0.417921466378827" P_Q="0.0" P_Z="0.01876507089075759" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0027479568135956433" TOTALS="SUB" TOTAL_1="384" TOTAL_2="499" WEIGHT="200.0" Z="2.3501653923133694">
<NAME>Episodes of more than four days</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.98168419852319" CI_END="0.874679991960399" CI_START="0.4226730281658392" DF="4" EFFECT_SIZE="0.6080325985323268" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="123" I2="19.70586973004448" ID="CMP-002.04.01" LOG_CI_END="-0.05815080771559494" LOG_CI_START="-0.37399546471528183" LOG_EFFECT_SIZE="-0.2160731362154384" NO="1" P_CHI2="0.28918204528269653" P_Z="0.007325569122786234" STUDIES="5" TAU2="0.034274224433588144" TOTAL_1="217" TOTAL_2="414" WEIGHT="100.0" Z="2.6816699641640374">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.259578162972177" CI_START="0.36130305888347947" EFFECT_SIZE="0.6746031746031746" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="14" LOG_CI_END="0.10022512276246384" LOG_CI_START="-0.44212836156900415" LOG_EFFECT_SIZE="-0.17095161940327014" ORDER="1" O_E="0.0" SE="0.31858112138934985" STUDY_ID="STD-Gothefors-1989" TOTAL_1="9" TOTAL_2="17" VAR="0.10149393090569565" WEIGHT="25.352708074531208"/>
<DICH_DATA CI_END="1.136387798207579" CI_START="0.4168188190829917" EFFECT_SIZE="0.6882352941176471" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="25" LOG_CI_END="0.05552656190449979" LOG_CI_START="-0.38005268116872437" LOG_EFFECT_SIZE="-0.1622630596321123" ORDER="1" O_E="0.0" SE="0.25586140353323905" STUDY_ID="STD-Bernstein-1995" TOTAL_1="68" TOTAL_2="65" VAR="0.065465057817999" WEIGHT="34.510880070822786"/>
<DICH_DATA CI_END="0.6503059659813768" CI_START="0.012745528494797901" EFFECT_SIZE="0.0910411622276029" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="35" LOG_CI_END="-0.18688226170653163" LOG_CI_START="-1.8946421517509482" LOG_EFFECT_SIZE="-1.0407622067287399" ORDER="1" O_E="0.0" SE="1.0031466129598832" STUDY_ID="STD-Joensuu-1997" TOTAL_1="59" TOTAL_2="188" VAR="1.0063031270928855" WEIGHT="3.307865967950482"/>
<DICH_DATA CI_END="4.712221937794067" CI_START="0.14206068738703811" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.6732257368065144" LOG_CI_START="-0.8475260882443147" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="1" O_E="0.0" SE="0.8932971498777985" STUDY_ID="STD-Santosham-1991a" TOTAL_1="11" TOTAL_2="9" VAR="0.797979797979798" WEIGHT="4.135865151066531"/>
<DICH_DATA CI_END="0.9684892851439266" CI_START="0.3407508847728258" EFFECT_SIZE="0.574468085106383" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="47" LOG_CI_END="-0.013905179724022025" LOG_CI_START="-0.46756300782943816" LOG_EFFECT_SIZE="-0.2407340937767301" ORDER="1" O_E="0.0" SE="0.2664808538715879" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="70" TOTAL_2="135" VAR="0.07101204548013058" WEIGHT="32.692680735629004"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6767917311396836" CI_END="1.9913365229530569" CI_START="0.5123493739609616" DF="2" EFFECT_SIZE="1.0100792151512656" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="11" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="0.29914465917941585" LOG_CI_START="-0.2904337901209984" LOG_EFFECT_SIZE="0.004355434529208751" NO="2" P_CHI2="0.7129130893482942" P_Z="0.9768981189337571" STUDIES="3" TAU2="0.0" TOTAL_1="167" TOTAL_2="85" WEIGHT="100.0" Z="0.028957960808779767">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="4.675808005203497" CI_START="0.41917888797375846" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.6698566701560675" LOG_CI_START="-0.3776005987995915" LOG_EFFECT_SIZE="0.14612803567823798" ORDER="1" O_E="0.0" SE="0.615281584781658" STUDY_ID="STD-Senturia-1987" TOTAL_1="20" TOTAL_2="14" VAR="0.37857142857142856" WEIGHT="31.68185274704987"/>
<DICH_DATA CI_END="1.997381474317727" CI_START="0.2890294150887035" EFFECT_SIZE="0.7598039215686274" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.3004610174843903" LOG_CI_START="-0.5390579559956049" LOG_EFFECT_SIZE="-0.11929846925560728" ORDER="1" O_E="0.0" SE="0.49313760070809" STUDY_ID="STD-Lanata-1989" TOTAL_1="136" TOTAL_2="62" VAR="0.2431846932321316" WEIGHT="49.31989795423349"/>
<DICH_DATA CI_END="5.824586591901149" CI_START="0.25859317624391503" EFFECT_SIZE="1.2272727272727273" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.7652651061396815" LOG_CI_START="-0.5873829394661193" LOG_EFFECT_SIZE="0.08894108333678108" ORDER="1" O_E="0.0" SE="0.7945521577046603" STUDY_ID="STD-Santosham-1991b" TOTAL_1="11" TOTAL_2="9" VAR="0.6313131313131313" WEIGHT="18.998249298716647"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>All-cause diarrhoea</NAME>
<OTHER_OUTCOME COLS="4" ID="CMP-003.01" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES">
<NAME>Episodes (number of episodes/number of person-years)</NAME>
<TR>
<TH>
<P>Episodes (vaccine)</P>
</TH>
<TH>
<P>Person-years vaccine</P>
</TH>
<TH>
<P>Episodes (placebo)</P>
</TH>
<TH>
<P>Person-years placebo</P>
</TH>
</TR>
<OTHER_SUBGROUP ID="CMP-003.01.01" NO="1" STUDIES="7">
<NAME>Rhesus rotavirus vaccines</NAME>
<OTHER_DATA ORDER="104" STUDY_ID="STD-Gothefors-1989">
<TR>
<TD>
<P>75</P>
</TD>
<TD>
<P>53</P>
</TD>
<TD>
<P>79</P>
</TD>
<TD>
<P>51</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="105" STUDY_ID="STD-Lanata-1996a">
<TR>
<TD>
<P>9104</P>
</TD>
<TD>
<P>1032</P>
</TD>
<TD>
<P>3000</P>
</TD>
<TD>
<P>339</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="106" STUDY_ID="STD-Lanata-1996b">
<TR>
<TD>
<P>6518</P>
</TD>
<TD>
<P>758</P>
</TD>
<TD>
<P>3200</P>
</TD>
<TD>
<P>386</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="107" STUDY_ID="STD-Linhares-1996">
<TR>
<TD>
<P>2579</P>
</TD>
<TD>
<P>361</P>
</TD>
<TD>
<P>2803</P>
</TD>
<TD>
<P>363</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="108" STUDY_ID="STD-Perez_x002d_Schael-1990a">
<TR>
<TD>
<P>294</P>
</TD>
<TD>
<P>141</P>
</TD>
<TD>
<P>290</P>
</TD>
<TD>
<P>130</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="109" STUDY_ID="STD-Santosham-1991a">
<TR>
<TD>
<P>397</P>
</TD>
<TD>
<P>130</P>
</TD>
<TD>
<P>383</P>
</TD>
<TD>
<P>125</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="110" STUDY_ID="STD-Santosham-1997">
<TR>
<TD>
<P>2559</P>
</TD>
<TD>
<P>1391</P>
</TD>
<TD>
<P>1331</P>
</TD>
<TD>
<P>680</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-003.01.02" NO="2" STUDIES="3">
<NAME>Bovine rotavirus vaccines</NAME>
<OTHER_DATA ORDER="111" STUDY_ID="STD-Bernstein-1990">
<TR>
<TD>
<P>153</P>
</TD>
<TD>
<P>102 (patients)</P>
</TD>
<TD>
<P>179</P>
</TD>
<TD>
<P>103 (patients)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="112" STUDY_ID="STD-Lanata-1989">
<TR>
<TD>
<P>3432</P>
</TD>
<TD>
<P>358</P>
</TD>
<TD>
<P>1343</P>
</TD>
<TD>
<P>127</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="113" STUDY_ID="STD-Santosham-1991b">
<TR>
<TD>
<P>404</P>
</TD>
<TD>
<P>125</P>
</TD>
<TD>
<P>383</P>
</TD>
<TD>
<P>125</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
<OTHER_SUBGROUP ID="CMP-003.01.03" NO="3" STUDIES="2">
<NAME>Human rotavirus vaccines</NAME>
<OTHER_DATA ORDER="114" STUDY_ID="STD-Barnes-1997">
<TR>
<TD>
<P>62</P>
</TD>
<TD>
<P>40 (patients)</P>
</TD>
<TD>
<P>23</P>
</TD>
<TD>
<P>20 (patients)</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA ORDER="115" STUDY_ID="STD-Georges_x002d_Courbot-1991">
<TR>
<TD>
<P>503</P>
</TD>
<TD>
<P>232 (patients)</P>
</TD>
<TD>
<P>455</P>
</TD>
<TD>
<P>230 (patients)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_SUBGROUP>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="59.874610547083186" CI_END="0.9004027302375487" CI_START="0.7915846321843091" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8442422425067568" ESTIMABLE="YES" EVENTS_1="2842" EVENTS_2="2807" I2="63.256545973355415" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-0.04556319678424089" LOG_CI_START="-0.10150264577228493" LOG_EFFECT_SIZE="-0.07353292127826291" METHOD="MH" NO="2" P_CHI2="2.332370731528144E-5" P_Q="0.0" P_Z="2.5665101705070783E-7" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.01398652762849119" TOTALS="SUB" TOTAL_1="6162" TOTAL_2="5134" WEIGHT="300.0" Z="5.152781444601555">
<NAME>Episodes (number of cases/number of participants)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="20.94749389421297" CI_END="0.9197365959450058" CI_START="0.8013462936013915" DF="10" EFFECT_SIZE="0.8585030647878265" ESTIMABLE="YES" EVENTS_1="2292" EVENTS_2="2205" I2="52.26159248213155" ID="CMP-003.02.01" LOG_CI_END="-0.03633653277059259" LOG_CI_START="-0.09617976743631623" LOG_EFFECT_SIZE="-0.06625815010345443" NO="1" P_CHI2="0.021462705567441565" P_Z="1.4240107194125554E-5" STUDIES="11" TAU2="0.005203853306632297" TOTAL_1="4225" TOTAL_2="3481" WEIGHT="100.00000000000001" Z="4.340125951092726">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.977528145587583" CI_START="0.5179257339380201" EFFECT_SIZE="0.7115384615384616" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="52" LOG_CI_END="-0.009870729280021211" LOG_CI_START="-0.28573250985558707" LOG_EFFECT_SIZE="-0.14780161956780413" ORDER="1" O_E="0.0" SE="0.16204257544792436" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.026257796257796256" WEIGHT="3.927569102966338"/>
<DICH_DATA CI_END="0.9941756488758148" CI_START="0.6299502643723327" EFFECT_SIZE="0.7913793103448276" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="58" LOG_CI_END="-0.0025368785822323147" LOG_CI_START="-0.20069373746911975" LOG_EFFECT_SIZE="-0.10161530802567606" ORDER="1" O_E="0.0" SE="0.1163983198024288" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.013548568852828489" WEIGHT="6.589431578856748"/>
<DICH_DATA CI_END="2.200513364997922" CI_START="0.6611815176504472" EFFECT_SIZE="1.206208425720621" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="11" LOG_CI_END="0.34252401063003485" LOG_CI_START="-0.1796792949895961" LOG_EFFECT_SIZE="0.0814223578202194" ORDER="1" O_E="0.0" SE="0.3067448066690235" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.09409237641841658" WEIGHT="1.2444359982223194"/>
<DICH_DATA CI_END="0.765818172912393" CI_START="0.4853810240794641" EFFECT_SIZE="0.6096832038254633" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="70" LOG_CI_END="-0.1158743320312561" LOG_CI_START="-0.3139172063696978" LOG_EFFECT_SIZE="-0.21489576920047693" ORDER="1" O_E="0.0" SE="0.11633136471443911" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.013532986416323849" WEIGHT="6.5949116598467885"/>
<DICH_DATA CI_END="1.2547560036328695" CI_START="0.8246862503827318" EFFECT_SIZE="1.0172413793103448" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="58" LOG_CI_END="0.09855928232850295" LOG_CI_START="-0.08371124617008925" LOG_EFFECT_SIZE="0.0074240180792068755" ORDER="1" O_E="0.0" SE="0.10706661069374049" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.011463259125444984" WEIGHT="7.413869874651301"/>
<DICH_DATA CI_END="0.9759703719972511" CI_START="0.3353749485691675" EFFECT_SIZE="0.5721153846153846" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="24" LOG_CI_END="-0.010563366219999535" LOG_CI_START="-0.4744693809204622" LOG_EFFECT_SIZE="-0.24251637357023084" ORDER="1" O_E="0.0" SE="0.27250068940685995" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.07425662572721395" WEIGHT="1.5550850468063522"/>
<DICH_DATA CI_END="1.0484861014457354" CI_START="0.77731856905455" EFFECT_SIZE="0.9027777777777778" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="45" LOG_CI_END="0.020562677905387537" LOG_CI_START="-0.10940095748221328" LOG_EFFECT_SIZE="-0.04441913978841287" ORDER="1" O_E="0.0" SE="0.07634128275704737" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.005827991452991458" WEIGHT="11.201009935333632"/>
<DICH_DATA CI_END="0.9799794766459171" CI_START="0.6219352854943884" EFFECT_SIZE="0.7806944444444445" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="48" LOG_CI_END="-0.008783019483791298" LOG_CI_START="-0.20625480279287006" LOG_EFFECT_SIZE="-0.10751891113833068" ORDER="1" O_E="0.0" SE="0.11599590301684518" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.013455049516693351" WEIGHT="6.622458133129394"/>
<DICH_DATA CI_END="0.9428015060715957" CI_START="0.832582713234603" EFFECT_SIZE="0.8859798169071117" ESTIMABLE="YES" EVENTS_1="724" EVENTS_2="808" LOG_CI_END="-0.025579732386512153" LOG_CI_START="-0.07957261053398831" LOG_EFFECT_SIZE="-0.052576171460250246" ORDER="2" O_E="0.0" SE="0.03171568389288479" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.0010058846047933914" WEIGHT="19.899036725888823"/>
<DICH_DATA CI_END="1.0519429282324169" CI_START="0.8503929310660905" EFFECT_SIZE="0.9458143739940787" ESTIMABLE="YES" EVENTS_1="448" EVENTS_2="236" LOG_CI_END="0.021992178386079406" LOG_CI_START="-0.07038035856442754" LOG_EFFECT_SIZE="-0.02419409008917406" ORDER="2" O_E="0.0" SE="0.05426008545616016" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.002944156873709803" WEIGHT="15.165396216087677"/>
<DICH_DATA CI_END="0.9356483690929477" CI_START="0.8244845822574276" EFFECT_SIZE="0.8783095438007277" ESTIMABLE="YES" EVENTS_1="689" EVENTS_2="795" LOG_CI_END="-0.02888733508094745" LOG_CI_START="-0.08381746118759804" LOG_EFFECT_SIZE="-0.05635239813427276" ORDER="2" O_E="0.0" SE="0.032266227983556085" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.0010411094682868177" WEIGHT="19.78679572821063"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="36.078323487114034" CI_END="0.8851404986838428" CI_START="0.5970109008708737" DF="10" EFFECT_SIZE="0.7269377734830784" ESTIMABLE="YES" EVENTS_1="523" EVENTS_2="572" I2="72.28252581201102" ID="CMP-003.02.02" LOG_CI_END="-0.052987788104251456" LOG_CI_START="-0.2240177389797646" LOG_EFFECT_SIZE="-0.13850276354200805" NO="2" P_CHI2="8.160680840596513E-5" P_Z="0.0015013639235156998" STUDIES="11" TAU2="0.0658329440865299" TOTAL_1="1797" TOTAL_2="1512" WEIGHT="100.0" Z="3.1744197658010185">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.8387520887290353" CI_START="0.27589639998084015" EFFECT_SIZE="0.48104956268221577" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="28" LOG_CI_END="-0.0763663853059742" LOG_CI_START="-0.5592539663517542" LOG_EFFECT_SIZE="-0.31781017582886417" ORDER="1" O_E="0.0" SE="0.2836505554383681" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.08045763760049474" WEIGHT="6.899270603865587"/>
<DICH_DATA CI_END="0.9120298765126801" CI_START="0.19699392660974857" EFFECT_SIZE="0.42386831275720166" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="-0.03999093470659414" LOG_CI_START="-0.7055471630796857" LOG_EFFECT_SIZE="-0.37276904889314" ORDER="1" O_E="0.0" SE="0.3909510231028184" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.15284270246514042" WEIGHT="4.615503947382645"/>
<DICH_DATA CI_END="0.8115768587487964" CI_START="0.3521781100679432" EFFECT_SIZE="0.5346209912536443" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="49" LOG_CI_END="-0.0906703449075247" LOG_CI_START="-0.4532376414753382" LOG_EFFECT_SIZE="-0.27195399319143143" ORDER="1" O_E="0.0" SE="0.21297382474099683" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.04535785002480883" WEIGHT="9.07717511977696"/>
<DICH_DATA CI_END="0.9972484337336552" CI_START="0.3293380007214721" EFFECT_SIZE="0.5730897009966778" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="28" LOG_CI_END="-0.0011966371152548345" LOG_CI_START="-0.48235815525384607" LOG_EFFECT_SIZE="-0.24177739618455044" ORDER="2" O_E="0.0" SE="0.28263665754253625" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.0798834801868169" WEIGHT="6.926455373090696"/>
<DICH_DATA CI_END="2.700829492835596" CI_START="0.7700871647168297" EFFECT_SIZE="1.4421768707482994" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="14" LOG_CI_END="0.43149716743142463" LOG_CI_START="-0.1134601150702739" LOG_EFFECT_SIZE="0.15901852618057535" ORDER="2" O_E="0.0" SE="0.3201106053235521" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="0.10247079964061095" WEIGHT="5.996885675294256"/>
<DICH_DATA CI_END="1.173287546586794" CI_START="0.8250873971200825" EFFECT_SIZE="0.9839028244124037" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="83" LOG_CI_END="0.0694044610431056" LOG_CI_START="-0.08350004650865447" LOG_EFFECT_SIZE="-0.007047792732774443" ORDER="2" O_E="0.0" SE="0.08981686462542321" STUDY_ID="STD-De-Mol-1986" TOTAL_1="122" TOTAL_2="123" VAR="0.008067069171141599" WEIGHT="13.657620145973548"/>
<DICH_DATA CI_END="1.098660222738566" CI_START="0.646121544069989" EFFECT_SIZE="0.8425366695427092" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="76" LOG_CI_END="0.04086340106273701" LOG_CI_START="-0.18968577774218268" LOG_EFFECT_SIZE="-0.07441118833972281" ORDER="2" O_E="0.0" SE="0.13542572886685053" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.01834012803911771" WEIGHT="11.990750537761974"/>
<DICH_DATA CI_END="1.1607000700658978" CI_START="0.8290874769605869" EFFECT_SIZE="0.9809800673810409" ESTIMABLE="YES" EVENTS_1="181" EVENTS_2="171" LOG_CI_END="0.06472001065718366" LOG_CI_START="-0.08139964465237443" LOG_EFFECT_SIZE="-0.008339816997595402" ORDER="2" O_E="0.0" SE="0.08583140883279351" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.007367030742222145" WEIGHT="13.788233018069928"/>
<DICH_DATA CI_END="0.7224950368323808" CI_START="0.4728292237997409" EFFECT_SIZE="0.5844799119427628" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="79" LOG_CI_END="-0.1411651319398758" LOG_CI_START="-0.32529568918529217" LOG_EFFECT_SIZE="-0.233230410562584" ORDER="2" O_E="0.0" SE="0.1081592007869158" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.011698412714864366" WEIGHT="13.017936890245885"/>
<DICH_DATA CI_END="0.9106581476001743" CI_START="0.27983146791643443" EFFECT_SIZE="0.5048076923076923" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="-0.04064462244904817" LOG_CI_START="-0.5531034493365987" LOG_EFFECT_SIZE="-0.29687403589282346" ORDER="2" O_E="0.0" SE="0.30102085162585185" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="0.09061355311355311" WEIGHT="6.451396023043403"/>
<DICH_DATA CI_END="1.3474337000124734" CI_START="0.4872254124744582" EFFECT_SIZE="0.8102493074792244" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="19" LOG_CI_END="0.1295074050816975" LOG_CI_START="-0.3122700680566148" LOG_EFFECT_SIZE="-0.09138133148745865" ORDER="293" O_E="0.0" SE="0.25950227455520547" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="0.06734143049932523" WEIGHT="7.5787726654951175"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4421414233045668" CI_START="0.5697171871114918" DF="0" EFFECT_SIZE="0.9064285714285715" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="30" I2="0.0" ID="CMP-003.02.03" LOG_CI_END="0.1590078514715856" LOG_CI_START="-0.24434067863865205" LOG_EFFECT_SIZE="-0.04266641358353323" NO="3" P_CHI2="1.0" P_Z="0.6783966889312859" STUDIES="1" TAU2="0.0" TOTAL_1="140" TOTAL_2="141" WEIGHT="100.0" Z="0.4146519832382211">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.4421414233045668" CI_START="0.5697171871114918" EFFECT_SIZE="0.9064285714285715" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="30" LOG_CI_END="0.1590078514715856" LOG_CI_START="-0.24434067863865205" LOG_EFFECT_SIZE="-0.04266641358353323" ORDER="2" O_E="0.0" SE="0.2369289231941785" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.056135314645952936" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="48.52562222120073" CI_END="1.1294108659128945" CI_START="0.9932415442253942" CI_STUDY="95" CI_TOTAL="95" DF="41" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0591401194007632" ESTIMABLE="YES" EVENTS_1="1563" EVENTS_2="983" I2="15.508553784010628" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.05285196171085718" LOG_CI_START="-0.0029451235410446973" LOG_EFFECT_SIZE="0.024953419084906243" METHOD="MH" NO="3" P_CHI2="0.19553016336640483" P_Q="0.0" P_Z="0.07959180973188652" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="40" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="9020" TOTAL_2="6154" WEIGHT="300.00000000000006" Z="1.7530594107828825">
<NAME>Episodes during first week after vaccine (one or multiple doses)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="34.61775474352138" CI_END="1.1365292330175554" CI_START="0.9821127440406265" DF="28" EFFECT_SIZE="1.056503593804233" ESTIMABLE="YES" EVENTS_1="1251" EVENTS_2="759" I2="19.116649223935806" ID="CMP-003.03.01" LOG_CI_END="0.055580610826442146" LOG_CI_START="-0.007838653451210998" LOG_EFFECT_SIZE="0.02387097868761557" NO="1" P_CHI2="0.18126921442080235" P_Z="0.14008921399876026" STUDIES="29" TAU2="0.0" TOTAL_1="7668" TOTAL_2="5005" WEIGHT="100.00000000000003" Z="1.475458885761173">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.9484348479116433" CI_START="0.00837524952213576" EFFECT_SIZE="0.15714285714285714" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.46959153553757393" LOG_CI_START="-2.0770022452496373" LOG_EFFECT_SIZE="-0.8037053548560318" ORDER="303" O_E="0.0" SE="1.4958817926769272" STUDY_ID="STD-Anderson-1986" TOTAL_1="13" TOTAL_2="10" VAR="2.2376623376623375" WEIGHT="0.31132084902962787"/>
<DICH_DATA CI_END="10.932041013276642" CI_START="0.5717139180514929" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.0387012523479482" LOG_CI_START="-0.2428212350038729" LOG_EFFECT_SIZE="0.3979400086720376" ORDER="304" O_E="0.0" SE="0.752772652709081" STUDY_ID="STD-Barnes-1997" TOTAL_1="15" TOTAL_2="15" VAR="0.5666666666666667" WEIGHT="0.22237203502116276"/>
<DICH_DATA CI_END="1.0699822426668513" CI_START="0.45537403502361373" EFFECT_SIZE="0.6980273141122914" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="33" LOG_CI_END="0.029376570231197895" LOG_CI_START="-0.34163173605606945" LOG_EFFECT_SIZE="-0.15612758291243578" ORDER="305" O_E="0.0" SE="0.21793211563387596" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.04749440702465708" WEIGHT="4.889711471794971"/>
<DICH_DATA CI_END="1.9792410434873755" CI_START="0.41755716602135373" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.2964986883356043" LOG_CI_START="-0.3792840586520544" LOG_EFFECT_SIZE="-0.04139268515822506" ORDER="306" O_E="0.0" SE="0.3969581307590986" STUDY_ID="STD-Bresee-2001" TOTAL_1="60" TOTAL_2="60" VAR="0.1575757575757576" WEIGHT="1.2230461926163951"/>
<DICH_DATA CI_END="32.36021971848744" CI_START="0.07676246070414712" EFFECT_SIZE="1.576086956521739" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.5100114617104052" LOG_CI_START="-1.1148511119315658" LOG_EFFECT_SIZE="0.19758017488941962" ORDER="307" O_E="0.0" SE="1.5418572690365862" STUDY_ID="STD-Dagan-1992" TOTAL_1="183" TOTAL_2="57" VAR="2.3773238380809594" WEIGHT="0.08453812901630982"/>
<DICH_DATA CI_END="3.1722262767998446" CI_START="0.3103675875123093" EFFECT_SIZE="0.9922480620155039" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.5013641582359242" LOG_CI_START="-0.5081236395386856" LOG_EFFECT_SIZE="-0.003379740651380603" ORDER="308" O_E="0.0" SE="0.592978129457996" STUDY_ID="STD-Dennehy-1996" TOTAL_1="129" TOTAL_2="64" VAR="0.35162306201550386" WEIGHT="0.594528342336373"/>
<DICH_DATA CI_END="5.083060192649951" CI_START="0.04918297059741634" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="309" O_E="0.0" SE="1.1832159566199232" STUDY_ID="STD-Flores-1988" TOTAL_1="20" TOTAL_2="20" VAR="1.4" WEIGHT="0.22237203502116276"/>
<DICH_DATA CI_END="88.29484803636674" CI_START="0.32558920871474384" EFFECT_SIZE="5.361702127659575" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="0" LOG_CI_END="1.94593536343427" LOG_CI_START="-0.48732999774261676" LOG_EFFECT_SIZE="0.7293026828458267" ORDER="310" O_E="0.0" SE="1.429312118013098" STUDY_ID="STD-Flores-1989" TOTAL_1="93" TOTAL_2="23" VAR="2.0429331306990886" WEIGHT="0.08857191225419195"/>
<DICH_DATA CI_END="4.07491101926019" CI_START="0.13197288854553013" EFFECT_SIZE="0.7333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.6101181298204837" LOG_CI_START="-0.8795152776153963" LOG_EFFECT_SIZE="-0.13469857389745624" ORDER="311" O_E="0.0" SE="0.8750180373321258" STUDY_ID="STD-Flores-1990" TOTAL_1="45" TOTAL_2="22" VAR="0.7656565656565656" WEIGHT="0.2987087037597709"/>
<DICH_DATA CI_END="1.1204429841826606" CI_START="0.4388903044974862" EFFECT_SIZE="0.70125" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="24" LOG_CI_END="0.04938976155393379" LOG_CI_START="-0.3576440130254981" LOG_EFFECT_SIZE="-0.15412712573578216" ORDER="312" O_E="0.0" SE="0.23909365403763752" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.057165775401069506" WEIGHT="3.5343899606012625"/>
<DICH_DATA CI_END="5.407844732265851" CI_START="1.296762196721243" EFFECT_SIZE="2.6481481481481484" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="8" LOG_CI_END="0.7330242138344325" LOG_CI_START="0.11286034144975425" LOG_EFFECT_SIZE="0.42294227764209336" ORDER="313" O_E="0.0" SE="0.36428732849943835" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.1327052577052577" WEIGHT="0.9062709351805879"/>
<DICH_DATA CI_END="11.621628720601862" CI_START="0.10240239756742692" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.0652669967980315" LOG_CI_START="-0.9896898750192319" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="314" O_E="0.0" SE="1.2070918387060312" STUDY_ID="STD-Ho-1989" TOTAL_1="66" TOTAL_2="36" VAR="1.4570707070707072" WEIGHT="0.14388778736663474"/>
<DICH_DATA CI_END="5.016745997979893" CI_START="0.47319159294375757" EFFECT_SIZE="1.5407407407407407" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="3" LOG_CI_END="0.7004221128937543" LOG_CI_START="-0.3249629799582435" LOG_EFFECT_SIZE="0.18772956646775543" ORDER="315" O_E="0.0" SE="0.6023162792793336" STUDY_ID="STD-Ing-1991" TOTAL_1="135" TOTAL_2="39" VAR="0.36278490028490024" WEIGHT="0.5175900815147754"/>
<DICH_DATA CI_END="1.9681186507776918" CI_START="0.9652005418341273" EFFECT_SIZE="1.378270361041142" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="50" LOG_CI_END="0.2940512769330939" LOG_CI_START="-0.015382442963515418" LOG_EFFECT_SIZE="0.13933441698478924" ORDER="316" O_E="0.0" SE="0.1817628987888851" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.03303775137613849" WEIGHT="5.522207958928375"/>
<DICH_DATA CI_END="1.52016586828158" CI_START="0.6895207706695652" EFFECT_SIZE="1.0238095238095237" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="28" LOG_CI_END="0.18189097725351783" LOG_CI_START="-0.16145264689014577" LOG_EFFECT_SIZE="0.010219165181686028" ORDER="317" O_E="0.0" SE="0.20168174440033793" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.04067552602436324" WEIGHT="4.669812735444418"/>
<DICH_DATA CI_END="1.0397276755656624" CI_START="0.9065914336885488" EFFECT_SIZE="0.970880118262155" ESTIMABLE="YES" EVENTS_1="385" EVENTS_2="197" LOG_CI_END="0.016919604215879146" LOG_CI_START="-0.042588388872488614" LOG_EFFECT_SIZE="-0.012834392328304736" ORDER="318" O_E="0.0" SE="0.03495528970942378" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.0012218722786697476" WEIGHT="29.267531974122964"/>
<DICH_DATA CI_END="1.9506756746669098" CI_START="0.8732463830991104" EFFECT_SIZE="1.3051515151515152" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="22" LOG_CI_END="0.2901850682611735" LOG_CI_START="-0.058863204491748214" LOG_EFFECT_SIZE="0.11566093188471263" ORDER="319" O_E="0.0" SE="0.20503268323188223" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.042038401193265365" WEIGHT="3.2907072447077894"/>
<DICH_DATA CI_END="3.277701662652139" CI_START="0.6365496216022911" EFFECT_SIZE="1.4444444444444444" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="9" LOG_CI_END="0.5155694214247419" LOG_CI_START="-0.19616773568971826" LOG_EFFECT_SIZE="0.15970084286751188" ORDER="320" O_E="0.0" SE="0.4180779292447824" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.17478915492160524" WEIGHT="1.0006741575952325"/>
<DICH_DATA CI_END="2.7879559678150594" CI_START="0.4955250444588483" EFFECT_SIZE="1.1753731343283582" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" LOG_CI_END="0.44528591035640364" LOG_CI_START="-0.30493439083478024" LOG_EFFECT_SIZE="0.07017575976081168" ORDER="321" O_E="0.0" SE="0.44068311857008524" STUDY_ID="STD-Perez_x002d_Schael-1990c" TOTAL_1="67" TOTAL_2="63" VAR="0.1942016109926558" WEIGHT="0.9168570059334095"/>
<DICH_DATA CI_END="3.636890039538266" CI_START="0.6031819255529614" EFFECT_SIZE="1.4811165845648604" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5607301704680512" LOG_CI_START="-0.2195516806499185" LOG_EFFECT_SIZE="0.17058924490906638" ORDER="322" O_E="0.0" SE="0.4583414218041514" STUDY_ID="STD-Perez_x002d_Schael-1994" TOTAL_1="87" TOTAL_2="82" VAR="0.210076858941451" WEIGHT="0.8013288125910539"/>
<DICH_DATA CI_END="1.2594183885632282" CI_START="0.9366703491960013" EFFECT_SIZE="1.0861214765390583" ESTIMABLE="YES" EVENTS_1="283" EVENTS_2="257" LOG_CI_END="0.10017003007549169" LOG_CI_START="-0.02841322737790035" LOG_EFFECT_SIZE="0.03587840134879566" ORDER="323" O_E="0.0" SE="0.0755304419255122" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1171" TOTAL_2="1155" VAR="0.005704847657463171" WEIGHT="28.771365788269073"/>
<DICH_DATA CI_END="2.4022439271173317" CI_START="0.05309661478100735" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.38061710415864775" LOG_CI_START="-1.274933166843086" LOG_EFFECT_SIZE="-0.4471580313422192" ORDER="324" O_E="0.0" SE="0.972478424292429" STUDY_ID="STD-Pichichero-1990" TOTAL_1="70" TOTAL_2="25" VAR="0.9457142857142857" WEIGHT="0.32770615687329246"/>
<DICH_DATA CI_END="1.2739825500848605" CI_START="0.1217163967287952" EFFECT_SIZE="0.39378238341968913" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="0.10516347944850295" LOG_CI_START="-0.9146509129024677" LOG_EFFECT_SIZE="-0.4047437167269824" ORDER="325" O_E="0.0" SE="0.5990440222296181" STUDY_ID="STD-Pichichero-1993" TOTAL_1="193" TOTAL_2="19" VAR="0.3588537405690391" WEIGHT="0.6073273975342134"/>
<DICH_DATA CI_END="3.38311843028248" CI_START="0.08941454644103082" EFFECT_SIZE="0.55" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.5293172010743866" LOG_CI_START="-1.048591822085899" LOG_EFFECT_SIZE="-0.2596373105057561" ORDER="326" O_E="0.0" SE="0.926871570979987" STUDY_ID="STD-Rennels-1987" TOTAL_1="20" TOTAL_2="11" VAR="0.859090909090909" WEIGHT="0.2869316580918229"/>
<DICH_DATA CI_END="8.189579304189335" CI_START="0.2981113143078194" EFFECT_SIZE="1.5625" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.9132615927785114" LOG_CI_START="-0.5256215407462856" LOG_EFFECT_SIZE="0.19382002601611284" ORDER="327" O_E="0.0" SE="0.8452070752188483" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.714375" WEIGHT="0.24968088142727046"/>
<DICH_DATA CI_END="1.6222249828038633" CI_START="0.6187118582045693" EFFECT_SIZE="1.001843218041852" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="23" LOG_CI_END="0.21011108539574108" LOG_CI_START="-0.20851156023107795" LOG_EFFECT_SIZE="7.997625823315372E-4" ORDER="328" O_E="0.0" SE="0.24590101425670957" STUDY_ID="STD-Rennels-1996" TOTAL_1="802" TOTAL_2="385" VAR="0.060467308812478485" WEIGHT="3.455665171019687"/>
<DICH_DATA CI_END="1.6875078834977129" CI_START="0.5220499305281254" EFFECT_SIZE="0.9385964912280702" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="19" LOG_CI_END="0.2272458103928743" LOG_CI_START="-0.28228795769540016" LOG_EFFECT_SIZE="-0.02752107365126294" ORDER="329" O_E="0.0" SE="0.2993026576078825" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="107" VAR="0.08958208085114135" WEIGHT="2.1223600737833768"/>
<DICH_DATA CI_END="1.7402373772837314" CI_START="0.8429141688909406" EFFECT_SIZE="1.2111443937640411" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="37" LOG_CI_END="0.240608492313071" LOG_CI_START="-0.07421664586733272" LOG_EFFECT_SIZE="0.08319592322286914" ORDER="330" O_E="0.0" SE="0.18492984457673686" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.034199047415176057" WEIGHT="5.512949911267274"/>
<DICH_DATA CI_END="6.04032877743861" CI_START="0.025627263557673804" EFFECT_SIZE="0.39344262295081966" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.7810605780816181" LOG_CI_START="-1.5912977646799402" LOG_EFFECT_SIZE="-0.405118593299161" ORDER="331" O_E="0.0" SE="1.3935350339013306" STUDY_ID="STD-Vesikari-1991c" TOTAL_1="61" TOTAL_2="24" VAR="1.9419398907103824" WEIGHT="0.15958463689754035"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.122563127939545" CI_END="1.1706536725547592" CI_START="0.8890626259082102" DF="9" EFFECT_SIZE="1.0201884277674513" ESTIMABLE="YES" EVENTS_1="286" EVENTS_2="211" I2="0.0" ID="CMP-003.03.02" LOG_CI_END="0.06842843192577636" LOG_CI_START="-0.05106764608443691" LOG_EFFECT_SIZE="0.008680392920669737" NO="2" P_CHI2="0.5218437734467889" P_Z="0.775835638048278" STUDIES="10" TAU2="0.0" TOTAL_1="1160" TOTAL_2="965" WEIGHT="100.00000000000001" Z="0.28475005672931">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.7028321948859158" CI_START="0.33033202078827606" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.23117185264505702" LOG_CI_START="-0.48104932586165683" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="332" O_E="0.0" SE="0.41836224580653675" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.1750269687162891" WEIGHT="5.069404322928425"/>
<DICH_DATA CI_END="5.618807697296675" CI_START="0.504512078760777" EFFECT_SIZE="1.683673469387755" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7496441686971328" LOG_CI_START="-0.29712843165430985" LOG_EFFECT_SIZE="0.22625786852141141" ORDER="333" O_E="0.0" SE="0.614879407054377" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.3780766852195423" WEIGHT="1.5923128963044413"/>
<DICH_DATA CI_END="2.6773883904193294" CI_START="0.4979155502736457" EFFECT_SIZE="1.1546052631578947" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.42771137588660535" LOG_CI_START="-0.30284431017246477" LOG_EFFECT_SIZE="0.06243353285707032" ORDER="334" O_E="0.0" SE="0.42913202630006686" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="0.18415429599640126" WEIGHT="3.3357119354334226"/>
<DICH_DATA CI_END="2.1142982815484856" CI_START="1.0010718984047573" EFFECT_SIZE="1.4548417764498167" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="37" LOG_CI_END="0.3251662568088475" LOG_CI_START="4.652702456543999E-4" LOG_EFFECT_SIZE="0.1628157635272509" ORDER="335" O_E="0.0" SE="0.19073096680302526" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.03637830169761672" WEIGHT="15.360503715934978"/>
<DICH_DATA CI_END="2.71073179801775" CI_START="0.23263933297694422" EFFECT_SIZE="0.7941176470588235" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.4330865502610529" LOG_CI_START="-0.6333168560275887" LOG_EFFECT_SIZE="-0.10011515288326783" ORDER="336" O_E="0.0" SE="0.6264106396359443" STUDY_ID="STD-Clements_x002d_Mann-1999" TOTAL_1="119" TOTAL_2="63" VAR="0.3923902894491129" WEIGHT="2.209740345891878"/>
<DICH_DATA CI_END="34.601029623660324" CI_START="0.06018198357180849" EFFECT_SIZE="1.4430379746835442" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.539089022296273" LOG_CI_START="-1.220533502204211" LOG_EFFECT_SIZE="0.15927776004603114" ORDER="337" O_E="0.0" SE="1.6210159312433918" STUDY_ID="STD-Eichelberger-2002" TOTAL_1="78" TOTAL_2="37" VAR="2.627692649344881" WEIGHT="0.28524426033571626"/>
<DICH_DATA CI_END="1.5643035705043686" CI_START="0.6961638297414454" EFFECT_SIZE="1.043557168784029" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="38" LOG_CI_END="0.19432103657656366" LOG_CI_START="-0.1572885449008728" LOG_EFFECT_SIZE="0.018516245837845443" ORDER="338" O_E="0.0" SE="0.2065372086553449" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="232" TOTAL_2="230" VAR="0.04265761855914148" WEIGHT="16.12260768792821"/>
<DICH_DATA CI_END="2.393017484738206" CI_START="0.4395870570051669" EFFECT_SIZE="1.0256410256410255" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="4" LOG_CI_END="0.3789458718259652" LOG_CI_START="-0.3569551032230388" LOG_EFFECT_SIZE="0.010995384301463145" ORDER="339" O_E="0.0" SE="0.43227187551236124" STUDY_ID="STD-Maldonado-1986" TOTAL_1="39" TOTAL_2="10" VAR="0.18685897435897433" WEIGHT="2.6898880080844703"/>
<DICH_DATA CI_END="1.5619325466882517" CI_START="0.46262203392425594" EFFECT_SIZE="0.8500496524329693" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="19" LOG_CI_END="0.19366227459017732" LOG_CI_START="-0.3347736863431069" LOG_EFFECT_SIZE="-0.07055570587646476" ORDER="340" O_E="0.0" SE="0.31040589925240486" STUDY_ID="STD-Santosham-1991a" TOTAL_1="106" TOTAL_2="107" VAR="0.09635182229069411" WEIGHT="7.988873479168896"/>
<DICH_DATA CI_END="1.0421556987820921" CI_START="0.7766679082303577" EFFECT_SIZE="0.8996715437444013" ESTIMABLE="YES" EVENTS_1="131" EVENTS_2="85" LOG_CI_END="0.01793260770676701" LOG_CI_START="-0.10976463943978643" LOG_EFFECT_SIZE="-0.04591601586650973" ORDER="341" O_E="0.0" SE="0.0750099950854534" STUDY_ID="STD-Treanor-1995" TOTAL_1="197" TOTAL_2="115" VAR="0.005626499362719743" WEIGHT="45.34571334798957"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7264508128824679" CI_END="3.650554765117044" CI_START="1.0288217064859164" DF="2" EFFECT_SIZE="1.9379809036902327" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="13" I2="0.0" ID="CMP-003.03.03" LOG_CI_END="0.562358868051352" LOG_CI_START="0.012340118592984098" LOG_EFFECT_SIZE="0.2873494933221681" NO="3" P_CHI2="0.6954297820453508" P_Z="0.04056874425802773" STUDIES="3" TAU2="0.0" TOTAL_1="192" TOTAL_2="184" WEIGHT="100.0" Z="2.0479107610127443">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="12.849756125241573" CI_START="0.5693945856079913" EFFECT_SIZE="2.7049180327868854" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1088948852963472" LOG_CI_START="-0.24458666689006855" LOG_EFFECT_SIZE="0.43215410920313924" ORDER="342" O_E="0.0" SE="0.7950417635960375" STUDY_ID="STD-Bernstein-1998" TOTAL_1="61" TOTAL_2="55" VAR="0.6320914058618976" WEIGHT="15.947593910906406"/>
<DICH_DATA CI_END="4.212325711818994" CI_START="0.9320905196000571" EFFECT_SIZE="1.9814814814814814" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="9" LOG_CI_END="0.6245219449865368" LOG_CI_START="-0.03054190926205453" LOG_EFFECT_SIZE="0.2969900178622411" ORDER="343" O_E="0.0" SE="0.3847877506039973" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.14806161301488402" WEIGHT="68.55215816403047"/>
<DICH_DATA CI_END="6.211054714026899" CI_START="0.14730732211436595" EFFECT_SIZE="0.9565217391304348" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7931653550216421" LOG_CI_START="-0.8317756654124154" LOG_EFFECT_SIZE="-0.01930515519538663" ORDER="344" O_E="0.0" SE="0.9544983989907418" STUDY_ID="STD-Flores-1990" TOTAL_1="23" TOTAL_2="22" VAR="0.9110671936758894" WEIGHT="15.500247925063128"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="22.502424374145445" CI_END="0.9779177286137336" CI_START="0.7110385914586781" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8338688411950521" ESTIMABLE="YES" EVENTS_1="297" EVENTS_2="245" I2="77.7801719634048" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="-0.009697680500741615" LOG_CI_START="-0.1481068273958032" LOG_EFFECT_SIZE="-0.07890225394827237" METHOD="MH" NO="4" P_CHI2="4.201000088278617E-4" P_Q="0.0" P_Z="0.025442636984126483" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.1906852733368288" TOTALS="SUB" TOTAL_1="1431" TOTAL_2="946" WEIGHT="200.0" Z="2.2346149731693044">
<NAME>Severe episodes (clinical or measured by any scale)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.894529164506842" CI_END="0.9961762960087857" CI_START="0.7205574698655115" DF="2" EFFECT_SIZE="0.8472321236780906" ESTIMABLE="YES" EVENTS_1="258" EVENTS_2="176" I2="0.0" ID="CMP-003.04.01" LOG_CI_END="-0.0016637965075315677" LOG_CI_START="-0.1423313752245744" LOG_EFFECT_SIZE="-0.07199758586605297" NO="1" P_CHI2="0.3878004379062703" P_Z="0.044821227652143636" STUDIES="3" TAU2="0.0" TOTAL_1="1033" TOTAL_2="630" WEIGHT="100.0" Z="2.006328345995724">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.112032987563293" CI_START="0.1958375158051529" EFFECT_SIZE="0.4666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" LOG_CI_END="0.046117670433285234" LOG_CI_START="-0.708104108516134" LOG_EFFECT_SIZE="-0.3309932190414244" ORDER="1" O_E="0.0" SE="0.4430336064129071" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.1962787764112267" WEIGHT="3.4784830084359735"/>
<DICH_DATA CI_END="1.2573969436150065" CI_START="0.5897201750365084" EFFECT_SIZE="0.8611111111111112" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="36" LOG_CI_END="0.09947240036540894" LOG_CI_START="-0.22935401423143809" LOG_EFFECT_SIZE="-0.06494080693301456" ORDER="1" O_E="0.0" SE="0.1931542636511917" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.03730856956663407" WEIGHT="18.300149177353"/>
<DICH_DATA CI_END="1.0408628060758551" CI_START="0.721679478063707" EFFECT_SIZE="0.8667002518891688" ESTIMABLE="YES" EVENTS_1="220" EVENTS_2="125" LOG_CI_END="0.017393489846021154" LOG_CI_START="-0.14165564428018038" LOG_EFFECT_SIZE="-0.06213107721707963" ORDER="2" O_E="0.0" SE="0.09342624869164223" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.008728463944592582" WEIGHT="78.22136781421104"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.725836423593748" CI_END="1.2560078004842168" CI_START="0.2106063415118996" DF="2" EFFECT_SIZE="0.5143181970049172" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="69" I2="79.43621594181626" ID="CMP-003.04.02" LOG_CI_END="0.09899233661195102" LOG_CI_START="-0.6765285560272618" LOG_EFFECT_SIZE="-0.2887681097076554" NO="2" P_CHI2="0.007727910551641903" P_Z="0.14440007652419215" STUDIES="3" TAU2="0.48872537358727086" TOTAL_1="398" TOTAL_2="316" WEIGHT="100.0" Z="1.459599864510725">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="3.934787500208613" CI_START="0.6395892263451116" EFFECT_SIZE="1.5863945578231293" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5949212830791312" LOG_CI_START="-0.19409886040153035" LOG_EFFECT_SIZE="0.20041121133880038" ORDER="1" O_E="0.0" SE="0.46347433799324134" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="0.2148084619782733" WEIGHT="29.496957295403536"/>
<DICH_DATA CI_END="0.6333984145474526" CI_START="0.1474910581965279" EFFECT_SIZE="0.30564784053156147" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="28" LOG_CI_END="-0.19832302804044788" LOG_CI_START="-0.8312343084561282" LOG_EFFECT_SIZE="-0.5147786682482881" ORDER="1" O_E="0.0" SE="0.37177521907753647" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.13821681352015022" WEIGHT="33.10051218485416"/>
<DICH_DATA CI_END="0.5550298730479596" CI_START="0.20258585674788657" EFFECT_SIZE="0.33532253481102586" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="34" LOG_CI_END="-0.25568364147058087" LOG_CI_START="-0.6933908775875519" LOG_EFFECT_SIZE="-0.4745372595290663" ORDER="1" O_E="0.0" SE="0.25711139718087134" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.06610627056029977" WEIGHT="37.40253051974229"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="17.892823201427575" CI_END="0.6397641647701726" CI_START="0.3143146613737952" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.44842753796887375" ESTIMABLE="YES" EVENTS_1="147" EVENTS_2="158" I2="44.111670431068966" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="-0.1939800897886911" LOG_CI_START="-0.5026353606138875" LOG_EFFECT_SIZE="-0.34830772520128933" METHOD="MH" NO="5" P_CHI2="0.05679878164201857" P_Q="0.0" P_Z="9.710792487477405E-6" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.13524464843626616" TOTALS="SUB" TOTAL_1="4580" TOTAL_2="3342" WEIGHT="300.0" Z="4.423514914269678">
<NAME>Episodes requiring re-hydration</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.924434446709745" CI_END="0.8779996813647333" CI_START="0.29628594841322103" DF="4" EFFECT_SIZE="0.5100382027845128" ESTIMABLE="YES" EVENTS_1="110" EVENTS_2="90" I2="63.384832235368194" ID="CMP-003.05.01" LOG_CI_END="-0.05650564170387829" LOG_CI_START="-0.5282889447781544" LOG_EFFECT_SIZE="-0.2923972932410164" NO="1" P_CHI2="0.027426605270348015" P_Z="0.015121539888017638" STUDIES="5" TAU2="0.21503057436629958" TOTAL_1="3318" TOTAL_2="2241" WEIGHT="99.99999999999999" Z="2.429455049362626">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="3.1686011277904726" CI_START="0.035066297911908864" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5008675724492677" LOG_CI_START="-1.4551100818885927" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="1" O_E="0.0" SE="1.1489509564036013" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="1.3200883002207504" WEIGHT="5.002859725178841"/>
<DICH_DATA CI_END="0.6026265901573175" CI_START="0.1013969690062271" EFFECT_SIZE="0.24719326383319967" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="24" LOG_CI_END="-0.2199517095298664" LOG_CI_START="-0.9939750268916805" LOG_EFFECT_SIZE="-0.6069633682107733" ORDER="1" O_E="0.0" SE="0.45466512809554377" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.20672037870613721" WEIGHT="18.209761792083878"/>
<DICH_DATA CI_END="0.6803116163942147" CI_START="0.1425384217573821" EFFECT_SIZE="0.31140093786635403" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="-0.1672921133510078" LOG_CI_START="-0.8460680541952647" LOG_EFFECT_SIZE="-0.5066800837731362" ORDER="1" O_E="0.0" SE="0.39871634764701297" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.15897472588097372" WEIGHT="20.534426613622333"/>
<DICH_DATA CI_END="1.0196741450888365" CI_START="0.41926609099435597" EFFECT_SIZE="0.6538461538461539" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="26" LOG_CI_END="0.0084614074486432" LOG_CI_START="-0.37751026063373133" LOG_EFFECT_SIZE="-0.18452442659254403" ORDER="2" O_E="0.0" SE="0.22672166842215744" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.051402714932126704" WEIGHT="28.825168248518796"/>
<DICH_DATA CI_END="1.6374844969700115" CI_START="0.6028718462030282" EFFECT_SIZE="0.9935760171306209" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="21" LOG_CI_END="0.21417719696168402" LOG_CI_START="-0.21977499698414668" LOG_EFFECT_SIZE="-0.002798900011231316" ORDER="352" O_E="0.0" SE="0.25490566682178506" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.06497689897785888" WEIGHT="27.42778362059615"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.664665094730511" CI_END="0.6737269296982829" CI_START="0.26007347654467505" DF="4" EFFECT_SIZE="0.41859109504193026" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="65" I2="14.24893494457634" ID="CMP-003.05.02" LOG_CI_END="-0.171516093013033" LOG_CI_START="-0.5849039368377593" LOG_EFFECT_SIZE="-0.37821001492539624" NO="2" P_CHI2="0.3234665888627267" P_Z="3.3533096974951035E-4" STUDIES="5" TAU2="0.0473078751320845" TOTAL_1="1154" TOTAL_2="994" WEIGHT="99.99999999999999" Z="3.5863561007876643">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.9912776750010556" CI_START="0.35570136539148767" EFFECT_SIZE="0.5938003220611916" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="24" LOG_CI_END="-0.003804674647892548" LOG_CI_START="-0.44891446773282906" LOG_EFFECT_SIZE="-0.2263595711903608" ORDER="1" O_E="0.0" SE="0.2614596957871023" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.06836117252108409" WEIGHT="50.9769029930479"/>
<DICH_DATA CI_END="0.8085003629842248" CI_START="0.11370419019807793" EFFECT_SIZE="0.30319940476190477" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="16" LOG_CI_END="-0.09231978077673843" LOG_CI_START="-0.9442235305068837" LOG_EFFECT_SIZE="-0.518271655641811" ORDER="1" O_E="0.0" SE="0.5004124795830592" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.2504126497224657" WEIGHT="19.805318509345266"/>
<DICH_DATA CI_END="0.7394435909978698" CI_START="0.08260148450324896" EFFECT_SIZE="0.24714193962748876" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.1310949508797454" LOG_CI_START="-1.0830121475249443" LOG_EFFECT_SIZE="-0.6070535492023449" ORDER="2" O_E="0.0" SE="0.5591608733755086" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.3126608823140615" WEIGHT="16.38044885713717"/>
<DICH_DATA CI_END="1.0244051033825095" CI_START="0.015756944365744884" EFFECT_SIZE="0.12704918032786885" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.010471733370525363" LOG_CI_START="-1.802527998379439" LOG_EFFECT_SIZE="-0.8960281325044568" ORDER="2" O_E="0.0" SE="1.0649650169233398" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="1.1341504872705295" WEIGHT="4.990823214051139"/>
<DICH_DATA CI_END="3.237149233206586" CI_START="0.12066944458197347" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5101627209237998" LOG_CI_START="-0.9184026862356492" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="356" O_E="0.0" SE="0.8391463916782737" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="0.7041666666666666" WEIGHT="7.846506426418517"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7076671595642257" CI_START="0.007399513340300138" DF="0" EFFECT_SIZE="0.14154652686762775" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" ID="CMP-003.05.03" LOG_CI_END="0.43259527757266714" LOG_CI_START="-2.130796842508529" LOG_EFFECT_SIZE="-0.8491007824679309" NO="3" P_CHI2="1.0" P_Z="0.1941357740144168" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="107" WEIGHT="100.0" Z="1.2984411864613281">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.7076671595642257" CI_START="0.007399513340300138" EFFECT_SIZE="0.14154652686762778" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43259527757266714" LOG_CI_START="-2.130796842508529" LOG_EFFECT_SIZE="-0.8491007824679307" ORDER="1" O_E="0.0" SE="1.5057492203313343" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="2.267280714528421" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.942589352652387" CI_END="0.9800286450879316" CI_START="0.654474084197826" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8008766134565052" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="139" I2="0.0" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="-0.008761230203615992" LOG_CI_START="-0.18410754592409517" LOG_EFFECT_SIZE="-0.09643438806385557" METHOD="MH" NO="6" P_CHI2="0.42965205098508996" P_Q="0.0" P_Z="0.03109738431815243" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3370" TOTAL_2="2452" WEIGHT="200.0" Z="2.155824337679442">
<NAME>Episodes requiring hospitalization</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.6515046736926395" CI_END="0.9926803621806531" CI_START="0.6593629619700374" DF="3" EFFECT_SIZE="0.8090344021714558" ESTIMABLE="YES" EVENTS_1="186" EVENTS_2="126" I2="0.0" ID="CMP-003.06.01" LOG_CI_END="-0.0031905695186283706" LOG_CI_START="-0.18087545189077803" LOG_EFFECT_SIZE="-0.09203301070470321" NO="1" P_CHI2="0.4485316277481666" P_Z="0.04232081980581072" STUDIES="4" TAU2="0.0" TOTAL_1="2946" TOTAL_2="2077" WEIGHT="100.0" Z="2.030351529762788">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.73961079538584" CI_START="0.022653271892166038" EFFECT_SIZE="0.24912075029308323" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.43768886887063246" LOG_CI_START="-1.644869062433018" LOG_EFFECT_SIZE="-0.6035900967811927" ORDER="1" O_E="0.0" SE="1.223304837675783" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="1.4964747258809736" WEIGHT="0.7279587588686502"/>
<DICH_DATA CI_END="1.098257517201417" CI_START="0.3112595282211121" EFFECT_SIZE="0.5846735128850998" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="26" LOG_CI_END="0.04070418454643788" LOG_CI_START="-0.5068773451475679" LOG_EFFECT_SIZE="-0.23308658030056498" ORDER="1" O_E="0.0" SE="0.3216521011145465" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.10346007415140245" WEIGHT="10.52939400117229"/>
<DICH_DATA CI_END="51.64699155869687" CI_START="0.12324444768180348" EFFECT_SIZE="2.522935779816514" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.7130450289048234" LOG_CI_START="-0.9092326371255453" LOG_EFFECT_SIZE="0.40190619588963905" ORDER="1" O_E="0.0" SE="1.5403388815100318" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="2.372643869891576" WEIGHT="0.45913838901596254"/>
<DICH_DATA CI_END="1.0495270390230655" CI_START="0.6790242588623889" EFFECT_SIZE="0.8441885570349047" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="98" LOG_CI_END="0.020993631815270742" LOG_CI_START="-0.16811470981099352" LOG_EFFECT_SIZE="-0.07356053899786143" ORDER="2" O_E="0.0" SE="0.11108317597265595" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012339471984172047" WEIGHT="88.2835088509431"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6423785728182567" CI_END="1.913466040736579" CI_START="0.1575724161183531" DF="2" EFFECT_SIZE="0.5490987772698841" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" I2="24.310618449086235" ID="CMP-003.06.02" LOG_CI_END="0.2818207589819524" LOG_CI_START="-0.8025198057301389" LOG_EFFECT_SIZE="-0.2603495233740933" NO="2" P_CHI2="0.2668179510602262" P_Z="0.34661654525922414" STUDIES="3" TAU2="0.3300283976555144" TOTAL_1="424" TOTAL_2="375" WEIGHT="100.0" Z="0.9411723692931799">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.9090123803853576" CI_START="0.1681105077912999" EFFECT_SIZE="0.5665024630541872" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.2808087449026295" LOG_CI_START="-0.7744051400218321" LOG_EFFECT_SIZE="-0.24679819755960125" ORDER="1" O_E="0.0" SE="0.6198378593976009" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="232" TOTAL_2="230" VAR="0.38419897194260016" WEIGHT="56.80284984147143"/>
<DICH_DATA CI_END="67.16386819017342" CI_START="0.1858148177189842" EFFECT_SIZE="3.532710280373832" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.827135700647516" LOG_CI_START="-0.7309196563434847" LOG_EFFECT_SIZE="0.5481080221520157" ORDER="1" O_E="0.0" SE="1.5026143792747504" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="2.2578499728032435" WEIGHT="15.676992586308785"/>
<DICH_DATA CI_END="1.4508851878921203" CI_START="0.021910041715202427" EFFECT_SIZE="0.17829457364341086" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.16163304700857148" LOG_CI_START="-1.6593567955718835" LOG_EFFECT_SIZE="-0.7488618742816561" ORDER="1" O_E="0.0" SE="1.0696584475768567" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="1.1441691944725312" WEIGHT="27.520157572219787"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Death</NAME>
<DICH_OUTCOME CHI2="2.9282354542688447" CI_END="3.1185180408470545" CI_START="0.164126321815374" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7154235777209983" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.4939482608186596" LOG_CI_START="-0.7848217632341541" LOG_EFFECT_SIZE="-0.14543675120774727" METHOD="MH" NO="1" P_CHI2="0.4028228708093483" P_Q="0.0" P_Z="0.6557270847863345" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3216" TOTAL_2="2813" WEIGHT="100.0" Z="0.4458202632749924">
<NAME>All-cause death</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.9282354542688447" CI_END="3.1185180408470545" CI_START="0.164126321815374" DF="3" EFFECT_SIZE="0.7154235777209983" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.4939482608186596" LOG_CI_START="-0.7848217632341541" LOG_EFFECT_SIZE="-0.14543675120774727" NO="1" P_CHI2="0.4028228708093483" P_Z="0.6557270847863345" STUDIES="4" TAU2="0.0" TOTAL_1="3216" TOTAL_2="2813" WEIGHT="100.0" Z="0.4458202632749924">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="15.620938062483207" CI_START="0.06401664202239551" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1937071104073198" LOG_CI_START="-1.1937071104073198" LOG_EFFECT_SIZE="0.0" ORDER="369" O_E="0.0" SE="1.4023789311975088" STUDY_ID="STD-Bresee-2001" TOTAL_1="60" TOTAL_2="60" VAR="1.9666666666666668" WEIGHT="28.68992029751972"/>
<DICH_DATA CI_END="8.284022302007914" CI_START="0.01377518971938815" EFFECT_SIZE="0.3378076062639821" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9182412594181719" LOG_CI_START="-1.860902411095706" LOG_EFFECT_SIZE="-0.47133057583876703" ORDER="370" O_E="0.0" SE="1.6324827490428906" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="2.6649999259226336" WEIGHT="21.172049338395915"/>
<DICH_DATA CI_END="2.7248597130361283" CI_START="0.007286520932215586" EFFECT_SIZE="0.1409068746952706" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4353441479254605" LOG_CI_START="-2.137479783149097" LOG_EFFECT_SIZE="-0.8510678176118184" ORDER="371" O_E="0.0" SE="1.5112895127970525" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1171" TOTAL_2="1155" VAR="2.283995991490352" WEIGHT="24.70385680564965"/>
<DICH_DATA CI_END="82.21856287673893" CI_START="0.23952619429174887" EFFECT_SIZE="4.437735849056604" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.9149698813453673" LOG_CI_START="-0.6206469857387437" LOG_EFFECT_SIZE="0.6471614478033119" ORDER="372" O_E="0.0" SE="1.489433899231127" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="2.218413340178839" WEIGHT="25.43417355843471"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Exploration of heterogeneity: methodological quality</NAME>
<DICH_OUTCOME CHI2="56.239019095615625" CI_END="0.7552221355009587" CI_START="0.4617881954442223" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5905528487040932" ESTIMABLE="YES" EVENTS_1="728" EVENTS_2="756" I2="80.44062614019248" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-0.1219252893865814" LOG_CI_START="-0.335557173019017" LOG_EFFECT_SIZE="-0.22874123120279924" METHOD="MH" NO="1" P_CHI2="4.5928620795443464E-8" P_Q="0.0" P_Z="2.7027208190038248E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.1278848682693645" TOTALS="SUB" TOTAL_1="5426" TOTAL_2="4272" WEIGHT="300.0" Z="4.197169142675359">
<NAME>Adequate allocation concealment (A)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="47.5961786767442" CI_END="0.7564112346371148" CI_START="0.44609218534166334" DF="8" EFFECT_SIZE="0.5808865127339903" ESTIMABLE="YES" EVENTS_1="699" EVENTS_2="698" I2="83.19192796057628" ID="CMP-005.01.01" LOG_CI_END="-0.12124202939776584" LOG_CI_START="-0.3505753846775053" LOG_EFFECT_SIZE="-0.23590870703763553" NO="1" P_CHI2="1.1800439614351177E-7" P_Z="5.522925839831269E-5" STUDIES="9" TAU2="0.11961365071196703" TOTAL_1="5059" TOTAL_2="3904" WEIGHT="100.00000000000001" Z="4.032318533596451">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="1" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="13.741254893805998"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="6.555521219366457"/>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="8.31649484667592"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="2" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="12.99069742869729"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="2" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="12.94251952984196"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="2" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="14.006048866633616"/>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="2" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="13.691348309909623"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="6.923409423671518"/>
<DICH_DATA CI_END="0.9278295537801063" CI_START="0.3934099314081769" EFFECT_SIZE="0.6041666666666666" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="48" LOG_CI_END="-0.03253179819018153" LOG_CI_START="-0.4051546807630808" LOG_EFFECT_SIZE="-0.21884323947663117" ORDER="2" O_E="0.0" SE="0.21888052573633768" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.04790868454661558" WEIGHT="10.832705481397618"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5570099086906626" CI_START="0.33321237460914066" DF="0" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" NO="2" P_CHI2="1.0" P_Z="0.40416010899136234" STUDIES="1" TAU2="0.0" TOTAL_1="119" TOTAL_2="120" WEIGHT="100.0" Z="0.8342145368957196">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="1" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.80084161658765" CI_END="1.9922274586748236" CI_START="0.11884930319424182" DF="1" EFFECT_SIZE="0.486595155409441" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="44" I2="85.29593752689459" ID="CMP-005.01.03" LOG_CI_END="0.29933892164183884" LOG_CI_START="-0.9250033601687235" LOG_EFFECT_SIZE="-0.3128322192634423" NO="3" P_CHI2="0.00911154576696882" P_Z="0.31654530476384213" STUDIES="2" TAU2="0.8825432419722246" TOTAL_1="248" TOTAL_2="248" WEIGHT="100.0" Z="1.001582469329362">
<NAME>Human vaccine rotavirus</NAME>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="2" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="49.25375390913689"/>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="383" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="50.7462460908631"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="66.80296394827778" CI_END="0.6131881671721576" CI_START="0.47234861044809007" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5381808048481289" ESTIMABLE="YES" EVENTS_1="688" EVENTS_2="727" I2="59.58263166151616" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-0.21240623441358625" LOG_CI_START="-0.3257373579104306" LOG_EFFECT_SIZE="-0.26907179616200844" METHOD="MH" NO="2" P_CHI2="3.167112045499021E-5" P_Q="0.0" P_Z="1.3182964776163299E-20" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10637300869186316" TOTALS="SUB" TOTAL_1="7189" TOTAL_2="4260" WEIGHT="300.0" Z="9.30672905131349">
<NAME>Unclear allocation concealment (B)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.8577924414764" CI_END="0.6653712302692778" CI_START="0.4845436750978138" DF="10" EFFECT_SIZE="0.5678040341693863" ESTIMABLE="YES" EVENTS_1="310" EVENTS_2="307" I2="7.9002471828404275" ID="CMP-005.02.01" LOG_CI_END="-0.1769359813533066" LOG_CI_START="-0.314667071040248" LOG_EFFECT_SIZE="-0.2458015261967773" NO="1" P_CHI2="0.36870424423873127" P_Z="2.6395289882874517E-12" STUDIES="11" TAU2="0.00582550874737788" TOTAL_1="2860" TOTAL_2="1563" WEIGHT="100.00000000000001" Z="6.995691964475021">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="6.9224890343544"/>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="1" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="20.8664631208179"/>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="2.433641523032403"/>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="1" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="16.918542180556727"/>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="1" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="1.4016335248411278"/>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="7.384733513044404"/>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="4.531509268598303"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="2" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="4.742702729432472"/>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="2" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="2.871274580722702"/>
<DICH_DATA CI_END="0.8778188036502038" CI_START="0.16667021644059082" EFFECT_SIZE="0.3825" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="-0.056595120421943645" LOG_CI_START="-0.7781420005987836" LOG_EFFECT_SIZE="-0.4173685605103636" ORDER="2" O_E="0.0" SE="0.42384020913053655" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.17964052287581697" WEIGHT="3.5291879806682243"/>
<DICH_DATA CI_END="0.6664001897444836" CI_START="0.3983950401410973" EFFECT_SIZE="0.5152577319587629" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.17626488794435038" LOG_CI_START="-0.3996860770072768" LOG_EFFECT_SIZE="-0.2879754824758136" ORDER="2" O_E="0.0" SE="0.1312387124082854" STUDY_ID="STD-Rennels-1996" TOTAL_1="900" TOTAL_2="459" VAR="0.017223599634584644" WEIGHT="28.397822543931337"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="44.839483949821755" CI_END="0.7604152336378942" CI_START="0.43061667819357957" DF="15" EFFECT_SIZE="0.5722302700460233" ESTIMABLE="YES" EVENTS_1="330" EVENTS_2="373" I2="66.547340248639" ID="CMP-005.02.02" LOG_CI_END="-0.11894919136129295" LOG_CI_START="-0.3659091535483677" LOG_EFFECT_SIZE="-0.24242917245483026" NO="2" P_CHI2="8.116863425955412E-5" P_Z="1.1908023042593608E-4" STUDIES="16" TAU2="0.1737984650173263" TOTAL_1="2847" TOTAL_2="2193" WEIGHT="100.0" Z="3.8480119822287975">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="1" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="1.5271794650241435"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="0.823633911462553"/>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="1" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="3.897250845786714"/>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="1" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="8.154224796336065"/>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="1" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="5.851605914306848"/>
<DICH_DATA CI_END="1.0100113315938297" CI_START="0.0036038497772461773" EFFECT_SIZE="0.06033182503770739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.00432624627874643" LOG_CI_START="-2.4432333204323675" LOG_EFFECT_SIZE="-1.2194535370768107" ORDER="1" O_E="0.0" SE="1.437708605101362" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="2.067006033182504" WEIGHT="0.9391270208167075"/>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="1" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="10.188022630523479"/>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="4.326429945551263"/>
<DICH_DATA CI_END="0.6103365201855264" CI_START="0.19150446401059254" EFFECT_SIZE="0.3418803418803419" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.21443064275760207" LOG_CI_START="-0.7178210980787965" LOG_EFFECT_SIZE="-0.46612587041819925" ORDER="1" O_E="0.0" SE="0.29569404527861104" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="115" VAR="0.08743496841322929" WEIGHT="8.055630648006249"/>
<DICH_DATA CI_END="1.446022792933408" CI_START="0.5571779516389909" EFFECT_SIZE="0.8976034858387799" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="27" LOG_CI_END="0.16017513857897522" LOG_CI_START="-0.2540060775872285" LOG_EFFECT_SIZE="-0.046915469504126665" ORDER="1" O_E="0.0" SE="0.24329209660611376" STUDY_ID="STD-Bernstein-1990" TOTAL_1="102" TOTAL_2="103" VAR="0.05919104427099858" WEIGHT="9.03216655142565"/>
<DICH_DATA CI_END="1.0318595193566296" CI_START="0.29941894419434845" EFFECT_SIZE="0.5558401639344263" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" LOG_CI_END="0.013620575080836642" LOG_CI_START="-0.523720725373086" LOG_EFFECT_SIZE="-0.25505007514612466" ORDER="1" O_E="0.0" SE="0.31563693976896945" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.09962667774672006" WEIGHT="7.696439439891184"/>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="2.4470493609180046"/>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="10.547616815068736"/>
<DICH_DATA CI_END="1.1677303907017897" CI_START="0.5915485874192178" EFFECT_SIZE="0.8311252992817239" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="35" LOG_CI_END="0.0673425830619302" LOG_CI_START="-0.2280095783708831" LOG_EFFECT_SIZE="-0.08033349765447646" ORDER="2" O_E="0.0" SE="0.17349132164241274" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.030099238685231115" WEIGHT="10.320861953879321"/>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="9.574477395073968"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="6.618283305929135"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5126179297564388" CI_START="0.23531934567258378" DF="0" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" I2="0.0" ID="CMP-005.02.03" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" NO="3" P_CHI2="1.0" P_Z="1.0136929840441862E-7" STUDIES="1" TAU2="0.0" TOTAL_1="1482" TOTAL_2="504" WEIGHT="100.0" Z="5.324251995909791">
<NAME>Human vaccine rotavirus</NAME>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="412" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="79.61398723999459" CI_END="0.6957852044945361" CI_START="0.48107627749787363" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5785548860016032" ESTIMABLE="YES" EVENTS_1="1018" EVENTS_2="1065" I2="76.1348468294586" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="-0.1575248105333825" LOG_CI_START="-0.31778605819987277" LOG_EFFECT_SIZE="-0.23765543436662767" METHOD="MH" NO="3" P_CHI2="2.1673135508493147E-9" P_Q="0.0" P_Z="6.137781868301836E-9" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="USER" STUDIES="20" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.11124155866251428" TOTALS="SUB" TOTAL_1="7754" TOTAL_2="5616" WEIGHT="199.99999999999997" Z="5.812959762526648">
<NAME>Exclusions after randomization reported</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="56.59247339098019" CI_END="0.7099627943693703" CI_START="0.48313072963922404" DF="14" EFFECT_SIZE="0.585666153077311" ESTIMABLE="YES" EVENTS_1="913" EVENTS_2="918" I2="75.26172799821231" ID="CMP-005.03.01" LOG_CI_END="-0.1487644099055112" LOG_CI_START="-0.31593533823629466" LOG_EFFECT_SIZE="-0.2323498740709029" NO="1" P_CHI2="4.601795453584856E-7" P_Z="5.0857975559230786E-8" STUDIES="15" TAU2="0.09118871318064044" TOTAL_1="7024" TOTAL_2="4985" WEIGHT="99.99999999999999" Z="5.448284453984554">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="1" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="8.26054697762218"/>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="4.195996228914277"/>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="5.359516355626855"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="3.8819346796049956"/>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="5.080901780532995"/>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="1" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="9.304108181625459"/>
<DICH_DATA CI_END="0.6664001897444836" CI_START="0.3983950401410973" EFFECT_SIZE="0.5152577319587629" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.17626488794435038" LOG_CI_START="-0.3996860770072768" LOG_EFFECT_SIZE="-0.2879754824758136" ORDER="2" O_E="0.0" SE="0.1312387124082854" STUDY_ID="STD-Rennels-1996" TOTAL_1="900" TOTAL_2="459" VAR="0.017223599634584644" WEIGHT="8.894429617528806"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="2" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="9.533786054676867"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="2" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="4.316820226597492"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="2" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="8.666086006004313"/>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="2" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="9.26109167827532"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="4.126282664165993"/>
<DICH_DATA CI_END="0.9278295537801063" CI_START="0.3934099314081769" EFFECT_SIZE="0.6041666666666666" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="48" LOG_CI_END="-0.03253179819018153" LOG_CI_START="-0.4051546807630808" LOG_EFFECT_SIZE="-0.21884323947663117" ORDER="2" O_E="0.0" SE="0.21888052573633768" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.04790868454661558" WEIGHT="6.932305720767547"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="2" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="8.625774354704594"/>
<DICH_DATA CI_END="0.8778188036502038" CI_START="0.16667021644059082" EFFECT_SIZE="0.3825" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="-0.056595120421943645" LOG_CI_START="-0.7781420005987836" LOG_EFFECT_SIZE="-0.4173685605103636" ORDER="2" O_E="0.0" SE="0.42384020913053655" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.17964052287581697" WEIGHT="3.560419473352292"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="22.124652135625407" CI_END="0.9632501251656408" CI_START="0.2633244216802523" DF="4" EFFECT_SIZE="0.503634075636938" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="147" I2="81.92061969842614" ID="CMP-005.03.02" LOG_CI_END="-0.016260925882318242" LOG_CI_START="-0.5795088609504149" LOG_EFFECT_SIZE="-0.2978848934163666" NO="2" P_CHI2="1.892890257687574E-4" P_Z="0.03815999547167517" STUDIES="5" TAU2="0.3875742185864508" TOTAL_1="730" TOTAL_2="631" WEIGHT="99.99999999999999" Z="2.0731320126865427">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.6103365201855264" CI_START="0.19150446401059254" EFFECT_SIZE="0.3418803418803419" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.21443064275760207" LOG_CI_START="-0.7178210980787965" LOG_EFFECT_SIZE="-0.46612587041819925" ORDER="1" O_E="0.0" SE="0.29569404527861104" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="115" VAR="0.08743496841322929" WEIGHT="23.044771764360796"/>
<DICH_DATA CI_END="1.446022792933408" CI_START="0.5571779516389909" EFFECT_SIZE="0.8976034858387799" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="27" LOG_CI_END="0.16017513857897522" LOG_CI_START="-0.2540060775872285" LOG_EFFECT_SIZE="-0.046915469504126665" ORDER="1" O_E="0.0" SE="0.24329209660611376" STUDY_ID="STD-Bernstein-1990" TOTAL_1="102" TOTAL_2="103" VAR="0.05919104427099858" WEIGHT="24.501632535998947"/>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="1" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="19.09035719643467"/>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="1" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="6.877047892529005"/>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="26.48619061067657"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="42.97782380233228" CI_END="0.7012300742119992" CI_START="0.47891239326200924" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="0.579506490962927" ESTIMABLE="YES" EVENTS_1="397" EVENTS_2="416" I2="55.791153857890485" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="-0.15413946624590563" LOG_CI_START="-0.3197439241692088" LOG_EFFECT_SIZE="-0.2369416952075572" METHOD="MH" NO="4" P_CHI2="0.001305380171480297" P_Q="0.0" P_Z="2.0407505663878637E-8" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="20" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.1207441815528396" TOTALS="SUB" TOTAL_1="4861" TOTAL_2="2916" WEIGHT="300.0" Z="5.608510723277227">
<NAME>Exclusions after randomization not reported</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.548162977282788" CI_END="0.7565940950558012" CI_START="0.44153752250319156" DF="4" EFFECT_SIZE="0.5779832889206077" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="87" I2="0.0" ID="CMP-005.04.01" LOG_CI_END="-0.12113705254193836" LOG_CI_START="-0.35503238353909083" LOG_EFFECT_SIZE="-0.23808471804051462" NO="1" P_CHI2="0.47059300012711935" P_Z="6.603450962827389E-5" STUDIES="5" TAU2="0.0" TOTAL_1="895" TOTAL_2="482" WEIGHT="100.0" Z="3.9901392698981533">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="7.173742373806829"/>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="1" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="57.44045619966502"/>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="1" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="4.0932226797616"/>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="22.794977202559007"/>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="2" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="8.497601544207544"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="22.557791858622025" CI_END="0.8240209677791552" CI_START="0.4588623674203825" DF="11" EFFECT_SIZE="0.6149082956662545" ESTIMABLE="YES" EVENTS_1="234" EVENTS_2="238" I2="51.23636183478842" ID="CMP-005.04.02" LOG_CI_END="-0.08406173724107928" LOG_CI_START="-0.338317558543829" LOG_EFFECT_SIZE="-0.21118964789245415" NO="2" P_CHI2="0.02039109371803627" P_Z="0.0011300744262771874" STUDIES="12" TAU2="0.1089124653449518" TOTAL_1="2236" TOTAL_2="1682" WEIGHT="100.0" Z="3.255965599183149">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="1" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="4.695115220209273"/>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="1" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="8.461833087979766"/>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="2.805443596369851"/>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="1" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="15.74484036291382"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="0.8957658908288159"/>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="5.291748180883841"/>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="1" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="11.546092587015323"/>
<DICH_DATA CI_END="1.0100113315938297" CI_START="0.0036038497772461773" EFFECT_SIZE="0.06033182503770739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.00432624627874643" LOG_CI_START="-2.4432333204323675" LOG_EFFECT_SIZE="-1.2194535370768107" ORDER="1" O_E="0.0" SE="1.437708605101362" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="2.067006033182504" WEIGHT="1.0251192522098873"/>
<DICH_DATA CI_END="1.0782937032140179" CI_START="0.29703898732765543" EFFECT_SIZE="0.565946348733234" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.03273706911806205" LOG_CI_START="-0.5271865443863982" LOG_EFFECT_SIZE="-0.2472247376341681" ORDER="2" O_E="0.0" SE="0.32890190223910776" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.1081764612965036" WEIGHT="10.274941143194056"/>
<DICH_DATA CI_END="1.1677303907017897" CI_START="0.5915485874192178" EFFECT_SIZE="0.8311252992817239" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="35" LOG_CI_END="0.0673425830619302" LOG_CI_START="-0.2280095783708831" LOG_EFFECT_SIZE="-0.08033349765447646" ORDER="2" O_E="0.0" SE="0.17349132164241274" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.030099238685231115" WEIGHT="16.04595785399345"/>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="14.399481867346514"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="8.8136609570554"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.414379605367589" CI_END="0.8462089593290466" CI_START="0.20922278829861995" DF="2" EFFECT_SIZE="0.42076858004620143" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="91" I2="73.0253897635331" ID="CMP-005.04.03" LOG_CI_END="-0.07252238084049784" LOG_CI_START="-0.6793910143872328" LOG_EFFECT_SIZE="-0.3759566976138653" NO="3" P_CHI2="0.024546489766415602" P_Z="0.015165373484083193" STUDIES="3" TAU2="0.2749661661301803" TOTAL_1="1730" TOTAL_2="752" WEIGHT="99.99999999999999" Z="2.4284055768818904">
<NAME>Human vaccine rotavirus</NAME>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="1" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="30.868927890826612"/>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="2" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="28.71461091915692"/>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="451" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="40.41646119001645"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="76.51154465080182" CI_END="0.7318661284939498" CI_START="0.5444245997306925" CI_STUDY="95" CI_TOTAL="95" DF="32" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6312257314636105" ESTIMABLE="YES" EVENTS_1="888" EVENTS_2="807" I2="58.17624628276977" I2_Q="0.0" ID="CMP-005.05" LOG_CI_END="-0.13556835196542372" LOG_CI_START="-0.26406225950484224" LOG_EFFECT_SIZE="-0.199815305735133" METHOD="MH" NO="5" P_CHI2="1.64173748868901E-5" P_Q="0.0" P_Z="1.0895273139496252E-9" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="33" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.09731916104433506" TOTALS="SUB" TOTAL_1="5823" TOTAL_2="3927" WEIGHT="300.0" Z="6.095710065951236">
<NAME>Sample size of less than 1000 participants</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="23.094807770810554" CI_END="0.7888139604687548" CI_START="0.5581194541040618" DF="14" EFFECT_SIZE="0.6635151972686718" ESTIMABLE="YES" EVENTS_1="570" EVENTS_2="418" I2="39.38031379635664" ID="CMP-005.05.01" LOG_CI_END="-0.10302541183346099" LOG_CI_START="-0.2532728392235391" LOG_EFFECT_SIZE="-0.17814912552850004" NO="1" P_CHI2="0.0587444677384692" P_Z="3.3536685805908314E-6" STUDIES="15" TAU2="0.03639547264794727" TOTAL_1="3128" TOTAL_2="1847" WEIGHT="100.0" Z="4.647878183053978">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="2.6004806525426494"/>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="1" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="11.246557279059596"/>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="6.225167972664244"/>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="1" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="15.946489268635343"/>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="1" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="1.5654765786950262"/>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="6.534248188269135"/>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="4.4506069277006866"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="4.023210514842105"/>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="5.770194206682866"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="4.354015223571904"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="2" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="16.80550908328681"/>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="2" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="3.0128207682723747"/>
<DICH_DATA CI_END="0.8778188036502038" CI_START="0.16667021644059082" EFFECT_SIZE="0.3825" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="-0.056595120421943645" LOG_CI_START="-0.7781420005987836" LOG_EFFECT_SIZE="-0.4173685605103636" ORDER="2" O_E="0.0" SE="0.42384020913053655" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.17964052287581697" WEIGHT="3.6054806952370675"/>
<DICH_DATA CI_END="0.9278295537801063" CI_START="0.3934099314081769" EFFECT_SIZE="0.6041666666666666" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="48" LOG_CI_END="-0.03253179819018153" LOG_CI_START="-0.4051546807630808" LOG_EFFECT_SIZE="-0.21884323947663117" ORDER="2" O_E="0.0" SE="0.21888052573633768" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.04790868454661558" WEIGHT="9.239326235592674"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="2" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="4.620416404947506"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="42.73969118901819" CI_END="0.7414562734721819" CI_START="0.4139170435625964" DF="15" EFFECT_SIZE="0.5539868127009392" ESTIMABLE="YES" EVENTS_1="299" EVENTS_2="345" I2="64.90381754593913" ID="CMP-005.05.02" LOG_CI_END="-0.12991445589614595" LOG_CI_START="-0.38308669060142986" LOG_EFFECT_SIZE="-0.2565005732487879" NO="2" P_CHI2="1.7278686667099308E-4" P_Z="7.143306022314962E-5" STUDIES="16" TAU2="0.17790599421081368" TOTAL_1="2447" TOTAL_2="1832" WEIGHT="100.0" Z="3.9714614532413415">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="4.508755204499266"/>
<DICH_DATA CI_END="0.6103365201855264" CI_START="0.19150446401059254" EFFECT_SIZE="0.3418803418803419" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.21443064275760207" LOG_CI_START="-0.7178210980787965" LOG_EFFECT_SIZE="-0.46612587041819925" ORDER="1" O_E="0.0" SE="0.29569404527861104" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="115" VAR="0.08743496841322929" WEIGHT="8.334951053027053"/>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="2.559483774718366"/>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="1" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="1.6002081500044492"/>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="1" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="8.435365645624502"/>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="1" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="10.498262358717115"/>
<DICH_DATA CI_END="1.446022792933408" CI_START="0.5571779516389909" EFFECT_SIZE="0.8976034858387799" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="27" LOG_CI_END="0.16017513857897522" LOG_CI_START="-0.2540060775872285" LOG_EFFECT_SIZE="-0.046915469504126665" ORDER="1" O_E="0.0" SE="0.24329209660611376" STUDY_ID="STD-Bernstein-1990" TOTAL_1="102" TOTAL_2="103" VAR="0.05919104427099858" WEIGHT="9.327842937203668"/>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="1" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="6.080256360556949"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="0.8642027514626238"/>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="1" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="4.064866197644279"/>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="1" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="6.649483141431148"/>
<DICH_DATA CI_END="1.0100113315938297" CI_START="0.0036038497772461773" EFFECT_SIZE="0.06033182503770739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.00432624627874643" LOG_CI_START="-2.4432333204323675" LOG_EFFECT_SIZE="-1.2194535370768107" ORDER="1" O_E="0.0" SE="1.437708605101362" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="2.067006033182504" WEIGHT="0.9851628521953645"/>
<DICH_DATA CI_END="1.1677303907017897" CI_START="0.5915485874192178" EFFECT_SIZE="0.8311252992817239" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="35" LOG_CI_END="0.0673425830619302" LOG_CI_START="-0.2280095783708831" LOG_EFFECT_SIZE="-0.08033349765447646" ORDER="2" O_E="0.0" SE="0.17349132164241274" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.030099238685231115" WEIGHT="10.632443737315862"/>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="10.861331947538307"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="6.866731786684957"/>
<DICH_DATA CI_END="1.0782937032140179" CI_START="0.29703898732765543" EFFECT_SIZE="0.565946348733234" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.03273706911806205" LOG_CI_START="-0.5271865443863982" LOG_EFFECT_SIZE="-0.2472247376341681" ORDER="2" O_E="0.0" SE="0.32890190223910776" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.1081764612965036" WEIGHT="7.730652101376108"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.80084161658765" CI_END="1.9922274586748236" CI_START="0.11884930319424182" DF="1" EFFECT_SIZE="0.486595155409441" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="44" I2="85.29593752689459" ID="CMP-005.05.03" LOG_CI_END="0.29933892164183884" LOG_CI_START="-0.9250033601687235" LOG_EFFECT_SIZE="-0.3128322192634423" NO="3" P_CHI2="0.00911154576696882" P_Z="0.31654530476384213" STUDIES="2" TAU2="0.8825432419722246" TOTAL_1="248" TOTAL_2="248" WEIGHT="100.0" Z="1.001582469329362">
<NAME>Human vaccine rotavirus</NAME>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="1" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="49.25375390913689"/>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="1" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="50.7462460908631"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.866324645420907" CI_END="0.630886516146705" CI_START="0.43007856358891766" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5208941990961229" ESTIMABLE="YES" EVENTS_1="527" EVENTS_2="674" I2="79.91048422853088" I2_Q="0.0" ID="CMP-005.06" LOG_CI_END="-0.20004875461281457" LOG_CI_START="-0.3664522034516118" LOG_EFFECT_SIZE="-0.28325047903221323" METHOD="MH" NO="6" P_CHI2="4.167659825349279E-5" P_Q="0.0" P_Z="2.515390995215511E-11" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.08926684089095338" TOTALS="SUB" TOTAL_1="6792" TOTAL_2="4605" WEIGHT="300.0" Z="6.6724667232668455">
<NAME>Sample size of at least 1000 participants</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="18.58858060382741" CI_END="0.648533828475157" CI_START="0.3868766524491564" DF="4" EFFECT_SIZE="0.5009017833472986" ESTIMABLE="YES" EVENTS_1="439" EVENTS_2="587" I2="78.48141240447161" ID="CMP-005.06.01" LOG_CI_END="-0.18806736555226874" LOG_CI_START="-0.4124274786490084" LOG_EFFECT_SIZE="-0.3002474221006386" NO="1" P_CHI2="9.465412750390145E-4" P_Z="1.5560568364961023E-7" STUDIES="5" TAU2="0.06776656456766444" TOTAL_1="4791" TOTAL_2="3620" WEIGHT="100.0" Z="5.245799938730721">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="1" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="18.614078159768965"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="2" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="19.771558154390977"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="2" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="19.6552103209713"/>
<DICH_DATA CI_END="0.6664001897444836" CI_START="0.3983950401410973" EFFECT_SIZE="0.5152577319587629" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.17626488794435038" LOG_CI_START="-0.3996860770072768" LOG_EFFECT_SIZE="-0.2879754824758136" ORDER="2" O_E="0.0" SE="0.1312387124082854" STUDY_ID="STD-Rennels-1996" TOTAL_1="900" TOTAL_2="459" VAR="0.017223599634584644" WEIGHT="20.436091393276072"/>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="2" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="21.523061971592682"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4110052581487775" CI_START="0.6087329424922199" DF="0" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" I2="0.0" ID="CMP-005.06.02" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" NO="2" P_CHI2="1.0" P_Z="0.7229306153074403" STUDIES="1" TAU2="0.0" TOTAL_1="519" TOTAL_2="481" WEIGHT="100.0" Z="0.35454482854327085">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5126179297564388" CI_START="0.23531934567258378" DF="0" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" I2="0.0" ID="CMP-005.06.03" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" NO="3" P_CHI2="1.0" P_Z="1.0136929840441862E-7" STUDIES="1" TAU2="0.0" TOTAL_1="1482" TOTAL_2="504" WEIGHT="100.0" Z="5.324251995909791">
<NAME>Human vaccine rotavirus</NAME>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="492" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Exploration of heterogeneity: multiple versus single dose</NAME>
<DICH_OUTCOME CHI2="68.64137249437633" CI_END="0.5744122418636409" CI_START="0.4085544131668541" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4844364317332635" ESTIMABLE="YES" EVENTS_1="901" EVENTS_2="1018" I2="79.60413743016721" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-0.24077631299073224" LOG_CI_START="-0.38875009393114396" LOG_EFFECT_SIZE="-0.3147632034609381" METHOD="MH" NO="1" P_CHI2="3.3976517155309693E-9" P_Q="0.0" P_Z="7.53691516374226E-17" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10859487518018164" TOTALS="SUB" TOTAL_1="8401" TOTAL_2="5646" WEIGHT="300.0" Z="8.33829531855139">
<NAME>Multiple doses (two or more) of rotavirus vaccine</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="31.155812312945663" CI_END="0.6852703734887956" CI_START="0.43592153019176627" DF="7" EFFECT_SIZE="0.5465565934158318" ESTIMABLE="YES" EVENTS_1="606" EVENTS_2="723" I2="77.53228216395628" ID="CMP-006.01.01" LOG_CI_END="-0.1641380437676975" LOG_CI_START="-0.36059168062084523" LOG_EFFECT_SIZE="-0.2623648621942714" NO="1" P_CHI2="5.819168662057894E-5" P_Z="1.6490952764356218E-7" STUDIES="8" TAU2="0.07636620793371929" TOTAL_1="5566" TOTAL_2="4132" WEIGHT="99.99999999999999" Z="5.235084358290383">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="1" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="12.191541044917974"/>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="1" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="14.993505489995108"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="2" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="13.807321620875623"/>
<DICH_DATA CI_END="0.9617690037595611" CI_START="0.4454601368846169" EFFECT_SIZE="0.6545454545454545" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="55" LOG_CI_END="-0.016929223636822716" LOG_CI_START="-0.35119115381709043" LOG_EFFECT_SIZE="-0.1840601887269566" ORDER="2" O_E="0.0" SE="0.19634711241112907" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.03855218855218855" WEIGHT="11.587928125598008"/>
<DICH_DATA CI_END="0.8120480917527467" CI_START="0.12970876126162564" EFFECT_SIZE="0.3245454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="-0.09041824986674628" LOG_CI_START="-0.8870306882253174" LOG_EFFECT_SIZE="-0.48872446904603184" ORDER="2" O_E="0.0" SE="0.46793408958699123" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.2189623121976063" WEIGHT="4.509100977431894"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="2" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="13.733276835475758"/>
<DICH_DATA CI_END="0.6498878927155749" CI_START="0.3898971264110547" EFFECT_SIZE="0.5033780109014878" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.18716155377888236" LOG_CI_START="-0.4090499656030404" LOG_EFFECT_SIZE="-0.2981057596909614" ORDER="2" O_E="0.0" SE="0.13033835147086315" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.01698808586414225" WEIGHT="14.264647769401039"/>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="2" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="14.912678136304583"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="18.34821037853615" CI_END="0.8637798608527523" CI_START="0.3919060989699586" DF="4" EFFECT_SIZE="0.5818252277407846" ESTIMABLE="YES" EVENTS_1="239" EVENTS_2="215" I2="78.19950873966856" ID="CMP-006.01.02" LOG_CI_END="-0.06359692580655685" LOG_CI_START="-0.4068179778375701" LOG_EFFECT_SIZE="-0.23520745182206346" NO="2" P_CHI2="0.0010549560858105211" P_Z="0.0072247206092448234" STUDIES="5" TAU2="0.14767583915136448" TOTAL_1="1245" TOTAL_2="903" WEIGHT="100.0" Z="2.68630453603428">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="1" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="17.52364979704264"/>
<DICH_DATA CI_END="0.6267170703918006" CI_START="0.19635640354517492" EFFECT_SIZE="0.35079895949461165" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.2029284759143624" LOG_CI_START="-0.7069549310170087" LOG_EFFECT_SIZE="-0.4549417034656856" ORDER="1" O_E="0.0" SE="0.29606763469848557" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.08765604431595589" WEIGHT="17.271985696850614"/>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="23.442011765718192"/>
<DICH_DATA CI_END="1.0318595193566296" CI_START="0.29941894419434845" EFFECT_SIZE="0.5558401639344263" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" LOG_CI_END="0.013620575080836642" LOG_CI_START="-0.523720725373086" LOG_EFFECT_SIZE="-0.25505007514612466" ORDER="2" O_E="0.0" SE="0.31563693976896945" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.09962667774672006" WEIGHT="16.435938365057357"/>
<DICH_DATA CI_END="0.9714613192689926" CI_START="0.623318925603991" EFFECT_SIZE="0.7781582267075149" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="62" LOG_CI_END="-0.012574487048211035" LOG_CI_START="-0.20528968658369665" LOG_EFFECT_SIZE="-0.10893208681595384" ORDER="2" O_E="0.0" SE="0.11320186216276716" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.012814661597118134" WEIGHT="25.3264143753312"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7876626643230138" CI_END="0.4505945999306007" CI_START="0.22694050392805665" DF="1" EFFECT_SIZE="0.31977830691826425" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="80" I2="0.0" ID="CMP-006.01.03" LOG_CI_END="-0.3462140173045868" LOG_CI_START="-0.6440879851085194" LOG_EFFECT_SIZE="-0.4951510012065531" NO="3" P_CHI2="0.3748078679534931" P_Z="7.219165760389252E-11" STUDIES="2" TAU2="0.0" TOTAL_1="1590" TOTAL_2="611" WEIGHT="100.0" Z="6.516031840100802">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="1" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="22.396400162005328"/>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="3" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="77.60359983799468"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="49.702907013810886" CI_END="0.7779672371699831" CI_START="0.5250687250497776" CI_STUDY="95" CI_TOTAL="95" DF="24" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6391293025291056" ESTIMABLE="YES" EVENTS_1="573" EVENTS_2="497" I2="51.71308593010234" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="-0.10903869223382438" LOG_CI_START="-0.2797838490578437" LOG_EFFECT_SIZE="-0.19441127064583402" METHOD="MH" NO="2" P_CHI2="0.0015444574187425397" P_Q="0.0" P_Z="8.072609074770696E-6" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="25" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.09554206819524388" TOTALS="SUB" TOTAL_1="4168" TOTAL_2="2855" WEIGHT="300.0" Z="4.463249157306717">
<NAME>Single dose of rotavirus vaccine</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="22.743644975746314" CI_END="0.8162547949716231" CI_START="0.5037033567526341" DF="11" EFFECT_SIZE="0.6412100125486498" ESTIMABLE="YES" EVENTS_1="408" EVENTS_2="288" I2="51.63484124145301" ID="CMP-006.02.01" LOG_CI_END="-0.08817425450878351" LOG_CI_START="-0.2978251549308762" LOG_EFFECT_SIZE="-0.19299970471982983" NO="1" P_CHI2="0.01920525502911319" P_Z="3.078611977178871E-4" STUDIES="12" TAU2="0.07629470984941929" TOTAL_1="2306" TOTAL_2="1301" WEIGHT="100.00000000000001" Z="3.608593805379811">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="9.532076638075"/>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="8.671768893537438"/>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="7.056798735198304"/>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="1" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="2.821796390710013"/>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="9.190208959721407"/>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="4.468106666424276"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="6.49492185539617"/>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="1" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="14.892278020984278"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="2" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="17.584090791588263"/>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="2" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="5.081862660379392"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="2" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="7.274516598647274"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="6.931573789338194"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="25.90602984976755" CI_END="0.83494875350222" CI_START="0.3954156697716047" DF="11" EFFECT_SIZE="0.5745883923218836" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="198" I2="57.53884302693066" ID="CMP-006.02.02" LOG_CI_END="-0.07834017931183765" LOG_CI_START="-0.4029461241966089" LOG_EFFECT_SIZE="-0.24064315175422327" NO="2" P_CHI2="0.0067021040834044365" P_Z="0.0036608525043946836" STUDIES="12" TAU2="0.19246735369777618" TOTAL_1="1722" TOTAL_2="1413" WEIGHT="99.99999999999999" Z="2.905996750810658">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="4.137857179641621"/>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="1" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="10.472718391715928"/>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="1" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="16.142515877853857"/>
<DICH_DATA CI_END="1.4440853901075372" CI_START="0.5418961953766118" EFFECT_SIZE="0.8846153846153846" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="26" LOG_CI_END="0.15959287422812996" LOG_CI_START="-0.2660838981345802" LOG_EFFECT_SIZE="-0.0532455119532251" ORDER="1" O_E="0.0" SE="0.25004464321986253" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.06252232360294835" WEIGHT="14.258227611637427"/>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="1" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="9.61071335028261"/>
<DICH_DATA CI_END="1.0100113315938297" CI_START="0.0036038497772461773" EFFECT_SIZE="0.06033182503770739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.00432624627874643" LOG_CI_START="-2.4432333204323675" LOG_EFFECT_SIZE="-1.2194535370768107" ORDER="1" O_E="0.0" SE="1.437708605101362" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="2.067006033182504" WEIGHT="1.6090921356642418"/>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="7.198344880613879"/>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="1" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="6.508136837449737"/>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="1" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="2.603187953722475"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="1.4126426461982307"/>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="15.24648549263325"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="10.80007764258673"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.2467086393612665" CI_START="0.4514767589010788" DF="0" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" I2="0.0" ID="CMP-006.02.03" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" NO="3" P_CHI2="1.0" P_Z="0.98612833643823" STUDIES="1" TAU2="0.0" TOTAL_1="140" TOTAL_2="141" WEIGHT="100.0" Z="0.017386427959658064">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="2" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>Exploration of heterogeneity: administered with other vaccines</NAME>
<DICH_OUTCOME CHI2="70.32736487594069" CI_END="0.6317904131539575" CI_START="0.4277388131326633" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5198473636280834" ESTIMABLE="YES" EVENTS_1="973" EVENTS_2="922" I2="84.35886227302232" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="-0.1994269684054247" LOG_CI_START="-0.36882133995935906" LOG_EFFECT_SIZE="-0.2841241541823919" METHOD="MH" NO="1" P_CHI2="1.0585565757281756E-10" P_Q="0.0" P_Z="4.869521722909142E-11" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="USER" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.11876698572181289" TOTALS="SUB" TOTAL_1="8093" TOTAL_2="5016" WEIGHT="300.0" Z="6.574871457970346">
<NAME>Concomitant use of DPT or OPV allowed</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="51.23358757623396" CI_END="0.7289851400443883" CI_START="0.4390267476118553" DF="7" EFFECT_SIZE="0.5657242924703345" ESTIMABLE="YES" EVENTS_1="818" EVENTS_2="777" I2="86.33708797069067" ID="CMP-007.01.01" LOG_CI_END="-0.13728132444265573" LOG_CI_START="-0.3575090196522656" LOG_EFFECT_SIZE="-0.24739517204746073" NO="1" P_CHI2="8.265082507286081E-9" P_Z="1.065214101218626E-5" STUDIES="8" TAU2="0.1114519294779244" TOTAL_1="5961" TOTAL_2="4091" WEIGHT="100.00000000000001" Z="4.403493635989837">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="1" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="12.215616496608954"/>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="1" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="13.506444693830773"/>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="8.61455650824974"/>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="2" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="13.454172125919248"/>
<DICH_DATA CI_END="0.6498878927155749" CI_START="0.3898971264110547" EFFECT_SIZE="0.5033780109014878" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.18716155377888236" LOG_CI_START="-0.4090499656030404" LOG_EFFECT_SIZE="-0.2981057596909614" ORDER="2" O_E="0.0" SE="0.13033835147086315" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.01698808586414225" WEIGHT="13.02922916293412"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="2" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="12.672834387641432"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="2" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="13.784211025407426"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="2" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="12.722935599408316"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.907757957124314" CI_END="1.1764486734852695" CI_START="0.44015139216768884" DF="2" EFFECT_SIZE="0.7195939976461534" ESTIMABLE="YES" EVENTS_1="107" EVENTS_2="98" I2="66.14620953473306" ID="CMP-007.01.02" LOG_CI_END="0.07057298437360268" LOG_CI_START="-0.3563979201628342" LOG_EFFECT_SIZE="-0.14291246789461576" NO="2" P_CHI2="0.05213717569113585" P_Z="0.18950373509637738" STUDIES="3" TAU2="0.10748921029917236" TOTAL_1="650" TOTAL_2="421" WEIGHT="100.0" Z="1.3120486058378729">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="1" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="44.8516174624162"/>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="7.925641129117573"/>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="47.22274140846622"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5126179297564388" CI_START="0.23531934567258378" DF="0" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" I2="0.0" ID="CMP-007.01.03" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" NO="3" P_CHI2="1.0" P_Z="1.0136929840441862E-7" STUDIES="1" TAU2="0.0" TOTAL_1="1482" TOTAL_2="504" WEIGHT="100.0" Z="5.324251995909791">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="3" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="31.225307166007156" CI_END="0.8695477125791663" CI_START="0.5209076252180281" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6730185985345294" ESTIMABLE="YES" EVENTS_1="212" EVENTS_2="285" I2="55.16457235930464" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="-0.06070658302142532" LOG_CI_START="-0.2832392851745696" LOG_EFFECT_SIZE="-0.17197293409799744" METHOD="MH" NO="2" P_CHI2="0.005154554613996054" P_Q="0.0" P_Z="0.0024510947481312427" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.14578492177614244" TOTALS="SUB" TOTAL_1="2160" TOTAL_2="1813" WEIGHT="300.0" Z="3.029314378394545">
<NAME>Concomitant use of DPT or OPV not allowed</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.456504350867567" CI_END="0.9681019019515502" CI_START="0.5150139850544619" DF="5" EFFECT_SIZE="0.7061062373771188" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="109" I2="22.558713999346335" ID="CMP-007.02.01" LOG_CI_END="-0.014078926652332069" LOG_CI_START="-0.2881809776587753" LOG_EFFECT_SIZE="-0.15112995215555367" NO="1" P_CHI2="0.26429701712446774" P_Z="0.03067167625254836" STUDIES="6" TAU2="0.035135883656788276" TOTAL_1="771" TOTAL_2="596" WEIGHT="100.0" Z="2.1613064340272583">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="20.929346009893983"/>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="8.691490941614415"/>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="14.91992682273565"/>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="2" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="10.076387463313356"/>
<DICH_DATA CI_END="0.8120480917527467" CI_START="0.12970876126162564" EFFECT_SIZE="0.3245454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="-0.09041824986674628" LOG_CI_START="-0.8870306882253174" LOG_EFFECT_SIZE="-0.48872446904603184" ORDER="2" O_E="0.0" SE="0.46793408958699123" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.2189623121976063" WEIGHT="10.202302422288815"/>
<DICH_DATA CI_END="0.9617690037595611" CI_START="0.4454601368846169" EFFECT_SIZE="0.6545454545454545" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="55" LOG_CI_END="-0.016929223636822716" LOG_CI_START="-0.35119115381709043" LOG_EFFECT_SIZE="-0.1840601887269566" ORDER="2" O_E="0.0" SE="0.19634711241112907" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.03855218855218855" WEIGHT="35.18054634015378"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="15.700676524678634" CI_END="0.997826154774158" CI_START="0.39625872293981435" DF="6" EFFECT_SIZE="0.6288062641281124" ESTIMABLE="YES" EVENTS_1="103" EVENTS_2="132" I2="61.78508619950815" ID="CMP-007.02.02" LOG_CI_END="-9.451166273212419E-4" LOG_CI_START="-0.4020211644387211" LOG_EFFECT_SIZE="-0.20148314053302116" NO="2" P_CHI2="0.015454008544122488" P_Z="0.04893000167857853" STUDIES="7" TAU2="0.20545683461648867" TOTAL_1="1141" TOTAL_2="969" WEIGHT="99.99999999999999" Z="1.969201108326667">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.6267170703918006" CI_START="0.19635640354517492" EFFECT_SIZE="0.35079895949461165" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.2029284759143624" LOG_CI_START="-0.7069549310170087" LOG_EFFECT_SIZE="-0.4549417034656856" ORDER="1" O_E="0.0" SE="0.29606763469848557" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.08765604431595589" WEIGHT="18.93624031487437"/>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="1" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="9.709896218196945"/>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="1" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="15.411566776898697"/>
<DICH_DATA CI_END="1.0100113315938297" CI_START="0.0036038497772461773" EFFECT_SIZE="0.06033182503770739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.00432624627874643" LOG_CI_START="-2.4432333204323675" LOG_EFFECT_SIZE="-1.2194535370768107" ORDER="1" O_E="0.0" SE="1.437708605101362" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="2.067006033182504" WEIGHT="2.442484756736806"/>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="10.713841339812982"/>
<DICH_DATA CI_END="1.4440853901075372" CI_START="0.5418961953766118" EFFECT_SIZE="0.8846153846153846" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="26" LOG_CI_END="0.15959287422812996" LOG_CI_START="-0.2660838981345802" LOG_EFFECT_SIZE="-0.0532455119532251" ORDER="1" O_E="0.0" SE="0.25004464321986253" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.06252232360294835" WEIGHT="20.71226714692644"/>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="22.073703446553754"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.80084161658765" CI_END="1.9922274586748236" CI_START="0.11884930319424182" DF="1" EFFECT_SIZE="0.486595155409441" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="44" I2="85.29593752689459" ID="CMP-007.02.03" LOG_CI_END="0.29933892164183884" LOG_CI_START="-0.9250033601687235" LOG_EFFECT_SIZE="-0.3128322192634423" NO="3" P_CHI2="0.00911154576696882" P_Z="0.31654530476384213" STUDIES="2" TAU2="0.8825432419722246" TOTAL_1="248" TOTAL_2="248" WEIGHT="100.0" Z="1.001582469329362">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="1" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="50.7462460908631"/>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="2" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="49.25375390913689"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="23.58455144310884" CI_END="0.6697668984076405" CI_START="0.4303363099847558" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5368659195839114" ESTIMABLE="YES" EVENTS_1="289" EVENTS_2="308" I2="49.11923583135911" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="-0.17407632020932523" LOG_CI_START="-0.36619200841261546" LOG_EFFECT_SIZE="-0.2701341643109703" METHOD="MH" NO="3" P_CHI2="0.023153895350340625" P_Q="0.0" P_Z="3.551486047920465E-8" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.08622093119029565" TOTALS="SUB" TOTAL_1="2316" TOTAL_2="1672" WEIGHT="200.0" Z="5.511816739121044">
<NAME>No information</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.2374227623328258" CI_END="0.7069898046579486" CI_START="0.43259982808525216" DF="5" EFFECT_SIZE="0.5530313444580285" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="125" I2="0.0" ID="CMP-007.03.01" LOG_CI_END="-0.15058684902165775" LOG_CI_START="-0.36391365748509463" LOG_EFFECT_SIZE="-0.2572502532533762" NO="1" P_CHI2="0.8154125400014635" P_Z="2.2782635724657185E-6" STUDIES="6" TAU2="0.0" TOTAL_1="1140" TOTAL_2="746" WEIGHT="100.0" Z="4.727031122080868">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="15.926377693408384"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="9.988200589234992"/>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="1" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="3.40496881551681"/>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="1" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="47.78214561253967"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="2" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="11.879078209950407"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="11.019229079349737"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="21.240527065082873" CI_END="0.7862139836723614" CI_START="0.2841857331107044" DF="6" EFFECT_SIZE="0.4726846700833626" ESTIMABLE="YES" EVENTS_1="183" EVENTS_2="183" I2="71.75211339334723" ID="CMP-007.03.02" LOG_CI_END="-0.10445923604666578" LOG_CI_START="-0.5463977286141125" LOG_EFFECT_SIZE="-0.3254284823303892" NO="2" P_CHI2="0.0016606772860795482" P_Z="0.0038955064348930716" STUDIES="7" TAU2="0.2671767758382521" TOTAL_1="1176" TOTAL_2="926" WEIGHT="100.0" Z="2.8865016993908923">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="1" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="14.876296351281875"/>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="1" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="19.174826994611077"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="2.544578032712497"/>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="1" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="4.580203834284714"/>
<DICH_DATA CI_END="1.0318595193566296" CI_START="0.29941894419434845" EFFECT_SIZE="0.5558401639344263" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" LOG_CI_END="0.013620575080836642" LOG_CI_START="-0.523720725373086" LOG_EFFECT_SIZE="-0.25505007514612466" ORDER="2" O_E="0.0" SE="0.31563693976896945" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.09962667774672006" WEIGHT="18.37238120591893"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="16.38293155471818"/>
<DICH_DATA CI_END="0.9714613192689926" CI_START="0.623318925603991" EFFECT_SIZE="0.7781582267075149" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="62" LOG_CI_END="-0.012574487048211035" LOG_CI_START="-0.20528968658369665" LOG_EFFECT_SIZE="-0.10893208681595384" ORDER="2" O_E="0.0" SE="0.11320186216276716" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.012814661597118134" WEIGHT="24.068782026472718"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>Exploration of heterogeneity: breastfeeding</NAME>
<DICH_OUTCOME CHI2="46.317809309423566" CI_END="0.7755825023236371" CI_START="0.47213580664187477" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6051283089989214" ESTIMABLE="YES" EVENTS_1="418" EVENTS_2="495" I2="74.09203893941817" I2_Q="0.0" ID="CMP-008.01" LOG_CI_END="-0.11037199746596095" LOG_CI_START="-0.3259330615528813" LOG_EFFECT_SIZE="-0.21815252950942113" METHOD="MH" NO="1" P_CHI2="6.1159437478863765E-6" P_Q="0.0" P_Z="7.276676431490028E-5" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="USER" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.16168577011750318" TOTALS="SUB" TOTAL_1="4023" TOTAL_2="3081" WEIGHT="200.0" Z="3.967053166914855">
<NAME>Breastfeeding allowed during vaccination</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.85488581196152" CI_END="0.8565719734703172" CI_START="0.31670578622557793" DF="3" EFFECT_SIZE="0.5208467147988088" ESTIMABLE="YES" EVENTS_1="142" EVENTS_2="262" I2="72.36267564699615" ID="CMP-008.01.01" LOG_CI_END="-0.06723613956624432" LOG_CI_START="-0.4993440019805232" LOG_EFFECT_SIZE="-0.28329007077338375" NO="1" P_CHI2="0.012537044610052783" P_Z="0.010172605666091987" STUDIES="4" TAU2="0.15124659398087303" TOTAL_1="2010" TOTAL_2="1642" WEIGHT="99.99999999999999" Z="2.5699061932888703">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="1" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="10.520071678792439"/>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="1" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="36.44210638449015"/>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="15.547585314406131"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="2" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="37.490236622311265"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="18.265534361181363" CI_END="0.8468140793033246" CI_START="0.4776045265321432" DF="8" EFFECT_SIZE="0.6359577324055563" ESTIMABLE="YES" EVENTS_1="276" EVENTS_2="233" I2="56.20166461156528" ID="CMP-008.01.02" LOG_CI_END="-0.07221192992410452" LOG_CI_START="-0.32093156580118276" LOG_EFFECT_SIZE="-0.19657174786264361" NO="2" P_CHI2="0.019321534810655794" P_Z="0.0019479532389490193" STUDIES="9" TAU2="0.08803566410888218" TOTAL_1="2013" TOTAL_2="1439" WEIGHT="100.00000000000003" Z="3.0980549230080014">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="1" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="8.793794136711782"/>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="1" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="7.793972130894408"/>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="1" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="17.67062300051652"/>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="2.756992726776003"/>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="5.327677577497688"/>
<DICH_DATA CI_END="1.0318595193566296" CI_START="0.29941894419434845" EFFECT_SIZE="0.5558401639344263" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" LOG_CI_END="0.013620575080836642" LOG_CI_START="-0.523720725373086" LOG_EFFECT_SIZE="-0.25505007514612466" ORDER="1" O_E="0.0" SE="0.31563693976896945" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.09962667774672006" WEIGHT="11.374130816676393"/>
<DICH_DATA CI_END="0.9714613192689926" CI_START="0.623318925603991" EFFECT_SIZE="0.7781582267075149" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="62" LOG_CI_END="-0.012574487048211035" LOG_CI_START="-0.20528968658369665" LOG_EFFECT_SIZE="-0.10893208681595384" ORDER="2" O_E="0.0" SE="0.11320186216276716" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.012814661597118134" WEIGHT="21.16498891487932"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="9.192297003040913"/>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="15.925523693006975"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="55.8414166485605" CI_END="0.7082283283233063" CI_START="0.5074539194737443" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5994941543418081" ESTIMABLE="YES" EVENTS_1="792" EVENTS_2="768" I2="60.602718698098926" I2_Q="0.0" ID="CMP-008.02" LOG_CI_END="-0.14982670594780248" LOG_CI_START="-0.2946033887386707" LOG_EFFECT_SIZE="-0.22221504734323658" METHOD="MH" NO="2" P_CHI2="9.009801160730913E-5" P_Q="0.0" P_Z="1.7809121597277328E-9" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.08312142043380001" TOTALS="SUB" TOTAL_1="5834" TOTAL_2="4084" WEIGHT="300.0" Z="6.016624793714058">
<NAME>Breastfeeding not allowed for at least one hour before and after vaccination</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="33.220145382956964" CI_END="0.7257207612387893" CI_START="0.5141776321080506" DF="14" EFFECT_SIZE="0.6108595440732776" ESTIMABLE="YES" EVENTS_1="728" EVENTS_2="647" I2="57.856897257341735" ID="CMP-008.02.01" LOG_CI_END="-0.13923045255236768" LOG_CI_START="-0.28888682007615774" LOG_EFFECT_SIZE="-0.21405863631426272" NO="1" P_CHI2="0.0026776588876513685" P_Z="2.0609272589771535E-8" STUDIES="15" TAU2="0.05380337049745067" TOTAL_1="5068" TOTAL_2="3400" WEIGHT="99.99999999999997" Z="5.606807444247498">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="5.656849210925486"/>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="5.070946742167198"/>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="5.421951685754441"/>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="1" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="11.664273824776508"/>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="4.016183980479562"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="3.6623229015526606"/>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="1" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="8.916975320708579"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="2" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="12.121055048084203"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="2" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="4.155076177490854"/>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="2" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="2.800589912909039"/>
<DICH_DATA CI_END="0.8120480917527467" CI_START="0.12970876126162564" EFFECT_SIZE="0.3245454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="-0.09041824986674628" LOG_CI_START="-0.8870306882253174" LOG_EFFECT_SIZE="-0.48872446904603184" ORDER="2" O_E="0.0" SE="0.46793408958699123" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.2189623121976063" WEIGHT="2.8331911320728485"/>
<DICH_DATA CI_END="0.6498878927155749" CI_START="0.3898971264110547" EFFECT_SIZE="0.5033780109014878" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.18716155377888236" LOG_CI_START="-0.4090499656030404" LOG_EFFECT_SIZE="-0.2981057596909614" ORDER="2" O_E="0.0" SE="0.13033835147086315" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.01698808586414225" WEIGHT="10.916533619510389"/>
<DICH_DATA CI_END="0.9617690037595611" CI_START="0.4454601368846169" EFFECT_SIZE="0.6545454545454545" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="55" LOG_CI_END="-0.016929223636822716" LOG_CI_START="-0.35119115381709043" LOG_EFFECT_SIZE="-0.1840601887269566" ORDER="2" O_E="0.0" SE="0.19634711241112907" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.03855218855218855" WEIGHT="8.36763180579167"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="2" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="10.459668538238807"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="3.9367500995377354"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.742914371584344" CI_END="0.9420597380166293" CI_START="0.21266180994406236" DF="5" EFFECT_SIZE="0.4475937096989251" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="77" I2="60.76250805585266" ID="CMP-008.02.02" LOG_CI_END="-0.025921556794823417" LOG_CI_START="-0.6723104942049841" LOG_EFFECT_SIZE="-0.3491160254999037" NO="2" P_CHI2="0.02591085242178337" P_Z="0.03424615670881638" STUDIES="6" TAU2="0.39732471989194185" TOTAL_1="518" TOTAL_2="436" WEIGHT="100.0" Z="2.1171613460686145">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.6267170703918006" CI_START="0.19635640354517492" EFFECT_SIZE="0.35079895949461165" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.2029284759143624" LOG_CI_START="-0.7069549310170087" LOG_EFFECT_SIZE="-0.4549417034656856" ORDER="1" O_E="0.0" SE="0.29606763469848557" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.08765604431595589" WEIGHT="29.7261401306027"/>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="1" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="18.88234386590139"/>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="1" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="9.001987946042046"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="5.188545209181868"/>
<DICH_DATA CI_END="1.0100113315938297" CI_START="0.0036038497772461773" EFFECT_SIZE="0.06033182503770739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.00432624627874643" LOG_CI_START="-2.4432333204323675" LOG_EFFECT_SIZE="-1.2194535370768107" ORDER="1" O_E="0.0" SE="1.437708605101362" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="2.067006033182504" WEIGHT="5.850110071265762"/>
<DICH_DATA CI_END="1.4440853901075372" CI_START="0.5418961953766118" EFFECT_SIZE="0.8846153846153846" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="26" LOG_CI_END="0.15959287422812996" LOG_CI_START="-0.2660838981345802" LOG_EFFECT_SIZE="-0.0532455119532251" ORDER="1" O_E="0.0" SE="0.25004464321986253" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.06252232360294835" WEIGHT="31.35087277700623"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.80084161658765" CI_END="1.9922274586748236" CI_START="0.11884930319424182" DF="1" EFFECT_SIZE="0.486595155409441" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="44" I2="85.29593752689459" ID="CMP-008.02.03" LOG_CI_END="0.29933892164183884" LOG_CI_START="-0.9250033601687235" LOG_EFFECT_SIZE="-0.3128322192634423" NO="3" P_CHI2="0.00911154576696882" P_Z="0.31654530476384213" STUDIES="2" TAU2="0.8825432419722246" TOTAL_1="248" TOTAL_2="248" WEIGHT="100.0" Z="1.001582469329362">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="1" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="49.25375390913689"/>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="1" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="50.7462460908631"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="22.25222710195593" CI_END="0.7084312930988177" CI_START="0.48411104450030207" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5856273672385609" ESTIMABLE="YES" EVENTS_1="264" EVENTS_2="252" I2="86.51820338587007" I2_Q="0.0" ID="CMP-008.03" LOG_CI_END="-0.14970226323581218" LOG_CI_START="-0.3150550092599123" LOG_EFFECT_SIZE="-0.23237863624786223" METHOD="MH" NO="3" P_CHI2="5.780492653328917E-5" P_Q="0.0" P_Z="3.6113538045871446E-8" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.1935000863766911" TOTALS="SUB" TOTAL_1="2712" TOTAL_2="1336" WEIGHT="300.0" Z="5.508874436907892">
<NAME>No information</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8687883427229207" CI_START="0.5563180686556838" DF="0" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" I2="0.0" ID="CMP-008.03.01" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" NO="1" P_CHI2="1.0" P_Z="0.0013892968844801269" STUDIES="1" TAU2="0.0" TOTAL_1="794" TOTAL_2="391" WEIGHT="99.99999999999999" Z="3.1968655048421604">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="2" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.979895514410622" CI_END="1.7056215721486858" CI_START="0.19840414123518396" DF="1" EFFECT_SIZE="0.5817236313700557" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="103" I2="90.89244520872221" ID="CMP-008.03.02" LOG_CI_END="0.23188268019702402" LOG_CI_START="-0.7024492671777143" LOG_EFFECT_SIZE="-0.23528329349034513" NO="2" P_CHI2="9.210663218768289E-4" P_Z="0.32358602483888144" STUDIES="2" TAU2="0.5488550972560938" TOTAL_1="436" TOTAL_2="441" WEIGHT="100.0" Z="0.9871155164944582">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="1" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="47.57553894407825"/>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="52.424461055921746"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5126179297564388" CI_START="0.23531934567258378" DF="0" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" I2="0.0" ID="CMP-008.03.03" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" NO="3" P_CHI2="1.0" P_Z="1.0136929840441862E-7" STUDIES="1" TAU2="0.0" TOTAL_1="1482" TOTAL_2="504" WEIGHT="100.0" Z="5.324251995909791">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="3" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" NO="9">
<NAME>Exploration of heterogeneity: one season versus multiple seasons follow up</NAME>
<DICH_OUTCOME CHI2="39.94687907745689" CI_END="0.5977404180927948" CI_START="0.38865092661750095" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4819879328038173" ESTIMABLE="YES" EVENTS_1="353" EVENTS_2="406" I2="62.45013291047083" I2_Q="0.0" ID="CMP-009.01" LOG_CI_END="-0.2234873769901533" LOG_CI_START="-0.4104402925168684" LOG_EFFECT_SIZE="-0.31696383475351086" METHOD="MH" NO="1" P_CHI2="4.619482287429033E-4" P_Q="0.0" P_Z="3.013148854080714E-11" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.13234027031970488" TOTALS="SUB" TOTAL_1="4241" TOTAL_2="2428" WEIGHT="300.0" Z="6.645926850280258">
<NAME>One season</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.621209330312936" CI_END="0.780268101257966" CI_START="0.42242915603774056" DF="7" EFFECT_SIZE="0.5741149671429694" ESTIMABLE="YES" EVENTS_1="164" EVENTS_2="179" I2="34.09413389469694" ID="CMP-009.01.01" LOG_CI_END="-0.1077561474492193" LOG_CI_START="-0.374246114457864" LOG_EFFECT_SIZE="-0.2410011309535417" NO="1" P_CHI2="0.156016431793514" P_Z="3.9261229939493964E-4" STUDIES="8" TAU2="0.05941313036433886" TOTAL_1="1776" TOTAL_2="1109" WEIGHT="100.0" Z="3.545000528196547">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="1" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="4.707106499896122"/>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="15.508190644706616"/>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="16.540999856876944"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="11.311835488328947"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="1.0040015529322386"/>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="2" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="8.703228258963632"/>
<DICH_DATA CI_END="0.6664001897444836" CI_START="0.3983950401410973" EFFECT_SIZE="0.5152577319587629" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.17626488794435038" LOG_CI_START="-0.3996860770072768" LOG_EFFECT_SIZE="-0.2879754824758136" ORDER="2" O_E="0.0" SE="0.1312387124082854" STUDY_ID="STD-Rennels-1996" TOTAL_1="900" TOTAL_2="459" VAR="0.017223599634584644" WEIGHT="31.97422042113702"/>
<DICH_DATA CI_END="0.8778188036502038" CI_START="0.16667021644059082" EFFECT_SIZE="0.3825" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="-0.056595120421943645" LOG_CI_START="-0.7781420005987836" LOG_EFFECT_SIZE="-0.4173685605103636" ORDER="2" O_E="0.0" SE="0.42384020913053655" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.17964052287581697" WEIGHT="10.250417277158473"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="21.817460761381408" CI_END="0.8340658273642623" CI_START="0.3201798791035212" DF="6" EFFECT_SIZE="0.5167698673199396" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="180" I2="72.49909113795468" ID="CMP-009.01.02" LOG_CI_END="-0.07879967198471037" LOG_CI_START="-0.49460596369990806" LOG_EFFECT_SIZE="-0.28670281784230917" NO="2" P_CHI2="0.0013066307627553897" P_Z="0.006875156385000567" STUDIES="7" TAU2="0.2308187160808782" TOTAL_1="983" TOTAL_2="815" WEIGHT="99.99999999999997" Z="2.702831623442389">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="2.283903061951869"/>
<DICH_DATA CI_END="0.6103365201855264" CI_START="0.19150446401059254" EFFECT_SIZE="0.3418803418803419" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.21443064275760207" LOG_CI_START="-0.7178210980787965" LOG_EFFECT_SIZE="-0.46612587041819925" ORDER="1" O_E="0.0" SE="0.29569404527861104" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="115" VAR="0.08743496841322929" WEIGHT="18.744932322934243"/>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="1" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="18.93283782326974"/>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="1" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="22.63344068922084"/>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="1" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="9.992859826756431"/>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="1" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="4.157285397530799"/>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="23.25474087833606"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5126179297564388" CI_START="0.23531934567258378" DF="0" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" I2="0.0" ID="CMP-009.01.03" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" NO="3" P_CHI2="1.0" P_Z="1.0136929840441862E-7" STUDIES="1" TAU2="0.0" TOTAL_1="1482" TOTAL_2="504" WEIGHT="100.0" Z="5.324251995909791">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="628" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="83.7649030962247" CI_END="0.7145743456318202" CI_START="0.49780028932311526" CI_STUDY="95" CI_TOTAL="95" DF="23" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5964187421588928" ESTIMABLE="YES" EVENTS_1="1051" EVENTS_2="1045" I2="72.542199477532" I2_Q="0.0" ID="CMP-009.02" LOG_CI_END="-0.1459525797240275" LOG_CI_START="-0.3029448553140147" LOG_EFFECT_SIZE="-0.22444871751902112" METHOD="MH" NO="2" P_CHI2="7.719269445871646E-9" P_Q="0.0" P_Z="2.091675209788846E-8" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="USER" STUDIES="24" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.11288777285172395" TOTALS="SUB" TOTAL_1="8378" TOTAL_2="6016" WEIGHT="300.0" Z="5.604242642643021">
<NAME>Two or more seasons</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="49.98785144928418" CI_END="0.7418067386764879" CI_START="0.48004934689360773" DF="11" EFFECT_SIZE="0.5967443677345645" ESTIMABLE="YES" EVENTS_1="818" EVENTS_2="778" I2="77.9946533386013" ID="CMP-009.02.01" LOG_CI_END="-0.12970922579748506" LOG_CI_START="-0.3187141168284834" LOG_EFFECT_SIZE="-0.22421167131298422" NO="1" P_CHI2="6.290975955725031E-7" P_Z="3.317574612741153E-6" STUDIES="12" TAU2="0.09778173885253089" TOTAL_1="5978" TOTAL_2="4194" WEIGHT="100.00000000000003" Z="4.650110357354814">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="1" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="11.181876196656356"/>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="6.825352382147576"/>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="1" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="9.994751179622988"/>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="5.214051964369713"/>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="3.415220131096239"/>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="1" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="9.43476461912288"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="2" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="10.457980558734457"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="2" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="5.359886547222015"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="5.129801068516049"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="2" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="11.441015740319758"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="2" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="10.412042916303363"/>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="2" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="11.133256695888617"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="24.921907371748976" CI_END="0.841019302739612" CI_START="0.4315996092886048" DF="9" EFFECT_SIZE="0.6024812050733129" ESTIMABLE="YES" EVENTS_1="214" EVENTS_2="223" I2="63.88719424339793" ID="CMP-009.02.02" LOG_CI_END="-0.07519403633395953" LOG_CI_START="-0.3649189571399141" LOG_EFFECT_SIZE="-0.22005649673693684" NO="2" P_CHI2="0.0030587991862243147" P_Z="0.0029077439231227926" STUDIES="10" TAU2="0.16426315862365737" TOTAL_1="2152" TOTAL_2="1574" WEIGHT="99.99999999999999" Z="2.9773262649871977">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="3.4056784576436554"/>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="1" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="8.273021132126496"/>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="6.073605470752685"/>
<DICH_DATA CI_END="0.6103365201855264" CI_START="0.19150446401059254" EFFECT_SIZE="0.3418803418803419" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.21443064275760207" LOG_CI_START="-0.7178210980787965" LOG_EFFECT_SIZE="-0.46612587041819925" ORDER="1" O_E="0.0" SE="0.29569404527861104" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="115" VAR="0.08743496841322929" WEIGHT="11.507127518492885"/>
<DICH_DATA CI_END="1.446022792933408" CI_START="0.5571779516389909" EFFECT_SIZE="0.8976034858387799" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="27" LOG_CI_END="0.16017513857897522" LOG_CI_START="-0.2540060775872285" LOG_EFFECT_SIZE="-0.046915469504126665" ORDER="1" O_E="0.0" SE="0.24329209660611376" STUDY_ID="STD-Bernstein-1990" TOTAL_1="102" TOTAL_2="103" VAR="0.05919104427099858" WEIGHT="12.96159305334124"/>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="1" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="9.080660666102547"/>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="13.775128953363117"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="9.390462494951109"/>
<DICH_DATA CI_END="1.0782937032140179" CI_START="0.29703898732765543" EFFECT_SIZE="0.565946348733234" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.03273706911806205" LOG_CI_START="-0.5271865443863982" LOG_EFFECT_SIZE="-0.2472247376341681" ORDER="2" O_E="0.0" SE="0.32890190223910776" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.1081764612965036" WEIGHT="10.631061828775309"/>
<DICH_DATA CI_END="1.1677303907017897" CI_START="0.5915485874192178" EFFECT_SIZE="0.8311252992817239" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="35" LOG_CI_END="0.0673425830619302" LOG_CI_START="-0.2280095783708831" LOG_EFFECT_SIZE="-0.08033349765447646" ORDER="2" O_E="0.0" SE="0.17349132164241274" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.030099238685231115" WEIGHT="14.901660424450956"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.80084161658765" CI_END="1.9922274586748236" CI_START="0.11884930319424182" DF="1" EFFECT_SIZE="0.486595155409441" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="44" I2="85.29593752689459" ID="CMP-009.02.03" LOG_CI_END="0.29933892164183884" LOG_CI_START="-0.9250033601687235" LOG_EFFECT_SIZE="-0.3128322192634423" NO="3" P_CHI2="0.00911154576696882" P_Z="0.31654530476384213" STUDIES="2" TAU2="0.8825432419722246" TOTAL_1="248" TOTAL_2="248" WEIGHT="100.0" Z="1.001582469329362">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="1" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="50.7462460908631"/>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="2" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="49.25375390913689"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" NO="10">
<NAME>Exploration of heterogeneity: different rotavirus vaccines</NAME>
<DICH_OUTCOME CHI2="125.72961523475456" CI_END="0.6093634346387931" CI_START="0.4789533665525348" CI_STUDY="95" CI_TOTAL="95" DF="39" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5402376037210529" ESTIMABLE="YES" EVENTS_1="1474" EVENTS_2="1515" I2="68.98105515778315" I2_Q="0.0" ID="CMP-010.01" LOG_CI_END="-0.21512360953415552" LOG_CI_START="-0.319706769747915" LOG_EFFECT_SIZE="-0.26741518964103533" METHOD="MH" NO="1" P_CHI2="4.713884838025706E-11" P_Q="0.0" P_Z="1.2064844577501748E-23" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="40" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10565457354441228" TOTALS="SUB" TOTAL_1="12569" TOTAL_2="8501" WEIGHT="800.0" Z="10.023107726791018">
<NAME>Rotavirus diarrhoea: episodes</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="51.63954736127991" CI_END="0.7220853727678134" CI_START="0.47198268428240375" DF="10" EFFECT_SIZE="0.5837908808126525" ESTIMABLE="YES" EVENTS_1="904" EVENTS_2="874" I2="80.63499679801969" ID="CMP-010.01.01" LOG_CI_END="-0.1414114523887241" LOG_CI_START="-0.32607393411707025" LOG_EFFECT_SIZE="-0.2337426932528972" NO="1" P_CHI2="1.3305139334729432E-7" P_Z="6.985025642595982E-7" STUDIES="11" TAU2="0.09213810002034244" TOTAL_1="6877" TOTAL_2="4713" WEIGHT="100.0" Z="4.961779524863261">
<NAME>Rhesus tetravalent vaccine (RRV-TV)</NAME>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="653" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="9.998313846907402"/>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="654" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="2.126533710560135"/>
<DICH_DATA CI_END="0.8120480917527467" CI_START="0.12970876126162564" EFFECT_SIZE="0.3245454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="-0.09041824986674628" LOG_CI_START="-0.8870306882253174" LOG_EFFECT_SIZE="-0.48872446904603184" ORDER="655" O_E="0.0" SE="0.46793408958699123" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.2189623121976063" WEIGHT="3.782090818008959"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="656" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="10.436651254977653"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="657" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="11.525072360873883"/>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="658" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="11.249942863560541"/>
<DICH_DATA CI_END="0.9617690037595611" CI_START="0.4454601368846169" EFFECT_SIZE="0.6545454545454545" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="55" LOG_CI_END="-0.016929223636822716" LOG_CI_START="-0.35119115381709043" LOG_EFFECT_SIZE="-0.1840601887269566" ORDER="659" O_E="0.0" SE="0.19634711241112907" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.03855218855218855" WEIGHT="9.00304089446789"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="660" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="10.485013207553676"/>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="661" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="9.412835888479238"/>
<DICH_DATA CI_END="0.6498878927155749" CI_START="0.3898971264110547" EFFECT_SIZE="0.5033780109014878" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.18716155377888236" LOG_CI_START="-0.4090499656030404" LOG_EFFECT_SIZE="-0.2981057596909614" ORDER="662" O_E="0.0" SE="0.13033835147086315" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.01698808586414225" WEIGHT="10.78210516560896"/>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="663" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="11.198399989001674"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.799603886856808" CI_END="0.7761890820856889" CI_START="0.4594961497431625" DF="8" EFFECT_SIZE="0.5972067436751309" ESTIMABLE="YES" EVENTS_1="110" EVENTS_2="137" I2="18.364047237362623" ID="CMP-010.01.02" LOG_CI_END="-0.11003247036086702" LOG_CI_START="-0.33771812334708456" LOG_EFFECT_SIZE="-0.22387529685397584" NO="2" P_CHI2="0.27937389021204273" P_Z="1.1604824463981223E-4" STUDIES="9" TAU2="0.02938775262291317" TOTAL_1="995" TOTAL_2="720" WEIGHT="100.0" Z="3.8543273421673776">
<NAME>Rhesus monovalent vaccine (RRV, RRV-D, RRV-DS1, or RRV-ST3)</NAME>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="10.646917061555797"/>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="15.942817040285306"/>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="13.976536941686868"/>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="15.143955259647704"/>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="6.114942215425208"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="9.586084685292487"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="10.406426035026398"/>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="2" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="7.1115600697653605"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="2" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="11.070760691314872"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="19.774439024701714" CI_END="0.8625887745012863" CI_START="0.4841810153483268" DF="9" EFFECT_SIZE="0.6462577726156195" ESTIMABLE="YES" EVENTS_1="278" EVENTS_2="233" I2="54.48669876926757" ID="CMP-010.01.03" LOG_CI_END="-0.06419619794507513" LOG_CI_START="-0.31499224317000163" LOG_EFFECT_SIZE="-0.18959422055753838" NO="3" P_CHI2="0.019356640137416337" P_Z="0.0030431338327577373" STUDIES="10" TAU2="0.09197439545094459" TOTAL_1="2118" TOTAL_2="1545" WEIGHT="100.0" Z="2.963346919098754">
<NAME>Bovine vaccine (RIT-4237)</NAME>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="2.78902886684929"/>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="5.364267722074986"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="1" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="0.877522529550649"/>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="1" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="7.81229307963753"/>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="1" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="8.798462781858099"/>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="1" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="17.399547496296584"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="9.19052690021842"/>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="15.730273706669012"/>
<DICH_DATA CI_END="1.0318595193566296" CI_START="0.29941894419434845" EFFECT_SIZE="0.5558401639344263" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" LOG_CI_END="0.013620575080836642" LOG_CI_START="-0.523720725373086" LOG_EFFECT_SIZE="-0.25505007514612466" ORDER="2" O_E="0.0" SE="0.31563693976896945" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.09962667774672006" WEIGHT="11.32709738669827"/>
<DICH_DATA CI_END="0.9714613192689926" CI_START="0.623318925603991" EFFECT_SIZE="0.7781582267075149" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="62" LOG_CI_END="-0.012574487048211035" LOG_CI_START="-0.20528968658369665" LOG_EFFECT_SIZE="-0.10893208681595384" ORDER="2" O_E="0.0" SE="0.11320186216276716" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.012814661597118134" WEIGHT="20.710979530147174"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.092528036439027" CI_END="1.2849849676093008" CI_START="0.4635632238102344" DF="2" EFFECT_SIZE="0.7717977546823113" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="99" I2="60.72677488097819" ID="CMP-010.01.04" LOG_CI_END="0.10889804710504326" LOG_CI_START="-0.3338910255337454" LOG_EFFECT_SIZE="-0.11249648921435104" NO="4" P_CHI2="0.0783740104986077" P_Z="0.3192938134382398" STUDIES="3" TAU2="0.11541644807861488" TOTAL_1="389" TOTAL_2="393" WEIGHT="100.0" Z="0.9959101561984288">
<NAME>Bovine vaccine (WC3)</NAME>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="1" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="14.04730465812808"/>
<DICH_DATA CI_END="1.4440853901075372" CI_START="0.5418961953766118" EFFECT_SIZE="0.8846153846153846" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="26" LOG_CI_END="0.15959287422812996" LOG_CI_START="-0.2660838981345802" LOG_EFFECT_SIZE="-0.0532455119532251" ORDER="1" O_E="0.0" SE="0.25004464321986253" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.06252232360294835" WEIGHT="38.01879999981871"/>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="47.933895342053205"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.576967111658689" CI_END="0.5640935785929203" CI_START="0.1879608190580902" DF="2" EFFECT_SIZE="0.3256186282412824" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="37" I2="0.0" ID="CMP-010.01.05" LOG_CI_END="-0.24864884407452456" LOG_CI_START="-0.7259326711632701" LOG_EFFECT_SIZE="-0.48729075761889734" NO="5" P_CHI2="0.4545337077472179" P_Z="6.277882225505526E-5" STUDIES="3" TAU2="0.0" TOTAL_1="261" TOTAL_2="172" WEIGHT="100.0" Z="4.002114803503246">
<NAME>Bovine-human vaccine (W179-9)</NAME>
<DICH_DATA CI_END="1.0100113315938297" CI_START="0.0036038497772461773" EFFECT_SIZE="0.06033182503770739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.00432624627874643" LOG_CI_START="-2.4432333204323675" LOG_EFFECT_SIZE="-1.2194535370768107" ORDER="1" O_E="0.0" SE="1.437708605101362" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="2.067006033182504" WEIGHT="3.802654748215987"/>
<DICH_DATA CI_END="0.6267170703918006" CI_START="0.19635640354517492" EFFECT_SIZE="0.35079895949461165" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.2029284759143624" LOG_CI_START="-0.7069549310170087" LOG_EFFECT_SIZE="-0.4549417034656856" ORDER="1" O_E="0.0" SE="0.29606763469848557" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.08765604431595589" WEIGHT="89.66991800748848"/>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="1" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="6.527427244295536"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5818306879595707" CI_START="0.18645858428377243" DF="0" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" I2="0.0" ID="CMP-010.01.06" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" NO="6" P_CHI2="1.0" P_Z="1.3050068926220797E-4" STUDIES="1" TAU2="0.0" TOTAL_1="199" TOTAL_2="206" WEIGHT="100.00000000000001" Z="3.8255117881559024">
<NAME>Bovine-human vaccine (WC3-QV)</NAME>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="1" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7876626643230138" CI_END="0.4505945999306007" CI_START="0.22694050392805665" DF="1" EFFECT_SIZE="0.31977830691826425" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="80" I2="0.0" ID="CMP-010.01.07" LOG_CI_END="-0.3462140173045868" LOG_CI_START="-0.6440879851085194" LOG_EFFECT_SIZE="-0.4951510012065531" NO="7" P_CHI2="0.3748078679534931" P_Z="7.219165760389252E-11" STUDIES="2" TAU2="0.0" TOTAL_1="1590" TOTAL_2="611" WEIGHT="100.0" Z="6.516031840100802">
<NAME>Human vaccine (89-12)</NAME>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="1" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="22.396400162005328"/>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="3" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="77.60359983799468"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.2467086393612665" CI_START="0.4514767589010788" DF="0" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" I2="0.0" ID="CMP-010.01.08" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" NO="8" P_CHI2="1.0" P_Z="0.98612833643823" STUDIES="1" TAU2="0.0" TOTAL_1="140" TOTAL_2="141" WEIGHT="100.0" Z="0.017386427959658064">
<NAME>Human vaccine (M37)</NAME>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="3" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="70.21814576982504" CI_END="0.4350250875788193" CI_START="0.2831955761295305" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3509945588006788" ESTIMABLE="YES" EVENTS_1="404" EVENTS_2="712" I2="68.6690672919277" I2_Q="0.0" ID="CMP-010.02" LOG_CI_END="-0.3614856968778346" LOG_CI_START="-0.5479135351543722" LOG_EFFECT_SIZE="-0.4546996160161034" METHOD="MH" NO="2" P_CHI2="6.111487534932181E-7" P_Q="0.0" P_Z="1.1690768209628571E-21" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.2048943823407621" TOTALS="SUB" TOTAL_1="9582" TOTAL_2="6868" WEIGHT="700.0" Z="9.560748860412156">
<NAME>Rotavirus diarrhoea: severe episodes</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="27.427205482942664" CI_END="0.5656177882897342" CI_START="0.2773112160072238" DF="6" EFFECT_SIZE="0.39604564972480466" ESTIMABLE="YES" EVENTS_1="235" EVENTS_2="402" I2="78.12391056853576" ID="CMP-010.02.01" LOG_CI_END="-0.24747694073415166" LOG_CI_START="-0.5570325647837007" LOG_EFFECT_SIZE="-0.40225475275892614" NO="1" P_CHI2="1.2041203693791136E-4" P_Z="3.509856067259027E-7" STUDIES="7" TAU2="0.17642332324292964" TOTAL_1="5481" TOTAL_2="4088" WEIGHT="99.99999999999997" Z="5.0937845528619015">
<NAME>Rhesus tetravalent vaccine (RRV-TV)</NAME>
<DICH_DATA CI_END="0.5987519438893242" CI_START="0.27685001228189854" EFFECT_SIZE="0.40714184631350536" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="85" LOG_CI_END="-0.22275306360821712" LOG_CI_START="-0.557755452885439" LOG_EFFECT_SIZE="-0.3902542582468281" ORDER="1" O_E="0.0" SE="0.19678206175001164" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.0387231798265854" WEIGHT="15.368033903026696"/>
<DICH_DATA CI_END="0.9161896071520315" CI_START="0.3333389286080207" EFFECT_SIZE="0.5526315789473685" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="38" LOG_CI_END="-0.03801463897570007" LOG_CI_START="-0.4771139647900816" LOG_EFFECT_SIZE="-0.2575643018828908" ORDER="1" O_E="0.0" SE="0.2579291175600855" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.06652742968532441" WEIGHT="13.609255017482305"/>
<DICH_DATA CI_END="0.1795633625396562" CI_START="0.04632957397102283" EFFECT_SIZE="0.09120906801007557" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="100" LOG_CI_END="-0.7457822705083856" LOG_CI_START="-1.334141693383821" LOG_EFFECT_SIZE="-1.0399619819461035" ORDER="1" O_E="0.0" SE="0.345605237423145" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.11944298013430842" WEIGHT="11.175246101189888"/>
<DICH_DATA CI_END="0.9667371658326467" CI_START="0.44198406197334955" EFFECT_SIZE="0.6536684323227769" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="38" LOG_CI_END="-0.014691584804480032" LOG_CI_START="-0.3545933911075277" LOG_EFFECT_SIZE="-0.18464248795600385" ORDER="1" O_E="0.0" SE="0.19966000356348707" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.039864117022971664" WEIGHT="15.286966035684367"/>
<DICH_DATA CI_END="0.5472427167348773" CI_START="0.2843050186045062" EFFECT_SIZE="0.3944411879640485" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="72" LOG_CI_END="-0.2618200097561964" LOG_CI_START="-0.5462154739957807" LOG_EFFECT_SIZE="-0.40401774187598855" ORDER="2" O_E="0.0" SE="0.1670553034745842" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.02790747441898542" WEIGHT="16.181499759819204"/>
<DICH_DATA CI_END="0.7438943926384873" CI_START="0.2876714303749857" EFFECT_SIZE="0.4625982749408442" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="33" LOG_CI_END="-0.1284887149242854" LOG_CI_START="-0.5411032672254031" LOG_EFFECT_SIZE="-0.33479599107484426" ORDER="2" O_E="0.0" SE="0.2423718304966511" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.05874410421829737" WEIGHT="14.059679901184786"/>
<DICH_DATA CI_END="0.7033226163459516" CI_START="0.2817068598791358" EFFECT_SIZE="0.4451188669701568" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" LOG_CI_END="-0.15284541700103546" LOG_CI_START="-0.5502025773259718" LOG_EFFECT_SIZE="-0.3515239971635037" ORDER="693" O_E="0.0" SE="0.23340956292453388" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.05448002406462194" WEIGHT="14.319319281612731"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.353600051089334" CI_END="0.9742975575393622" CI_START="0.2736381891883658" DF="3" EFFECT_SIZE="0.5163380863114" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="41" I2="31.091511282728952" ID="CMP-010.02.02" LOG_CI_END="-0.01130838617902122" LOG_CI_START="-0.5628232921990397" LOG_EFFECT_SIZE="-0.2870658391890304" NO="2" P_CHI2="0.22572670545798235" P_Z="0.04131656569755179" STUDIES="4" TAU2="0.12985455837278026" TOTAL_1="578" TOTAL_2="459" WEIGHT="100.0" Z="2.0403390728367525">
<NAME>Rhesus monovalent vaccine (RRV-MMU 18006)</NAME>
<DICH_DATA CI_END="1.9440155409681266" CI_START="0.12859979497668989" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28869973246768516" LOG_CI_START="-0.8907597237956476" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="1" O_E="0.0" SE="0.6928203230275509" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.48" WEIGHT="17.20930926604981"/>
<DICH_DATA CI_END="1.7852310923406094" CI_START="0.40105526642056916" EFFECT_SIZE="0.8461538461538461" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.2516944420909467" LOG_CI_START="-0.3967957763881701" LOG_EFFECT_SIZE="-0.07255066714861173" ORDER="1" O_E="0.0" SE="0.38092636441298616" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.14510489510489513" WEIGHT="38.1699031242784"/>
<DICH_DATA CI_END="0.7715368475652773" CI_START="0.012961143763330034" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.11264332778342294" LOG_CI_START="-1.8873566722165767" LOG_EFFECT_SIZE="-1.0" ORDER="1" O_E="0.0" SE="1.0424754034927717" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="1.0867549668874172" WEIGHT="8.626576961990155"/>
<DICH_DATA CI_END="1.012292162157116" CI_START="0.2092587824801562" EFFECT_SIZE="0.4602510460251046" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.005305874263223388" LOG_CI_START="-0.6793163058430487" LOG_EFFECT_SIZE="-0.33700521578991266" ORDER="1" O_E="0.0" SE="0.40215045752887174" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.16172499049068087" WEIGHT="35.99421064768164"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.915992847434724" CI_END="0.7861607734862629" CI_START="0.18798294578716615" DF="4" EFFECT_SIZE="0.38442791009793337" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="98" I2="71.25609330319999" ID="CMP-010.02.03" LOG_CI_END="-0.10448862966305048" LOG_CI_START="-0.7258815490686914" LOG_EFFECT_SIZE="-0.41518508936587095" NO="3" P_CHI2="0.00756808053982172" P_Z="0.008815983270214094" STUDIES="5" TAU2="0.4108659786418168" TOTAL_1="1138" TOTAL_2="993" WEIGHT="100.00000000000001" Z="2.619108768904211">
<NAME>Bovine vaccine (RIT-4237)</NAME>
<DICH_DATA CI_END="0.49718286349299734" CI_START="0.028416957778963605" EFFECT_SIZE="0.11886304909560723" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="18" LOG_CI_END="-0.30348384869227213" LOG_CI_START="-1.5464224179824027" LOG_EFFECT_SIZE="-0.9249531333373373" ORDER="1" O_E="0.0" SE="0.7301082682461691" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.53305808336142" WEIGHT="14.11467060918171"/>
<DICH_DATA CI_END="1.4707139942162637" CI_START="0.5880462845566141" EFFECT_SIZE="0.9299719887955182" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="21" LOG_CI_END="0.16752822486189484" LOG_CI_START="-0.23058848967820864" LOG_EFFECT_SIZE="-0.03153013240815689" ORDER="1" O_E="0.0" SE="0.23385572883037695" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.0546885019067868" WEIGHT="28.617869168731087"/>
<DICH_DATA CI_END="1.1529787394529891" CI_START="0.017999116591201656" EFFECT_SIZE="0.14405762304921968" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.061821299121777605" LOG_CI_START="-1.7447488098401032" LOG_EFFECT_SIZE="-0.8414637553591628" ORDER="1" O_E="0.0" SE="1.0611882246704736" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="1.1261204481792717" WEIGHT="8.668376625037935"/>
<DICH_DATA CI_END="0.7179656953268364" CI_START="0.2197344608609051" EFFECT_SIZE="0.39719240297274977" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="35" LOG_CI_END="-0.14389630601699868" LOG_CI_START="-0.6581018275214423" LOG_EFFECT_SIZE="-0.4009990667692205" ORDER="705" O_E="0.0" SE="0.3020468686900926" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.09123231088549007" WEIGHT="26.534998212798957"/>
<DICH_DATA CI_END="0.8662469474617329" CI_START="0.15480904625884115" EFFECT_SIZE="0.3662005785920926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.06235828277304996" LOG_CI_START="-0.8102036649353841" LOG_EFFECT_SIZE="-0.436280973854217" ORDER="708" O_E="0.0" SE="0.4392880793765001" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.19297401668229427" WEIGHT="22.064085384250323"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.740871987210131" CI_END="1.1234850621782468" CI_START="0.285756539534129" DF="2" EFFECT_SIZE="0.5666067450942863" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="69" I2="46.536529268098235" ID="CMP-010.02.04" LOG_CI_END="0.05056730242787839" LOG_CI_START="-0.5440038219962378" LOG_EFFECT_SIZE="-0.24671825978417966" NO="4" P_CHI2="0.1540565773171524" P_Z="0.10382621996186138" STUDIES="3" TAU2="0.16621159062074076" TOTAL_1="389" TOTAL_2="393" WEIGHT="100.0" Z="1.6265805170870002">
<NAME>Bovine vaccine (WC3)</NAME>
<DICH_DATA CI_END="0.8052997862943447" CI_START="0.0029445761454306423" EFFECT_SIZE="0.04869565217391304" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.09404241615803753" LOG_CI_START="-2.530977210536785" LOG_EFFECT_SIZE="-1.3125098133474113" ORDER="1" O_E="0.0" SE="1.4314675612398584" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="2.0490993788819876" WEIGHT="5.506151205216278"/>
<DICH_DATA CI_END="1.3088284690680698" CI_START="0.27505514168432793" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" LOG_CI_END="0.11688273301482338" LOG_CI_START="-0.5605802322475362" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="1" O_E="0.0" SE="0.3979450992908726" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.15836030204962243" WEIGHT="37.581310766932226"/>
<DICH_DATA CI_END="1.0633674611113753" CI_START="0.4500505159968466" EFFECT_SIZE="0.691786870768325" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="43" LOG_CI_END="0.026683366833919513" LOG_CI_START="-0.3467387360305029" LOG_EFFECT_SIZE="-0.16002768459829167" ORDER="711" O_E="0.0" SE="0.21934999169178265" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.048114418855185116" WEIGHT="56.91253802785149"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.4163395199834392" CI_START="0.04878156216266573" DF="0" EFFECT_SIZE="0.14251207729468598" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="16" I2="0.0" ID="CMP-010.02.05" LOG_CI_END="-0.3805523628434299" LOG_CI_START="-1.3117442961140797" LOG_EFFECT_SIZE="-0.8461483294787548" NO="5" P_CHI2="1.0" P_Z="3.68138520452286E-4" STUDIES="1" TAU2="0.0" TOTAL_1="207" TOTAL_2="118" WEIGHT="100.0" Z="3.5619300213054426">
<NAME>Bovine-human vaccine (W179-9)</NAME>
<DICH_DATA CI_END="0.4163395199834392" CI_START="0.04878156216266573" EFFECT_SIZE="0.14251207729468598" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="16" LOG_CI_END="-0.3805523628434299" LOG_CI_START="-1.3117442961140797" LOG_EFFECT_SIZE="-0.8461483294787548" ORDER="1" O_E="0.0" SE="0.54698675107759" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.2991945058544174" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.6192770239174124" CI_START="0.15889690599860884" DF="0" EFFECT_SIZE="0.31368966042332874" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="33" I2="0.0" ID="CMP-010.02.06" LOG_CI_END="-0.20811503265147768" LOG_CI_START="-0.7988845591854038" LOG_EFFECT_SIZE="-0.5034997959184407" NO="6" P_CHI2="1.0" P_Z="8.351695720085007E-4" STUDIES="1" TAU2="0.0" TOTAL_1="199" TOTAL_2="206" WEIGHT="100.0" Z="3.340867874527174">
<NAME>Bovine-human vaccine (QHBRV)</NAME>
<DICH_DATA CI_END="0.6192770239174124" CI_START="0.15889690599860884" EFFECT_SIZE="0.31368966042332874" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="33" LOG_CI_END="-0.20811503265147768" LOG_CI_START="-0.7988845591854038" LOG_EFFECT_SIZE="-0.5034997959184407" ORDER="2" O_E="0.0" SE="0.347020944242348" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.12042353574285078" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6084286712326639" CI_END="0.3490813787178486" CI_START="0.1320707884863827" DF="1" EFFECT_SIZE="0.2147171463418323" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="53" I2="0.0" ID="CMP-010.02.07" LOG_CI_END="-0.4570733174298166" LOG_CI_START="-0.879193229335224" LOG_EFFECT_SIZE="-0.6681332733825204" NO="7" P_CHI2="0.43538023691638006" P_Z="5.487825462841406E-10" STUDIES="2" TAU2="0.0" TOTAL_1="1590" TOTAL_2="611" WEIGHT="100.0" Z="6.20447941814241">
<NAME>Human vaccine (89-12)</NAME>
<DICH_DATA CI_END="0.46051655088281557" CI_START="0.04349894471460124" EFFECT_SIZE="0.14153439153439154" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="21" LOG_CI_END="-0.3367547567203159" LOG_CI_START="-1.361521278911678" LOG_EFFECT_SIZE="-0.8491380178159968" ORDER="1" O_E="0.0" SE="0.6019529278113018" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.3623473273005983" WEIGHT="16.967654775030056"/>
<DICH_DATA CI_END="0.3985458640164984" CI_START="0.13716135414275926" EFFECT_SIZE="0.23380566801619435" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="32" LOG_CI_END="-0.3995216934820587" LOG_CI_START="-0.8627682359089087" LOG_EFFECT_SIZE="-0.6311449646954838" ORDER="715" O_E="0.0" SE="0.2721133121288995" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.07404565463775989" WEIGHT="83.03234522496994"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="59.87461054708318" CI_END="0.8947535528907611" CI_START="0.8175207534220956" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.855265805867598" ESTIMABLE="YES" EVENTS_1="2842" EVENTS_2="2807" I2="63.256545973355415" I2_Q="0.0" ID="CMP-010.03" LOG_CI_END="-0.048296568436377904" LOG_CI_START="-0.08750121361288314" LOG_EFFECT_SIZE="-0.06789889102463052" METHOD="MH" NO="3" P_CHI2="2.3323707314504283E-5" P_Q="0.0" P_Z="1.1294486602617148E-11" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.013986527628491187" TOTALS="SUB" TOTAL_1="6162" TOTAL_2="5134" WEIGHT="600.0" Z="6.788959848984345">
<NAME>All-cause diarrhoea: episodes (number of cases/number of participants)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.042581851311754" CI_END="0.9309900359503462" CI_START="0.8422712709954058" DF="4" EFFECT_SIZE="0.885520276935518" ESTIMABLE="YES" EVENTS_1="1965" EVENTS_2="1921" I2="20.675556333122113" ID="CMP-010.03.01" LOG_CI_END="-0.031054967090557366" LOG_CI_START="-0.07454801239281407" LOG_EFFECT_SIZE="-0.052801489741685734" NO="1" P_CHI2="0.2829562488718669" P_Z="1.946733795741851E-6" STUDIES="5" TAU2="6.821303121518341E-4" TOTAL_1="3543" TOTAL_2="3018" WEIGHT="99.99999999999999" Z="4.758876620598254">
<NAME>Rhesus tetravalent vaccine (RRV-TV)</NAME>
<DICH_DATA CI_END="0.9759703719972511" CI_START="0.3353749485691675" EFFECT_SIZE="0.5721153846153846" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="24" LOG_CI_END="-0.010563366219999535" LOG_CI_START="-0.4744693809204622" LOG_EFFECT_SIZE="-0.24251637357023084" ORDER="1" O_E="0.0" SE="0.27250068940685995" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.07425662572721395" WEIGHT="0.870980353453258"/>
<DICH_DATA CI_END="0.9941756488758148" CI_START="0.6299502643723327" EFFECT_SIZE="0.7913793103448276" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="58" LOG_CI_END="-0.0025368785822323147" LOG_CI_START="-0.20069373746911975" LOG_EFFECT_SIZE="-0.10161530802567606" ORDER="1" O_E="0.0" SE="0.1163983198024288" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.013548568852828489" WEIGHT="4.586576068105964"/>
<DICH_DATA CI_END="0.9428015060715957" CI_START="0.832582713234603" EFFECT_SIZE="0.8859798169071117" ESTIMABLE="YES" EVENTS_1="724" EVENTS_2="808" LOG_CI_END="-0.025579732386512153" LOG_CI_START="-0.07957261053398831" LOG_EFFECT_SIZE="-0.052576171460250246" ORDER="2" O_E="0.0" SE="0.03171568389288479" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.0010058846047933914" WEIGHT="38.66682904712283"/>
<DICH_DATA CI_END="1.0519429282324169" CI_START="0.8503929310660905" EFFECT_SIZE="0.9458143739940787" ESTIMABLE="YES" EVENTS_1="448" EVENTS_2="236" LOG_CI_END="0.021992178386079406" LOG_CI_START="-0.07038035856442754" LOG_EFFECT_SIZE="-0.02419409008917406" ORDER="2" O_E="0.0" SE="0.05426008545616016" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.002944156873709803" WEIGHT="17.99917681009744"/>
<DICH_DATA CI_END="0.9356483690929477" CI_START="0.8244845822574276" EFFECT_SIZE="0.8783095438007277" ESTIMABLE="YES" EVENTS_1="689" EVENTS_2="795" LOG_CI_END="-0.02888733508094745" LOG_CI_START="-0.08381746118759804" LOG_EFFECT_SIZE="-0.05635239813427276" ORDER="2" O_E="0.0" SE="0.032266227983556085" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.0010411094682868177" WEIGHT="37.8764377212205"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="15.473552146037385" CI_END="0.9825239692911825" CI_START="0.6903023841369815" DF="5" EFFECT_SIZE="0.8235524503475378" ESTIMABLE="YES" EVENTS_1="327" EVENTS_2="284" I2="67.68679904387405" ID="CMP-010.03.02" LOG_CI_END="-0.007656845935824575" LOG_CI_START="-0.16096062666131442" LOG_EFFECT_SIZE="-0.0843087362985695" NO="2" P_CHI2="0.008519472797544836" P_Z="0.03110342189843529" STUDIES="6" TAU2="0.0301902805887125" TOTAL_1="682" TOTAL_2="463" WEIGHT="99.99999999999999" Z="2.1557470526205504">
<NAME>Rhesus monovalent vaccine (RRV, RRV-D, RRV-DS1, or RRV-ST3)</NAME>
<DICH_DATA CI_END="0.9799794766459171" CI_START="0.6219352854943884" EFFECT_SIZE="0.7806944444444445" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="48" LOG_CI_END="-0.008783019483791298" LOG_CI_START="-0.20625480279287006" LOG_EFFECT_SIZE="-0.10751891113833068" ORDER="1" O_E="0.0" SE="0.11599590301684518" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.013455049516693351" WEIGHT="18.57989059054036"/>
<DICH_DATA CI_END="1.0484861014457354" CI_START="0.77731856905455" EFFECT_SIZE="0.9027777777777778" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="45" LOG_CI_END="0.020562677905387537" LOG_CI_START="-0.10940095748221328" LOG_EFFECT_SIZE="-0.04441913978841287" ORDER="1" O_E="0.0" SE="0.07634128275704737" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.005827991452991458" WEIGHT="22.514279896812468"/>
<DICH_DATA CI_END="0.765818172912393" CI_START="0.4853810240794641" EFFECT_SIZE="0.6096832038254633" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="70" LOG_CI_END="-0.1158743320312561" LOG_CI_START="-0.3139172063696978" LOG_EFFECT_SIZE="-0.21489576920047693" ORDER="1" O_E="0.0" SE="0.11633136471443911" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.013532986416323849" WEIGHT="18.546771860690328"/>
<DICH_DATA CI_END="0.977528145587583" CI_START="0.5179257339380201" EFFECT_SIZE="0.7115384615384616" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="52" LOG_CI_END="-0.009870729280021211" LOG_CI_START="-0.28573250985558707" LOG_EFFECT_SIZE="-0.14780161956780413" ORDER="1" O_E="0.0" SE="0.16204257544792436" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.026257796257796256" WEIGHT="14.36586511798254"/>
<DICH_DATA CI_END="1.2547560036328695" CI_START="0.8246862503827318" EFFECT_SIZE="1.0172413793103448" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="58" LOG_CI_END="0.09855928232850295" LOG_CI_START="-0.08371124617008925" LOG_EFFECT_SIZE="0.0074240180792068755" ORDER="1" O_E="0.0" SE="0.10706661069374049" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.011463259125444984" WEIGHT="19.468344436303337"/>
<DICH_DATA CI_END="2.200513364997922" CI_START="0.6611815176504472" EFFECT_SIZE="1.206208425720621" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="11" LOG_CI_END="0.34252401063003485" LOG_CI_START="-0.1796792949895961" LOG_EFFECT_SIZE="0.0814223578202194" ORDER="1" O_E="0.0" SE="0.3067448066690235" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.09409237641841658" WEIGHT="6.524848097670955"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="17.000547267915547" CI_END="1.0145258475952554" CI_START="0.6689335049435818" DF="6" EFFECT_SIZE="0.8238023616667728" ESTIMABLE="YES" EVENTS_1="408" EVENTS_2="433" I2="64.70701851273012" ID="CMP-010.03.03" LOG_CI_END="0.00626311625353452" LOG_CI_START="-0.17461705094869878" LOG_EFFECT_SIZE="-0.08417696734758214" NO="3" P_CHI2="0.009281261965026766" P_Z="0.06811678894946183" STUDIES="7" TAU2="0.04194606888701446" TOTAL_1="1487" TOTAL_2="1285" WEIGHT="100.0" Z="1.8242334345545441">
<NAME>Bovine vaccine (RIT-4237)</NAME>
<DICH_DATA CI_END="1.173287546586794" CI_START="0.8250873971200825" EFFECT_SIZE="0.9839028244124037" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="83" LOG_CI_END="0.0694044610431056" LOG_CI_START="-0.08350004650865447" LOG_EFFECT_SIZE="-0.007047792732774443" ORDER="1" O_E="0.0" SE="0.08981686462542321" STUDY_ID="STD-De-Mol-1986" TOTAL_1="122" TOTAL_2="123" VAR="0.008067069171141599" WEIGHT="22.572153788624625"/>
<DICH_DATA CI_END="0.8115768587487964" CI_START="0.3521781100679432" EFFECT_SIZE="0.5346209912536443" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="49" LOG_CI_END="-0.0906703449075247" LOG_CI_START="-0.4532376414753382" LOG_EFFECT_SIZE="-0.27195399319143143" ORDER="1" O_E="0.0" SE="0.21297382474099683" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.04535785002480883" WEIGHT="12.930739625108966"/>
<DICH_DATA CI_END="0.9120298765126801" CI_START="0.19699392660974857" EFFECT_SIZE="0.42386831275720166" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="-0.03999093470659414" LOG_CI_START="-0.7055471630796857" LOG_EFFECT_SIZE="-0.37276904889314" ORDER="1" O_E="0.0" SE="0.3909510231028184" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.15284270246514042" WEIGHT="5.795530388450827"/>
<DICH_DATA CI_END="0.9972484337336552" CI_START="0.3293380007214721" EFFECT_SIZE="0.5730897009966778" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="28" LOG_CI_END="-0.0011966371152548345" LOG_CI_START="-0.48235815525384607" LOG_EFFECT_SIZE="-0.24177739618455044" ORDER="2" O_E="0.0" SE="0.28263665754253625" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.0798834801868169" WEIGHT="9.266259723380188"/>
<DICH_DATA CI_END="2.700829492835596" CI_START="0.7700871647168297" EFFECT_SIZE="1.4421768707482994" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="14" LOG_CI_END="0.43149716743142463" LOG_CI_START="-0.1134601150702739" LOG_EFFECT_SIZE="0.15901852618057535" ORDER="2" O_E="0.0" SE="0.3201106053235521" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="0.10247079964061095" WEIGHT="7.816983259711562"/>
<DICH_DATA CI_END="1.098660222738566" CI_START="0.646121544069989" EFFECT_SIZE="0.8425366695427092" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="76" LOG_CI_END="0.04086340106273701" LOG_CI_START="-0.18968577774218268" LOG_EFFECT_SIZE="-0.07441118833972281" ORDER="2" O_E="0.0" SE="0.13542572886685053" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.01834012803911771" WEIGHT="18.725749860845326"/>
<DICH_DATA CI_END="1.1607000700658978" CI_START="0.8290874769605869" EFFECT_SIZE="0.9809800673810409" ESTIMABLE="YES" EVENTS_1="181" EVENTS_2="171" LOG_CI_END="0.06472001065718366" LOG_CI_START="-0.08139964465237443" LOG_EFFECT_SIZE="-0.008339816997595402" ORDER="2" O_E="0.0" SE="0.08583140883279351" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.007367030742222145" WEIGHT="22.892583353878493"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8387520887290353" CI_START="0.27589639998084015" DF="0" EFFECT_SIZE="0.48104956268221577" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="28" I2="0.0" ID="CMP-010.03.04" LOG_CI_END="-0.0763663853059742" LOG_CI_START="-0.5592539663517542" LOG_EFFECT_SIZE="-0.31781017582886417" NO="4" P_CHI2="1.0" P_Z="0.009883406924965149" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="55" WEIGHT="99.99999999999999" Z="2.5798820387797985">
<NAME>Bovine vaccine (WC3)</NAME>
<DICH_DATA CI_END="0.8387520887290353" CI_START="0.27589639998084015" EFFECT_SIZE="0.48104956268221577" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="28" LOG_CI_END="-0.0763663853059742" LOG_CI_START="-0.5592539663517542" LOG_EFFECT_SIZE="-0.31781017582886417" ORDER="1" O_E="0.0" SE="0.2836505554383681" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.08045763760049474" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.7406293215531843" CI_END="0.7244962660125734" CI_START="0.4997097839035353" DF="2" EFFECT_SIZE="0.6016958305722762" ESTIMABLE="YES" EVENTS_1="103" EVENTS_2="111" I2="0.0" ID="CMP-010.03.05" LOG_CI_END="-0.13996384850103816" LOG_CI_START="-0.30128214734804815" LOG_EFFECT_SIZE="-0.22062299792454318" NO="5" P_CHI2="0.4188201042320352" P_Z="8.276575568765914E-8" STUDIES="3" TAU2="0.0" TOTAL_1="261" TOTAL_2="172" WEIGHT="100.00000000000001" Z="5.360992933646652">
<NAME>Bovine-human vaccine (W179-9)</NAME>
<DICH_DATA CI_END="0.9106581476001743" CI_START="0.27983146791643443" EFFECT_SIZE="0.5048076923076923" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="-0.04064462244904817" LOG_CI_START="-0.5531034493365987" LOG_EFFECT_SIZE="-0.29687403589282346" ORDER="2" O_E="0.0" SE="0.30102085162585185" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="0.09061355311355311" WEIGHT="9.909444531517678"/>
<DICH_DATA CI_END="0.7224950368323808" CI_START="0.4728292237997409" EFFECT_SIZE="0.5844799119427628" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="79" LOG_CI_END="-0.1411651319398758" LOG_CI_START="-0.32529568918529217" LOG_EFFECT_SIZE="-0.233230410562584" ORDER="2" O_E="0.0" SE="0.1081592007869158" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.011698412714864366" WEIGHT="76.7565652083336"/>
<DICH_DATA CI_END="1.3474337000124734" CI_START="0.4872254124744582" EFFECT_SIZE="0.8102493074792244" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="19" LOG_CI_END="0.1295074050816975" LOG_CI_START="-0.3122700680566148" LOG_EFFECT_SIZE="-0.09138133148745865" ORDER="736" O_E="0.0" SE="0.25950227455520547" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="0.06734143049932523" WEIGHT="13.333990260148735"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4421414233045668" CI_START="0.5697171871114918" DF="0" EFFECT_SIZE="0.9064285714285715" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="30" I2="0.0" ID="CMP-010.03.06" LOG_CI_END="0.1590078514715856" LOG_CI_START="-0.24434067863865205" LOG_EFFECT_SIZE="-0.04266641358353323" NO="6" P_CHI2="1.0" P_Z="0.6783966889312859" STUDIES="1" TAU2="0.0" TOTAL_1="140" TOTAL_2="141" WEIGHT="100.0" Z="0.4146519832382211">
<NAME>Human vaccine (M37)</NAME>
<DICH_DATA CI_END="1.4421414233045668" CI_START="0.5697171871114918" EFFECT_SIZE="0.9064285714285715" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="30" LOG_CI_END="0.1590078514715856" LOG_CI_START="-0.24434067863865205" LOG_EFFECT_SIZE="-0.04266641358353323" ORDER="1" O_E="0.0" SE="0.2369289231941785" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.056135314645952936" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2008-11-03 11:24:41 +0000" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Exploration of heterogeneity: country of origin - income status</NAME>
<DICH_OUTCOME CHI2="125.72961523475456" CI_END="0.6818346055702" CI_START="0.5477092061212059" CI_STUDY="95" CI_TOTAL="95" DF="39" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6111031750226961" ESTIMABLE="YES" EVENTS_1="1474" EVENTS_2="1515" I2="68.98105515778315" I2_Q="0.0" ID="CMP-011.01" LOG_CI_END="-0.16632096053337242" LOG_CI_START="-0.2614499592099078" LOG_EFFECT_SIZE="-0.21388545987164007" METHOD="MH" NO="1" P_CHI2="4.713884838025706E-11" P_Q="0.0" P_Z="1.2134174035979604E-18" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="40" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10565457354441228" TOTALS="SUB" TOTAL_1="12569" TOTAL_2="8501" WEIGHT="700.0" Z="8.813459702033079">
<NAME>Rotavirus diarrhoea: episodes</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="29.679196411665785" CI_END="0.6819367435652686" CI_START="0.46466131274696626" DF="13" EFFECT_SIZE="0.5629117359546068" ESTIMABLE="YES" EVENTS_1="532" EVENTS_2="619" I2="56.19827498129233" ID="CMP-011.01.01" LOG_CI_END="-0.16625590862014375" LOG_CI_START="-0.33286348495590273" LOG_EFFECT_SIZE="-0.2495596967880233" NO="1" P_CHI2="0.00523727751921399" P_Z="4.31562387196724E-9" STUDIES="14" TAU2="0.06093296297125371" TOTAL_1="4937" TOTAL_2="3245" WEIGHT="100.00000000000003" Z="5.8716179474520125">
<NAME>Rhesus vaccines: high-income countries</NAME>
<DICH_DATA CI_END="1.3105652585924907" CI_START="0.20658133226424313" EFFECT_SIZE="0.5203252032520326" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.11745865118188174" LOG_CI_START="-0.6849089260929031" LOG_EFFECT_SIZE="-0.2837251374555107" ORDER="1" O_E="0.0" SE="0.4713146866747723" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.22213753387533874" WEIGHT="3.383530457507073"/>
<DICH_DATA CI_END="0.7332156521560342" CI_START="0.23732194307859072" EFFECT_SIZE="0.41714285714285715" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="-0.13476827260720303" LOG_CI_START="-0.624662104524474" LOG_EFFECT_SIZE="-0.3797151885658385" ORDER="1" O_E="0.0" SE="0.28776606188178305" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.0828093063709502" WEIGHT="6.663159362135478"/>
<DICH_DATA CI_END="3.712001431098211" CI_START="0.2591346748859103" EFFECT_SIZE="0.9807692307692307" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5696081349816133" LOG_CI_START="-0.5864744700553388" LOG_EFFECT_SIZE="-0.008433167536862813" ORDER="1" O_E="0.0" SE="0.6790886448998952" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.4611613876319759" WEIGHT="1.834491498702267"/>
<DICH_DATA CI_END="2.0037980004277887" CI_START="0.6233836683289481" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.3018539388912002" LOG_CI_START="-0.2052445797420901" LOG_EFFECT_SIZE="0.04830467957455504" ORDER="1" O_E="0.0" SE="0.2978721800233456" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.08872783563186039" WEIGHT="6.399656133347509"/>
<DICH_DATA CI_END="0.8687883427229207" CI_START="0.5563180686556838" EFFECT_SIZE="0.6952141057934509" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="102" LOG_CI_END="-0.0610860150170545" LOG_CI_START="-0.2546768343787402" LOG_EFFECT_SIZE="-0.15788142469789734" ORDER="1" O_E="0.0" SE="0.11371620558306512" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012931375412209931" WEIGHT="12.966712606695841"/>
<DICH_DATA CI_END="0.8470509867691219" CI_START="0.4161957993162583" EFFECT_SIZE="0.59375" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="48" LOG_CI_END="-0.07209044727728793" LOG_CI_START="-0.38070230745686606" LOG_EFFECT_SIZE="-0.226396377367077" ORDER="1" O_E="0.0" SE="0.18128013432282974" STUDY_ID="STD-Rennels-1995" TOTAL_1="544" TOTAL_2="272" VAR="0.03286248710010319" WEIGHT="10.21134444126507"/>
<DICH_DATA CI_END="0.716578777608464" CI_START="0.38298716597027765" EFFECT_SIZE="0.5238706665110306" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="-0.1447360581626778" LOG_CI_START="-0.4168157791428056" LOG_EFFECT_SIZE="-0.28077591865274165" ORDER="1" O_E="0.0" SE="0.1598209749200671" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.025542744024400724" WEIGHT="11.07568450120027"/>
<DICH_DATA CI_END="0.6498878927155749" CI_START="0.3898971264110547" EFFECT_SIZE="0.5033780109014878" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="97" LOG_CI_END="-0.18716155377888236" LOG_CI_START="-0.4090499656030404" LOG_EFFECT_SIZE="-0.2981057596909614" ORDER="1" O_E="0.0" SE="0.13033835147086315" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.01698808586414225" WEIGHT="12.291642143130792"/>
<DICH_DATA CI_END="0.4213670592901756" CI_START="0.24005942454907897" EFFECT_SIZE="0.31804580452685927" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="188" LOG_CI_END="-0.375339418722419" LOG_CI_START="-0.6196812392915088" LOG_EFFECT_SIZE="-0.4975103290069639" ORDER="1" O_E="0.0" SE="0.1435275949138019" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.02060017050174041" WEIGHT="11.74709724629124"/>
<DICH_DATA CI_END="1.0396259264319732" CI_START="0.2499938024234696" EFFECT_SIZE="0.5098039215686274" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="17" LOG_CI_END="0.01687710150033093" LOG_CI_START="-0.6020707577545678" LOG_EFFECT_SIZE="-0.29259682812711846" ORDER="1" O_E="0.0" SE="0.3635730363676438" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.13218535277358806" WEIGHT="4.9595381153156515"/>
<DICH_DATA CI_END="0.9290893492448735" CI_START="0.2713371185324389" EFFECT_SIZE="0.502092050209205" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="-0.03194251849495577" LOG_CI_START="-0.5664907913060702" LOG_EFFECT_SIZE="-0.2992166549005129" ORDER="1" O_E="0.0" SE="0.313996301505874" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.09859367735936773" WEIGHT="6.003872743242737"/>
<DICH_DATA CI_END="1.3097896474747042" CI_START="0.2982349118067404" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="0.11720155346003126" LOG_CI_START="-0.5254415187718808" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="1" O_E="0.0" SE="0.37749172176353746" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.1425" WEIGHT="4.708075002758748"/>
<DICH_DATA CI_END="3.0062687991583203" CI_START="0.4024922855663372" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.4780278095084087" LOG_CI_START="-0.39524243919195845" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="1" O_E="0.0" SE="0.5129632668440433" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="0.2631313131313131" WEIGHT="2.9555175264025935"/>
<DICH_DATA CI_END="1.4856461742223006" CI_START="0.3452133243429693" EFFECT_SIZE="0.7161458333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.17191538891314492" LOG_CI_START="-0.4619124499876811" LOG_EFFECT_SIZE="-0.14499853053726813" ORDER="1" O_E="0.0" SE="0.3723136100687487" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.13861742424242426" WEIGHT="4.799678222004751"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="18.9824274929124" CI_END="0.8342211000775733" CI_START="0.4834515213460417" DF="5" EFFECT_SIZE="0.6350633511481129" ESTIMABLE="YES" EVENTS_1="482" EVENTS_2="392" I2="73.6598493429416" ID="CMP-011.01.02" LOG_CI_END="-0.07871882967675166" LOG_CI_START="-0.3156470687732783" LOG_EFFECT_SIZE="-0.197182949225015" NO="2" P_CHI2="0.001936680807645641" P_Z="0.0011049243836532023" STUDIES="6" TAU2="0.07223149226065087" TOTAL_1="2935" TOTAL_2="2188" WEIGHT="100.0" Z="3.262350493298249">
<NAME>Rhesus vaccines: middle-income countries</NAME>
<DICH_DATA CI_END="0.9593172951730201" CI_START="0.6194538637399452" EFFECT_SIZE="0.7708779443254818" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="87" LOG_CI_END="-0.0180377257265265" LOG_CI_START="-0.20799103387112322" LOG_EFFECT_SIZE="-0.11301437979882487" ORDER="1" O_E="0.0" SE="0.11157951348817614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.012449987830258082" WEIGHT="22.872857127342442"/>
<DICH_DATA CI_END="0.7909805044887394" CI_START="0.16717403805564993" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="22" LOG_CI_END="-0.10183422054442609" LOG_CI_START="-0.7768311671160992" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="1" O_E="0.0" SE="0.39649654770497395" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.15720951234196268" WEIGHT="8.441853707910372"/>
<DICH_DATA CI_END="0.676830605794514" CI_START="0.38836653501031565" EFFECT_SIZE="0.5126971398021919" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="135" LOG_CI_END="-0.16952001104004136" LOG_CI_START="-0.4107581996870793" LOG_EFFECT_SIZE="-0.2901391053635603" ORDER="1" O_E="0.0" SE="0.14170450615956284" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.020080167065925587" WEIGHT="20.98226171624693"/>
<DICH_DATA CI_END="0.8120480917527467" CI_START="0.12970876126162564" EFFECT_SIZE="0.3245454545454545" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="-0.09041824986674628" LOG_CI_START="-0.8870306882253174" LOG_EFFECT_SIZE="-0.48872446904603184" ORDER="1" O_E="0.0" SE="0.46793408958699123" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.2189623121976063" WEIGHT="6.6516092231244945"/>
<DICH_DATA CI_END="0.9617690037595611" CI_START="0.4454601368846169" EFFECT_SIZE="0.6545454545454545" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="55" LOG_CI_END="-0.016929223636822716" LOG_CI_START="-0.35119115381709043" LOG_EFFECT_SIZE="-0.1840601887269566" ORDER="1" O_E="0.0" SE="0.19634711241112907" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.03855218855218855" WEIGHT="17.483688763902972"/>
<DICH_DATA CI_END="1.117105568972639" CI_START="0.7555312762031311" EFFECT_SIZE="0.9186991869918699" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="82" LOG_CI_END="0.048094216854050235" LOG_CI_START="-0.1217475527660066" LOG_EFFECT_SIZE="-0.03682666795597821" ORDER="1" O_E="0.0" SE="0.09976589620514012" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.009953234045614791" WEIGHT="23.567729461472773"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="33.63859837026698" CI_END="0.7127408166019089" CI_START="0.34635579492402824" DF="13" EFFECT_SIZE="0.49685200221892556" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="258" I2="61.353918921037305" ID="CMP-011.01.03" LOG_CI_END="-0.14706836970395992" LOG_CI_START="-0.4604775417286734" LOG_EFFECT_SIZE="-0.30377295571631663" NO="3" P_CHI2="0.0013653570499571055" P_Z="1.4504440165141882E-4" STUDIES="14" TAU2="0.2388184203012642" TOTAL_1="2202" TOTAL_2="1871" WEIGHT="100.00000000000001" Z="3.7994041389083097">
<NAME>Bovine vaccines: high-income countries</NAME>
<DICH_DATA CI_END="0.8597854022233513" CI_START="0.03343426787103593" EFFECT_SIZE="0.16954732510288065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.0656099327799162" LOG_CI_START="-1.475808182350439" LOG_EFFECT_SIZE="-0.7707090575651776" ORDER="1" O_E="0.0" SE="0.8283574323916421" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.6861760357984737" WEIGHT="3.6640338598241984"/>
<DICH_DATA CI_END="4.113584643318476" CI_START="0.459605226082041" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.6142204380097697" LOG_CI_START="-0.3376150416772067" LOG_EFFECT_SIZE="0.13830269816628143" ORDER="1" O_E="0.0" SE="0.5591128724297431" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="0.3126072041166381" WEIGHT="6.146270425638702"/>
<DICH_DATA CI_END="103.88534653485917" CI_START="0.24521189902138602" EFFECT_SIZE="5.047169811320755" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0165542928135864" LOG_CI_START="-0.6104584593006701" LOG_EFFECT_SIZE="0.7030479167564582" ORDER="2" O_E="0.0" SE="1.543120294514762" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="2.3812202433433254" WEIGHT="1.293572898113101"/>
<DICH_DATA CI_END="1.1257899330339274" CI_START="0.2541331970744748" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.05145736082146319" LOG_CI_START="-0.5949385999454506" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="2" O_E="0.0" SE="0.3796961870660952" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.14416919447253118" WEIGHT="8.849401068232671"/>
<DICH_DATA CI_END="1.0318595193566296" CI_START="0.29941894419434845" EFFECT_SIZE="0.5558401639344263" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" LOG_CI_END="0.013620575080836642" LOG_CI_START="-0.523720725373086" LOG_EFFECT_SIZE="-0.25505007514612466" ORDER="2" O_E="0.0" SE="0.31563693976896945" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.09962667774672006" WEIGHT="10.014064398765765"/>
<DICH_DATA CI_END="1.0100113315938297" CI_START="0.0036038497772461773" EFFECT_SIZE="0.06033182503770739" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.00432624627874643" LOG_CI_START="-2.4432333204323675" LOG_EFFECT_SIZE="-1.2194535370768107" ORDER="2" O_E="0.0" SE="1.437708605101362" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="2.067006033182504" WEIGHT="1.4698478031050886"/>
<DICH_DATA CI_END="1.5570099086906626" CI_START="0.33321237460914066" EFFECT_SIZE="0.7202881152460985" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.19229137639341554" LOG_CI_START="-0.4772788784397033" LOG_EFFECT_SIZE="-0.14249375102314393" ORDER="2" O_E="0.0" SE="0.39330888211518983" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="0.15469187675070029" WEIGHT="8.612763205155849"/>
<DICH_DATA CI_END="0.6267170703918006" CI_START="0.19635640354517492" EFFECT_SIZE="0.35079895949461165" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.2029284759143624" LOG_CI_START="-0.7069549310170087" LOG_EFFECT_SIZE="-0.4549417034656856" ORDER="2" O_E="0.0" SE="0.29606763469848557" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.08765604431595589" WEIGHT="10.381243786624598"/>
<DICH_DATA CI_END="0.7874810437946201" CI_START="0.07346484197310525" EFFECT_SIZE="0.24052478134110788" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.10375989172817848" LOG_CI_START="-1.1339204512575125" LOG_EFFECT_SIZE="-0.6188401714928454" ORDER="2" O_E="0.0" SE="0.6051214120445421" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.36617192331478043" WEIGHT="5.60209107973806"/>
<DICH_DATA CI_END="0.5818306879595707" CI_START="0.18645858428377243" EFFECT_SIZE="0.3293741434444952" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="44" LOG_CI_END="-0.23520337614495507" LOG_CI_START="-0.7294176175520501" LOG_EFFECT_SIZE="-0.48231049684850263" ORDER="2" O_E="0.0" SE="0.2903038918024776" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.08427634959566463" WEIGHT="10.489835562427418"/>
<DICH_DATA CI_END="0.42346245817503203" CI_START="0.07815275195798152" EFFECT_SIZE="0.18191964285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="32" LOG_CI_END="-0.37318508575859416" LOG_CI_START="-1.1070557247577408" LOG_EFFECT_SIZE="-0.7401204052581674" ORDER="2" O_E="0.0" SE="0.4310792460663495" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.18582931638913233" WEIGHT="7.9812294155005095"/>
<DICH_DATA CI_END="2.6848004915933457" CI_START="0.03637374557468292" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4289120186689645" LOG_CI_START="-1.4392119753087766" LOG_EFFECT_SIZE="-0.505149978319906" ORDER="2" O_E="0.0" SE="1.0973452814254347" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="1.2041666666666666" WEIGHT="2.34874985050655"/>
<DICH_DATA CI_END="1.4440853901075372" CI_START="0.5418961953766118" EFFECT_SIZE="0.8846153846153846" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="26" LOG_CI_END="0.15959287422812996" LOG_CI_START="-0.2660838981345802" LOG_EFFECT_SIZE="-0.0532455119532251" ORDER="2" O_E="0.0" SE="0.25004464321986253" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.06252232360294835" WEIGHT="11.247105065806963"/>
<DICH_DATA CI_END="1.4110052581487775" CI_START="0.6087329424922199" EFFECT_SIZE="0.9267822736030829" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" LOG_CI_END="0.14952863216734866" LOG_CI_START="-0.21557319511660078" LOG_EFFECT_SIZE="-0.03302228147462609" ORDER="2" O_E="0.0" SE="0.21446262062978444" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.045994215647394844" WEIGHT="11.899791580560542"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9714613192689926" CI_START="0.623318925603991" DF="0" EFFECT_SIZE="0.7781582267075149" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="62" I2="0.0" ID="CMP-011.01.04" LOG_CI_END="-0.012574487048211035" LOG_CI_START="-0.20528968658369665" LOG_EFFECT_SIZE="-0.10893208681595384" NO="4" P_CHI2="1.0" P_Z="0.026709613286720692" STUDIES="1" TAU2="0.0" TOTAL_1="358" TOTAL_2="127" WEIGHT="100.0" Z="2.215735628893627">
<NAME>Bovine vaccines: middle-income countries</NAME>
<DICH_DATA CI_END="0.9714613192689926" CI_START="0.623318925603991" EFFECT_SIZE="0.7781582267075149" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="62" LOG_CI_END="-0.012574487048211035" LOG_CI_START="-0.20528968658369665" LOG_EFFECT_SIZE="-0.10893208681595384" ORDER="2" O_E="0.0" SE="0.11320186216276716" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.012814661597118134" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.3331484655329064" CI_END="1.1753924538359606" CI_START="0.5704285603179023" DF="1" EFFECT_SIZE="0.8188268591406693" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="93" I2="57.13946134278285" ID="CMP-011.01.05" LOG_CI_END="0.0701828981633706" LOG_CI_START="-0.24379873827900173" LOG_EFFECT_SIZE="-0.08680792005781555" NO="5" P_CHI2="0.12664564073539053" P_Z="0.27847116312746534" STUDIES="2" TAU2="0.0389770071616696" TOTAL_1="407" TOTAL_2="318" WEIGHT="100.00000000000001" Z="1.0837601766393623">
<NAME>Bovine vaccines: low-income countries</NAME>
<DICH_DATA CI_END="1.3347361872573338" CI_START="0.71186159146034" EFFECT_SIZE="0.9747550597153687" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.1253954351834699" LOG_CI_START="-0.14760443881861887" LOG_EFFECT_SIZE="-0.011104501817574492" ORDER="2" O_E="0.0" SE="0.1603614773599979" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.02571580342108112" WEIGHT="52.58085960632392"/>
<DICH_DATA CI_END="0.9622947164016067" CI_START="0.4733562574047475" EFFECT_SIZE="0.6749134948096885" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="34" LOG_CI_END="-0.016691898747011227" LOG_CI_START="-0.32481187747046425" LOG_EFFECT_SIZE="-0.1707518881087377" ORDER="2" O_E="0.0" SE="0.18099120072064936" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.03275781473830239" WEIGHT="47.419140393676095"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.80084161658765" CI_END="1.9922274586748236" CI_START="0.11884930319424182" DF="1" EFFECT_SIZE="0.486595155409441" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="44" I2="85.29593752689459" ID="CMP-011.01.06" LOG_CI_END="0.29933892164183884" LOG_CI_START="-0.9250033601687235" LOG_EFFECT_SIZE="-0.3128322192634423" NO="6" P_CHI2="0.00911154576696882" P_Z="0.31654530476384213" STUDIES="2" TAU2="0.8825432419722246" TOTAL_1="248" TOTAL_2="248" WEIGHT="100.0" Z="1.001582469329362">
<NAME>Human vaccines: high-income countries</NAME>
<DICH_DATA CI_END="0.4957333910797009" CI_START="0.11636542659997533" EFFECT_SIZE="0.24017957351290684" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="33" LOG_CI_END="-0.30475182736626816" LOG_CI_START="-0.9341760340091" LOG_EFFECT_SIZE="-0.619463930687684" ORDER="1" O_E="0.0" SE="0.3697268946820716" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.13669797665124767" WEIGHT="50.7462460908631"/>
<DICH_DATA CI_END="2.2467086393612665" CI_START="0.4514767589010788" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3515467553198338" LOG_CI_START="-0.34536460136555014" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="3" O_E="0.0" SE="0.40936918068384726" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.16758312609376438" WEIGHT="49.25375390913689"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5126179297564388" CI_START="0.23531934567258378" DF="0" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" I2="0.0" ID="CMP-011.01.07" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" NO="7" P_CHI2="1.0" P_Z="1.0136929840441862E-7" STUDIES="1" TAU2="0.0" TOTAL_1="1482" TOTAL_2="504" WEIGHT="100.0" Z="5.324251995909791">
<NAME>Human vaccines: middle-income countries</NAME>
<DICH_DATA CI_END="0.5126179297564388" CI_START="0.23531934567258378" EFFECT_SIZE="0.34731673701438537" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="47" LOG_CI_END="-0.2902062076365525" LOG_CI_START="-0.6283423678792762" LOG_EFFECT_SIZE="-0.45927428775791435" ORDER="3" O_E="0.0" SE="0.1986228543275638" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.03945103826122863" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="70.21814576982504" CI_END="0.541523988216207" CI_START="0.3823961673554198" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.45505680703061574" ESTIMABLE="YES" EVENTS_1="404" EVENTS_2="712" I2="68.6690672919277" I2_Q="0.0" ID="CMP-011.02" LOG_CI_END="-0.2663823004067479" LOG_CI_START="-0.41748646918028276" LOG_EFFECT_SIZE="-0.34193438479351534" METHOD="MH" NO="2" P_CHI2="6.111487534932181E-7" P_Q="0.0" P_Z="7.286742922057423E-19" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.20489438234076196" TOTALS="SUB" TOTAL_1="9582" TOTAL_2="6868" WEIGHT="600.0" Z="8.87042475016783">
<NAME>Rotavirus diarrhoea: severe episodes</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="24.72972798460717" CI_END="0.6066878222087899" CI_START="0.24552407533255774" DF="6" EFFECT_SIZE="0.3859487874878431" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="272" I2="75.73770320589594" ID="CMP-011.02.01" LOG_CI_END="-0.21703472238017024" LOG_CI_START="-0.6099059158773381" LOG_EFFECT_SIZE="-0.41347031912875426" NO="1" P_CHI2="3.8311825678793987E-4" P_Z="3.699966382567282E-5" STUDIES="7" TAU2="0.2569813169690593" TOTAL_1="3924" TOTAL_2="2661" WEIGHT="99.99999999999999" Z="4.1254586621886435">
<NAME>Rhesus vaccines: high-income countries</NAME>
<DICH_DATA CI_END="1.7852310923406094" CI_START="0.40105526642056916" EFFECT_SIZE="0.8461538461538461" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.2516944420909467" LOG_CI_START="-0.3967957763881701" LOG_EFFECT_SIZE="-0.07255066714861173" ORDER="1" O_E="0.0" SE="0.38092636441298616" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.14510489510489513" WEIGHT="13.245135191358235"/>
<DICH_DATA CI_END="0.5472427167348773" CI_START="0.2843050186045062" EFFECT_SIZE="0.3944411879640485" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="72" LOG_CI_END="-0.2618200097561964" LOG_CI_START="-0.5462154739957807" LOG_EFFECT_SIZE="-0.40401774187598855" ORDER="1" O_E="0.0" SE="0.1670553034745842" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.02790747441898542" WEIGHT="18.693912847720956"/>
<DICH_DATA CI_END="0.1795633625396562" CI_START="0.04632957397102283" EFFECT_SIZE="0.09120906801007557" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="100" LOG_CI_END="-0.7457822705083856" LOG_CI_START="-1.334141693383821" LOG_EFFECT_SIZE="-1.0399619819461035" ORDER="1" O_E="0.0" SE="0.345605237423145" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.11944298013430842" WEIGHT="14.148093729555955"/>
<DICH_DATA CI_END="1.9440155409681266" CI_START="0.12859979497668989" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28869973246768516" LOG_CI_START="-0.8907597237956476" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="1" O_E="0.0" SE="0.6928203230275509" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.48" WEIGHT="7.226351760724828"/>
<DICH_DATA CI_END="1.012292162157116" CI_START="0.2092587824801562" EFFECT_SIZE="0.4602510460251046" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.005305874263223388" LOG_CI_START="-0.6793163058430487" LOG_EFFECT_SIZE="-0.33700521578991266" ORDER="1" O_E="0.0" SE="0.40215045752887174" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.16172499049068087" WEIGHT="12.719383832097503"/>
<DICH_DATA CI_END="0.7438943926384873" CI_START="0.2876714303749857" EFFECT_SIZE="0.4625982749408442" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="33" LOG_CI_END="-0.1284887149242854" LOG_CI_START="-0.5411032672254031" LOG_EFFECT_SIZE="-0.33479599107484426" ORDER="1" O_E="0.0" SE="0.2423718304966511" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.05874410421829737" WEIGHT="16.868094490054744"/>
<DICH_DATA CI_END="0.7033226163459516" CI_START="0.2817068598791358" EFFECT_SIZE="0.4451188669701568" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" LOG_CI_END="-0.15284541700103546" LOG_CI_START="-0.5502025773259718" LOG_EFFECT_SIZE="-0.3515239971635037" ORDER="2" O_E="0.0" SE="0.23340956292453388" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="330" VAR="0.05448002406462194" WEIGHT="17.099028148487772"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.529995557864677" CI_END="0.7171709602482619" CI_START="0.3490395866473339" DF="3" EFFECT_SIZE="0.5003209525100112" ESTIMABLE="YES" EVENTS_1="107" EVENTS_2="171" I2="45.75040850198433" ID="CMP-011.02.02" LOG_CI_END="-0.1443773042454814" LOG_CI_START="-0.45712531433732684" LOG_EFFECT_SIZE="-0.3007513092914041" NO="2" P_CHI2="0.1368556199257447" P_Z="1.635333300622226E-4" STUDIES="4" TAU2="0.05739132582054235" TOTAL_1="2135" TOTAL_2="1886" WEIGHT="99.99999999999999" Z="3.769563453601575">
<NAME>Rhesus vaccines: middle-income countries</NAME>
<DICH_DATA CI_END="0.9161896071520315" CI_START="0.3333389286080207" EFFECT_SIZE="0.5526315789473685" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="38" LOG_CI_END="-0.03801463897570007" LOG_CI_START="-0.4771139647900816" LOG_EFFECT_SIZE="-0.2575643018828908" ORDER="1" O_E="0.0" SE="0.2579291175600855" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.06652742968532441" WEIGHT="27.234993189998775"/>
<DICH_DATA CI_END="0.5987519438893242" CI_START="0.27685001228189854" EFFECT_SIZE="0.40714184631350536" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="85" LOG_CI_END="-0.22275306360821712" LOG_CI_START="-0.557755452885439" LOG_EFFECT_SIZE="-0.3902542582468281" ORDER="1" O_E="0.0" SE="0.19678206175001164" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.0387231798265854" WEIGHT="35.11360163164153"/>
<DICH_DATA CI_END="0.9667371658326467" CI_START="0.44198406197334955" EFFECT_SIZE="0.6536684323227769" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="38" LOG_CI_END="-0.014691584804480032" LOG_CI_START="-0.3545933911075277" LOG_EFFECT_SIZE="-0.18464248795600385" ORDER="1" O_E="0.0" SE="0.19966000356348707" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.039864117022971664" WEIGHT="34.70167184108894"/>
<DICH_DATA CI_END="0.7715368475652773" CI_START="0.012961143763330034" EFFECT_SIZE="0.1" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.11264332778342294" LOG_CI_START="-1.8873566722165767" LOG_EFFECT_SIZE="-1.0" ORDER="1" O_E="0.0" SE="1.0424754034927717" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="1.0867549668874172" WEIGHT="2.949733337270749"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.741975122271816" CI_END="0.45828182827151026" CI_START="0.20305844876667772" DF="7" EFFECT_SIZE="0.3050540888871511" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="152" I2="28.145987726895267" ID="CMP-011.02.03" LOG_CI_END="-0.3388673629993146" LOG_CI_START="-0.692378935864111" LOG_EFFECT_SIZE="-0.5156231494317127" NO="3" P_CHI2="0.20367321903314317" P_Z="1.0809694197495119E-8" STUDIES="8" TAU2="0.09113499549139335" TOTAL_1="1526" TOTAL_2="1392" WEIGHT="100.0" Z="5.71750901556926">
<NAME>Bovine vaccines: high-income countries</NAME>
<DICH_DATA CI_END="1.1529787394529891" CI_START="0.017999116591201656" EFFECT_SIZE="0.14405762304921968" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.061821299121777605" LOG_CI_START="-1.7447488098401032" LOG_EFFECT_SIZE="-0.8414637553591628" ORDER="2" O_E="0.0" SE="1.0611882246704736" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="1.1261204481792717" WEIGHT="3.5424257020187055"/>
<DICH_DATA CI_END="0.8052997862943447" CI_START="0.0029445761454306423" EFFECT_SIZE="0.04869565217391304" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.09404241615803753" LOG_CI_START="-2.530977210536785" LOG_EFFECT_SIZE="-1.3125098133474113" ORDER="2" O_E="0.0" SE="1.4314675612398584" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="2.0490993788819876" WEIGHT="2.0147498896440386"/>
<DICH_DATA CI_END="0.4163395199834392" CI_START="0.04878156216266573" EFFECT_SIZE="0.14251207729468598" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="16" LOG_CI_END="-0.3805523628434299" LOG_CI_START="-1.3117442961140797" LOG_EFFECT_SIZE="-0.8461483294787548" ORDER="2" O_E="0.0" SE="0.54698675107759" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.2991945058544174" WEIGHT="11.04717156841526"/>
<DICH_DATA CI_END="0.8662469474617329" CI_START="0.15480904625884115" EFFECT_SIZE="0.3662005785920926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.06235828277304996" LOG_CI_START="-0.8102036649353841" LOG_EFFECT_SIZE="-0.436280973854217" ORDER="2" O_E="0.0" SE="0.4392880793765001" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.19297401668229427" WEIGHT="15.17740298553085"/>
<DICH_DATA CI_END="0.49718286349299734" CI_START="0.028416957778963605" EFFECT_SIZE="0.11886304909560723" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="18" LOG_CI_END="-0.30348384869227213" LOG_CI_START="-1.5464224179824027" LOG_EFFECT_SIZE="-0.9249531333373373" ORDER="2" O_E="0.0" SE="0.7301082682461691" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.53305808336142" WEIGHT="6.908178119350692"/>
<DICH_DATA CI_END="0.6192770239174124" CI_START="0.15889690599860884" EFFECT_SIZE="0.31368966042332874" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="33" LOG_CI_END="-0.20811503265147768" LOG_CI_START="-0.7988845591854038" LOG_EFFECT_SIZE="-0.5034997959184407" ORDER="2" O_E="0.0" SE="0.347020944242348" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="0.12042353574285078" WEIGHT="20.38224100169578"/>
<DICH_DATA CI_END="1.3088284690680698" CI_START="0.27505514168432793" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" LOG_CI_END="0.11688273301482338" LOG_CI_START="-0.5605802322475362" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="2" O_E="0.0" SE="0.3979450992908726" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.15836030204962243" WEIGHT="17.283039047548662"/>
<DICH_DATA CI_END="0.7179656953268364" CI_START="0.2197344608609051" EFFECT_SIZE="0.39719240297274977" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="35" LOG_CI_END="-0.14389630601699868" LOG_CI_START="-0.6581018275214423" LOG_EFFECT_SIZE="-0.4009990667692205" ORDER="793" O_E="0.0" SE="0.3020468686900926" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.09123231088549007" WEIGHT="23.644791685796008"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8561961557471212" CI_END="1.0871591010732033" CI_START="0.5806733082364717" DF="1" EFFECT_SIZE="0.7945339966291975" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="64" I2="0.0" ID="CMP-011.02.04" LOG_CI_END="0.0362931058727768" LOG_CI_START="-0.23606813668758983" LOG_EFFECT_SIZE="-0.0998875154074065" NO="4" P_CHI2="0.3548054485753145" P_Z="0.15054201156668467" STUDIES="2" TAU2="0.0" TOTAL_1="407" TOTAL_2="318" WEIGHT="100.0" Z="1.4376196177054406">
<NAME>Bovine vaccines: low-income countries</NAME>
<DICH_DATA CI_END="1.0633674611113753" CI_START="0.4500505159968466" EFFECT_SIZE="0.691786870768325" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="43" LOG_CI_END="0.026683366833919513" LOG_CI_START="-0.3467387360305029" LOG_EFFECT_SIZE="-0.16002768459829167" ORDER="2" O_E="0.0" SE="0.21934999169178265" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.048114418855185116" WEIGHT="53.19742036650067"/>
<DICH_DATA CI_END="1.4707139942162637" CI_START="0.5880462845566141" EFFECT_SIZE="0.9299719887955182" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="21" LOG_CI_END="0.16752822486189484" LOG_CI_START="-0.23058848967820864" LOG_EFFECT_SIZE="-0.03153013240815689" ORDER="2" O_E="0.0" SE="0.23385572883037695" STUDY_ID="STD-Hanlon-1987" TOTAL_1="170" TOTAL_2="83" VAR="0.0546885019067868" WEIGHT="46.80257963349933"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.46051655088281557" CI_START="0.04349894471460124" DF="0" EFFECT_SIZE="0.14153439153439154" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="21" I2="0.0" ID="CMP-011.02.05" LOG_CI_END="-0.3367547567203159" LOG_CI_START="-1.361521278911678" LOG_EFFECT_SIZE="-0.8491380178159968" NO="5" P_CHI2="1.0" P_Z="0.0011617216626247614" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="107" WEIGHT="100.0" Z="3.2481153448771662">
<NAME>Human vaccines: high-income countries</NAME>
<DICH_DATA CI_END="0.46051655088281557" CI_START="0.04349894471460124" EFFECT_SIZE="0.14153439153439154" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="21" LOG_CI_END="-0.3367547567203159" LOG_CI_START="-1.361521278911678" LOG_EFFECT_SIZE="-0.8491380178159968" ORDER="3" O_E="0.0" SE="0.6019529278113018" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.3623473273005983" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.3985458640164984" CI_START="0.13716135414275926" DF="0" EFFECT_SIZE="0.23380566801619437" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="32" I2="0.0" ID="CMP-011.02.06" LOG_CI_END="-0.3995216934820587" LOG_CI_START="-0.8627682359089087" LOG_EFFECT_SIZE="-0.6311449646954838" NO="6" P_CHI2="1.0" P_Z="9.260822677132971E-8" STUDIES="1" TAU2="0.0" TOTAL_1="1482" TOTAL_2="504" WEIGHT="100.0" Z="5.340661123325218">
<NAME>Human vaccines: middle-income countries</NAME>
<DICH_DATA CI_END="0.3985458640164984" CI_START="0.13716135414275926" EFFECT_SIZE="0.23380566801619435" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="32" LOG_CI_END="-0.3995216934820587" LOG_CI_START="-0.8627682359089087" LOG_EFFECT_SIZE="-0.6311449646954838" ORDER="3" O_E="0.0" SE="0.2721133121288995" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.07404565463775989" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.463415037971878" CI_END="0.5880795297012237" CI_START="0.28821949678504044" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.41169890225754785" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="163" I2="44.09091014281619" I2_Q="0.0" ID="CMP-011.03" LOG_CI_END="-0.23056393757216206" LOG_CI_START="-0.5402766444111272" LOG_EFFECT_SIZE="-0.38542029099164465" METHOD="MH" NO="3" P_CHI2="0.043992626791910405" P_Q="0.0" P_Z="1.0709470014706203E-6" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.19725573006277544" TOTALS="SUB" TOTAL_1="6785" TOTAL_2="4912" WEIGHT="700.0" Z="4.878133008907161">
<NAME>Rotavirus diarrhoea: severe episodes requiring hospitalization</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.299167676872204" CI_END="1.3284837542826975" CI_START="0.017749932753140185" DF="2" EFFECT_SIZE="0.15355942596323127" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="22" I2="39.37864952968646" ID="CMP-011.03.01" LOG_CI_END="0.12335624789306454" LOG_CI_START="-1.7508032879607442" LOG_EFFECT_SIZE="-0.8137235200338397" NO="1" P_CHI2="0.1921300352753803" P_Z="0.08876356494212388" STUDIES="3" TAU2="1.4328854264147841" TOTAL_1="2098" TOTAL_2="1684" WEIGHT="99.99999999999999" Z="1.7019562765374836">
<NAME>Rhesus vaccine: high-income countries</NAME>
<DICH_DATA CI_END="7.946196188253989" CI_START="0.031240682588898096" EFFECT_SIZE="0.49824150058616645" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.9001592834004785" LOG_CI_START="-1.5052794856349017" LOG_EFFECT_SIZE="-0.3025601011172115" ORDER="1" O_E="0.0" SE="1.4129666400453245" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="1.9964747258809736" WEIGHT="35.34070596978242"/>
<DICH_DATA CI_END="0.40821006870015514" CI_START="0.0014966833651320242" EFFECT_SIZE="0.024717629726632835" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="20" LOG_CI_END="-0.38911628740292603" LOG_CI_START="-2.8248700682747545" LOG_EFFECT_SIZE="-1.6069931778388402" ORDER="1" O_E="0.0" SE="1.4307738280597828" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="2.047113747060845" WEIGHT="34.826447583816176"/>
<DICH_DATA CI_END="7.7109576353923535" CI_START="0.013380598324132867" EFFECT_SIZE="0.3212121212121212" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8871083170834013" LOG_CI_START="-1.8735244663096358" LOG_EFFECT_SIZE="-0.4932080746131172" ORDER="1" O_E="0.0" SE="1.6216093623177397" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="2.6296169239565463" WEIGHT="29.832846446401387"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.659116177493824" CI_END="0.9460033870894574" CI_START="0.35380876269603967" DF="3" EFFECT_SIZE="0.5785363323875031" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="103" I2="54.948976410123876" ID="CMP-011.03.02" LOG_CI_END="-0.024107308638769948" LOG_CI_START="-0.45123141522671917" LOG_EFFECT_SIZE="-0.23766936193274465" NO="2" P_CHI2="0.08359424558661632" P_Z="0.029167990215870205" STUDIES="4" TAU2="0.12487506441334868" TOTAL_1="2135" TOTAL_2="1886" WEIGHT="100.0" Z="2.1812086109491293">
<NAME>Rhesus vaccine: middle-income countries</NAME>
<DICH_DATA CI_END="2.2108377197122735" CI_START="0.028269827062718106" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3445568655909182" LOG_CI_START="-1.548676848246843" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="1" O_E="0.0" SE="1.1120948551663286" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="1.2367549668874172" WEIGHT="4.623003789580317"/>
<DICH_DATA CI_END="1.3379594148962786" CI_START="0.4614093162335333" EFFECT_SIZE="0.7857142857142857" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="28" LOG_CI_END="0.12644293992364353" LOG_CI_START="-0.3359136409636695" LOG_EFFECT_SIZE="-0.104735350520013" ORDER="1" O_E="0.0" SE="0.27159054431519475" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.07376142376142375" WEIGHT="31.690153468537172"/>
<DICH_DATA CI_END="0.6052539177138491" CI_START="0.14832957666232618" EFFECT_SIZE="0.29962819858569656" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="33" LOG_CI_END="-0.21806239075694459" LOG_CI_START="-0.8287722427644523" LOG_EFFECT_SIZE="-0.5234173167606985" ORDER="1" O_E="0.0" SE="0.35873399013173285" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.1286900756758342" WEIGHT="24.825261045330674"/>
<DICH_DATA CI_END="1.106064978857614" CI_START="0.519816859366691" EFFECT_SIZE="0.7582553814944213" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="38" LOG_CI_END="0.04378064155308812" LOG_CI_START="-0.28414963901125884" LOG_EFFECT_SIZE="-0.12018449872908535" ORDER="805" O_E="0.0" SE="0.19262787008456614" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.03710549633331649" WEIGHT="38.86158169655184"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.017213801272326378" CI_END="0.9878767166486566" CI_START="0.03108944553704957" DF="1" EFFECT_SIZE="0.17524993403584424" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" I2="0.0" ID="CMP-011.03.03" LOG_CI_END="-0.005297250371821842" LOG_CI_START="-1.5073870232880096" LOG_EFFECT_SIZE="-0.7563421368299157" NO="3" P_CHI2="0.8956160119023272" P_Z="0.048405859377607614" STUDIES="2" TAU2="0.0" TOTAL_1="367" TOTAL_2="369" WEIGHT="100.00000000000001" Z="1.973787951832909">
<NAME>Bovine vaccines: high-income countries</NAME>
<DICH_DATA CI_END="4.284918285674742" CI_START="0.009999957325499529" EFFECT_SIZE="0.207" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6319425442477975" LOG_CI_START="-2.000001853333962" LOG_EFFECT_SIZE="-0.6840296545430823" ORDER="2" O_E="0.0" SE="1.5460171674744119" STUDY_ID="STD-Clark-1995" TOTAL_1="199" TOTAL_2="206" VAR="2.390169082125604" WEIGHT="32.57154490493333"/>
<DICH_DATA CI_END="1.3284788461358168" CI_START="0.019683372038407615" EFFECT_SIZE="0.16170634920634921" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.12335464336832916" LOG_CI_START="-1.7059004987794266" LOG_EFFECT_SIZE="-0.7912729277055487" ORDER="2" O_E="0.0" SE="1.0745135254565819" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="1.1545793163891325" WEIGHT="67.42845509506668"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9254276064702759" CI_START="0.13598748373215405" DF="0" EFFECT_SIZE="0.35474860335195524" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" I2="0.0" ID="CMP-011.03.04" LOG_CI_END="-0.033657549185725534" LOG_CI_START="-0.8665010621901095" LOG_EFFECT_SIZE="-0.45007930568791754" NO="4" P_CHI2="1.0" P_Z="0.034142957468665275" STUDIES="1" TAU2="0.0" TOTAL_1="358" TOTAL_2="127" WEIGHT="100.0" Z="2.1183793006993583">
<NAME>Bovine vaccines: middle-income countries</NAME>
<DICH_DATA CI_END="0.9254276064702758" CI_START="0.13598748373215408" EFFECT_SIZE="0.3547486033519553" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="-0.03365754918572558" LOG_CI_START="-0.8665010621901095" LOG_EFFECT_SIZE="-0.45007930568791754" ORDER="2" O_E="0.0" SE="0.4892164021806536" STUDY_ID="STD-Lanata-1989" TOTAL_1="358" TOTAL_2="127" VAR="0.23933268816258302" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9099163764334488" CI_START="0.1680925952886181" DF="0" EFFECT_SIZE="0.5666063893911996" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-011.03.05" LOG_CI_END="0.28101435256262075" LOG_CI_START="-0.7744514174119447" LOG_EFFECT_SIZE="-0.24671853242466196" NO="5" P_CHI2="1.0" P_Z="0.3595117690814249" STUDIES="1" TAU2="0.0" TOTAL_1="237" TOTAL_2="235" WEIGHT="100.0" Z="0.9162958224264685">
<NAME>Bovine vaccines: low-income countries</NAME>
<DICH_DATA CI_END="1.9099163764334488" CI_START="0.1680925952886181" EFFECT_SIZE="0.5666063893911996" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.28101435256262075" LOG_CI_START="-0.7744514174119447" LOG_EFFECT_SIZE="-0.24671853242466196" ORDER="812" O_E="0.0" SE="0.619985817922883" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.38438241442550625" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.07970823927158" CI_START="0.009625546598610708" DF="0" EFFECT_SIZE="0.1981651376146789" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-011.03.06" LOG_CI_END="0.6106291055886245" LOG_CI_START="-2.0165745991680097" LOG_EFFECT_SIZE="-0.7029727467896927" NO="6" P_CHI2="1.0" P_Z="0.2942366765019544" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="107" WEIGHT="100.0" Z="1.0488728097683788">
<NAME>Human vaccines: high-income countries</NAME>
<DICH_DATA CI_END="4.07970823927158" CI_START="0.009625546598610708" EFFECT_SIZE="0.1981651376146789" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106291055886245" LOG_CI_START="-2.0165745991680097" LOG_EFFECT_SIZE="-0.7029727467896927" ORDER="3" O_E="0.0" SE="1.5432324610421255" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="2.381566428814135" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5019922024345329" CI_START="0.08724910160680603" DF="0" EFFECT_SIZE="0.20928059794456555" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" I2="0.0" ID="CMP-011.03.07" LOG_CI_END="-0.29930302880309956" LOG_CI_START="-1.0592390362222548" LOG_EFFECT_SIZE="-0.6792710325126773" NO="7" P_CHI2="1.0" P_Z="4.586023075506794E-4" STUDIES="1" TAU2="0.0" TOTAL_1="1482" TOTAL_2="504" WEIGHT="100.0" Z="3.503839129790983">
<NAME>Human vaccines: middle-income countries</NAME>
<DICH_DATA CI_END="0.5019922024345329" CI_START="0.08724910160680603" EFFECT_SIZE="0.20928059794456555" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" LOG_CI_END="-0.29930302880309956" LOG_CI_START="-1.0592390362222548" LOG_EFFECT_SIZE="-0.6792710325126773" ORDER="3" O_E="0.0" SE="0.4463901725019172" STUDY_ID="STD-Perez_x002d_Schael-2002" TOTAL_1="1482" TOTAL_2="504" VAR="0.19926418610629137" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="59.87461054708319" CI_END="0.9117433672072079" CI_START="0.8288114424121007" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8692889826085866" ESTIMABLE="YES" EVENTS_1="2842" EVENTS_2="2807" I2="63.25654597335542" I2_Q="0.0" ID="CMP-011.04" LOG_CI_END="-0.04012738742826069" LOG_CI_START="-0.08154426177098058" LOG_EFFECT_SIZE="-0.06083582459962067" METHOD="MH" NO="4" P_CHI2="2.3323707315059394E-5" P_Q="0.0" P_Z="8.519321612508352E-9" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.013986527628491197" TOTALS="SUB" TOTAL_1="6162" TOTAL_2="5134" WEIGHT="500.0" Z="5.757847596049281">
<NAME>All-cause diarrhoea: episodes (number of cases/number of participants)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="20.09396974645031" CI_END="0.9354352353628117" CI_START="0.7690026742961932" DF="8" EFFECT_SIZE="0.848146330313874" ESTIMABLE="YES" EVENTS_1="1478" EVENTS_2="1339" I2="60.187060591084865" ID="CMP-011.04.01" LOG_CI_END="-0.028986275398831095" LOG_CI_START="-0.1140721498863971" LOG_EFFECT_SIZE="-0.07152921264261411" NO="1" P_CHI2="0.009986327220593005" P_Z="9.829248604140998E-4" STUDIES="9" TAU2="0.010474308262532914" TOTAL_1="2778" TOTAL_2="2146" WEIGHT="99.99999999999999" Z="3.295369095431182">
<NAME>Rhesus vaccines: high-income countries</NAME>
<DICH_DATA CI_END="0.9799794766459171" CI_START="0.6219352854943884" EFFECT_SIZE="0.7806944444444445" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="48" LOG_CI_END="-0.008783019483791298" LOG_CI_START="-0.20625480279287006" LOG_EFFECT_SIZE="-0.10751891113833068" ORDER="1" O_E="0.0" SE="0.11599590301684518" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.013455049516693351" WEIGHT="10.439004732586861"/>
<DICH_DATA CI_END="1.0484861014457354" CI_START="0.77731856905455" EFFECT_SIZE="0.9027777777777778" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="45" LOG_CI_END="0.020562677905387537" LOG_CI_START="-0.10940095748221328" LOG_EFFECT_SIZE="-0.04441913978841287" ORDER="1" O_E="0.0" SE="0.07634128275704737" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.005827991452991458" WEIGHT="15.32291047668745"/>
<DICH_DATA CI_END="1.2547560036328695" CI_START="0.8246862503827318" EFFECT_SIZE="1.0172413793103448" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="58" LOG_CI_END="0.09855928232850295" LOG_CI_START="-0.08371124617008925" LOG_EFFECT_SIZE="0.0074240180792068755" ORDER="1" O_E="0.0" SE="0.10706661069374049" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.011463259125444984" WEIGHT="11.386799397001532"/>
<DICH_DATA CI_END="1.0519429282324169" CI_START="0.8503929310660905" EFFECT_SIZE="0.9458143739940787" ESTIMABLE="YES" EVENTS_1="448" EVENTS_2="236" LOG_CI_END="0.021992178386079406" LOG_CI_START="-0.07038035856442754" LOG_EFFECT_SIZE="-0.02419409008917406" ORDER="1" O_E="0.0" SE="0.05426008545616016" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.002944156873709803" WEIGHT="18.616039656459023"/>
<DICH_DATA CI_END="0.977528145587583" CI_START="0.5179257339380201" EFFECT_SIZE="0.7115384615384616" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="52" LOG_CI_END="-0.009870729280021211" LOG_CI_START="-0.28573250985558707" LOG_EFFECT_SIZE="-0.14780161956780413" ORDER="1" O_E="0.0" SE="0.16204257544792436" STUDY_ID="STD-Vesikari-1990" TOTAL_1="100" TOTAL_2="100" VAR="0.026257796257796256" WEIGHT="6.8005545112956325"/>
<DICH_DATA CI_END="0.9759703719972511" CI_START="0.3353749485691675" EFFECT_SIZE="0.5721153846153846" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="24" LOG_CI_END="-0.010563366219999535" LOG_CI_START="-0.4744693809204622" LOG_EFFECT_SIZE="-0.24251637357023084" ORDER="1" O_E="0.0" SE="0.27250068940685995" STUDY_ID="STD-Escobar-1988" TOTAL_1="52" TOTAL_2="51" VAR="0.07425662572721395" WEIGHT="2.948140275844651"/>
<DICH_DATA CI_END="0.9356483690929477" CI_START="0.8244845822574276" EFFECT_SIZE="0.8783095438007277" ESTIMABLE="YES" EVENTS_1="689" EVENTS_2="795" LOG_CI_END="-0.02888733508094745" LOG_CI_START="-0.08381746118759804" LOG_EFFECT_SIZE="-0.05635239813427276" ORDER="1" O_E="0.0" SE="0.032266227983556085" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.0010411094682868177" WEIGHT="21.69254168144929"/>
<DICH_DATA CI_END="0.765818172912393" CI_START="0.4853810240794641" EFFECT_SIZE="0.6096832038254633" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="70" LOG_CI_END="-0.1158743320312561" LOG_CI_START="-0.3139172063696978" LOG_EFFECT_SIZE="-0.21489576920047693" ORDER="1" O_E="0.0" SE="0.11633136471443911" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.013532986416323849" WEIGHT="10.405115713646197"/>
<DICH_DATA CI_END="2.200513364997922" CI_START="0.6611815176504472" EFFECT_SIZE="1.206208425720621" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="11" LOG_CI_END="0.34252401063003485" LOG_CI_START="-0.1796792949895961" LOG_EFFECT_SIZE="0.0814223578202194" ORDER="1" O_E="0.0" SE="0.3067448066690235" STUDY_ID="STD-Wright-1987" TOTAL_1="41" TOTAL_2="32" VAR="0.09409237641841658" WEIGHT="2.388893555029357"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8783160396779035" CI_END="0.9334294463054822" CI_START="0.8279188926030295" DF="1" EFFECT_SIZE="0.8790926421648028" ESTIMABLE="YES" EVENTS_1="814" EVENTS_2="866" I2="0.0" ID="CMP-011.04.02" LOG_CI_END="-0.029918502822763492" LOG_CI_START="-0.08201220695941956" LOG_EFFECT_SIZE="-0.055965354891091494" NO="2" P_CHI2="0.3486634187556623" P_Z="2.539496661414551E-5" STUDIES="2" TAU2="0.0" TOTAL_1="1447" TOTAL_2="1335" WEIGHT="100.0" Z="4.211260527022413">
<NAME>Rhesus vaccines: middle-income countries</NAME>
<DICH_DATA CI_END="0.9428015060715957" CI_START="0.832582713234603" EFFECT_SIZE="0.8859798169071117" ESTIMABLE="YES" EVENTS_1="724" EVENTS_2="808" LOG_CI_END="-0.025579732386512153" LOG_CI_START="-0.07957261053398831" LOG_EFFECT_SIZE="-0.052576171460250246" ORDER="1" O_E="0.0" SE="0.03171568389288479" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.0010058846047933914" WEIGHT="93.08881911833915"/>
<DICH_DATA CI_END="0.9941756488758148" CI_START="0.6299502643723327" EFFECT_SIZE="0.7913793103448276" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="58" LOG_CI_END="-0.0025368785822323147" LOG_CI_START="-0.20069373746911975" LOG_EFFECT_SIZE="-0.10161530802567606" ORDER="1" O_E="0.0" SE="0.1163983198024288" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.013548568852828489" WEIGHT="6.911180881660861"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="29.873376266396747" CI_END="0.861198225956232" CI_START="0.5548303360028215" DF="9" EFFECT_SIZE="0.6912444582579523" ESTIMABLE="YES" EVENTS_1="442" EVENTS_2="489" I2="69.87283954869304" ID="CMP-011.04.03" LOG_CI_END="-0.0648968734818675" LOG_CI_START="-0.255839801386696" LOG_EFFECT_SIZE="-0.16036833743428175" NO="3" P_CHI2="4.610240797122689E-4" P_Z="9.938833575557624E-4" STUDIES="10" TAU2="0.073818426904155" TOTAL_1="1675" TOTAL_2="1389" WEIGHT="100.0" Z="3.2922524974417815">
<NAME>Bovine vaccines: high-income countries</NAME>
<DICH_DATA CI_END="0.9120298765126801" CI_START="0.19699392660974857" EFFECT_SIZE="0.42386831275720166" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="-0.03999093470659414" LOG_CI_START="-0.7055471630796857" LOG_EFFECT_SIZE="-0.37276904889314" ORDER="1" O_E="0.0" SE="0.3909510231028184" STUDY_ID="STD-Mutz-1989" TOTAL_1="243" TOTAL_2="103" VAR="0.15284270246514042" WEIGHT="5.5501575457748284"/>
<DICH_DATA CI_END="0.9106581476001743" CI_START="0.27983146791643443" EFFECT_SIZE="0.5048076923076923" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="-0.04064462244904817" LOG_CI_START="-0.5531034493365987" LOG_EFFECT_SIZE="-0.29687403589282346" ORDER="2" O_E="0.0" SE="0.30102085162585185" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="0.09061355311355311" WEIGHT="7.650610163347555"/>
<DICH_DATA CI_END="0.7224950368323808" CI_START="0.4728292237997409" EFFECT_SIZE="0.5844799119427628" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="79" LOG_CI_END="-0.1411651319398758" LOG_CI_START="-0.32529568918529217" LOG_EFFECT_SIZE="-0.233230410562584" ORDER="2" O_E="0.0" SE="0.1081592007869158" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.011698412714864366" WEIGHT="14.710611186139452"/>
<DICH_DATA CI_END="0.8387520887290353" CI_START="0.27589639998084015" EFFECT_SIZE="0.48104956268221577" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="28" LOG_CI_END="-0.0763663853059742" LOG_CI_START="-0.5592539663517542" LOG_EFFECT_SIZE="-0.31781017582886417" ORDER="2" O_E="0.0" SE="0.2836505554383681" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.08045763760049474" WEIGHT="8.15424597160971"/>
<DICH_DATA CI_END="1.098660222738566" CI_START="0.646121544069989" EFFECT_SIZE="0.8425366695427092" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="76" LOG_CI_END="0.04086340106273701" LOG_CI_START="-0.18968577774218268" LOG_EFFECT_SIZE="-0.07441118833972281" ORDER="2" O_E="0.0" SE="0.13542572886685053" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="0.01834012803911771" WEIGHT="13.650441657610543"/>
<DICH_DATA CI_END="2.700829492835596" CI_START="0.7700871647168297" EFFECT_SIZE="1.4421768707482994" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="14" LOG_CI_END="0.43149716743142463" LOG_CI_START="-0.1134601150702739" LOG_EFFECT_SIZE="0.15901852618057535" ORDER="2" O_E="0.0" SE="0.3201106053235521" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="0.10247079964061095" WEIGHT="7.136028685130051"/>
<DICH_DATA CI_END="0.9972484337336552" CI_START="0.3293380007214721" EFFECT_SIZE="0.5730897009966778" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="28" LOG_CI_END="-0.0011966371152548345" LOG_CI_START="-0.48235815525384607" LOG_EFFECT_SIZE="-0.24177739618455044" ORDER="2" O_E="0.0" SE="0.28263665754253625" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.0798834801868169" WEIGHT="8.18470636644906"/>
<DICH_DATA CI_END="1.1607000700658978" CI_START="0.8290874769605869" EFFECT_SIZE="0.9809800673810409" ESTIMABLE="YES" EVENTS_1="181" EVENTS_2="171" LOG_CI_END="0.06472001065718366" LOG_CI_START="-0.08139964465237443" LOG_EFFECT_SIZE="-0.008339816997595402" ORDER="2" O_E="0.0" SE="0.08583140883279351" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.007367030742222145" WEIGHT="15.495447263257223"/>
<DICH_DATA CI_END="0.8115768587487964" CI_START="0.3521781100679432" EFFECT_SIZE="0.5346209912536443" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="49" LOG_CI_END="-0.0906703449075247" LOG_CI_START="-0.4532376414753382" LOG_EFFECT_SIZE="-0.27195399319143143" ORDER="2" O_E="0.0" SE="0.21297382474099683" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.04535785002480883" WEIGHT="10.555833844790149"/>
<DICH_DATA CI_END="1.3474337000124734" CI_START="0.4872254124744582" EFFECT_SIZE="0.8102493074792244" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="19" LOG_CI_END="0.1295074050816975" LOG_CI_START="-0.3122700680566148" LOG_EFFECT_SIZE="-0.09138133148745865" ORDER="828" O_E="0.0" SE="0.25950227455520547" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="0.06734143049932523" WEIGHT="8.911917315891426"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.6249223114236187E-30" CI_END="1.173287546586794" CI_START="0.8250873971200825" DF="0" EFFECT_SIZE="0.9839028244124037" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="83" I2="100.0" ID="CMP-011.04.04" LOG_CI_END="0.0694044610431056" LOG_CI_START="-0.08350004650865447" LOG_EFFECT_SIZE="-0.007047792732774443" NO="4" P_CHI2="0.0" P_Z="0.8566184838866566" STUDIES="1" TAU2="0.0" TOTAL_1="122" TOTAL_2="123" WEIGHT="100.0" Z="0.18068034942743624">
<NAME>Bovine vaccines: low-income countries</NAME>
<DICH_DATA CI_END="1.173287546586794" CI_START="0.8250873971200825" EFFECT_SIZE="0.9839028244124037" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="83" LOG_CI_END="0.0694044610431056" LOG_CI_START="-0.08350004650865447" LOG_EFFECT_SIZE="-0.007047792732774443" ORDER="2" O_E="0.0" SE="0.08981686462542321" STUDY_ID="STD-De-Mol-1986" TOTAL_1="122" TOTAL_2="123" VAR="0.008067069171141599" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4421414233045668" CI_START="0.5697171871114918" DF="0" EFFECT_SIZE="0.9064285714285715" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="30" I2="0.0" ID="CMP-011.04.05" LOG_CI_END="0.1590078514715856" LOG_CI_START="-0.24434067863865205" LOG_EFFECT_SIZE="-0.04266641358353323" NO="5" P_CHI2="1.0" P_Z="0.6783966889312859" STUDIES="1" TAU2="0.0" TOTAL_1="140" TOTAL_2="141" WEIGHT="100.0" Z="0.4146519832382211">
<NAME>Human vaccines: high-income countries</NAME>
<DICH_DATA CI_END="1.4421414233045668" CI_START="0.5697171871114918" EFFECT_SIZE="0.9064285714285715" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="30" LOG_CI_END="0.1590078514715856" LOG_CI_START="-0.24434067863865205" LOG_EFFECT_SIZE="-0.04266641358353323" ORDER="3" O_E="0.0" SE="0.2369289231941785" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="141" VAR="0.056135314645952936" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="22.502424374145445" CI_END="0.9779177286137336" CI_START="0.7110385914586781" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8338688411950521" ESTIMABLE="YES" EVENTS_1="297" EVENTS_2="245" I2="77.7801719634048" I2_Q="0.0" ID="CMP-011.05" LOG_CI_END="-0.009697680500741615" LOG_CI_START="-0.1481068273958032" LOG_EFFECT_SIZE="-0.07890225394827237" METHOD="MH" NO="5" P_CHI2="4.201000088278617E-4" P_Q="0.0" P_Z="0.025442636984126483" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.1906852733368288" TOTALS="SUB" TOTAL_1="1431" TOTAL_2="946" WEIGHT="300.0" Z="2.2346149731693044">
<NAME>All-cause diarrhoea: severe episodes (clinical or measured by any scale)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="9.102134706657182E-4" CI_END="1.0207658664173973" CI_START="0.7340848752044951" DF="1" EFFECT_SIZE="0.8656377901074002" ESTIMABLE="YES" EVENTS_1="251" EVENTS_2="161" I2="0.0" ID="CMP-011.05.01" LOG_CI_END="0.008926139164684195" LOG_CI_START="-0.13425372386874157" LOG_EFFECT_SIZE="-0.06266379235202868" NO="1" P_CHI2="0.9759316794287343" P_Z="0.0862376075857543" STUDIES="2" TAU2="0.0" TOTAL_1="882" TOTAL_2="479" WEIGHT="99.99999999999999" Z="1.7155872836112487">
<NAME>Rhesus vaccines: high-income countries</NAME>
<DICH_DATA CI_END="1.2573969436150065" CI_START="0.5897201750365084" EFFECT_SIZE="0.8611111111111112" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="36" LOG_CI_END="0.09947240036540894" LOG_CI_START="-0.22935401423143809" LOG_EFFECT_SIZE="-0.06494080693301456" ORDER="1" O_E="0.0" SE="0.1931542636511917" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.03730856956663407" WEIGHT="18.95965764706374"/>
<DICH_DATA CI_END="1.0408628060758551" CI_START="0.721679478063707" EFFECT_SIZE="0.8667002518891688" ESTIMABLE="YES" EVENTS_1="220" EVENTS_2="125" LOG_CI_END="0.017393489846021154" LOG_CI_START="-0.14165564428018038" LOG_EFFECT_SIZE="-0.06213107721707963" ORDER="1" O_E="0.0" SE="0.09342624869164223" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.008728463944592582" WEIGHT="81.04034235293625"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.112032987563293" CI_START="0.1958375158051529" DF="0" EFFECT_SIZE="0.4666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" I2="0.0" ID="CMP-011.05.02" LOG_CI_END="0.046117670433285234" LOG_CI_START="-0.708104108516134" LOG_EFFECT_SIZE="-0.3309932190414244" NO="2" P_CHI2="1.0" P_Z="0.0853822954654372" STUDIES="1" TAU2="0.0" TOTAL_1="151" TOTAL_2="151" WEIGHT="100.0" Z="1.720275936215508">
<NAME>Rhesus vaccines: middle-income countries</NAME>
<DICH_DATA CI_END="1.112032987563293" CI_START="0.1958375158051529" EFFECT_SIZE="0.4666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" LOG_CI_END="0.046117670433285234" LOG_CI_START="-0.708104108516134" LOG_EFFECT_SIZE="-0.3309932190414244" ORDER="1" O_E="0.0" SE="0.4430336064129071" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.1962787764112267" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.725836423593748" CI_END="1.2560078004842168" CI_START="0.2106063415118996" DF="2" EFFECT_SIZE="0.5143181970049172" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="69" I2="79.43621594181626" ID="CMP-011.05.03" LOG_CI_END="0.09899233661195102" LOG_CI_START="-0.6765285560272618" LOG_EFFECT_SIZE="-0.2887681097076554" NO="3" P_CHI2="0.007727910551641903" P_Z="0.14440007652419215" STUDIES="3" TAU2="0.48872537358727086" TOTAL_1="398" TOTAL_2="316" WEIGHT="100.0" Z="1.459599864510725">
<NAME>Bovine vaccines: high-income countries</NAME>
<DICH_DATA CI_END="3.934787500208613" CI_START="0.6395892263451116" EFFECT_SIZE="1.5863945578231293" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5949212830791312" LOG_CI_START="-0.19409886040153035" LOG_EFFECT_SIZE="0.20041121133880038" ORDER="1" O_E="0.0" SE="0.46347433799324134" STUDY_ID="STD-Senturia-1987" TOTAL_1="105" TOTAL_2="106" VAR="0.2148084619782733" WEIGHT="29.496957295403536"/>
<DICH_DATA CI_END="0.6333984145474526" CI_START="0.1474910581965279" EFFECT_SIZE="0.30564784053156147" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="28" LOG_CI_END="-0.19832302804044788" LOG_CI_START="-0.8312343084561282" LOG_EFFECT_SIZE="-0.5147786682482881" ORDER="2" O_E="0.0" SE="0.37177521907753647" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.13821681352015022" WEIGHT="33.10051218485416"/>
<DICH_DATA CI_END="0.5550298730479596" CI_START="0.20258585674788657" EFFECT_SIZE="0.33532253481102586" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="34" LOG_CI_END="-0.25568364147058087" LOG_CI_START="-0.6933908775875519" LOG_EFFECT_SIZE="-0.4745372595290663" ORDER="2" O_E="0.0" SE="0.25711139718087134" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.06610627056029977" WEIGHT="37.40253051974229"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.942132952978245" CI_END="0.9788068301054381" CI_START="0.6544822663298905" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.800382228979744" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="139" I2="0.0" I2_Q="0.0" ID="CMP-011.06" LOG_CI_END="-0.009303008806605959" LOG_CI_START="-0.1841021164767276" LOG_EFFECT_SIZE="-0.09670256264166674" METHOD="MH" MODIFIED="2008-11-03 11:24:41 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.4297036658940455" P_Q="0.0" P_Z="0.03011404976757183" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3375" TOTAL_2="2457" WEIGHT="300.0" Z="2.1685870427677507">
<NAME>All-cause diarrhoea: episodes requiring hospitalization</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.6515046736926395" CI_END="0.9926803621806531" CI_START="0.6593629619700374" DF="3" EFFECT_SIZE="0.8090344021714558" ESTIMABLE="YES" EVENTS_1="186" EVENTS_2="126" I2="0.0" ID="CMP-011.06.01" LOG_CI_END="-0.0031905695186283706" LOG_CI_START="-0.18087545189077803" LOG_EFFECT_SIZE="-0.09203301070470321" NO="1" P_CHI2="0.4485316277481666" P_Z="0.04232081980581072" STUDIES="4" TAU2="0.0" TOTAL_1="2946" TOTAL_2="2077" WEIGHT="100.0" Z="2.030351529762788">
<NAME>Rhesus vaccine: high-income countries</NAME>
<DICH_DATA CI_END="1.098257517201417" CI_START="0.3112595282211121" EFFECT_SIZE="0.5846735128850998" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="26" LOG_CI_END="0.04070418454643788" LOG_CI_START="-0.5068773451475679" LOG_EFFECT_SIZE="-0.23308658030056498" ORDER="1" O_E="0.0" SE="0.3216521011145465" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.10346007415140245" WEIGHT="10.52939400117229"/>
<DICH_DATA CI_END="2.73961079538584" CI_START="0.022653271892166038" EFFECT_SIZE="0.24912075029308323" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.43768886887063246" LOG_CI_START="-1.644869062433018" LOG_EFFECT_SIZE="-0.6035900967811927" ORDER="1" O_E="0.0" SE="1.223304837675783" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="1.4964747258809736" WEIGHT="0.7279587588686502"/>
<DICH_DATA CI_END="51.64699155869687" CI_START="0.12324444768180348" EFFECT_SIZE="2.522935779816514" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.7130450289048234" LOG_CI_START="-0.9092326371255453" LOG_EFFECT_SIZE="0.40190619588963905" ORDER="1" O_E="0.0" SE="1.5403388815100318" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="54" VAR="2.372643869891576" WEIGHT="0.45913838901596254"/>
<DICH_DATA CI_END="1.0495270390230655" CI_START="0.6790242588623889" EFFECT_SIZE="0.8441885570349047" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="98" LOG_CI_END="0.020993631815270742" LOG_CI_START="-0.16811470981099352" LOG_EFFECT_SIZE="-0.07356053899786143" ORDER="1" O_E="0.0" SE="0.11108317597265595" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.012339471984172047" WEIGHT="88.2835088509431"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6284060082671834" CI_END="12.067595557901303" CI_START="0.035982583696532594" DF="1" EFFECT_SIZE="0.658956195189095" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" I2="61.95412745007134" ID="CMP-011.06.02" LOG_CI_END="1.0816207464884446" LOG_CI_START="-1.4439076557525323" LOG_EFFECT_SIZE="-0.1811434546320438" MODIFIED="2008-11-03 11:24:14 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1049670960902015" P_Z="0.7785901952210055" STUDIES="2" TAU2="2.769934226115996" TOTAL_1="192" TOTAL_2="145" WEIGHT="100.0" Z="0.2811567249047275">
<NAME>Bovine vaccines: high-income countries</NAME>
<DICH_DATA CI_END="67.16386819017342" CI_START="0.1858148177189842" EFFECT_SIZE="3.532710280373832" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.827135700647516" LOG_CI_START="-0.7309196563434847" LOG_EFFECT_SIZE="0.5481080221520157" ORDER="1" O_E="0.0" SE="1.5026143792747504" STUDY_ID="STD-Santosham-1991b" TOTAL_1="106" TOTAL_2="53" VAR="2.2578499728032435" WEIGHT="43.77267515697084"/>
<DICH_DATA CI_END="1.4508851878921203" CI_START="0.021910041715202427" EFFECT_SIZE="0.17829457364341086" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.16163304700857148" LOG_CI_START="-1.6593567955718835" LOG_EFFECT_SIZE="-0.7488618742816561" ORDER="2" O_E="0.0" SE="1.0696584475768567" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="1.1441691944725312" WEIGHT="56.227324843029166"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9099163764334488" CI_START="0.1680925952886181" DF="0" EFFECT_SIZE="0.5666063893911996" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-011.06.03" LOG_CI_END="0.28101435256262075" LOG_CI_START="-0.7744514174119447" LOG_EFFECT_SIZE="-0.24671853242466196" MODIFIED="2008-11-03 11:24:14 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.3595117690814249" STUDIES="1" TAU2="0.0" TOTAL_1="237" TOTAL_2="235" WEIGHT="100.0" Z="0.9162958224264685">
<NAME>Bovine vaccines: low-income countries</NAME>
<DICH_DATA CI_END="1.9099163764334488" CI_START="0.1680925952886181" EFFECT_SIZE="0.5666063893911996" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.28101435256262075" LOG_CI_START="-0.7744514174119447" LOG_EFFECT_SIZE="-0.24671853242466196" ORDER="2" O_E="0.0" SE="0.619985817922883" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="237" TOTAL_2="235" VAR="0.38438241442550625" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="17.892823201427575" CI_END="0.6073488615414181" CI_START="0.3129020284217926" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4359365673305879" ESTIMABLE="YES" EVENTS_1="147" EVENTS_2="158" I2="44.111670431068966" I2_Q="0.0" ID="CMP-011.07" LOG_CI_END="-0.21656177824809336" LOG_CI_START="-0.5045916214829658" LOG_EFFECT_SIZE="-0.3605766998655296" METHOD="MH" MODIFIED="2008-11-03 11:23:28 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.05679878164201857" P_Q="0.0" P_Z="9.236187557751174E-7" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.13524464843626607" TOTALS="SUB" TOTAL_1="4580" TOTAL_2="3342" WEIGHT="400.0" Z="4.907250842229273">
<NAME>All-cause diarrhoea: episodes requiring re-hydration</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.6803116163942147" CI_START="0.1425384217573821" DF="0" EFFECT_SIZE="0.31140093786635403" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" I2="0.0" ID="CMP-011.07.01" LOG_CI_END="-0.1672921133510078" LOG_CI_START="-0.8460680541952647" LOG_EFFECT_SIZE="-0.5066800837731362" NO="1" P_CHI2="1.0" P_Z="0.0034326797499237235" STUDIES="1" TAU2="0.0" TOTAL_1="853" TOTAL_2="425" WEIGHT="100.0" Z="2.926075177749833">
<NAME>Rhesus vaccine: high-income countries</NAME>
<DICH_DATA CI_END="0.6803116163942147" CI_START="0.1425384217573821" EFFECT_SIZE="0.31140093786635403" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="-0.1672921133510078" LOG_CI_START="-0.8460680541952647" LOG_EFFECT_SIZE="-0.5066800837731362" ORDER="1" O_E="0.0" SE="0.39871634764701297" STUDY_ID="STD-Rennels-1996" TOTAL_1="853" TOTAL_2="425" VAR="0.15897472588097372" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.682212313312915" CI_END="1.049007800123341" CI_START="0.32589012265757505" DF="3" EFFECT_SIZE="0.5846890461184889" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="74" I2="60.94874916694062" ID="CMP-011.07.02" LOG_CI_END="0.020778717495684336" LOG_CI_START="-0.4869288022851407" LOG_EFFECT_SIZE="-0.23307504239472823" NO="2" P_CHI2="0.05305697999930026" P_Z="0.07193411565138316" STUDIES="4" TAU2="0.19009819390529176" TOTAL_1="2465" TOTAL_2="1816" WEIGHT="100.0" Z="1.7995348541854175">
<NAME>Rhesus vaccine: middle-income countries</NAME>
<DICH_DATA CI_END="3.1686011277904726" CI_START="0.035066297911908864" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5008675724492677" LOG_CI_START="-1.4551100818885927" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="1" O_E="0.0" SE="1.1489509564036013" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="1.3200883002207504" WEIGHT="5.889410331151294"/>
<DICH_DATA CI_END="1.0196741450888365" CI_START="0.41926609099435597" EFFECT_SIZE="0.6538461538461539" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="26" LOG_CI_END="0.0084614074486432" LOG_CI_START="-0.37751026063373133" LOG_EFFECT_SIZE="-0.18452442659254403" ORDER="1" O_E="0.0" SE="0.22672166842215744" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.051402714932126704" WEIGHT="36.82846571173234"/>
<DICH_DATA CI_END="0.6026265901573175" CI_START="0.1013969690062271" EFFECT_SIZE="0.24719326383319967" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="24" LOG_CI_END="-0.2199517095298664" LOG_CI_START="-0.9939750268916805" LOG_EFFECT_SIZE="-0.6069633682107733" ORDER="1" O_E="0.0" SE="0.45466512809554377" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1247" TOTAL_2="1233" VAR="0.20672037870613721" WEIGHT="22.413537456021032"/>
<DICH_DATA CI_END="1.6374844969700115" CI_START="0.6028718462030282" EFFECT_SIZE="0.9935760171306209" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="21" LOG_CI_END="0.21417719696168402" LOG_CI_START="-0.21977499698414668" LOG_EFFECT_SIZE="-0.002798900011231316" ORDER="853" O_E="0.0" SE="0.25490566682178506" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.06497689897785888" WEIGHT="34.86858650109533"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.664665094730512" CI_END="0.6737269296982829" CI_START="0.26007347654467494" DF="4" EFFECT_SIZE="0.41859109504193026" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="65" I2="14.248934944576359" ID="CMP-011.07.03" LOG_CI_END="-0.171516093013033" LOG_CI_START="-0.5849039368377595" LOG_EFFECT_SIZE="-0.37821001492539624" NO="3" P_CHI2="0.3234665888627266" P_Z="3.3533096974951035E-4" STUDIES="5" TAU2="0.047307875132084565" TOTAL_1="1154" TOTAL_2="994" WEIGHT="100.0" Z="3.5863561007876643">
<NAME>Bovine vaccines: high-income countries</NAME>
<DICH_DATA CI_END="1.0244051033825095" CI_START="0.015756944365744884" EFFECT_SIZE="0.12704918032786885" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.010471733370525363" LOG_CI_START="-1.802527998379439" LOG_EFFECT_SIZE="-0.8960281325044568" ORDER="2" O_E="0.0" SE="1.0649650169233398" STUDY_ID="STD-Vesikari-1991a" TOTAL_1="244" TOTAL_2="217" VAR="1.1341504872705295" WEIGHT="4.990823214051142"/>
<DICH_DATA CI_END="0.9912776750010556" CI_START="0.35570136539148767" EFFECT_SIZE="0.5938003220611916" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="24" LOG_CI_END="-0.003804674647892548" LOG_CI_START="-0.44891446773282906" LOG_EFFECT_SIZE="-0.2263595711903608" ORDER="2" O_E="0.0" SE="0.2614596957871023" STUDY_ID="STD-Treanor-1995" TOTAL_1="207" TOTAL_2="118" VAR="0.06836117252108409" WEIGHT="50.976902993047894"/>
<DICH_DATA CI_END="0.7394435909978698" CI_START="0.08260148450324896" EFFECT_SIZE="0.24714193962748876" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.1310949508797454" LOG_CI_START="-1.0830121475249443" LOG_EFFECT_SIZE="-0.6070535492023449" ORDER="2" O_E="0.0" SE="0.5591608733755086" STUDY_ID="STD-Ruuska-1990" TOTAL_1="519" TOTAL_2="481" VAR="0.3126608823140615" WEIGHT="16.38044885713718"/>
<DICH_DATA CI_END="3.237149233206586" CI_START="0.12066944458197347" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5101627209237998" LOG_CI_START="-0.9184026862356492" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="2" O_E="0.0" SE="0.8391463916782737" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="0.7041666666666666" WEIGHT="7.846506426418519"/>
<DICH_DATA CI_END="0.8085003629842248" CI_START="0.11370419019807793" EFFECT_SIZE="0.30319940476190477" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="16" LOG_CI_END="-0.09231978077673843" LOG_CI_START="-0.9442235305068837" LOG_EFFECT_SIZE="-0.518271655641811" ORDER="2" O_E="0.0" SE="0.5004124795830592" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.2504126497224657" WEIGHT="19.805318509345273"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7076671595642257" CI_START="0.007399513340300138" DF="0" EFFECT_SIZE="0.14154652686762775" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" ID="CMP-011.07.04" LOG_CI_END="0.43259527757266714" LOG_CI_START="-2.130796842508529" LOG_EFFECT_SIZE="-0.8491007824679309" MODIFIED="2008-11-03 11:23:28 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.1941357740144168" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="107" WEIGHT="100.0" Z="1.2984411864613281">
<NAME>Human vaccines: high-income countries</NAME>
<DICH_DATA CI_END="2.7076671595642257" CI_START="0.007399513340300138" EFFECT_SIZE="0.14154652686762778" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43259527757266714" LOG_CI_START="-2.130796842508529" LOG_EFFECT_SIZE="-0.8491007824679307" ORDER="3" O_E="0.0" SE="1.5057492203313343" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="2.267280714528421" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" NO="12">
<NAME>Adverse events</NAME>
<DICH_OUTCOME CHI2="0.7400502193991747" CI_END="2.423933721392001" CI_START="0.07295556968686479" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4205228478065795" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-012.01" LOG_CI_END="0.3845207405655148" LOG_CI_START="-1.1369415469242532" LOG_EFFECT_SIZE="-0.37621040317936927" METHOD="MH" NO="1" P_CHI2="0.69071712316415" P_Q="0.0" P_Z="0.33240725001743865" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2255" TOTAL_2="1868" WEIGHT="99.99999999999999" Z="0.9692765268042383">
<NAME>Bowel obstruction and/or intussusception</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.7400502193991747" CI_END="2.423933721392001" CI_START="0.07295556968686479" DF="2" EFFECT_SIZE="0.4205228478065795" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-012.01.01" LOG_CI_END="0.3845207405655148" LOG_CI_START="-1.1369415469242532" LOG_EFFECT_SIZE="-0.37621040317936927" NO="1" P_CHI2="0.69071712316415" P_Z="0.33240725001743865" STUDIES="3" TAU2="0.0" TOTAL_1="2255" TOTAL_2="1868" WEIGHT="99.99999999999999" Z="0.9692765268042383">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="16.18356344077523" CI_START="0.06346245414413894" EFFECT_SIZE="1.0134340890008395" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2090741546231334" LOG_CI_START="-1.19748313739399" LOG_EFFECT_SIZE="0.00579550861457167" ORDER="862" O_E="0.0" SE="1.4136236659815784" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="1.9983318690231973" WEIGHT="39.96961577861295"/>
<DICH_DATA CI_END="8.1462975993359" CI_START="0.013639461332737095" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9109602716213977" LOG_CI_START="-1.8652027810607228" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="863" O_E="0.0" SE="1.6307319193742202" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="2.659286592865928" WEIGHT="30.03533249003282"/>
<DICH_DATA CI_END="4.02541753393874" CI_START="0.006710956647829027" EFFECT_SIZE="0.16436058700209644" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6048109339662393" LOG_CI_START="-2.17321556667759" LOG_EFFECT_SIZE="-0.7842023163556755" ORDER="864" O_E="0.0" SE="1.6318265179311442" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="2.662857784623283" WEIGHT="29.995051731354227"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="643.7280209355691" CI_END="1.6371627605071726" CI_START="1.1331697724710368" CI_STUDY="95" CI_TOTAL="95" DF="48" EFFECT_MEASURE="RR" EFFECT_SIZE="1.362051156462916" ESTIMABLE="YES" EVENTS_1="2764" EVENTS_2="1404" I2="92.54343473657731" I2_Q="0.0" ID="CMP-012.02" LOG_CI_END="0.2140918574671363" LOG_CI_START="0.05429498111126575" LOG_EFFECT_SIZE="0.134193419289201" METHOD="MH" NO="2" P_CHI2="-1.5543122344752192E-15" P_Q="0.0" P_Z="9.952804700914374E-4" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="47" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.2904436186921917" TOTALS="SUB" TOTAL_1="9769" TOTAL_2="6833" WEIGHT="300.0" Z="3.2918574476184275">
<NAME>Fever (one or multiple doses of vaccine)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="679.0031177459937" CI_END="2.644398586476799" CI_START="1.5131768891913362" DF="31" EFFECT_SIZE="2.0003606741952638" ESTIMABLE="YES" EVENTS_1="2563" EVENTS_2="1256" I2="95.43448340813117" ID="CMP-012.02.01" LOG_CI_END="0.4223269163434534" LOG_CI_START="0.17988969967508023" LOG_EFFECT_SIZE="0.30110830800926686" NO="1" P_CHI2="5.551115123125783E-16" P_Z="1.1240795828559683E-6" STUDIES="32" TAU2="0.3414670810083997" TOTAL_1="8215" TOTAL_2="5503" WEIGHT="100.0" Z="4.868571313052411">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="10.848272787768423" CI_START="0.054544717662200495" EFFECT_SIZE="0.7692307692307693" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0353605973132751" LOG_CI_START="-1.2632473019269486" LOG_EFFECT_SIZE="-0.11394335230683675" ORDER="865" O_E="0.0" SE="1.3502136583063153" STUDY_ID="STD-Anderson-1986" TOTAL_1="13" TOTAL_2="10" VAR="1.823076923076923" WEIGHT="0.9369304714692978"/>
<DICH_DATA CI_END="2.571672723405065" CI_START="1.0494372957588067" EFFECT_SIZE="1.6428053044797783" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="23" LOG_CI_END="0.41021569852006223" LOG_CI_START="0.02095649444820501" LOG_EFFECT_SIZE="0.21558609648413363" ORDER="866" O_E="0.0" SE="0.2286527833359451" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="332" VAR="0.05228209532727466" WEIGHT="5.150556131029957"/>
<DICH_DATA CI_END="16.166580265947694" CI_START="0.7577360083877888" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.208618162844101" LOG_CI_START="-0.12048207414354975" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="867" O_E="0.0" SE="0.7807200583588264" STUDY_ID="STD-Bresee-2001" TOTAL_1="60" TOTAL_2="60" VAR="0.6095238095238094" WEIGHT="2.132541178316382"/>
<DICH_DATA CI_END="4.48749179850439" CI_START="1.4359440131781707" EFFECT_SIZE="2.5384615384615383" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="13" LOG_CI_END="0.652003667855447" LOG_CI_START="0.15713750728665435" LOG_EFFECT_SIZE="0.4045705875710507" ORDER="868" O_E="0.0" SE="0.2906868323451107" STUDY_ID="STD-Christy-1988" TOTAL_1="88" TOTAL_2="88" VAR="0.0844988344988345" WEIGHT="4.761008241348974"/>
<DICH_DATA CI_END="3.9059634305944075" CI_START="0.15523847806125807" EFFECT_SIZE="0.7786885245901639" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.5917281729084659" LOG_CI_START="-0.8090006236802669" LOG_EFFECT_SIZE="-0.10863622538590048" ORDER="869" O_E="0.0" SE="0.8227950288355904" STUDY_ID="STD-Dagan-1992" TOTAL_1="183" TOTAL_2="57" VAR="0.6769916594765601" WEIGHT="1.9912708818209133"/>
<DICH_DATA CI_END="7.767267261244548" CI_START="0.690121949364733" EFFECT_SIZE="2.3152454780361755" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="3" LOG_CI_END="0.8902682489020307" LOG_CI_START="-0.16107415961560317" LOG_EFFECT_SIZE="0.36459704464321374" ORDER="870" O_E="0.0" SE="0.6175637349921129" STUDY_ID="STD-Dennehy-1996" TOTAL_1="129" TOTAL_2="64" VAR="0.38138496677740863" WEIGHT="2.8055910479548607"/>
<DICH_DATA CI_END="7.723921203524791" CI_START="0.014385324265142151" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8878378346245852" LOG_CI_START="-1.84208034406391" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="871" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Flores-1988" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.6962237842495407"/>
<DICH_DATA CI_END="29.9811107554638" CI_START="0.5895761393124903" EFFECT_SIZE="4.204301075268817" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="1" LOG_CI_END="1.47684771877352" LOG_CI_START="-0.22946010108965673" LOG_EFFECT_SIZE="0.6236938088419317" ORDER="872" O_E="0.0" SE="1.0022936597475596" STUDY_ID="STD-Flores-1989" TOTAL_1="93" TOTAL_2="23" VAR="1.0045925803701565" WEIGHT="1.5066399301994646"/>
<DICH_DATA CI_END="12.869263042632472" CI_START="0.784681420488909" EFFECT_SIZE="3.1777777777777776" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="2" LOG_CI_END="1.1095536777760304" LOG_CI_START="-0.10530663039659424" LOG_EFFECT_SIZE="0.5021235236897181" ORDER="873" O_E="0.0" SE="0.7136149586761121" STUDY_ID="STD-Flores-1990" TOTAL_1="45" TOTAL_2="22" VAR="0.5092463092463092" WEIGHT="2.38391361590829"/>
<DICH_DATA CI_END="1.3542144981432664" CI_START="0.7682682480703533" EFFECT_SIZE="1.02" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="42" LOG_CI_END="0.1316874590182758" LOG_CI_START="-0.11448711549444067" LOG_EFFECT_SIZE="0.008600171761917567" ORDER="874" O_E="0.0" SE="0.1446041636525666" STUDY_ID="STD-Flores-1993" TOTAL_1="200" TOTAL_2="102" VAR="0.02091036414565826" WEIGHT="5.596449948482652"/>
<DICH_DATA CI_END="26.203778781556103" CI_START="3.901520034705597" EFFECT_SIZE="10.11111111111111" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="4" LOG_CI_END="1.4183639243595427" LOG_CI_START="0.5912338414039946" LOG_EFFECT_SIZE="1.0047988828817687" ORDER="875" O_E="0.0" SE="0.48586030508803263" STUDY_ID="STD-Gothefors-1989" TOTAL_1="54" TOTAL_2="52" VAR="0.23606023606023613" WEIGHT="3.511569365337369"/>
<DICH_DATA CI_END="11.621628720601862" CI_START="0.10240239756742692" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.0652669967980315" LOG_CI_START="-0.9896898750192319" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="876" O_E="0.0" SE="1.2070918387060312" STUDY_ID="STD-Ho-1989" TOTAL_1="66" TOTAL_2="36" VAR="1.4570707070707072" WEIGHT="1.1275977895519769"/>
<DICH_DATA CI_END="5.298422879368685" CI_START="0.5057901797657786" EFFECT_SIZE="1.637037037037037" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="3" LOG_CI_END="0.7241466173902804" LOG_CI_START="-0.2960296070100713" LOG_EFFECT_SIZE="0.21405850519010458" ORDER="877" O_E="0.0" SE="0.5992565641665221" STUDY_ID="STD-Ing-1991" TOTAL_1="135" TOTAL_2="39" VAR="0.35910842969666495" WEIGHT="2.8948017783588815"/>
<DICH_DATA CI_END="1.931702034583957" CI_START="1.6577769265534" EFFECT_SIZE="1.7895058149974092" ESTIMABLE="YES" EVENTS_1="867" EVENTS_2="491" LOG_CI_END="0.2859401372369149" LOG_CI_START="0.21952609069871215" LOG_EFFECT_SIZE="0.2527331139678135" ORDER="878" O_E="0.0" SE="0.03901193969137277" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.0015219314384833057" WEIGHT="5.912805252260883"/>
<DICH_DATA CI_END="5.242773059556633" CI_START="0.8146664108082353" EFFECT_SIZE="2.066666666666667" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="5" LOG_CI_END="0.7195610591031238" LOG_CI_START="-0.08902018954594082" LOG_EFFECT_SIZE="0.31527043477859146" ORDER="879" O_E="0.0" SE="0.4749646279981935" STUDY_ID="STD-Lanata-1996a" TOTAL_1="600" TOTAL_2="200" VAR="0.22559139784946236" WEIGHT="3.5763987487647544"/>
<DICH_DATA CI_END="1.056338729438187" CI_START="0.9903238803357535" EFFECT_SIZE="1.0227988411638747" ESTIMABLE="YES" EVENTS_1="455" EVENTS_2="221" LOG_CI_END="0.023803202986803457" LOG_CI_START="-0.004222748393224915" LOG_EFFECT_SIZE="0.009790227296789262" ORDER="880" O_E="0.0" SE="0.0164625825713254" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="2.710166249177068E-4" WEIGHT="5.934448773223295"/>
<DICH_DATA CI_END="9.943956970544608" CI_START="0.7151188538099287" EFFECT_SIZE="2.6666666666666665" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.99755923636011" LOG_CI_START="-0.14562177181554778" LOG_EFFECT_SIZE="0.4259687322722811" ORDER="881" O_E="0.0" SE="0.6715101830396364" STUDY_ID="STD-Linhares-1996" TOTAL_1="270" TOTAL_2="270" VAR="0.4509259259259259" WEIGHT="2.559370434262033"/>
<DICH_DATA CI_END="2.9037116789251325" CI_START="0.9093964180966758" EFFECT_SIZE="1.625" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="16" LOG_CI_END="0.462953491343402" LOG_CI_START="-0.04124676071361566" LOG_EFFECT_SIZE="0.21085336531489315" ORDER="882" O_E="0.0" SE="0.29616972388979207" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.08771650534895567" WEIGHT="4.725314058434394"/>
<DICH_DATA CI_END="15.468297463497338" CI_START="1.4289893332201438" EFFECT_SIZE="4.701492537313433" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="3" LOG_CI_END="1.1894425151926808" LOG_CI_START="0.1550289869848673" LOG_EFFECT_SIZE="0.6722357510887741" ORDER="883" O_E="0.0" SE="0.6076196268988155" STUDY_ID="STD-Perez_x002d_Schael-1990c" TOTAL_1="67" TOTAL_2="63" VAR="0.36920161099265575" WEIGHT="2.853688725970626"/>
<DICH_DATA CI_END="2.6942697411922794" CI_START="0.8142118450628144" EFFECT_SIZE="1.4811165845648604" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="14" LOG_CI_END="0.43044107366126766" LOG_CI_START="-0.08926258384313494" LOG_EFFECT_SIZE="0.17058924490906638" ORDER="884" O_E="0.0" SE="0.30527650099268067" STUDY_ID="STD-Perez_x002d_Schael-1994" TOTAL_1="87" TOTAL_2="82" VAR="0.09319374205833415" WEIGHT="4.665769553269212"/>
<DICH_DATA CI_END="1.671294771166485" CI_START="1.2507014378741497" EFFECT_SIZE="1.4457837920690184" ESTIMABLE="YES" EVENTS_1="343" EVENTS_2="234" LOG_CI_END="0.22305305444213724" LOG_CI_START="0.09715364913471804" LOG_EFFECT_SIZE="0.16010335178842766" ORDER="885" O_E="0.0" SE="0.07395393388968534" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1171" TOTAL_2="1155" VAR="0.005469184337759949" WEIGHT="5.84553255693871"/>
<DICH_DATA CI_END="33.69515255163168" CI_START="0.6397395713210906" EFFECT_SIZE="4.642857142857143" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="1" LOG_CI_END="1.5275674269395616" LOG_CI_START="-0.19399678501032638" LOG_EFFECT_SIZE="0.6667853209646176" ORDER="886" O_E="0.0" SE="1.0112553399796524" STUDY_ID="STD-Pichichero-1990" TOTAL_1="70" TOTAL_2="25" VAR="1.0226373626373626" WEIGHT="1.4867096458123932"/>
<DICH_DATA CI_END="32.41524154774031" CI_START="0.11836259311110855" EFFECT_SIZE="1.958762886597938" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="1.5107492621709102" LOG_CI_START="-0.926785528797742" LOG_EFFECT_SIZE="0.29198186668658405" ORDER="887" O_E="0.0" SE="1.4318200022067995" STUDY_ID="STD-Pichichero-1993" TOTAL_1="193" TOTAL_2="19" VAR="2.050108518719479" WEIGHT="0.8479879266599217"/>
<DICH_DATA CI_END="137.26199291238538" CI_START="0.5352493155333805" EFFECT_SIZE="8.571428571428571" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.1375503001394454" LOG_CI_START="-0.27144387940067205" LOG_EFFECT_SIZE="0.9330532103693868" ORDER="888" O_E="0.0" SE="1.415055105775373" STUDY_ID="STD-Rennels-1987" TOTAL_1="20" TOTAL_2="11" VAR="2.0023809523809524" WEIGHT="0.8652554284123308"/>
<DICH_DATA CI_END="519.2347582304956" CI_START="1.993047252481189" EFFECT_SIZE="32.16923076923077" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="0" LOG_CI_END="2.7153637569865428" LOG_CI_START="0.2995175953630898" LOG_EFFECT_SIZE="1.5074406761748163" ORDER="889" O_E="0.0" SE="1.4190799939689827" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="2.013788029283008" WEIGHT="0.8610647846180799"/>
<DICH_DATA CI_END="1.3459005395516592" CI_START="0.5411463103153966" EFFECT_SIZE="0.8534220005541702" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="27" LOG_CI_END="0.129012967228317" LOG_CI_START="-0.26668529834644283" LOG_EFFECT_SIZE="-0.0688361655590629" ORDER="890" O_E="0.0" SE="0.23243511993661867" STUDY_ID="STD-Rennels-1996" TOTAL_1="802" TOTAL_2="385" VAR="0.05402608497995031" WEIGHT="5.127843939339884"/>
<DICH_DATA CI_END="3.489924492120908" CI_START="0.6328292315647577" EFFECT_SIZE="1.4861111111111112" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.5428160306812493" LOG_CI_START="-0.19871346817336694" LOG_EFFECT_SIZE="0.1720512812539412" ORDER="891" O_E="0.0" SE="0.4355780982574201" STUDY_ID="STD-Santosham-1991a" TOTAL_1="108" TOTAL_2="107" VAR="0.1897282796815507" WEIGHT="3.8178556974397737"/>
<DICH_DATA CI_END="1.3108725641730994" CI_START="0.9282139104653216" EFFECT_SIZE="1.1030730478589421" ESTIMABLE="YES" EVENTS_1="280" EVENTS_2="125" LOG_CI_END="0.11756047401923363" LOG_CI_START="-0.03235192741336693" LOG_EFFECT_SIZE="0.04260427330293337" ORDER="892" O_E="0.0" SE="0.08805928667986476" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.007754437970566607" WEIGHT="5.807280262090182"/>
<DICH_DATA CI_END="12.04989294795095" CI_START="1.4685407044060117" EFFECT_SIZE="4.206632653061225" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="4" LOG_CI_END="1.0809831886270118" LOG_CI_START="0.16688598862111131" LOG_EFFECT_SIZE="0.6239345886240616" ORDER="893" O_E="0.0" SE="0.5369452201375818" STUDY_ID="STD-Vesikari-1990" TOTAL_1="98" TOTAL_2="97" VAR="0.28831016942859616" WEIGHT="3.2202294269227347"/>
<DICH_DATA CI_END="65.96116210850572" CI_START="1.3517519300929484" EFFECT_SIZE="9.442622950819672" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="1" LOG_CI_END="1.8192882984713514" LOG_CI_START="0.13089699835353877" LOG_EFFECT_SIZE="0.975092648412445" ORDER="894" O_E="0.0" SE="0.9917694073609294" STUDY_ID="STD-Vesikari-1991c" TOTAL_1="61" TOTAL_2="24" VAR="0.9836065573770493" WEIGHT="1.5305015325297513"/>
<DICH_DATA CI_END="17.29368212527524" CI_START="2.369733935106745" EFFECT_SIZE="6.401673640167364" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="4" LOG_CI_END="1.2378874719573063" LOG_CI_START="0.37469958778161583" LOG_EFFECT_SIZE="0.8062935298694611" ORDER="895" O_E="0.0" SE="0.5070408360137391" STUDY_ID="STD-Vesikari-1992" TOTAL_1="239" TOTAL_2="120" VAR="0.2570904093855115" WEIGHT="3.3881912210789586"/>
<DICH_DATA CI_END="19.34934272513951" CI_START="0.36212705076132723" EFFECT_SIZE="2.6470588235294117" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.2866662171227252" LOG_CI_START="-0.44113903232858565" LOG_EFFECT_SIZE="0.42276359239706973" ORDER="896" O_E="0.0" SE="1.0149213563016222" STUDY_ID="STD-Wright-1987" TOTAL_1="17" TOTAL_2="9" VAR="1.030065359477124" WEIGHT="1.478657867943524"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.911389884448791" CI_END="1.2261054084711767" CI_START="0.7293927684646471" DF="11" EFFECT_SIZE="0.9456809283866671" ESTIMABLE="YES" EVENTS_1="140" EVENTS_2="118" I2="14.803904936299519" ID="CMP-012.02.02" LOG_CI_END="0.08852780815102346" LOG_CI_START="-0.13703854679611763" LOG_EFFECT_SIZE="-0.024255369322547075" NO="2" P_CHI2="0.2991565622972079" P_Z="0.6733800372074692" STUDIES="12" TAU2="0.030119727402126064" TOTAL_1="1182" TOTAL_2="986" WEIGHT="100.0" Z="0.42151366337457874">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.1351986513052224" CI_START="0.4056199178390894" EFFECT_SIZE="0.6785714285714286" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="28" LOG_CI_END="0.05507186647774066" LOG_CI_START="-0.3918807272565212" LOG_EFFECT_SIZE="-0.16840443038939024" ORDER="897" O_E="0.0" SE="0.2625421660105264" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.0689283889334988" WEIGHT="17.724648302076243"/>
<DICH_DATA CI_END="2.2231083981437054" CI_START="0.5163757127776653" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.3469606392927456" LOG_CI_START="-0.2870341925378591" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="898" O_E="0.0" SE="0.3724117025423291" STUDY_ID="STD-Christy-1993" TOTAL_1="16" TOTAL_2="15" VAR="0.1386904761904762" WEIGHT="10.399803979082568"/>
<DICH_DATA CI_END="4.011594143563346" CI_START="0.5583335221522094" EFFECT_SIZE="1.4965986394557824" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.603316988623846" LOG_CI_START="-0.25310629647578564" LOG_EFFECT_SIZE="0.17510534607403014" ORDER="899" O_E="0.0" SE="0.5030672770311564" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.2530766852195423" WEIGHT="6.199206447496351"/>
<DICH_DATA CI_END="3.783171268555266" CI_START="0.8526722229611209" EFFECT_SIZE="1.7960526315789473" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="8" LOG_CI_END="0.5778560027531705" LOG_CI_START="-0.06921788456120351" LOG_EFFECT_SIZE="0.25431905909598346" ORDER="900" O_E="0.0" SE="0.38009440447586385" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="0.14447175631386158" WEIGHT="10.05543334454933"/>
<DICH_DATA CI_END="4.8916077778331" CI_START="0.7425753879354737" EFFECT_SIZE="1.9058823529411764" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="5" LOG_CI_END="0.6894516268696164" LOG_CI_START="-0.12925944921294" LOG_EFFECT_SIZE="0.28009608882833814" ORDER="901" O_E="0.0" SE="0.4809149387760811" STUDY_ID="STD-Clements_x002d_Mann-1999" TOTAL_1="119" TOTAL_2="63" VAR="0.23127917833800185" WEIGHT="6.716145280184999"/>
<DICH_DATA CI_END="4.950625529358932" CI_START="0.4090690998509685" EFFECT_SIZE="1.4230769230769231" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="3" LOG_CI_END="0.6946600770720073" LOG_CI_START="-0.3882033248796532" LOG_EFFECT_SIZE="0.15322837609617704" ORDER="902" O_E="0.0" SE="0.6360793225666942" STUDY_ID="STD-Eichelberger-2002" TOTAL_1="78" TOTAL_2="37" VAR="0.40459690459690456" WEIGHT="4.038476786496631"/>
<DICH_DATA CI_END="1.5988307666086738" CI_START="0.2489361193553692" EFFECT_SIZE="0.6308777429467085" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.20380249688091912" LOG_CI_START="-0.603912084915469" LOG_EFFECT_SIZE="-0.20005479401727497" ORDER="903" O_E="0.0" SE="0.47445554359886133" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="232" TOTAL_2="230" VAR="0.22510806285169102" WEIGHT="6.878533976594766"/>
<DICH_DATA CI_END="9.776575763015222" CI_START="0.16812179741165442" EFFECT_SIZE="1.2820512820512822" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="0.9901867701629272" LOG_CI_START="-0.774375975543888" LOG_EFFECT_SIZE="0.10790539730951963" ORDER="904" O_E="0.0" SE="1.0365128915546464" STUDY_ID="STD-Maldonado-1986" TOTAL_1="39" TOTAL_2="10" VAR="1.0743589743589743" WEIGHT="1.5895218479385578"/>
<DICH_DATA CI_END="2.8317210814176734" CI_START="0.4554182138976546" EFFECT_SIZE="1.1356132075471699" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4520504740294997" LOG_CI_START="-0.3415896042938582" LOG_EFFECT_SIZE="0.05523043486782071" ORDER="905" O_E="0.0" SE="0.4661881105888875" STUDY_ID="STD-Santosham-1991a" TOTAL_1="106" TOTAL_2="107" VAR="0.2173313544544368" WEIGHT="7.094707422009687"/>
<DICH_DATA CI_END="1.008546509385544" CI_START="0.4480295006965046" EFFECT_SIZE="0.67220427626519" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="33" LOG_CI_END="0.003695930613985538" LOG_CI_START="-0.34869338875210265" LOG_EFFECT_SIZE="-0.17249872906905855" ORDER="906" O_E="0.0" SE="0.20699523055090369" STUDY_ID="STD-Treanor-1995" TOTAL_1="197" TOTAL_2="115" VAR="0.042847025470821774" WEIGHT="24.06017751795782"/>
<DICH_DATA CI_END="1.7125139106487643" CI_START="0.16706468375943603" EFFECT_SIZE="0.5348837209302325" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.23363410792706837" LOG_CI_START="-0.7771153470510557" LOG_EFFECT_SIZE="-0.2717406195619937" ORDER="907" O_E="0.0" SE="0.5937192331446443" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.3525025278058645" WEIGHT="4.588319166321772"/>
<DICH_DATA CI_END="73.51891786769303" CI_START="0.12446626345164322" EFFECT_SIZE="3.025" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8663991060011735" LOG_CI_START="-0.9049483480241981" LOG_EFFECT_SIZE="0.48072537898848766" ORDER="908" O_E="0.0" SE="1.627903212885648" STUDY_ID="STD-Vesikari-1987b" TOTAL_1="119" TOTAL_2="120" VAR="2.6500688705234157" WEIGHT="0.6550259292912848"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.44152891506073" CI_END="3.6373021203227887" CI_START="0.8463883630453279" DF="4" EFFECT_SIZE="1.7545854745555447" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="30" I2="61.691433960112384" ID="CMP-012.02.03" LOG_CI_END="0.560779375770049" LOG_CI_START="-0.07243031636269706" LOG_EFFECT_SIZE="0.24417452970367598" NO="3" P_CHI2="0.03361205428412983" P_Z="0.13064095909434056" STUDIES="5" TAU2="0.41354470270846794" TOTAL_1="372" TOTAL_2="344" WEIGHT="100.00000000000001" Z="1.5115791501842097">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="4.4869472965209996" CI_START="0.396210978264932" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.6519509683597887" LOG_CI_START="-0.40207349514318896" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="909" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Barnes-2002" TOTAL_1="40" TOTAL_2="20" VAR="0.3833333333333333" WEIGHT="17.36114861303994"/>
<DICH_DATA CI_END="1.3760569343170181" CI_START="0.2392434274004623" EFFECT_SIZE="0.5737704918032787" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.13863640319322848" LOG_CI_START="-0.6211599845142113" LOG_EFFECT_SIZE="-0.24126179066049142" ORDER="910" O_E="0.0" SE="0.44630815919212674" STUDY_ID="STD-Bernstein-1998" TOTAL_1="61" TOTAL_2="55" VAR="0.19919097296146476" WEIGHT="22.578606990792505"/>
<DICH_DATA CI_END="10.630538678767886" CI_START="1.6287834701730461" EFFECT_SIZE="4.161111111111111" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="5" LOG_CI_END="1.0265552719822795" LOG_CI_START="0.21186335321004135" LOG_EFFECT_SIZE="0.6192093125961604" ORDER="911" O_E="0.0" SE="0.47855406587685057" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.22901399396726502" WEIGHT="21.53066806466522"/>
<DICH_DATA CI_END="12.72929144241448" CI_START="0.6468863231008019" EFFECT_SIZE="2.869565217391304" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.104804229952649" LOG_CI_START="-0.18917203090409734" LOG_EFFECT_SIZE="0.45781609952427577" ORDER="912" O_E="0.0" SE="0.7600880609130471" STUDY_ID="STD-Flores-1990" TOTAL_1="23" TOTAL_2="22" VAR="0.577733860342556" WEIGHT="13.95643820603533"/>
<DICH_DATA CI_END="4.503838024206043" CI_START="0.9895538204312874" EFFECT_SIZE="2.111111111111111" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="9" LOG_CI_END="0.6535827631802242" LOG_CI_START="-0.00456058015321593" LOG_EFFECT_SIZE="0.3245110915135041" ORDER="913" O_E="0.0" SE="0.3865966577361543" STUDY_ID="STD-Vesikari-1991b" TOTAL_1="140" TOTAL_2="140" VAR="0.14945697577276523" WEIGHT="24.57313812546701"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="42.661502824066716" CI_END="1.0514359700578164" CI_START="0.9270663127790164" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9872947218965207" ESTIMABLE="YES" EVENTS_1="1427" EVENTS_2="1137" I2="36.7110902976244" I2_Q="0.0" ID="CMP-012.03" LOG_CI_END="0.021782830329743028" LOG_CI_START="-0.0328891997886419" LOG_EFFECT_SIZE="-0.005553184729449449" METHOD="MH" NO="3" P_CHI2="0.028291911781103685" P_Q="0.0" P_Z="0.6905140210984442" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="7305" TOTAL_2="5331" WEIGHT="300.0" Z="0.3981575970620002">
<NAME>Vomiting (one or multiple doses of vaccine)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="21.467911216535214" CI_END="1.0321506684623645" CI_START="0.8983919848495714" DF="15" EFFECT_SIZE="0.9629516538766189" ESTIMABLE="YES" EVENTS_1="1141" EVENTS_2="923" I2="30.128274480441483" ID="CMP-012.03.01" LOG_CI_END="0.0137430981687716" LOG_CI_START="-0.046534131358275596" LOG_EFFECT_SIZE="-0.016395516594751993" NO="1" P_CHI2="0.1225337513666751" P_Z="0.2863207972448243" STUDIES="16" TAU2="0.0" TOTAL_1="6027" TOTAL_2="4262" WEIGHT="99.99999999999999" Z="1.0662275716976493">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="73.71087119779105" CI_START="0.20938123805339395" EFFECT_SIZE="3.9285714285714284" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.8675315442096114" LOG_CI_START="-0.6790622365775999" LOG_EFFECT_SIZE="0.5942346538160057" ORDER="914" O_E="0.0" SE="1.4958817926769272" STUDY_ID="STD-Anderson-1986" TOTAL_1="13" TOTAL_2="10" VAR="2.2376623376623375" WEIGHT="0.05513973578401815"/>
<DICH_DATA CI_END="1.5356425881010172" CI_START="0.5776921011279049" EFFECT_SIZE="0.9418750412350729" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="23" LOG_CI_END="0.18629014793663565" LOG_CI_START="-0.2383035705925954" LOG_EFFECT_SIZE="-0.026006711327979905" ORDER="915" O_E="0.0" SE="0.24940845203687403" STUDY_ID="STD-Bernstein-1995" TOTAL_1="659" TOTAL_2="332" VAR="0.062204575947429695" WEIGHT="3.0119395101569952"/>
<DICH_DATA CI_END="1.8929768168521355" CI_START="0.8049314371181847" EFFECT_SIZE="1.2343891402714933" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="26" LOG_CI_END="0.2771452952237844" LOG_CI_START="-0.09424111062512316" LOG_EFFECT_SIZE="0.09145209229933063" ORDER="916" O_E="0.0" SE="0.21815421318800648" STUDY_ID="STD-Christy-1988" TOTAL_1="85" TOTAL_2="88" VAR="0.04759126073167819" WEIGHT="2.5156650718967817"/>
<DICH_DATA CI_END="22.89892557080124" CI_START="0.0390524014439676" EFFECT_SIZE="0.9456521739130435" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.3598151055006287" LOG_CI_START="-1.4083522549545022" LOG_EFFECT_SIZE="-0.024268574726936755" ORDER="917" O_E="0.0" SE="1.6260352101807716" STUDY_ID="STD-Dagan-1992" TOTAL_1="183" TOTAL_2="57" VAR="2.643990504747626" WEIGHT="0.07486504858514861"/>
<DICH_DATA CI_END="1.5049057571380537" CI_START="0.24646624709468481" EFFECT_SIZE="0.6090225563909775" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.17750930362657702" LOG_CI_START="-0.6082425478034491" LOG_EFFECT_SIZE="-0.21536662208843602" ORDER="918" O_E="0.0" SE="0.4615545270643915" STUDY_ID="STD-Dennehy-1996" TOTAL_1="76" TOTAL_2="36" VAR="0.21303258145363407" WEIGHT="0.9354062320503078"/>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="919" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Flores-1988" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="0.049231906950016203"/>
<DICH_DATA CI_END="1.2507853874808856" CI_START="0.2378670746675728" EFFECT_SIZE="0.5454545454545454" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.09718279887926798" LOG_CI_START="-0.6236656684284309" LOG_EFFECT_SIZE="-0.26324143477458145" ORDER="920" O_E="0.0" SE="0.4234299579540036" STUDY_ID="STD-Ho-1989" TOTAL_1="66" TOTAL_2="36" VAR="0.17929292929292928" WEIGHT="1.1468138324827304"/>
<DICH_DATA CI_END="7.968692962649345" CI_START="0.4424877955824449" EFFECT_SIZE="1.8777777777777778" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="2" LOG_CI_END="0.9013870935844426" LOG_CI_START="-0.35409870323574505" LOG_EFFECT_SIZE="0.2736441951743487" ORDER="921" O_E="0.0" SE="0.7374785718071026" STUDY_ID="STD-Ing-1991" TOTAL_1="135" TOTAL_2="39" VAR="0.5438746438746438" WEIGHT="0.3055773534828592"/>
<DICH_DATA CI_END="1.384493858458765" CI_START="0.8505773962212146" EFFECT_SIZE="1.085181635124793" ESTIMABLE="YES" EVENTS_1="121" EVENTS_2="113" LOG_CI_END="0.14129103357860692" LOG_CI_START="-0.07028616268340276" LOG_EFFECT_SIZE="0.03550243544760209" ORDER="922" O_E="0.0" SE="0.12428149240831704" STUDY_ID="STD-Joensuu-1997" TOTAL_1="1191" TOTAL_2="1207" VAR="0.015445889355238565" WEIGHT="11.052173032617231"/>
<DICH_DATA CI_END="0.9407853692158552" CI_START="0.7344271492372584" EFFECT_SIZE="0.8312269947236568" ESTIMABLE="YES" EVENTS_1="256" EVENTS_2="153" LOG_CI_END="-0.026509445220134795" LOG_CI_START="-0.13405127714178866" LOG_EFFECT_SIZE="-0.08028036118096171" ORDER="923" O_E="0.0" SE="0.06317060441143298" STUDY_ID="STD-Lanata-1996b" TOTAL_1="467" TOTAL_2="232" VAR="0.003990525261705756" WEIGHT="20.129722366155125"/>
<DICH_DATA CI_END="1.9459298258477962" CI_START="0.7607046040999217" EFFECT_SIZE="1.2166666666666666" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="18" LOG_CI_END="0.2891271746802338" LOG_CI_START="-0.1187839552066094" LOG_EFFECT_SIZE="0.08517160973681223" ORDER="924" O_E="0.0" SE="0.23960901688818978" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.05741248097412481" WEIGHT="2.384325538386435"/>
<DICH_DATA CI_END="0.9908082918207803" CI_START="0.19936335396884292" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="18" LOG_CI_END="-0.0040103675717259755" LOG_CI_START="-0.700354668650999" LOG_EFFECT_SIZE="-0.35218251811136253" ORDER="925" O_E="0.0" SE="0.40903608941384717" STUDY_ID="STD-Perez_x002d_Schael-1990a" TOTAL_1="151" TOTAL_2="151" VAR="0.16731052244297276" WEIGHT="1.7723486502005834"/>
<DICH_DATA CI_END="1.0763834307032298" CI_START="0.8930735210079193" EFFECT_SIZE="0.9804537421075596" ESTIMABLE="YES" EVENTS_1="500" EVENTS_2="503" LOG_CI_END="0.03196700383573267" LOG_CI_START="-0.04911278696394982" LOG_EFFECT_SIZE="-0.008572891564108587" ORDER="926" O_E="0.0" SE="0.047626670467170854" STUDY_ID="STD-Perez_x002d_Schael-1997" TOTAL_1="1171" TOTAL_2="1155" VAR="0.002268299739788484" WEIGHT="49.867984881083224"/>
<DICH_DATA CI_END="18.511681297981866" CI_START="0.9973775190067607" EFFECT_SIZE="4.296875" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="2" LOG_CI_END="1.267445864742976" LOG_CI_START="-0.0011404250502248562" LOG_EFFECT_SIZE="0.6331527198463754" ORDER="927" O_E="0.0" SE="0.7451738662279367" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.5552840909090909" WEIGHT="0.22111172244217803"/>
<DICH_DATA CI_END="1.8032575405893252" CI_START="0.42246388306647964" EFFECT_SIZE="0.8728179551122195" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="11" LOG_CI_END="0.25605775693280225" LOG_CI_START="-0.3742104134726156" LOG_EFFECT_SIZE="-0.05907632826990665" ORDER="928" O_E="0.0" SE="0.3702226431739027" STUDY_ID="STD-Rennels-1996" TOTAL_1="802" TOTAL_2="385" VAR="0.13706480551867087" WEIGHT="1.4636019649976173"/>
<DICH_DATA CI_END="1.338561433719347" CI_START="0.6324463726775102" EFFECT_SIZE="0.920091475540236" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="38" LOG_CI_END="0.126638308069126" LOG_CI_START="-0.1989762939270547" LOG_EFFECT_SIZE="-0.03616899292896433" ORDER="929" O_E="0.0" SE="0.19126762903083147" STUDY_ID="STD-Santosham-1997" TOTAL_1="794" TOTAL_2="391" VAR="0.03658330591507577" WEIGHT="5.014093152728739"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="15.58583939784525" CI_END="1.219427121139026" CI_START="0.8986668629561094" DF="9" EFFECT_SIZE="1.0468327209051158" ESTIMABLE="YES" EVENTS_1="262" EVENTS_2="202" I2="42.25527563665096" ID="CMP-012.03.02" LOG_CI_END="0.086155849887179" LOG_CI_START="-0.04640127199649981" LOG_EFFECT_SIZE="0.0198772889453396" NO="2" P_CHI2="0.07605049512989426" P_Z="0.556664193982026" STUDIES="10" TAU2="0.0" TOTAL_1="1109" TOTAL_2="907" WEIGHT="100.0" Z="0.5878035052292216">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="2.1214465706028536" CI_START="0.47137647200599964" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.3266320983771803" LOG_CI_START="-0.3266320983771804" LOG_EFFECT_SIZE="0.0" ORDER="930" O_E="0.0" SE="0.383730622883438" STUDY_ID="STD-Bernstein-1990" TOTAL_1="103" TOTAL_2="103" VAR="0.14724919093851133" WEIGHT="5.409815822683351"/>
<DICH_DATA CI_END="7.425632582113423" CI_START="0.47129980654275766" EFFECT_SIZE="1.870748299319728" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8707334566719468" LOG_CI_START="-0.3267027385077737" LOG_EFFECT_SIZE="0.2720153590820865" ORDER="931" O_E="0.0" SE="0.7033799484533299" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.494743351886209" WEIGHT="1.2744277659205971"/>
<DICH_DATA CI_END="4.4179391171695075" CI_START="0.37253091592435095" EFFECT_SIZE="1.2828947368421053" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.645219726641909" LOG_CI_START="-0.4288376798064179" LOG_EFFECT_SIZE="0.10819102341774547" ORDER="932" O_E="0.0" SE="0.6309066372176553" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="0.3980431848852901" WEIGHT="1.7798528247789378"/>
<DICH_DATA CI_END="4.40960161856014" CI_START="0.6508602931376083" EFFECT_SIZE="1.6941176470588235" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.6443993553008944" LOG_CI_START="-0.18651222253898056" LOG_EFFECT_SIZE="0.22894356638095692" ORDER="933" O_E="0.0" SE="0.48808157390178775" STUDY_ID="STD-Clements_x002d_Mann-1999" TOTAL_1="119" TOTAL_2="63" VAR="0.2382236227824463" WEIGHT="2.947656057231313"/>
<DICH_DATA CI_END="6.716467109019785" CI_START="0.3015198163145084" EFFECT_SIZE="1.4230769230769231" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="0.8271408923223753" LOG_CI_START="-0.5206841401300212" LOG_EFFECT_SIZE="0.15322837609617704" ORDER="934" O_E="0.0" SE="0.7917190959040503" STUDY_ID="STD-Eichelberger-2002" TOTAL_1="78" TOTAL_2="37" VAR="0.6268191268191268" WEIGHT="1.223088794693627"/>
<DICH_DATA CI_END="1.5063938797621692" CI_START="0.9187527377245515" EFFECT_SIZE="1.1764367816091954" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="75" LOG_CI_END="0.1779385425430499" LOG_CI_START="-0.03680135378323799" LOG_EFFECT_SIZE="0.07056859437990594" ORDER="935" O_E="0.0" SE="0.12613927808169184" STUDY_ID="STD-Georges_x002d_Courbot-1991" TOTAL_1="232" TOTAL_2="230" VAR="0.01591111747497038" WEIGHT="33.957718367492895"/>
<DICH_DATA CI_END="1.2359037142072191" CI_START="0.1629154400841007" EFFECT_SIZE="0.44871794871794873" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.09198463740542898" LOG_CI_START="-0.7880377540858384" LOG_EFFECT_SIZE="-0.34802655834020474" ORDER="936" O_E="0.0" SE="0.5169295089430639" STUDY_ID="STD-Maldonado-1986" TOTAL_1="39" TOTAL_2="10" VAR="0.26721611721611715" WEIGHT="2.8705145181585126"/>
<DICH_DATA CI_END="0.9381736896297628" CI_START="0.5597434042974343" EFFECT_SIZE="0.7246630491860668" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="58" LOG_CI_END="-0.027716750677745976" LOG_CI_START="-0.25201101520155417" LOG_EFFECT_SIZE="-0.13986388293965007" ORDER="937" O_E="0.0" SE="0.1317515612558006" STUDY_ID="STD-Treanor-1995" TOTAL_1="197" TOTAL_2="115" VAR="0.017358473893340977" WEIGHT="33.01952755874998"/>
<DICH_DATA CI_END="2.930399513528943" CI_START="0.9181741731766293" EFFECT_SIZE="1.6403100775193797" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="15" LOG_CI_END="0.46692683355994424" LOG_CI_START="-0.037074927432145896" LOG_EFFECT_SIZE="0.21492595306389914" ORDER="938" O_E="0.0" SE="0.29605312925570704" STUDY_ID="STD-Vesikari-1984" TOTAL_1="86" TOTAL_2="92" VAR="0.08764745534209639" WEIGHT="6.534328100432137"/>
<DICH_DATA CI_END="1.8102026207583082" CI_START="0.6581645716337784" EFFECT_SIZE="1.0915178571428572" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="24" LOG_CI_END="0.25772718931791155" LOG_CI_START="-0.18166549906695897" LOG_EFFECT_SIZE="0.03803084512547627" ORDER="939" O_E="0.0" SE="0.2581014401861589" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.06661635342616935" WEIGHT="10.983070189858646"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.933004061559374" CI_END="3.746030776751973" CI_START="0.9996553497977048" DF="1" EFFECT_SIZE="1.9351329945218136" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="12" I2="0.0" ID="CMP-012.03.03" LOG_CI_END="0.573571341143502" LOG_CI_START="-1.4970548053787447E-4" LOG_EFFECT_SIZE="0.28671081783148206" NO="3" P_CHI2="0.334083691500594" P_Z="0.05011968182812392" STUDIES="2" TAU2="0.0" TOTAL_1="169" TOTAL_2="162" WEIGHT="99.99999999999999" Z="1.9589411273453634">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="16.26104518181441" CI_START="0.7999028333366033" EFFECT_SIZE="3.6065573770491803" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2111484565167505" LOG_CI_START="-0.0969627648938719" LOG_EFFECT_SIZE="0.5570928458114393" ORDER="940" O_E="0.0" SE="0.7683910067115771" STUDY_ID="STD-Bernstein-1998" TOTAL_1="61" TOTAL_2="55" VAR="0.590424739195231" WEIGHT="17.31238862121312"/>
<DICH_DATA CI_END="3.3340371497693653" CI_START="0.7536844847407943" EFFECT_SIZE="1.5851851851851853" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="10" LOG_CI_END="0.5229704346791347" LOG_CI_START="-0.12281042497076519" LOG_EFFECT_SIZE="0.20008000485418476" ORDER="941" O_E="0.0" SE="0.37933487362516166" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.14389494634821737" WEIGHT="82.68761137878687"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.949544991116552" CI_END="1.1080855781110093" CI_START="0.8585166196712402" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9753511597503309" ESTIMABLE="YES" EVENTS_1="315" EVENTS_2="267" I2="0.0" I2_Q="0.0" ID="CMP-012.04" LOG_CI_END="0.044573302509889265" LOG_CI_START="-0.06625129309287636" LOG_EFFECT_SIZE="-0.010838995291493566" METHOD="MH" NO="4" P_CHI2="0.5420862445331374" P_Q="0.0" P_Z="0.7014370455457323" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="826" TOTAL_2="708" WEIGHT="300.0" Z="0.3833813294672014">
<NAME>Irritability (one or multiple doses of vaccine)</NAME>
<GROUP_LABEL_1>Vaccine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vaccine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.4637094186691169" CI_END="1.199484396146297" CI_START="0.8477972999262486" DF="4" EFFECT_SIZE="1.0084243314976575" ESTIMABLE="YES" EVENTS_1="183" EVENTS_2="126" I2="0.0" ID="CMP-012.04.01" LOG_CI_END="0.07899460269014574" LOG_CI_START="-0.07170797091122573" LOG_EFFECT_SIZE="0.0036433158894600085" NO="1" P_CHI2="0.8330499410035065" P_Z="0.9245003994480603" STUDIES="5" TAU2="0.0" TOTAL_1="463" TOTAL_2="344" WEIGHT="100.0" Z="0.09476637003602104">
<NAME>Rhesus rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.3126225549359778" CI_START="0.6576495162649953" EFFECT_SIZE="0.9291101055806938" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="39" LOG_CI_END="0.1181398625142884" LOG_CI_START="-0.18200549499498372" LOG_EFFECT_SIZE="-0.03193281624034767" ORDER="942" O_E="0.0" SE="0.17630686874442786" STUDY_ID="STD-Christy-1988" TOTAL_1="85" TOTAL_2="88" VAR="0.03108411196646491" WEIGHT="26.428097642147367"/>
<DICH_DATA CI_END="2.377762999089942" CI_START="0.617907601992515" EFFECT_SIZE="1.2121212121212122" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="9" LOG_CI_END="0.376168564615347" LOG_CI_START="-0.2090764617151971" LOG_EFFECT_SIZE="0.08354605145007493" ORDER="943" O_E="0.0" SE="0.3437758254761643" STUDY_ID="STD-Ho-1989" TOTAL_1="66" TOTAL_2="36" VAR="0.11818181818181818" WEIGHT="8.03183441251101"/>
<DICH_DATA CI_END="1.2140741162398219" CI_START="0.743613260855086" EFFECT_SIZE="0.9501587301587302" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="42" LOG_CI_END="0.08424520015888175" LOG_CI_START="-0.12865287405769998" LOG_EFFECT_SIZE="-0.022203836949409094" ORDER="944" O_E="0.0" SE="0.12505738265728397" STUDY_ID="STD-Madore-1992" TOTAL_1="150" TOTAL_2="73" VAR="0.01563934895709035" WEIGHT="38.96405605743213"/>
<DICH_DATA CI_END="1.5423645311672334" CI_START="0.6183196625278504" EFFECT_SIZE="0.9765625" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="20" LOG_CI_END="0.18818702946366603" LOG_CI_START="-0.20878694274328993" LOG_EFFECT_SIZE="-0.010299956639811952" ORDER="945" O_E="0.0" SE="0.23318447632722036" STUDY_ID="STD-Rennels-1990" TOTAL_1="64" TOTAL_2="50" VAR="0.05437499999999999" WEIGHT="15.485798052121174"/>
<DICH_DATA CI_END="2.3358525292251686" CI_START="0.7225110949886349" EFFECT_SIZE="1.2991071428571428" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.36844542073255887" LOG_CI_START="-0.14115547942906995" LOG_EFFECT_SIZE="0.11364497065174445" ORDER="946" O_E="0.0" SE="0.29934209132007994" STUDY_ID="STD-Vesikari-1990" TOTAL_1="98" TOTAL_2="97" VAR="0.08960568763587909" WEIGHT="11.090213835788319"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.0262291193616526" CI_END="1.3627335542437797" CI_START="0.8575613772817321" DF="2" EFFECT_SIZE="1.081030833808789" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="89" I2="0.0" ID="CMP-012.04.02" LOG_CI_END="0.13441094957386795" LOG_CI_START="-0.06673478689936765" LOG_EFFECT_SIZE="0.03383808133725016" NO="2" P_CHI2="0.5986282846501793" P_Z="0.5096155110332802" STUDIES="3" TAU2="0.0" TOTAL_1="255" TOTAL_2="257" WEIGHT="99.99999999999999" Z="0.6594365049917126">
<NAME>Bovine rotavirus vaccines</NAME>
<DICH_DATA CI_END="1.4692252750066916" CI_START="0.5955007817626393" EFFECT_SIZE="0.935374149659864" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="24" LOG_CI_END="0.16708839088311123" LOG_CI_START="-0.2251176640469005" LOG_EFFECT_SIZE="-0.029014636581894623" ORDER="947" O_E="0.0" SE="0.2303837781171721" STUDY_ID="STD-Clark-1988" TOTAL_1="49" TOTAL_2="55" VAR="0.053076685219542376" WEIGHT="25.61539936750986"/>
<DICH_DATA CI_END="2.6461359503520825" CI_START="0.7401964799855492" EFFECT_SIZE="1.3995215311004785" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="11" LOG_CI_END="0.42261215314361567" LOG_CI_START="-0.13065298452932522" LOG_EFFECT_SIZE="0.14597958430714525" ORDER="948" O_E="0.0" SE="0.32499068057568625" STUDY_ID="STD-Clark-1990" TOTAL_1="38" TOTAL_2="39" VAR="0.10561894246104775" WEIGHT="12.297383175461487"/>
<DICH_DATA CI_END="1.4521155776512409" CI_START="0.8003324796850612" EFFECT_SIZE="1.0780423280423281" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="54" LOG_CI_END="0.1620011843658294" LOG_CI_START="-0.09672955788828919" LOG_EFFECT_SIZE="0.032635813238770114" ORDER="949" O_E="0.0" SE="0.1519797187378989" STUDY_ID="STD-Vesikari-1985a" TOTAL_1="168" TOTAL_2="163" VAR="0.023097834907650855" WEIGHT="62.08721745702864"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9765751657217707" CI_START="0.5088750162648106" DF="0" EFFECT_SIZE="0.7049501424501424" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="52" I2="0.0" ID="CMP-012.04.03" LOG_CI_END="-0.010294324007590516" LOG_CI_START="-0.2933888707314979" LOG_EFFECT_SIZE="-0.15184159736954422" NO="3" P_CHI2="1.0" P_Z="0.03550893092623487" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="107" WEIGHT="100.0" Z="2.1025064992833062">
<NAME>Human rotavirus vaccines</NAME>
<DICH_DATA CI_END="0.9765751657217707" CI_START="0.5088750162648106" EFFECT_SIZE="0.7049501424501424" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="52" LOG_CI_END="-0.010294324007590516" LOG_CI_START="-0.2933888707314979" LOG_EFFECT_SIZE="-0.15184159736954422" ORDER="950" O_E="0.0" SE="0.16629113808623006" STUDY_ID="STD-Bernstein-1999" TOTAL_1="108" TOTAL_2="107" VAR="0.027652742606013636" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-01" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>The size of the circle is proportional to the size of the trial.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAyMAAAJpBAMAAABMSfBIAAAAMFBMVEX////39/dzc3MAAACpqann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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2010-08-04 14:36:21 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2010-08-04 14:36:21 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-11-09 14:51:48 +0000" MODIFIED_BY="[Empty name]">Types of oral rotavirus vaccines in research field trials</TITLE>
<APPENDIX_BODY MODIFIED="2010-08-04 14:36:21 +0100" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="9">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Vaccine</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Years on trial</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Serotype</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Live attenuated bovine rotavirus (NCDV - RIT 4237)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1982 to 1987</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G6, P6</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Live attenuated rhesus monovalent rotavirus (RRV - MMU18006)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1984 to 1988</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G3, P3</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Live attenuated bovine rotavirus (WC3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1986 to 1990</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G6, P5</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Live attenuated human rotavirus (M37)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1990 to 1994</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G1</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Live attenuated rhesus-human reassortant rotavirus tetravalent (RRV-TV: RRV-D + RRV-DS1 + RRV + RRV-ST3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1989 to present</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G1-4, P3</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Live attenuated bovine-human ressortant multivalent (QHBRV)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1994 to present</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G1-3, P5, P8</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Live attenuated human rotavirus (HRV 89-12)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1996 to present</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G1</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Live attenuated human-bovine rotavirus (W179-9)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1988 to present</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G1, P8</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-11-09 14:52:41 +0000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-11-09 14:52:15 +0000" MODIFIED_BY="[Empty name]">Rotavirus diarrhoea: overall effect by vaccine (random vs fixed effect model)</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-09 14:52:41 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="6" ROWS="8">
<TR>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Type of vaccine</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2" VALIGN="BOTTOM">
<P>Random-effects model</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2" VALIGN="BOTTOM">
<P>Fixed-effect model</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Heterogeneity test</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Risk ratio (95% CI)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Z statistics</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Risk ratio (95% CI)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Z statistics</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Rhesus tetravalent vaccine (RRV-TV)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.58 (0.47 to 0.72)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.96, P &lt; 0.00001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.59 (0.54 to 0.64)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11.96, P &lt; 0.00001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Chi squared 51.64, df 10, P &lt; 0.00001, I squared 80.6%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Rhesus monovalent vaccine (RRV, RRV-D, RRV-DS1, or RRV-ST3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.60 (0.46 to 0.78)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.85, P 0.0001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.59 (0.47 to 0.75)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.42, P &lt; 0.00001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Chi squared 9.80, df 8, P 0.28, I squared 18.4%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine vaccine (RIT-4237)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.65 (0.48 to 0.86)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.96, P 0.003</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.68 (0.58 to 0.79)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.84, P &lt; 0.00001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Chi squared 19.77, df 9, P 0.02, I squared 54.5%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine vaccine (WC3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.77 (0.46 to 1.28)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.00, P 0.32</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.85 (0.66 to 1.10)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.22, P 0.22</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Chi squared 5.09, df 2, P 0.08, I squared 60.7%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine-human vaccine (W179-9)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.33 (0.19 to 0.56)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.00, P 0.00001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.29 (0.17 to 0.51)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.36, P &lt; 0.0001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Chi squared 1.58, df 2, P 0.45, I squared 0%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Human vaccine (89-12)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.32 (0.23 to 0.45)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6.52, P &lt; 0.00001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.31 (0.22 to 0.44)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6.60, P &lt; 0.00001</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Chi squared 0.79, df 1, P 0.37, I squared 0%</P>
</TD>
</TR>
</TABLE>
<P>CI: confidence interval.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2008-11-09 14:53:20 +0000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2008-11-09 14:52:52 +0000" MODIFIED_BY="[Empty name]">Data on number of deaths and intussusception (published/unpublished)</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-09 14:53:20 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="5" ROWS="23">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Trial</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Type of vaccine</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Intussusceptions</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Deaths</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Cause of deaths</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Gothefors-1989" TYPE="STUDY">Gothefors 1989</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-MV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No information</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Perez_x002d_Schael-1990a" TYPE="STUDY">Perez-Schael 1990a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-MV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 case, group allocation unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Described by authors as "not related to vaccine"</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wright-1987" TYPE="STUDY">Wright 1987</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-MV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wright-1991" TYPE="STUDY">Wright 1991</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-MV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bresee-2001" TYPE="STUDY">Bresee 2001</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 cases, 1 case placebo group and 1 case vaccine group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Pneumonia and sudden death syndrome</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ing-1991" TYPE="STUDY">Ing 1991</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Dennehy-1996" TYPE="STUDY">Dennehy 1996</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Joensuu-1997" TYPE="STUDY">Joensuu 1997</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Vaccine: 1 case, 6 days after thirrd dose; Placebo: 1 case, 44 days after second dose</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 case, placebo group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Suffocation due to foreign body in the bronchia, 11 months old boy</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lanata-1996a" TYPE="STUDY">Lanata 1996a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 cases, group allocation unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Described by authors as "not related to vaccine"</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lanata-1996b" TYPE="STUDY">Lanata 1996b</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 cases, group allocation unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Described by authors as "not related to vaccine"</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Linhares-1996" TYPE="STUDY">Linhares 1996</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Placebo: 1 case, during follow up</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 cases, group allocation unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gastrointestinal reflux + asphyxia, measles + sepsis, poisoning, gastroenteritis + pneumonia, acute respiratory distress</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Perez_x002d_Schael-1997" TYPE="STUDY">Perez-Schael 1997</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 cases, placebo group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bronchial aspiration + diarrhoea + dehydration, pneumonia + sepsis, accidental intoxication</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Santosham-1997" TYPE="STUDY">Santosham 1997</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Placebo: 1 case</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 cases, vaccine group, all after one month of receiving the vaccine</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>HiB (hemophilus influenza B vaccine), sudden death syndrome, asphyxia, unknown</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lanata-1989" TYPE="STUDY">Lanata 1989</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RIT-4237</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Maldonado-1986" TYPE="STUDY">Maldonado 1986</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RIT-4237</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Senturia-1987" TYPE="STUDY">Senturia 1987</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RIT-4237</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Mutz-1989" TYPE="STUDY">Mutz 1989</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RIT-4237</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Christy-1993" TYPE="STUDY">Christy 1993</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>W179-9</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bernstein-1998" TYPE="STUDY">Bernstein 1998</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>HRV89-12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bernstein-1999" TYPE="STUDY">Bernstein 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>HRV89-12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 case</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Pneumococcal sepsis</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Georges_x002d_Courbot-1991" TYPE="STUDY">Georges-Courbot 1991</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>WC3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 cases, group allocation unknown</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Described by authors as "not related to vaccine"</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ho-1989" TYPE="STUDY">Ho 1989</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>WC3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Vaccine: 2 cases (1 week and 1 month after)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No cases</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2008-11-09 14:53:53 +0000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2008-11-09 14:53:33 +0000" MODIFIED_BY="[Empty name]">Type of rotavirus vaccines assessed in the included trials</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-09 14:53:53 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="8">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Rotavirus vaccine</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Trials</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Dosage</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RIT-4237: live attenuated bovine</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hanlon-1987" TYPE="STUDY">Hanlon 1987</LINK>, <LINK REF="STD-Lanata-1989" TYPE="STUDY">Lanata 1989</LINK>, <LINK REF="STD-Maldonado-1986" TYPE="STUDY">Maldonado 1986</LINK> <LINK REF="STD-Ruuska-1990" TYPE="STUDY">Ruuska 1990</LINK>, <LINK REF="STD-Santosham-1991a" TYPE="STUDY">Santosham 1991a</LINK>, <LINK REF="STD-Santosham-1991b" TYPE="STUDY">Santosham 1991b</LINK>, <LINK REF="STD-Senturia-1987" TYPE="STUDY">Senturia 1987</LINK> <LINK REF="STD-Vesikari-1984" TYPE="STUDY">Vesikari 1984</LINK>, <LINK REF="STD-Vesikari-1985a" TYPE="STUDY">Vesikari 1985a</LINK>, <LINK REF="STD-Vesikari-1986a" TYPE="STUDY">Vesikari 1986a</LINK>, <LINK REF="STD-Vesikari-1987b" TYPE="STUDY">Vesikari 1987b</LINK> <LINK REF="STD-Vesikari-1991a" TYPE="STUDY">Vesikari 1991a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10^7.8 to 10^8.3 TCID50 or 10^6.5 to 10^8 PFU</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>WC3: live attenuated bovine</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bernstein-1990" TYPE="STUDY">Bernstein 1990</LINK>, <LINK REF="STD-Clark-1988" TYPE="STUDY">Clark 1988</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10^7 to 10^7.5 PFU</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>W179-9: live attenuated human-bovine</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Clark-1990" TYPE="STUDY">Clark 1990</LINK>, <LINK REF="STD-Christy-1993" TYPE="STUDY">Christy 1993</LINK>, <LINK REF="STD-Treanor-1995" TYPE="STUDY">Treanor 1995</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10^7 to 10^7.5 PFU</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-MV (RRV or RRV-D or RRV-DS1 or RRV-ST3): live attenuated rhesus monovalent</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Anderson-1986" TYPE="STUDY">Anderson 1986</LINK>, <LINK REF="STD-Barnes-1997" TYPE="STUDY">Barnes 1997</LINK>, <LINK REF="STD-Christy-1988" TYPE="STUDY">Christy 1988</LINK>, <LINK REF="STD-Flores-1988" TYPE="STUDY">Flores 1988</LINK>, <LINK REF="STD-Flores-1989" TYPE="STUDY">Flores 1989</LINK>, <LINK REF="STD-Gothefors-1989" TYPE="STUDY">Gothefors 1989</LINK>, <LINK REF="STD-Ho-1989" TYPE="STUDY">Ho 1989</LINK>, <LINK REF="STD-Madore-1992" TYPE="STUDY">Madore 1992</LINK>, <LINK REF="STD-Perez_x002d_Schael-1990a" TYPE="STUDY">Perez-Schael 1990a</LINK>, <LINK REF="STD-Pichichero-1990" TYPE="STUDY">Pichichero 1990</LINK>, <LINK REF="STD-Rennels-1987" TYPE="STUDY">Rennels 1987</LINK>, <LINK REF="STD-Santosham-1991a" TYPE="STUDY">Santosham 1991a</LINK>, <LINK REF="STD-Santosham-1991b" TYPE="STUDY">Santosham 1991b</LINK> <LINK REF="STD-Vesikari-1990" TYPE="STUDY">Vesikari 1990</LINK>, <LINK REF="STD-Wright-1987" TYPE="STUDY">Wright 1987</LINK>, <LINK REF="STD-Wright-1991" TYPE="STUDY">Wright 1991</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10^3 to 10^5 PFU</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RRV-TV: live attenuated rhesus tetravalent</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bernstein-1995" TYPE="STUDY">Bernstein 1995</LINK>, <LINK REF="STD-Dagan-1992" TYPE="STUDY">Dagan 1992</LINK> <LINK REF="STD-Dennehy-1996" TYPE="STUDY">Dennehy 1996</LINK> <LINK REF="STD-Escobar-1988" TYPE="STUDY">Escobar 1988</LINK>,<LINK REF="STD-Flores-1990" TYPE="STUDY">Flores 1990</LINK> <LINK REF="STD-Flores-1993" TYPE="STUDY">Flores 1993</LINK>, <LINK REF="STD-Ing-1991" TYPE="STUDY">Ing 1991</LINK>, <LINK REF="STD-Joensuu-1997" TYPE="STUDY">Joensuu 1997</LINK>, <LINK REF="STD-Lanata-1996a" TYPE="STUDY">Lanata 1996a</LINK> <LINK REF="STD-Lanata-1996b" TYPE="STUDY">Lanata 1996b</LINK> <LINK REF="STD-Linhares-1996" TYPE="STUDY">Linhares 1996</LINK>, <LINK REF="STD-Perez_x002d_Schael-1997" TYPE="STUDY">Perez-Schael 1997</LINK>, <LINK REF="STD-Pichichero-1993" TYPE="STUDY">Pichichero 1993</LINK>, <LINK REF="STD-Rennels-1995" TYPE="STUDY">Rennels 1995</LINK>, <LINK REF="STD-Rennels-1996" TYPE="STUDY">Rennels 1996</LINK>, <LINK REF="STD-Santosham-1997" TYPE="STUDY">Santosham 1997</LINK>, <LINK REF="STD-Vesikari-1999" TYPE="STUDY">Vesikari 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 x 10^4 to 4 x 10^6 PFU</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>HRV 89-12: live attenuated human</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bernstein-1998" TYPE="STUDY">Bernstein 1998</LINK> <LINK REF="STD-Bernstein-1999" TYPE="STUDY">Bernstein 1999</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10^4 to 10^5 PFU</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>QHBRV: live attenuated human-bovine quadrivalent or pentavalent</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Clark-1995" TYPE="STUDY">Clark 1995</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 x 10^7 PFU</P>
</TD>
</TR>
</TABLE>
<P>PFU: plaque-forming units.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2008-11-09 14:54:11 +0000" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2008-11-09 14:54:03 +0000" MODIFIED_BY="[Empty name]">Exploration of heterogeneity: different rotavirus vaccines</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-09 14:54:11 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="7" ROWS="22">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Outcome</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Vaccine</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>No. trials</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>No. participants</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>RR (95% CI)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>NNT (95% CI)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Analysis</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="8" VALIGN="TOP">
<P>Rotavirus diarrhoea: episodes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Rhesus tetravalent (RRV-TV)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11,590</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.58 (0.47 to 0.72)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>19 (15 to 25)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Rhesus monovalent (RRV, RRV-D, RRV-DS1, or RRV-ST3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1715</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.60 (0.46 to 0.78)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 (9 to 22)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine (RIT-4237)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3663</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.65 (0.48 to 0.86)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine (WC3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>782</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.77 (0.46 to 1.28)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine-human (W179-9)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>433</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.33 (0.19 to 0.56)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 (5 to 12)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine-human (WC3-QV)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>405</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.33 (0.19 to 0.58)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 (5 to 13)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Human (89-12)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2201</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.32 (0.23 to 0.45)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 (8 to 15)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Human (M37)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>281</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.01 (0.45 to 2.25)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="7" VALIGN="TOP">
<P>Rotavirus diarrhoea: severe episodes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Rhesus tetravalent (RRV-TV)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9569</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.40 (0.28 to 0.57)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18 (15 to 22)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Rhesus monovalent (RRV-MMU 18006)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1037</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.52 (0.27 to 0.97)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>23 (13 to 72)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine (RIT-4237)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2131</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.38 (0.19 to 0.79)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24 (16 to 53)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine (WC3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>782</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.57 (0.29 to 1.12)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 (8 to 37)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine-human (W179-9)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>325</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.14 (0.05 to 0.42)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine-human (QHBRV)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>405</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.31 (0.16 to 0.62)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Human (89-12)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2201</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.21 (0.13 to 0.35)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 (10 to 20)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>All-cause diarrhoea: episodes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Rhesus tetravalent (RRV-TV)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6561</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.89 (0.84 to 0.93)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 (10 to 17)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Rhesus monovalent (RRV or RRV-D or RRV-DS1 or RRV-ST3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1145</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.82 (0.69 to 0.98)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 (5 to 13)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine (RIT-4237)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2772</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.82 (0.67 to 1.01)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 (10 to 35)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine (WC3)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>104</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.48 (0.28 to 84)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bovine-human (W179-9)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>433</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.60 (0.50 to 0.72)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 (3 to 7)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Human (M37)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>281</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.91 (0.57 to 1.44)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>
</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>